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Abstract 
The purpose of this study was to estimate the worst-case dose commitments and potential 
consequences of accidental releases at nuclear risk sites in the Russian Far East. The nuclear 
risk sites of concern are near Petropavlovsk (52°55'N & 158°30'E) and Vladivostok (42°55'N & 
132°25'E). The region of interest includes the territories of the Russian Far East, China, Japan, 
North and South Korea, State of Alaska, the Aleutian Islands, Mongolia, Burma, Hong Kong, 
Laos, Taiwan, Thailand, and Vietnam. The transboundary region (i.e., that outside of Russia) is 
of primary interest because the largest doses resulting from hypothetical releases from these 
sites would reside in Russia and would be examined using site specific information and detailed 
models that were unavailable for this study. However, the transboundary region can be 
examined, in general, using existing information and models. The methodology from the United 
Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 1993 Report 
was used in this study to estimate effective dose commitments. It is recognized that this 
methodology is not the only acceptable manner to estimate such doses; the methodology was 
selected because it is independent, defensible, and, because it is based upon a multiplicative 
model, lends itself to a facile examination of parameter variation. 
The research tool used to generate the deposition data used as the basis of this study was a long-
range transport model—the Danish Emergency Response Model of the Atmosphere 
(DERMA)—which was used to simulate the 5-d atmospheric transport, dispersion and 
deposition of Cs-137 for a one-day release at a rate of 1010 Bq s-1 for a total “unit hypothetical 
release” of 8.64x1014 Bq. The meteorological data from the European Center for Medium-
Range Weather Forecasts (ECMWF, Reading, UK) based on the ECMWF global model forecast 
and analysis were used as input data for the model simulation. Using the DERMA model, the 
total Cs-137 depositions (i.e., sums of pertinent dry and wet deposition values) were computed 
for over 90% of the days in calendar year 2000. The necessary meteorological data was missing 
for the remaining days. 
In this report, Sr-90 and I-131 were radionuclides that might also have been of concern 
depending upon the conditions of the study. However, because of a lack of time and resources, 
the deposition values were not computed for these radionuclides for all calendar year 2000 days. 
There were Sr-90 and I-131 concentration and deposition data provided for selected days that 
were considered representative of the variation of the climactic conditions for the region for the 
year 2000. These data were used to generate simple, linear relationships between the 
unavailable Sr-90 and I-131 concentration and deposition data and the corresponding Cs-137 
data. These relationships were found to be sufficiently accurate for the general examination 
undertaken in this report and were used to generate the necessary, unavailable data. From an 
examination of the appropriate source term information and deposition to dose transfer factors 
from both the UNSCEAR 1993 Report and the worst-case scenario, Cs-137 was determined to 
be the radionuclide of primary concern for this study. The Cs-137 deposition-to-dose transfer 
factor was dominated by the external exposure (to ground deposition) pathway. 
For the Petropavlovsk nuclear risk site, the maximum Cs-137 total deposition (located in 
Russia) translated into a worst-case maximum effective dose commitment of 108 mSv per 
person for the maximum exposed individual (i.e., teen). For the transboundary region (i.e., that 
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area outside of Russia), the maximum effective dose commitment was 5.0 mSv per teen. This 
maximum value was located in the State of Alaska; the maximum effective dose commitment 
for the Aleutian Islands was 3.3 mSv per teen. The maximum effective dose commitments in the 
effected U.S. territories were generally three to four times higher than those in Japan, the 
transboundary country with the next highest maximum dose commitments resulting from 
accidental releases from the Petropavlovsk risk site.  
For the Vladivostok nuclear risk site, the maximum Cs-137 total deposition (located again in 
Russia) translated into a worst-case maximum effective dose commitment of 102 mSv per teen. 
For the transboundary region, the maximum effective dose commitment for Cs-137 was 27 mSv 
per teen. These maximum values were located in China, which is proximate to the Vladivostok 
site. The maximum effective dose commitments for Japan and N. Korea are approximately the 
same (i.e., within a factor of two) as that for China. Note that the maximum effective dose 
commitments in the U.S. territories are generally more than a factor of 60 lower than those in 
China, the transboundary country with the highest maximum dose commitments resulting from 
accidental releases from the Vladivostok risk site. 
The maximum worst-case dose commitments corresponding to the potential Petropavlovsk and 
Vladivostok releases for both the regional and transboundary conditions were also compared to 
various annual reference levels (i.e., 0.15, 1.0, 10, and 100 mSv per person) discussed in the 
International Commission on Radiological Protection (ICRP) 82 Report pertaining to practices 
and interventions and the annual background radiation dose (i.e., 2.4 mSv per person) provided 
in the UNSCEAR 1993 Report. These comparisons were conservative because the effective 
dose commitments computed in this report are being compared to annual reference values and 
background doses. The worst-case maximum dose commitments from the Petropavlovsk site for 
the transboundary region on over 99% of all year 2000 days studied are less than the average 
annual background radiation dose. For the Vladivostok releases, the worst-case maximum dose 
commitments are less than the average annual background radiation dose for more than 44% of 
all year 2000 days studied. Furthermore, the maximum dose commitments corresponding to the 
Vladivostok releases for more than 90% of the year 2000 days studied are less than the annual 
10 mSv per person level in which interventions are rarely justified and are all less than the 
annual 100 mSv per person level in which interventions are almost always justifiable according 
to ICRP 82. Therefore, the impacts from the adjusted Vladivostok releases would be, in general, 
more significant than those from Petropavlovsk (even though the Petropavlovsk releases 
translate into the maximum, worst-case dose commitment). The more significant impacts of the 
potential Vladivostok releases were compounded by the fact that many more people were 
impacted than from the corresponding hypothetical Petropavlovsk releases. However, the dose 
commitments from the potential Vladivostok releases could be considered negligible when 
compared to the 10 mSv per person level in which interventions are rarely justified. 
The maximum collective dose commitments corresponding to the worst-case dose commitments 
were also computed. The results indicate that even though the maximum effective dose 
commitments from the Petropavlovsk and Vladivostok releases were similar, the larger 
populations impacted by the Vladivostok releases generally resulted in significantly larger 
collective dose commitments and thus potential mortalities than those for the Petropavlovsk 
releases. For example, the maximum number of additional mortalities on a regional basis 
resulting from the worst-case Petropavlovsk scenario would be 355 with as many as 329 in 
Japan, 83 in China, 18 in the State of Alaska, and 10 in S. Korea. However, for the Vladivostok 
releases, there could be as many as 9771 additional mortalities on a regional basis, and the 
additional mortalities for Japan, China, N. Korea, S. Korea, Russia, and Taiwan would be 9501, 
8575, 2485, 2436, 1614, and 318, respectively. The U.S. territories and Hong Kong might have 
an additional two mortalities each. However, even though these mortality numbers may appear 
large, it should be noted that none of the transboundary values exceed 9 mortalities per 100 000 
persons, which is found in N. Korea resulting from the worst-case Vladivostok scenario.  
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Because the aggregation of doses over large areas is contrary to the recommendation of the 
ICRP, a series of threshold values were imposed on the worst-case results to determine whether 
the conclusions would change dramatically. The impact on the maximum worst-case collective 
dose commitments for the Petropavlovsk releases would be significant. For example, if a 
threshold of 1 mSv per person is imposed on the collective dose computation, then the collective 
dose commitment for all transboundary areas except for the U.S. territories falls to zero (and 
this includes Japan, which had the largest collective dose commitment). However, the impact of 
imposing such thresholds on the collective dose commitments from the Vladivostok releases 
was much less profound than that for the corresponding Petropavlovsk dose commitments; in 
fact, the imposition of thresholds up to 1 mSv per person had little impact on the collective dose 
commitments for most countries in the region of interest. Even though the impact on the 
collective doses related to the Vladivostok releases was small, it remains true that the worst-case 
impacts of the effective dose commitments for the releases from both the Vladivostok and 
Petropavlovsk sites were negligible when compared to metrics such as the average annual 
background dose and other causes of death in the affected countries. 
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1 Introduction 
Beginning in the year 2000, the Radiation Safety of the Biosphere (RAD) Project of the International 
Institute for Applied Systems Analysis (IIASA) initiated a study entitled: “Assessment of Impact of 
Russian Nuclear Fleet Operations on Russian Far East Coastal Regions” Study (FARECS). In that 
year, research activities concentrated on gathering available information, evaluating these data, and 
performing preliminary analyses. In 2001, the focus shifted to the analysis, from the probabilistic point 
of view, of potential danger to the environment and population in countries neighboring Russia due to 
atmospheric transport [1]. Two nuclear risk sites (NRS) of concern were selected–Petropavlovsk 
(52°55’N & 158°30’E) and Vladivostok (42°55’N & 132°25’E) NRS, which will be referred to as 
PRS and VRS, respectively—both located in the Russian Far East (as illustrated in Figure 1). From 
Figure 1, it should be noted that the following countries (or parts thereof) are within the region of 
interest:  Burma  China  Hong Kong  Japan  Laos  Mongolia  North Korea
 Russia  South Korea  Taiwan  Thailand  Aleutian Islands (U.S.)  State of Alaska (U.S.)  Vietnam 
 
The Aleutian Islands will be considered separately from the remainder of the effected U.S. territories 
in this study to assure that the islands’ proximity to the NRS do not overly bias the results. Each of the 
countries (or parts thereof) will be considered during the analysis. The transboundary region (i.e., 
those areas outside of Russia) will also be examined to examine the impact of release outside of 
Russia because those within Russia would likely be analyzed using site-specific information and 
models. 
Beginning in 2002, the focus of study was a probabilistic analysis of atmospheric transport and 
deposition patterns (employing the methodology described in [2,3,4,5]) to meld the results of 
atmospheric transport and dispersion modeling. The purpose of this study is to examine potential 
consequences of accidental releases at these sites via radiological dose estimation using deposition 
results provided from the previous studies [6] on the people in the region described above. 
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Figure 1. This figure represents the region of interest for this study. Both the Petropavlovsk (PRS) and 
Vladivostok (VRS) Nuclear Risk Sites are shown. The inset illustrates the lower left-hand 
corner of this region where the countries of Burma, Thailand, Laos, and Vietnam are located. A 
larger version of this figure is available as Figure A 1 in Appendix A. 
1.1 Population Information Used in this Study 
Estimation of the dose commitment for a population in a given area impacted by a release from one of 
the NRS examined in this study requires an estimate of the population for that given area. Because the 
deposition information [6] was on the basis of a 0.5 by 0.5 degree grid (or 2 cells per degree) covering 
the area illustrated in Figure 1, it would be convenient if either the population information was 
available on the same “gridded” basis or if available information could be easily converted to the 
desired 0.5 by 0.5 degree basis. Fortunately a “gridded” representation of the world’s population as of 
1995 is available [7] on the Internet on a 0.083 by 0.083 degree (or 12 cells per degree) basis.  
The population data was downloaded as a text file and loaded into MatLab [8]. A contour plot of the 
original data over the region of interest is provided in Figure 2a. MatLab® routines were then used to 
sum each 6 by 6 set of cells into a single cell to produce a matrix of the same dimensions representing 
the same geographic region as the original data [6]. The corresponding contour plot of the resulting 0.5 
by 0.5 degree population data is shown in Figure 2b. It should also be noted that the total population 
for the matrices illustrated in Figure 2 both total 1.484x109 people.1 The 2 cells per degree (or 0.5 by 
0.5 degree) population data matrix thus obtained (as illustrated in Figure 2b) is used for all 
calculations in this memorandum. No attempt was made to forecast population changes since 1995 
because there are just too many variables that are unknown; it is suggested that the variations 
introduced below in the parametric study will cover these population changes.  
                                                     
1 The maximum population in any cell are 1.286x106 and 1.192x107 people for the 12 cells per degree and 2 
cells per degree grids, respectively. The contours for Figure 2a and Figure 2b are at 8572 and 158 944 
persons each, respectively.  
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(a) Original data (12 cells per degree) 
Contours every 8572 people 
(b) Converted data (2 cells per degree) 
Contours every 158 944 people 
Figure 2. The above figures illustrate contour plots of the “gridded” population data used in this study. 
The original GPW data [7] are illustrated on the left (a) and the data converted to a 2 cells per 
degree grid are illustrated on the right (b).  Larger views of Figure 2(a) and Figure 2(b) are 
provided in Appendix A as Figure A 2 and Figure A 3, respectively. 
 
2 Deposition Data Analysis 
Some description of the deposition data used as input to this study must be provided to make sense of 
the resulting dose estimates. The research tool used to generate the deposition results used in this study 
is a dispersion model. The Danish Meteorological Institute (DMI) long-range transport model – the 
Danish Emergency Response Model of the Atmosphere DERMA [9,10]—was employed to simulate 
5-day atmospheric transport, dispersion, and deposition of Cs-137 for a series of one-day “unit 
hypothetical releases” (at the rate of 1010 Bq s-1 for a total release of (24 h d-1)(3600 s h-1)(1010 Bq s-1) 
= 8.64x1014 Bq). Only the releases for Cs-137 were simulated for a single calendar year, 2000, to save 
computational resources. (It was recognized that a multi-year approach would have provided better 
data for statistical analysis; however, such a study was impracticable for the resources available [6]). 
The “unit hypothetical release” of 1010 Bq s-1 resulting in a total release over a 24-h period of 
8.64x1014 Bq selected for the original data [6] is comparable to the radioactivity (i.e., 8x1014 Bq) of 
Cs-137 and Sr-90 in the spent nuclear fuels (in both reactors) at two years after the shutdown of a 
Russian nuclear submarine [11]. Thus it appears that any likely accident involving such a submarine 
would likely release significantly less activity to the atmosphere than considered in this study. The 
“unit hypothetical release” appears, therefore, a conservative one. How the “hypothetical unit release” 
compares to conceivable accident scenarios will be discussed in detail in the section concerning 
parameter variation below. 
The meteorological data from the European Center for Medium-Range Weather Forecasts (ECMWF, 
Reading, UK) based on the ECMWF global model forecast and analysis were used as input data for 
the model simulation. Using the DERMA model, several important metrics were calculated for the 
region illustrated in Figure 1: 
1) air concentration (Bq m-3) of the radionuclide in the surface layer (surface air),  
2) integrated in time air concentration (Bq h m-3) of the radionuclide in the surface layer (integral 
concentration at surface or integrated concentration)  
3) dry deposition (ddep) in Bq m-2 of the radionuclide on the underlying ground surface (dry 
deposition), and  
4) wet deposition (wdep) in Bq m-2 of the radionuclide on the underlying ground surface (wet 
deposition). 
 4 
The assumptions used in this study are discussed in Reference 6. Thus, for each initial day of release 
for each site, there are approximately 804 000 results for each of the four metrics listed above to 
examine for this study.2  
Using the wet and dry deposition and integrated concentration data [6], the maximum dry, wet, and 
total depositions as well as integrated concentrations were computed (by day after release3) for each 
initial day of release for CY2000 having complete (i.e., 24x6 hours = 144 hours of) recorded data. 
These are the data from which the doses will be estimated. The results are discussed below. 
2.1 Petropavlovsk Risk Site (PRS) 
For the PRS releases, no depositions for the time periods (of up to six days after initial release) 
considered were found for the following countries: 
 Burma  Hong Kong  Laos 
 Taiwan  Thailand  Vietnam 
 
for any day of CY2000. For the countries in which depositions were found resulting from the 
hypothetical “unit release” from the PRS of (24 h d-1)(3600 s h-1)(1010 Bq s-1) = 8.64x1014 Bq, the 
maximum such release and other pertinent information are presented in Table 2 through Table 5 for 
Cs-137, which is the only radionuclide for which data are provided [6] for all available days of 
CY2000. The regional information is also presented. The maximum (non-zero) total deposition (tdep) 
values for Cs-137 from the PRS for CY2000 are provided in Exhibit 1. 
Exhibit 1. Summary of Maximum Non-Zero Cs-137 Total Deposition (tdep) Values for the PRS Releases 
 
 
Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
Cell 
Area* 
(m
2
) 
 
 
Population
Regional 21-Mar 2.78E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 2.20E+04 52.50 159.00 65 1.89E+09 N/A
China 05-Jan 1.95E+02 52.50 126.00 2169 1.89E+09 7721
Japan 26-Apr 2.76E+02 43.50 142.50 1581 2.25E+09 155 808
Mongolia 04-Jan 1.09E+01 46.50 119.50 2855 2.13E+09 1835
N. Korea 07-Jan 5.42E+01 43.00 130.00 2372 2.26E+09 175 327
Russia 21-Mar 2.78E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 4.09E+00 37.50 126.50 3001 2.45E+09 2 006 368
                                                     
2  The geographical region in Figure 1 was divided into a grid representing two cells per degree. Thus there 
were 241 columns by 139 rows of cells representing the geographical region of interest (20°N & 100°E to 
90°N & 140°W). For each day of CY2000, the surface air concentration and integrated concentration as well 
as wet and dry depositions were computed every three hours [6] after the initial release; the total release 
lasted for 24 hours (with one release of 3600x1010 Bq every hour). The resulting data were then resampled 
every six hours after the initial release (up to a period of six days after the initial and five days after the final 
release) as input to this study. Thus the data set to be examined for each site on a given initial release date of 
CY2000 consisted of a file containing 241 columns by 139 rows by 24 records (i.e., 6 days by 24 hours per 
day = 144 hours by 1 record every six hours = 24 records) for a total of 803 976 results. 
3  It was decided to examine the available data on a daily basis instead of the monthly or seasonal basis used by 
Mahura [6] to capture as much of the variation in the data as possible. This appears appropriate when one is 
searching for maximum doses. 
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Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
Cell 
Area* 
(m
2
) 
 
 
Population
Aleutian Islands (U.S.) 24-Jan 8.56E+02 52.50 185.50 1807 1.89E+09 63
Alaska (U.S.) 18-Feb 1.28E+03 58.50 198.00 2507 1.62E+09 22
 
* Distance and Cell Area represent the distance from the risk site to the maximum total deposition and 
area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia. For this case, the 
maximum transboundary deposition was found in the ocean. 
 
Because the deposition and integrated concentration information for Sr-90 and I-131 was not available 
for all days of CY2000 [6], it was initially determined whether reasonable estimates of these 
parameters could be made from the available Cs-137 information. The simplest approach was to 
determine whether there were definitive relationships between the unknown Sr-90 and I-131 values 
and those for the Cs-137 data. To do this, the Cs-137, Sr-90, and I-131 data [6] for releases from five 
specific days (i.e., the “specific case studies” for 05-Apr-2000, 26-Apr-2000, 05-Aug-2000, 
10-Aug-2000, and 15-Nov-2000) were examined. These data are considered representative of the 
variation of the climactic conditions for the region for CY2000 [6]. These days were selected based 
upon the: 
1) main direction of atmospheric transport, 
2) possibility of precipitation during atmospheric transport, 
3) relatively short travel time of the radioactive cloud from a given NRS location toward the 
region of interest, 
4) relatively large coverage of the region of interest by the radioactive cloud during atmospheric 
transport, and 
5) boundary layer height, which influences the stable boundary layer and velocity of atmospheric 
transport. 
The simplest relationship between Sr-90 or I-131 and Cs-137 is a linear one. To see if such a 
relationship is reasonable for the data from the five chosen days, pair-wise correlations were computed 
using S-Plus, which is an application specially created for exploratory data analysis and statistics [12]. 
That is, if the pair-wise correlation between two parameters is unity, then a unique, linear relationship 
exists between them. The S-Plus results for the I-131 (for every day or 24-h period after initial release) 
versus Cs-137 (for every 6-h period after initial release) for dry deposition (on a Bq m-2 or “raw” 
basis) for the PRS are provided in Table 1. Note that the largest pair-wise correlations between the 
I-131 (at the desired or td time period in hours) and Cs-137 data primarily exist at the 42-h time period 
for Cs-137; the only exception is the I-131 24-h values, which are the largest using the Cs-137 values 
at the 24-h period. The results for all other I-131 data were similar; those for the Sr-90 versus Cs-137 
manifested even higher pair-wise correlations. Therefore, it was decided to use simple, linear 
relationships to estimate the Sr-90 and I-131 deposition data from existing Cs-137 information.  
The Sr-90 and I-131 values were predicted from the corresponding Cs-137 information (i.e., wdep or 
wet deposition, ddep or dry deposition, and integrated concentration) using the least-squares 
parameter, Aj,td, from the linear regression of the non-zero
4 data for the five specific release dates in 
relationships of the form:  
 
Equation 1 ( ) ( )pjtd,jdj t137CsAtX =  
 
where Xj(td) is the value of the parameter represented by j (i.e., j = wdep, ddep, or integrated 
concentration) at the desired time, td, and Cs137j(tp) is the value of the corresponding Cs-137 
parameter at either the same or previous time (or tp ≤ td) that provides the best least-squares fit.  
                                                     
4  Thus only those data with at least one value for I-131 or Sr-90 and the corresponding Cs-137 value for the 
same location and times were used in the regression analyses. 
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For example, the S-Plus [12] results for the PRS I-131 ddep data at td = 144 hours (or six days after 
initial release) versus the corresponding Cs-137 data at 42 hours are provided in Exhibit 3 below. The 
linear model was forced through the origin (i.e., no intercept) because there was no deposition at time 
zero. The breakdown of the contributions of data from the various days for the regression analysis 
presented in Exhibit 3 is provided in Exhibit 2. 
Exhibit 2.  Data Availability for Regression Analysis of Cs-137, Sr-90, and I-131  
Total Depositions as Presented in Exhibit 3. 
Release 
Date 
 
Count
Percentage
of Total 
5-Apr-00 12532 31.4%
26-Apr-00 5869 14.7%
5-Aug-00 8110 20.3%
10-Aug-00 4771 11.9%
15-Nov-00 8650 21.7%
Total 39932 100.0%
 
Note that in this case (as illustrated in Exhibit 2), the data from each of the five days are well 
represented; the data from no single release date dominate the regression analysis. This is also true of 
the other regression analyses. The results of the fit in Exhibit 3 are amongst the poorest in this study—
and these appear to represent the data reasonably well for the purpose of this study. In fact the simple, 
linear models used for I-131 describe more than 90% of the variation in the data. The Sr-90 
relationships appear especially strong, that is, over 99% of the variation is described by the simple, 
linear models employed likely because the deposition velocities used in the Mahura study for Sr-90 
and Cs-137 were very close [6]. Thus the results of the linear regression analyses were used without 
additional regard for prediction error or the like. The above analysis (as represented in Exhibit 3) was 
performed for both the Sr-90 and I-131 depositions and concentrations as functions of the 
corresponding Cs-137 information.  
 
Exhibit 3.  S-Plus Linear Regression Results for the PRS I-131 Dry Deposition (ddep) data at 144 hours 
versus the Cs-137 data at 42 hours. The necessary function call (i.e., lm(formula = …) and 
corresponding results for this case are provided in the right-hand side of the exhibit. Note that 
the relationship was forced through the origin using “… + (-1)” in the function call. 
Fitted : Cs137(042) + (-1)
I1
3
1
(1
4
4
)
0 1000 2000 3000 4000 5000 6000
0
1
0
0
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0
0
 
*** Linear Model *** 
 
Call: lm(formula = I131(144) ~ Cs137(042) + (-1), 
         data = I131.prs.ddepdata.144,  
         na.action = na.exclude) 
 
Residuals: 
   Min    1Q    Median   3Q  Max  
 -1209 0.000163 0.0342 0.87 1110 
 
Coefficients: 
             Value Std. Error t value Pr(>|t|)  
Cs137(042)   1.440   0.002    827.920   0.000  
 
Residual standard error: 25.4 on 39931 degrees of 
freedom 
 
Multiple R-Squared: 0.945  
 
F-statistic: 685000 on 1 and 39931 degrees of 
freedom, the p-value is 0  
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A summary of the fitted parameters (i.e., Aj,td and td values in hours after initial release) for I-131 and 
Sr-90 are provided in Table 6 and Table 7, respectively. In these tables, “Raw” indicates the original 
value in Bq m-2 [6] and “Frac” indicates the value as a fraction of the total release—or the “raw” value 
in Bq m-2 times the area impacted normalized by the total release of 8.64x1014 Bq.  The “Corr.” and 
“R2” represent the pair-wise correlation and multiple R2 value for the fit (representing how much of 
the variation in the data is accounted for by the fit), respectively. In the results listed below, only the 
raw (or Bq m-2) valued are used; however, the normalized values (in terms of fraction of the total 
released) could also have been used and are provided for completeness. 
Using the “Raw” parameters from Table 6 and Table 7, the corresponding Sr-90 deposition values are 
computed and the results provided in Table 8 through Table 11. The maximum (non-zero) total 
deposition (tdep) values computed for Sr-90 from the PRS Cs-137 results for CY2000 are illustrated in 
Exhibit 4. Note how closely these Sr-90 values correspond to their respective Cs-137 values.  
Exhibit 4. Summary of Maximum Non-Zero Sr-90 Total Deposition (tdep) Values for the PRS Releases 
 
 
Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m-2) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
 
Area* 
(m2) 
 
 
Population
Regional 21-Mar 2.86E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 2.30E+04 52.50 159.00 65 1.89E+09 N/A
China 05-Jan 1.93E+02 52.50 126.00 2169 1.89E+09 7721
Japan 26-Apr 3.19E+02 43.50 142.50 1581 2.25E+09 155 808
Mongolia 04-Jan 1.11E+01 46.50 119.50 2855 2.13E+09 1835
N. Korea 07-Jan 6.04E+01 43.00 130.00 2372 2.26E+09 175 327
Russia 21-Mar 2.86E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 2.14E+00 37.50 126.50 3001 2.45E+09 2 006 368
Aleutian Islands (U.S.) 24-Jan 8.51E+02 52.50 185.50 1807 1.89E+09 63
Alaska (U.S.) 18-Feb 1.36E+03 58.50 198.00 2507 1.62E+09 22
 
* Distance and Area represent the distance from the risk site to the maximum total deposition and area 
impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia. For this case, the 
maximum transboundary deposition was found in the ocean. 
 
Those computed for I-131 are provided in Table 12 through Table 15. Note that the maximum value in 
Table 13 for the general region is located in the ocean (i.e., with zero population) and thus does not 
reside in Russia as do the other regional maximum values. The maximum (non-zero) total deposition 
(tdep) values computed for I-131 from the PRS Cs-137 results for CY2000 are provided in Exhibit 5.  
Exhibit 5. Summary of Maximum Non-Zero I-131 Total Deposition (tdep) Values for the PRS Releases 
 
 
Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
 
Area* 
(m
2
) 
 
 
Population
Regional 12-Jun 4.65E+04 54.00 159.00 116 1.82E+09 1872
Transboundary** 07-Feb 3.09E+04 52.50 159.00 65 1.89E+09 N/A
China 04-Dec 6.19E-05 52.50 123.00 2365 1.89E+09 5976
Japan 03-Jan 3.83E+01 44.50 145.50 1338 2.21E+09 2136
Russia 12-Jun 4.65E+04 54.00 159.00 116 1.82E+09 1872
Aleutian Islands (U.S.) 18-Jan 5.06E+02 52.50 174.00 1043 1.89E+09 0
Alaska (U.S.) 20-Jan 3.41E+01 54.50 195.00 2379 1.80E+09 38
 
* Distance and Area represent the distance from the risk site to the maximum total deposition and area 
impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia. For this case, the 
maximum transboundary deposition was found in the ocean. 
 
 8 
Furthermore, the Cs-137 data from the PRS, the maximum values for wet, dry, and total deposition (as 
well as the integrated concentration) are less than 90 km from the risk site. (All distances and areas in 
this report are computed using commands from the MatLab [8] Mapping Toolbox.) The 144-h and 
48-h deposition maximum values are also provided to support the notion that the maximum values for 
Cs-137 are, in general, the same as those at the end of the time period considered and that most of the 
deposition has occurred in the first two days after the initial release.  
In terms of the total deposition (which is what matters most in this assessment), the maximum value of 
2.78x104 Bq m-2 for Cs-137 for the overall region (which resides in Russia) impacts “only” 
approximately 2000 people [7]5 (not that this impact would be insignificant to said 2000 people as it 
corresponds to an effective dose commitment of more than 4 mSv using the UNSCEAR 1993 Report 
methodology [13] described below). Figure 3 provides a histogram of the maximum total depositions 
for the overall region including Russia; note that 95% of the total depositions are less than 1.06x104 
Bq m-2. 
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Figure 3. Frequency histogram and cumulative percentages for the PRS Cs-137 total deposition (tdep) 
maximum values (left) and corresponding distances from source in km (right). 
 
Figure 4 illustrates the results for the transboundary (i.e., all areas, including the ocean, excluding 
Russia) depositions; note that the impact on the maximum values is small (because of the proximity of 
China to the PRS as illustrated in Figure 1). The transboundary region is important because it indicates 
the impact on countries (e.g., Japan, the United States, etc.) outside Russia where the releases may 
take place. Furthermore, it is likely that specialized models would be used for the areas near the risk 
sites; this study is more relevant for the areas outside Russia. 
 
                                                     
5  All population estimates are obtained using the “Gridded Population of the World (GPW)” database [7], 
which was converted from a 0.083 by 0.083 degree cell size to a 0.5 by 0.5 degree cell size to conform to the 
original data [6]. The conversion was performed using MatLab [8] to sum each 36 (i.e., 6x6) set of GPW 
cells into the corresponding cell for the data in this study. The population information will be covered in 
more detail below. 
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Figure 4. Transboundary frequency histogram and cumulative percentages for the PRS Cs-137 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km (right). 
 
The “large” populations (of over 2000 people) that are impacted by the maximum releases are in the 
countries of S. Korea, Japan, and N. Korea, and China (even though these depositions occur on 25% or 
fewer of the days considered). However, the most severely impacted countries (i.e., Alaska and the 
Aleutian Islands) in terms of the dose commitment are to the northeast of the PRS, or in the direction 
opposite to that of countries with large, impacted populations. The maximum total deposition for these 
countries (i.e., those with affected populations greater than 2000) ranges from 4.09 to 276 Bq m-2. It is, 
therefore, possible that significant maximum and collective doses may be experienced from the PRS 
releases because there are large populations impacted by relatively small dose commitments (or less 
than 0.042 mSv per person) and larger dose commitments (albeit only approximately 0.2 mSv per 
person [13]) impacting much smaller populations. A parameter variation study will be performed 
below to determine whether the “worst-case” maximum dose commitments are radiologically 
significant to the impacted populations. 
Finally, the Aleutian Islands were considered separately from the remainder of the United States 
territory (in the region of interest as indicated in Figure 1) to assure that any impact on the outlying 
islands would not bias the results of the analysis. It is interesting to note that the Cs-137 depositions 
from the PRS for the mainland United States territory are often larger than those for the Aleutian 
Islands, which are more proximate to the risk site. Not surprisingly (and to compound the impact), 
many more people are impacted on the mainland than on the Aleutian Islands. 
Because of the manner in which the results for the Sr-90 depositions are computed from the Cs-137 
results, the maximum values necessarily follow those for Cs-137. There are no results that differ 
significantly from those presented for Cs-137 above except that the maximum total deposition is 
2.86x104 Bq m-2 (which impacts, again, approximately 2000 persons with an effective dose 
commitment of 1.6 mSv [13]). Figure 5 provides a histogram of the maximum total Sr-90 depositions 
for the overall region; note that 95% of the total depositions are less than 1.27x104 Bq m-2.  The 
depositions for S. Korea, Japan, and N. Korea, and China range from 2.14 to 319 Bq m-2. Figure 6 
illustrates the maximum depositions for the transboundary conditions; again note the small impact on 
the maximum deposition. 
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Figure 5. Frequency histogram and cumulative percentages for the PRS Sr-90 total deposition (tdep) 
maximum values (left) and corresponding distances from source in km (right). 
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Figure 6. Transboundary frequency histogram and cumulative percentages for the PRS Sr-90 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km (right). 
 
However, the I-131 results do appear to be significantly different from those for Cs-137 (and thus 
Sr-90); these results are not surprising considering the differences in the deposition velocities6 used to 
produce the results (for the five specific days studied above) [6].  The maximum total I-131 deposition 
is 4.65x104 Bq m-2, which impacts almost 1900 people (in Russia) and is more than 60% higher than 
either the corresponding Cs-137 or Sr-90 depositions; however, the effective dose commitment using 
the UNSCEAR 1993 Report methodology [13] would be less than 0.18 mSv per person. This result 
appears reasonable because the I-131 deposition velocity used to generate the results is 3 to 4 times 
higher than that for either Sr-90 or Cs-137, respectively. Figure 7 provides a histogram of the 
maximum total I-131 depositions for the overall region; note that 95% of the total depositions are less 
than 2.33x104 Bq m-2. Figure 8 illustrates the distribution of the maximum I-131 depositions for the 
transboundary conditions; note again the small impact of this condition on the maximum deposition. 
This is again due to the proximity of China to the PRS as illustrated in Figure 1.  
 
                                                     
6  The deposition values given in Ref. 6 are 0.0015, 0.002, and 0.006 m s-1 for Cs-137, Sr-90, and I-131, 
respectively. 
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Figure 7. Frequency histogram and cumulative percentages for the PRS I-131 total deposition (tdep) 
maximum values (left) and corresponding distances from source in km (right). 
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Figure 8. Transboundary frequency histogram and cumulative percentages for the PRS I-131 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km (right). 
 
For I-131, an additional three countries (i.e., Mongolia, N. Korea, and S. Korea for a total of seven) 
are not predicted to have depositions during CY2000. Furthermore, those countries, with the exception 
of Russia, that have predicted depositions tend to have many fewer days during the year with 
depositions of I-131 (as illustrated in the appropriate N(%) columns in Table 12 through Table 15) 
than either Cs-137 or Sr-90. Furthermore, none of the maximum total depositions impact more than 
6000 people, which is in China where the maximum total deposition of 6.19x10-5 Bq m-2 is negligible 
because it translates into an effective dose commitment of 3x10-10 mSv per person (as indicated 
below). 
2.1.1 Specific Case Examples: Japan and U.S. Depositions from the PRS 
Because it is apparent that air masses from the Asian continent can move rapidly and only slightly 
diluted across the Pacific Ocean [14,15], it has been decided to examine these specific areas for 
possible impacts from the nuclear risk sites in this report. The importance of this examination is 
highlighted in Table 4, Table 10, and Table 14 by the fact that the maximum Cs-137, Sr-90, and I-131 
depositions, respectively, to any country other that Russia and China, which are both proximate to the 
nuclear risk sites, are to either Japan or the U.S. territories. Furthermore, because the Sr-90 depositions 
necessarily follow those for Cs-137 and the I-131 depositions are smaller and will have significantly 
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less impact on the transboundary region (which includes both Japan and the U.S.), it was decided to 
examine only Cs-137 for the specific examples. 
The histograms showing the Cs-137 depositions and distances from the PRS for Japan are provided in 
Figure 9. As indicated in Table 4, there are no depositions in Japan on approximately 75% of all 
CY2000 days. Furthermore, the maximum depositions will be less than 15 Bq m-2 on approximately 
95% of all CY2000 days. The maximum deposition of 276 Bq m-2 appears to be an isolated case. 
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Figure 9. Japan Results: Frequency histogram and cumulative percentages for the PRS Cs-137 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km (right). 
 
The histograms for the U.S. territory considered in this study are provided in Figure 10. Note that the 
depositions are normally about an order of magnitude higher than those in Japan (as illustrated in 
Figure 9). There is also a much higher frequency of deposition from the PRS for both Alaska in Figure 
10(a) and the Aleutian Islands in Figure 10(b) than in Japan. Again the maximum total depositions of 
1280 and 856 Bq m-2 for Alaska and the Aleutian Islands, respectively, appear to be isolated cases that 
occur within three weeks of each other early in the year (i.e., before 18-Feb-2000). As a point of 
comparison, the maximum deposition for Japan occurred in late April. This is not surprising 
considering the relative distances and orientations of these areas from the PRS as shown in Figure 1. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 10. U.S. Results: Frequency histogram and cumulative percentages for the PRS Cs-137 total 
deposition (tdep) maximum values for Alaska (left) and Aleutian Islands (right). 
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2.2 Vladivostok Risk Site (VRS) 
 
For releases from the VRS (which is shown in Figure 1), no depositions for the time periods (of up to 
six days after initial release) considered were found for the following countries:  Burma  Laos  Thailand 
For the countries in which depositions were found resulting from the hypothetical “unit release” from 
the VRS of (24 h d-1)(3600 s h-1)(1010 Bq s-1) = 8.64x1014 Bq, the maximum such release and other 
pertinent information are presented in Table 16 through Table 19 for Cs-137, which is the only 
radionuclide for which data are provided [6] for all days of CY2000. The regional information is also 
presented. The maximum (non-zero) total deposition (tdep) values for Cs-137 from the VRS for 
CY2000 are presented in Exhibit 6. 
Exhibit 6. Summary of Maximum (Non-Zero) Cs-137 Total Depositions (tdep) for the VRS Releases 
 
 
Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
 
Area* 
(m
2
) 
 
 
Population
Regional 02-Aug 2.64E+04 43.50 133.50 134 2.25E+09 34 008
Transboundary** 18-Nov 9.06E+03 42.00 133.50 166 2.30E+09 N/A
China 07-Jun 6.93E+03 43.50 131.50 69 2.25E+09 42 463
Hong Kong 12-Sep 5.57E+00 22.50 114.50 2794 2.85E+09 125 994
Japan 16-Dec 3.85E+03 40.50 141.00 796 2.35E+09 358 298
Mongolia 10-May 6.70E+01 47.00 120.00 1042 2.11E+09 33 341
N. Korea 20-Aug 4.26E+03 42.00 129.00 270 2.30E+09 200 822
Russia 02-Aug 2.64E+04 43.50 133.50 134 2.25E+09 34 008
S. Korea 11-Jan 1.03E+03 38.50 127.50 628 2.42E+09 292 252
Taiwan 29-Nov 1.91E+02 24.00 121.50 2322 2.82E+09 152 461
Aleutian Islands (U.S.) 23-Apr 5.86E+01 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 24-Mar 1.12E+02 60.00 210.00 5359 1.55E+09 1314
Vietnam 29-Nov 2.88E-06 20.50 107.00 3416 2.89E+09 13 869
 
* Distance and Area represent the distance from the risk site to the maximum total deposition and area 
impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  For this case, the 
maximum transboundary deposition was found in the ocean. 
 
The Sr-90 and I-131 data corresponding to that in Exhibit 6 from the VRS were estimated using 
simple relationships (i.e., of the form presented in Equation 1) derived from the Cs-137, Sr-90, and 
I-131 data [6] for releases from five specific days (i.e., 05-Apr-2000, 26-Apr-2000, 05-Aug-2000, 
10-Aug-2000, and 15-Nov-2000). The necessary fitted parameters for I-131 and Sr-90 are provided in 
Table 6 and Table 7. Using the appropriate parameters and Equation 1, the corresponding Sr-90 
deposition values are provided in Table 20 through Table 23. The maximum (non-zero) total 
deposition (tdep) values computed for Sr-90 from the VRS Cs-137 results for CY2000 are provided in 
Exhibit 7. 
Exhibit 7. Summary of Maximum (Non-Zero) Sr-90 Total Depositions (tdep) for the VRS Releases 
 
 
Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
 
Area* 
(m
2
) 
 
 
Population
Regional 02-Aug 3.26E+04 43.50 133.50 134 2.25E+09 34 008
Transboundary** 02-Aug 1.09E+04 42.50 133.50 135 2.28E+09 717
China 07-Jun 7.87E+03 43.50 131.50 69 2.25E+09 42 463
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Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
 
Area* 
(m
2
) 
 
 
Population
Hong Kong 29-Nov 2.26E-03 22.50 114.50 2794 2.85E+09 125 994
Japan 16-Dec 4.40E+03 40.50 141.00 796 2.35E+09 358 298
Mongolia 10-May 7.52E+01 47.00 120.00 1042 2.11E+09 33 341
N. Korea 20-Aug 5.16E+03 42.00 129.00 270 2.30E+09 200 822
Russia 02-Aug 3.26E+04 43.50 133.50 134 2.25E+09 34 008
S. Korea 11-Jan 1.19E+03 38.50 127.50 628 2.42E+09 292 252
Taiwan 29-Nov 2.17E+02 24.00 121.50 2322 2.82E+09 152 461
Aleutian Islands (U.S.) 23-Apr 6.05E+01 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 25-Mar 4.17E+01 58.50 202.50 4986 1.62E+09 15
Vietnam 29-Nov 4.41E-10 20.50 107.00 3416 2.89E+09 13 869
 
* Distance and Area represent the distance from the risk site to the maximum total deposition and area 
impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia. 
 
Note again how closely these Sr-90 values correspond to their respective Cs-137 values. Those 
computed for I-131 are provided in Table 24 through Table 27. The maximum (non-zero) total 
deposition (tdep) values computed for I-131 from the VRS Cs-137 results for CY2000 are presented in 
Exhibit 8. 
Exhibit 8. Summary of Maximum (Non-Zero) I-131 Total Depositions (tdep) for the VRS Releases 
 
 
Region 
 
CY2000 
Date 
Maximum
Deposition
(Bq m
-2
) 
 
 
Latitude
 
 
Longitude
 
Distance*
(km) 
 
Area* 
(m
2
) 
 
 
Population
Regional 12-Jun 5.28E+04 43.50 133.50 134 2.25E+09 34 008
Transboundary** 12-Jun 1.76E+04 42.50 133.50 135 2.28E+09 717
China 07-Jun 1.64E+04 43.50 131.50 69 2.25E+09 42 463
Japan 20-Nov 2.61E+03 36.00 138.00 933 2.50E+09 405 254
Mongolia 21-Apr 5.86E-04 47.00 120.00 1042 2.11E+09 33 341
N. Korea 20-Aug 9.86E+03 42.00 129.00 270 2.30E+09 200 822
Russia 12-Jun 5.28E+04 43.50 133.50 134 2.25E+09 34 008
S. Korea 11-Jan 1.14E+03 37.50 129.00 662 2.45E+09 155 901
Aleutian Islands (U.S.) 07-Mar 6.59E+00 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 14-Nov 5.36E-12 55.00 198.00 4801 1.78E+09 46
 
* Distance and Area represent the distance from the risk site to the maximum total deposition and area 
impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia. 
 
Note that for the Cs-137 data from the VRS, the maximum values for dry and total deposition (as well 
as the integrated concentration) are 134 km from the risk site, which are similar to the results 
mentioned above for the PRS. In terms of the total deposition (which is of primary importance in this 
assessment), the maximum value of 2.64x104 Bq m-2 for the overall region (which resides again in 
Russia and translates into an effective dose commitment of approximately 4 mSv per person using the 
UNSCEAR 1993 Report methodology [13]) impacts over 34 000 people, which is many more than for 
the releases from the PRS. Figure 11 provides a histogram of the maximum total depositions for the 
overall region; note that 95% of the maximum total depositions are less than 8850 Bq m-2. Figure 12 
illustrates the depositions for the transboundary (i.e., excluding Russia) conditions; note again the 
small impact (i.e., by approximately a factor of three lower) on the maximum deposition value. The 
appearance of the distance histogram in Figure 12 is explained by the fact that many of the maximum 
depositions described by this figure are found in the ocean around the VRS. This will not be the case 
when doses are computed below. 
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Figure 11. Frequency histogram and cumulative percentages for the VRS Cs-137 total deposition (tdep) 
maximum values (left) and corresponding distances from source in km (right). 
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Figure 12. Transboundary frequency histogram and cumulative percentages for the VRS Cs-137 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km 
(right). 
 
Also unlike the PRS, there are seven countries with maximum depositions of 5.6 to 6930 Bq m-2 from 
the VRS releases that impact between 33 000 and 358 000 people. Only the depositions for the 
Aleutian Islands, Alaska, and Vietnam impact significantly fewer (i.e., fewer than 14 000) people. 
Therefore, larger maximum individual and collective doses will be experienced from the VRS 
depositions than those from the PRS; these are evaluated below. 
Because of the manner in which the results for the Sr-90 depositions are computed from the Cs-137 
results, the maximum values necessarily follow those for Cs-137. There are no results that differ 
significantly from those presented for Cs-137 above except that the maximum total deposition is 
3.26x104 Bq m-2 (which impacts, again, more than 34 000 persons). Figure 13 provides a histogram of 
the maximum total Sr-90 depositions for the overall region; note that 95% of the total depositions are 
less than 1.09x104 Bq m-2.  The depositions for those countries (other than Russia) in which the 
maximum total deposition impacts over 30 000 people range from 2.26x10-3 to 7870 Bq m-2. Figure 14 
illustrates the distribution of maximum total depositions for transboundary conditions. Note again the 
small impact on the maximum deposition value. The appearance of the distance histogram is explained 
by the fact that many of the maximum depositions are found in the ocean around the VRS. 
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Figure 13.  Frequency histogram and cumulative percentages for the VRS Sr-90 total deposition (tdep) 
maximum values (left) and corresponding distances from source in km (right). 
 
0
10
20
30
40
50
60
70
80
90
3.
82
E+
01
1.
24
E+
03
2.
44
E+
03
3.
64
E+
03
4.
85
E+
03
6.
05
E+
03
7.
25
E+
03
8.
45
E+
03
9.
65
E+
03
M
or
e
F
r
e
q
u
e
n
c
y
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
Total deposition (Bq m-2)      
0
20
40
60
80
100
120
140
56 19
3
33
0
46
8
60
5
74
2
88
0
10
17
11
54
M
or
e
Distance from Source, km
F
re
q
u
e
n
cy
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
 
Figure 14. Transboundary frequency histogram and cumulative percentages for the VRS Sr-90 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km 
(right). 
 
However, the I-131 results are again significantly different from those for Cs-137 (and thus Sr-90).  
The maximum total I-131 deposition is 5.28x104 Bq m-2, which again impacts over 34 000 people (in 
Russia), but is more than 60% and 100% higher than either the corresponding Sr-90 or Cs-137 
deposition, respectively. This result appears reasonable because the I-131 deposition velocity used to 
generate these results is 3 to 4 times higher than that for either Sr-90 or Cs-137, respectively. 
However, the effective dose commitment for this deposition value is 0.25 mSv per person [13] or 
approximately two orders of magnitude lower than the corresponding maximum Cs-137 dose 
commitment. 
Figure 15 provides a histogram of the maximum total I-131 depositions for the overall region; note 
that 95% of the total depositions are less than 1.78x104 Bq m-2. Figure 16 illustrates the distribution of 
maximum total depositions for transboundary conditions. Note again the small impact on the 
maximum deposition value. The appearance of the distance histogram is explained by the fact that 
many of the maximum depositions are found in the ocean around the VRS. 
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Figure 15.  Frequency histogram and cumulative percentages for the VRS I-131 total deposition (tdep) 
maximum values (left) and corresponding distances from source in km (right). 
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Figure 16. Transboundary frequency histogram and cumulative percentages for the VRS I-131 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km 
(right). 
 
An additional three countries (i.e., Hong Kong, Taiwan, and Vietnam for a total of four) are predicted 
to not have I-131 depositions from the VRS releases for any day during CY2000. Furthermore, those 
countries, with the exception of Russia, that have predicted depositions tend to have many fewer days 
during the year with depositions of I-131 (as illustrated in the appropriate N(%) columns in Table 24 
through Table 27) than either Cs-137 or Sr-90. Furthermore, most of the maximum total depositions 
impact more than 33 000 people. Therefore, the VRS I-131 depositions impact many more people than 
those from the PRS; however, the dose commitments themselves were small in either case as 
illustrated above. 
2.2.1 Specific Case Examples: Japan and U.S. Depositions from the VRS 
The histograms showing the Cs-137 depositions and distances from the VRS for Japan are provided in 
Figure 17. As indicated in Table 18, the deposition frequency and magnitudes for the VRS are very 
different than those for the PRS releases. There are depositions on more than 96% of CY2000 days 
and the maximum deposition of 3850 Bq m-2 in December is well over an order of magnitude higher 
than that from the PRS. Also there are maximum depositions over 1000 Bq m-2 on approximately 10% 
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of all CY2000 days. Therefore the impact from the VRS on Japan is likely to be much more profound 
than that from the PRS. 
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Figure 17. Japan Results: Frequency histogram and cumulative percentages for the VRS Cs-137 total 
deposition (tdep) maximum values (left) and corresponding distances from source in km 
(right). 
 
The histograms for the U.S. territory considered in this study are provided in Figure 18. Note that the 
depositions are normally about an order of magnitude less than those in Japan (as illustrated in Figure 
17). There is also a much lower frequency of deposition from the VRS for both Alaska (in Figure 18a) 
and the Aleutian Islands (in Figure 18b) than in Japan. Again the maximum depositions of 112 and 59 
Bq m-2 for Alaska and the Aleutian Islands, respectively, appear to be isolated cases and occur within 
approximately one month of each other. The maximum deposition in Japan, on the other hand, 
occurred in December 2000. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 18. U.S. Results: Frequency histogram and cumulative percentages for the VRS Cs-137 total 
deposition (tdep) maximum values for Alaska (left) and the Aleutian Islands (right). 
 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 19
3 Dose Calculations 
The purpose of this study is to estimate doses for the deposition results provided by Mahura [6]. It was 
decided to estimate the effective dose commitments for both the maximum exposed individual (which 
will be described below) and adults corresponding to the depositions. The basis selected for the dose 
estimation methodology is that provided in the UNSCEAR 1993 Report [13]. It is recognized that this 
methodology is not the only acceptable manner in which to estimate such doses. The UNSCEAR 
methodology was selected because it is independent, defensible, and lends itself to a facile 
examination of variation (which will be described below). To wit [13], 
“Although the terminology was developed for evaluations of doses from 
radionuclides produced during atmospheric nuclear testing, the methodology is 
generally applicable to any source of release of radionuclides to the air or terrestrial 
environment.” [Italics are the author’s.] 
3.1 UNSCEAR Effective Dose Commitment Estimates 
In the UNSCEAR 1993 Report, the effective dose commitments for an adult individual were 
computed for Cs-137 and Sr-90 and that for an age-weighted individual was computed for I-131. The 
effective dose commitment is is the sum of the products of the weighting factors applicable to each of 
the body organs or tissues that are irradiated and the committed dose to these organs or tissues; the 
committed dose is the dose to organs or tissues of reference that will be received from an intake of 
radioactive material by an individual during the 50-year period following the intake (or a 70-year 
period for infants). The effective dose commitment, Dc, for a specific radionuclide due to an 
environmental input, A0, is given in the UNSCEAR 1993 Report by [13]: 
 
Equation 2 0
ground
external
2512
gamma
cloud
15
inhalation
4514
ingestion
4534231201c A]PPPPPPPPP[PD +++=  
 
where P01 is the integrated concentration of a radionuclide in the air
7 at a given location or averaged 
for a broader region divided by the amount released, A0; the other parameters will be defined in detail 
subsequently. The first term in the equation above relates deposition to dose via the ingestion pathway, 
the second term via the inhalation pathway, the third term accounts for direct (cloud gamma) 
irradiation from the nuclide in air, and the fourth term accounts for the component of external 
irradiation from the radionuclides deposited on the ground.  
A set of effective ingestion, inhalation, and external exposure transfer coefficients, each referred to as 
P25 in the UNSCEAR 1993 Report, from deposition to dose in units of nSv per Bq m
-2 was defined 
using average or nominal values of the appropriate input parameters. However, because the ways in 
which the P25 coefficients are derived differ from pathway to pathway, the individual deposition-to-
dose coefficients will be referred to using the nomenclature set forth in the 2000 UNSCEAR Report 
[16]. This will be described in detail below. Using the depositions [6] as summarized above, these 
transfer coefficients are then used to compute the 
1) corresponding maximum effective dose commitments to determine the potential impact of the 
releases relative to a number of reference levels (e.g., 0.15, 1.0, and 10.0 mSv per year8 
                                                     
7  Note that this equation involves the integrated air concentration even though the deposition data presented 
earlier involves deposition to ground. Each part of the equation relating deposition to dose will be translated 
below into the correct form incorporating the original deposition values [6]. 
8  “In respect of CERCLA, US EPA has proposed a 15 mrem [or 0.15 mSv] per annum dose limit, as compared 
with the international reference level of 100 mrem (1 mSv) and the proposed level of 1000 mrem (10 mSv) 
below which intervention is rarely justified.” [17] The same reference indicates that “… in practice, [1000 
mrem or] 10 mSv represents a more realistic generic reference level below which interventions are rarely 
justifiable and [10 000 mrem or] 100 mSv represents a more realistic generic level above which interventions 
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[17,18]) for practices and interventions9 [19] as well as to the average natural background 
radiation level of 2.4 mSv per year [13,16] and  
2) collective (or population) effective dose commitments for a series of hypothetical threshold 
values (i.e., 0 or no threshold, 0.1, 0.15, 1.0, and 10.0 mSv) to study the impact of such 
thresholds on collective dose commitments—this is not meant to support or refute the use of 
such thresholds, merely to examine their impact. The threshold levels used in this report were 
selected to be relatively small; they correspond to the conservative reference levels described 
above (because they will be applied to committed—not annual—doses).  
However, to illustrate the methodology, each transfer coefficient will be discussed briefly before the 
dose commitments are computed. 
3.1.1 UNSCEAR Ingestion Pathway 
As indicated in Equation 2, the UNSCEAR transfer coefficients for ingestion are computed using the 
following form:  
 
Equation 3 4534232345 PPPP ≡  
 
where P23 represents the transfer from deposition to diet, P34 links the concentrations of radionuclides 
in diet to those in the body, and P45 the concentrations in body to dose. Note that P12 represents the 
ground deposition and, therefore, the resulting P2345 coefficient is what is necessary to relate the 
ground deposition to dose.  The transfer, represented by the coefficient P23 in units of mBq a kg
-1 per 
Bq m-2 (where the “a” represents annum or year per the UNSCEAR 1993 Report), of Sr-90 and 
Cs-137 from deposition to diet was modeled using a three-component model considering transfer in 
the first year from mainly direct deposition, transfer in the second year from lagged use of stored foods 
and uptake from the surface deposits, and transfer via root uptake from the accumulated deposits. (The 
manner in which P23 values were obtained for I-131 will be discussed below.) The parameters 
provided in the UNSCEAR 1993 Report for Sr-90 and Cs-137 were obtained from regression analysis 
for data from Argentina, Denmark, and the United States; the fact that only the United States is from 
the region of interest will be discussed below in the section concerning sensitivities to parameter 
variation. The P23 ranges are provided in Table 28 (although the reason for differences for Sr-90 and 
Cs-137 is not readily apparent to the author even though it may have to do with fitting data from 
different regions of the U.S.).  
The UNSCEAR values for the P34 transfer coefficient, which relates the concentrations of 
radionuclides in the diet to those in the body, is, in effect, the consumption rate of the five food groups 
listed in Table 28. The fractional consumptions by weight provided in the report (based again upon 
Argentina, Denmark, and the United States) were used assuming an average food consumption rate of 
500 kg a-1 [13]. These values are provided in Table 29.  
The UNSCEAR P45 transfer coefficients represent the effective committed dose per unit intake for the 
ingestion of, in this case Sr-90 and Cs-137, and were given as 28 and 13 nSv Bq-1 [13,20], 
                                                                                                                                                                      
are almost always justifiable.” Note that because committed doses are estimated in this report, comparison to 
the above annual limits will be conservative. The ICRP also recommended permanent resettlement following 
an accident at an averted dose of 1000 mSv in a lifetime, corresponding to an average annual dose of 15-20 
mSv [18].  
9  The concepts of practices and interventions were introduced by the ICRP in Publication 60 [19], as “human 
activities [that] increase the overall exposure to radiation…” and “human activities [that] can decrease the 
overall exposure…”, respectively. “The clearest distinction between practices and interventions is the ability 
to choose a priori whether to accept beneficial sources and the consequent exposures. If a choice is still 
available, the exposure can usually be said to be due to a practice…. Subsequent steps to reduce the annual 
doses attributable to the practice are improvements in the practice and not necessarily an intervention. If there 
is no choice, because the sources already exist, any action taken to reduce exposures is an intervention.” [19] 
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respectively. The Sr-90 and Cs-137 P45 values represent the committed equivalent doses for a period 
of 50 years after intake for adults.  
Therefore, the UNSCEAR P2345 transfer coefficients for Cs-137 and Sr-90 can be obtained by 
multiplication of the appropriate parameters as indicated in Equation 3: 
( )( )( )
Csfor  m Bqper  nSv 55
Bq nSv 13a kg 500m Bqper  kg a Bq 10x4.8
PPPP
1372-
1-1-2-1-3
4534232345
==
= −  
( )( )( )
Srfor  m Bqper  nSv 50
Bq nSv 82a kg 500m Bqper  kg a Bq 10x6.3
PPPP
902-
1-1-2-1-3
4534232345
==
= −  
or upon separating the P23 and P34 coefficients into those for the individual food groups: 
Equation 4 
( )[ ]( )( )[ ( )( )( )( )( )( )( )( )]( )
Csfor  m Bqper  nSv 56
Bq nSv 13 kg 7.66m Bqper  kg a Bq 10x1.20   
 kg 1.77m Bqper  kg a Bq 10x3.3   
 kg 3.123m Bqper  kg a Bq 10x2.3   
 kg 3.38m Bqper  kg a Bq 10x7.15   
 kg 7.156m Bqper  kg a Bq 10x8.6
PPPP
1372-
1-1-2-1-3
1-2-1-3
1-2-1-3
1-2-1-3
1-2-1-3
45i342352345
= +
++
+=
Σ=
−
−
−
−
−
 
( )[ ]( )( )[ ( )( )( )( )( )( )( )( )]( )
rSfor  m Bqper  nSv 52
Bq nSv 82 kg 0.07m Bqper  kg a Bq 10x4.1   
 kg 0.57m Bqper  kg a Bq 10x8.1   
 kg 7.111m Bqper  kg a Bq 10x5.2   
 kg 0.58m Bqper  kg a Bq 10x1.9   
 kg 3.153m Bqper  kg a Bq 10x7.3
PPPP
902-
1-1-2-1-3
1-2-1-3
1-2-1-3
1-2-1-3
1-2-1-3
45i342352345
= +
++
+=
Σ=
−
−
−
−
−
 
where values of 55 and 52 nSv per Bq m-2 are provided in Reference 13 (and any differences are due 
to round-off errors). The above transfer factors can also be defined in terms of their percent 
contributions as illustrated in Table 30. 
3.1.2 I-131 Ingestion Pathway 
For I-131, only the milk pathway was assumed significant in the UNSCEAR 1993 Report (which 
appears a reasonable assumption). The P23 value used for I-131 is 0.63 mBq a L
-1 per Bq m-2 [21]. For 
an average milk consumption rate, P34, of 0.3 L d
-1 (or 109.5 L a-1), this would give a P234 = P23P34 
coefficient for I-131 of  
 
Equation 5 ( )( )[ ]( )
Ifor  m Bqper  Bq 07.0
a L 5.109mBqper  Bq 10m Bqper  L a mBq 63.0
PPP
1312-
1-3-2-1-
3423234
==
≡
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However, age-dependent factors were considered in the UNSCEAR 1993 Report. Milk consumption 
rates (i.e., age-specific P34 values) for age groups of 0-1 year, 1-9 years, 9-19 years, and adult were 
330, 180, 150, and 90 L a-1, respectively. However, the P34 parameter used in the UNSCEAR 1993 
Report to derive the P45 coefficient was the average, 109.5 L a
-1 [13]. This will be explained below.  
The population distribution for the same age groups was assumed to be 2, 16, 20, and 62%, 
respectively, in the UNSCEAR 1993 Report. (The potential differences in population distribution for 
the countries studied will be discussed during the parameter variation study below.) The individual P45 
coefficients for the same age groups were 210, 110, 29, and 22 nSv Bq-1, respectively, where the 0-1 
age group coefficient used in the UNSCEAR 1993 Report [13] was the average (i.e., 210 nSv Bq-1) of 
the values for 3 months (240 nSv Bq-1) and 1 year (180 nSv Bq-1) as given in Reference 20. The P2345 
computed from this information would, therefore, be: 
 
Equation 6 
( )( )( )( )( )[ ( )( )( )( )( )( )( )( )( ) ]
Ifor  m Bqper  nSv 2.4
adultsfor  Bq nSv 22a L 0962.0
years 19-9for  Bq nSv 92a L 50120.0
years 9-1for  Bq nSv 110a L 80116.0
year 1-0for  Bq nSv 210a L 33002.0m Bqper  L a Bq x1063.0
PpPPP
1312-
1-1-
1-1-
1-1-
1-1-2-1-3-
i4
4534232345
= +
++
=
= ∑
 
 
where pi is the fraction of the population in the specific age group. If an average milk consumption 
rate of 109.5 L a-1 is to be used (to obtained the same P25 value of 4.2 nSv per Bq m
-2 as above), then 
the necessary P45 value would be 60.7 nSv Bq
-1 [21], which is nominally the same as that, 61 nSv Bq-1, 
provided in the UNSCEAR 1993 Report. Thus the overall UNSCEAR P2345 coefficient for I-131 is 
given by: 
 
Equation 7 
( )( )( )
,Ifor  m Bqper  nSv 3.4
Bq nSv 61a L 5.109m Bqper  L a Bq 10x63.0PPPP
1312-
-1-1-2-13
4534232345 = ==
−
 
 
which agrees reasonably with the value of 4.2 nSv per Bq m-2 given in Reference 13. The above 
detailed calculations are provided because they are important when deriving new parameters in the 
parameter variation study below. An alternative development of this ingestion coefficient is also 
provided in Appendix B. 
3.1.3 UNSCEAR Inhalation Pathway 
Per the UNSCEAR 1993 Report [13], the transfer coefficient, P245, relating deposition to dose for the 
inhalation pathway is computed using the following information: 
 
Equation 8 
12
4514
245
451424512
P
PP
P
PPPP
=
=
 
 
where P14 is the average breathing rate (i.e., 7300 m
3 a-1 [13]), P45 is the appropriate dose per unit 
intake factor in nSv Bq-1 for an adult,10 and P12 is the deposition velocity (i.e., assumed to be 1.76 cm 
                                                     
10  The text on page 98 of the UNSCEAR 1993 Report [13], which indicates that the inhalation coefficients are 
in terms of nGy Bq-1, is in disagreement with the values provided in Table 7 in said report, which indicate 
that these coefficients are in terms of nSv Bq-1. The fact that the normal quality factor, which relates Gy to 
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s-1 or 5.56x105 m a-1 for all radionuclides [13]). Using the P45 values for inhalation of 8.5, 350, and 13 
nSv Bq-1 for Cs-137, Sr-90, and I-131, respectively, [13] Equation 8 provides the following transfer 
coefficients: 
 ( )( )( ) Csfor  m Bqper  nSv 11.0a m 10x56.5 Bq nSv 5.8a m 7300PPPP 1372-1-5 -1-13124514245 ===  ( )( )( ) Srfor  m Bqper  nSv 6.4a m 10x56.5 Bq nSv 503a m 7300PPPP 902-1-5 -1-13124514245 ===  ( )( )( ) Ifor  m Bqper  nSv 17.0a m 10x56.5 Bq nSv 31a m 7300PPPP 1312-1-5 -1-13124514245 ===  
 
which agree with the values in the UNSCEAR 1993 Report. Note that the UNSCEAR 1993 Report 
absorption assumptions for the inhalation pathway are Class D (days) for I-131 and Cs-137 and Class 
Y (years) for Sr-90. These classifications changed after the UNSCEAR 1993 Report was issued; 
however, the older nomenclature is used so it will be consistent with the information from the 1993 
Report. 
3.1.4 UNSCEAR External Irradiation 
In addition to internal radiation from inhaled or ingested radionuclides, people are also irradiated 
externally from gamma-emitting nuclides dispersed in air and on the ground. As the contamination 
normally spends much more time on the ground than in the air, the external dose due to irradiation 
from the earth’s surface is normally significantly higher11 than the dose due to irradiation while the 
cloud of contamination passes [13]. Therefore, the external exposure due to radioactive cloud passage 
will be assumed negligible for the purpose of this study (as it was in the UNSCEAR 1993 Report 
[13]).  
In the UNSCEAR 1993 Report [13], the P25 transfer coefficients for external irradiation due to ground 
contamination were computed by multiplying the appropriate exposure rate [22] by the mean lifetime 
of the radionuclide (i.e., half-life divided by ln(2)) and then by an average factor assuming 80% indoor 
occupancy with a shielding factor of 0.2. The latter factor also incorporates a factor of 0.7 Sv per Gy 
accounting for the equivalent dose rate in the body per unit absorbed dose rate in air [13]). For I-131, 
the dose rate conversion factor applying to an infinite plane source [22] is 7.30x10-3 mR h-1 per mCi 
km-2, which is converted to the units used in this report via:  
 
Equation 9 
( )( )( )( )( )( )( )( )( )
Ifor  m Bqper  snGy  10x8.4
kmper  m 1000Bqper  Ci 10x703.2x      
Ciper  mCi 1000s 60per  h 1Gyper nGy  10rad 100per  Gy 1x      
Rper  rad 876.0R 10per  R 1km mCiper  h R 10x30.7
1312-1-7
22211
1-29
6-2-13
−
−
−
=
µµ
 
 
                                                                                                                                                                      
Sv, is unity for the types of radiation involved means that these coefficients should be interchangeable for the 
radionuclides considered; however, this issue will arise below when external radiation is considered. 
11  “The average ratio of the absorbed dose from ground surface contamination to that from immersion is 
proportional to the half-life of the radionuclide and is, for example, of the order of 100 for short-lived 140Ba 
[with a half-life of 12.75 days] and 1,000,000 for long-lived 137Cs [with a half-life of 31.14 years] [13].” 
Thus the ratio will be somewhat less than 100 for the short-lived 131I, but still not likely to be significant. 
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where the value of 0.876 rad per R [23] is based upon 33.97 eV per ion pair12. Using the mean lifetime 
of I-131 (with half-life, t1/2, of 6.95x10
5 s [6]); indoor occupancy rate, Ri, of 80% (or 0.80 fraction); 
shielding factor, Sh, of 0.2; and conversion from nGy to nSv of 0.7 provides the following P25 transfer 
factor for I-131: 
 
Equation 10 
( )( ) ( ) ( )[ ]( )( ) ( ) ( ) ( )( )[ ]
Ifor  m Bqper  nSv 12.0
2.08.08.01s 
2ln
10x95.6
m Bqper  snGy  10x8.4nGyper  nSv 7.0
SRR1s 
2ln
t
m Bqper  snGy  10x8.4nGyper  nSv 7.0P
1312-
5
2-1-7
hii
2/12-1-7
25
=
+−=
+−=
−
−
 
 
which agrees with the value in the UNSCEAR 1993 Report [13]. No value was given for Sr-90 (likely 
because Sr-90 is a pure beta emitter). 
For Cs-137, the exposure rate of 4.32x10-3 mR h-1 per mCi km-2 applying to an exponential 
concentration profile in the ground with mean depth 3 cm was used13. This is converted to the units 
used in this report via: 
 
Equation 11 
( )( )( )( )( )( )( )( )( )
Csfor  m Bqper  snGy  10x84.2
kmper  m 1000Bqper  Ci 10x703.2x      
Ciper  mCi 1000s 60per  h 1Gyper nGy  10rad 100per  Gy 1x      
Rper  rad 876.0R 10per  R 1km mCiper  h R 10x32.4
1372-1-7
22211
1-29
6-2-13
−
−
−
=
µµ
 
 
Using the mean lifetime of Cs-137 (with half-life, t1/2, of 9.50x10
8 s [6]); indoor occupancy rate, Ri, of 
80% (or 0.80 fraction); shielding factor, Sh, of 0.2; and conversion from nGy to nSv of 0.7 provides 
the following P25 transfer factor for Cs-137: 
 
Equation 12 
( )( ) ( ) ( )[ ]( )( ) ( ) ( ) ( )( )[ ]
Csfor  m Bqper  nSv 98
2.08.08.01s 
2ln
10x50.9
m Bqper  snGy  10x84.2nGyper  nSv 7.0
SRR1s 
2ln
t
m Bqper  snGy  10x84.2nGyper  nSv 7.0P
1372-
5
2-1-7
hii
2/12-1-7
25
=
+−=
+−=
−
−
 
 
which agrees well with the value in the UNSCEAR 1993 Report of 97 nSv per Bq m-2. The above 
derivations are provided because they are necessary to derive new coefficients for the parameter 
variation study below. 
To summarize, the UNSCEAR values for the external exposure P25 coefficients for Cs-137, I-131, and 
Sr-90 were 97, 0.12, and 0 nSv per Bq m-2, respectively, which compare well to those computed in this 
report as a check on the methodology (and will subsequently be used to examine the sensitivity to 
variations in the various parameters used to compute the aforementioned values). Thus the deposition-
to-dose transfer coefficients needed to estimate dose commitments for the deposition values 
summarized in Table 4, Table 10, Table 14 for PRS and Table 18, Table 22, and Table 26 for the 
VRS. 
                                                     
12  In these calculations and the ones to follow, the small fraction of photon energy that is converted to electrons 
and then not absorbed due to bremmstrahlung production by electrons is assumed negligible. 
13  In Reference 22, the exposure rate for Cs-137 at a relaxation length of 4.8 g cm-2 in soil is given as 4.32x10-3 
mR h-1 per mCi km-2.  The soil density is not provided in Reference 13, thus it is assumed to be 1.6 g cm-3 
giving the corresponding exposure rate at a depth of 3 cm. 
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3.1.5 UNSCEAR Deposition-to-Dose Transfer Coefficient Summary 
The various transfer coefficients needed to translate from deposition to effective dose commitments 
are summarized in Table 31. The Cs-137 dose commitments are dominated by the external exposure 
pathway with a significant contribution from ingestion; the inhalation pathway plays little part in the 
dose commitment. For Sr-90 and I-131, the ingestion pathway dominates with little contribution from 
either inhalation or external exposure. 
3.2 UNSCEAR Maximum Effective Dose Commitment Estimates 
Using Equation 8 and the assumption that the irradiation due to cloud passage can be assumed 
negligible, Equation 2 can be rewritten as 
  
Equation 13 
( )
( ) ( ) ( ) ]PP/PPPPP[APP
]PPP[APPD
ground
external
25
inhalation
124514
ingestion
453423501201
ground
external
25
inhalation
245
ingestion
234501201c
++Σ=
++=
 
 
where the term, P01P12A0, in the parentheses is the total deposition of the radionuclide in question for a 
given area and each of the terms in the brackets represent the corresponding UNSCEAR deposition-to-
dose transfer factor identified above (where the ingestion pathway is limited to five food groups).  As 
an example of how to use these factors, the maximum total Cs-137 deposition for the PRS (on a 
regional basis) is given in Table 4 as 2.78x104 Bq m-2. To convert this deposition to dose, the 
UNSCEAR 1993 transfer factors for Cs-137 defined above can be used: 
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Thus for the PRS, the maximum dose commitment to an adult individual is approximately 4 mSv (or 
0.4 rem), which is less than twice the average annual background radiation dose (2.4 mSv) for the area 
under study [13]. The maximum total Cs-137 deposition for the VRS is 2.64x104 Bq m-2 from Table 
18. This translates into an effective, committed dose of 4.01 mSv (or 0.4 rem) per person using a 
computation similar to that provided in Equation 14. The proximity of these maximum values may be 
surprising; however, these maximum values are both found in Russia near the risk site, which explains 
why these values can be approximately the same. On the other hand, the maximum effective Cs-137 
dose commitment for the VRS transboundary area is approximately five times that for the PRS 
because the effected populations are at greater distances from the source of the release. 
Transboundary effects will also be considered below. Unlike those for the depositions above (where 
the ocean outside of Russia was examined), the transboundary dose commitments will only be 
computed for those areas on land. It makes little or no sense to compute a dose commitment from the 
ingestion pathway on areas of the ocean. Furthermore, even those ocean areas where fisherman may 
be impacted are excluded because there is little chance that the fishermen will spend enough time at 
sea to have the long-term dose commitments computed in this report. If desired, the depositions 
presented earlier can be used to examine the impact of acute doses of radiation; however, that is not 
the purpose of this study nor is it likely that the values determined in this report would lead to 
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significant acute doses. It is outside the scope of this report to examine the deposition on the oceans, 
uptake by fish, and subsequent doses to consumers; however, this could be done with the deposition 
values provided in this report. 
3.2.1 UNSCEAR Maximum Effective Dose Commitments for the PRS 
Using the transfer factors described above, the effective dose commitments for the maximum total 
depositions for Cs-137, Sr-90, and I-131 corresponding to the values in Table 4, Table 10, and Table 
14, respectively, were computed for the PRS. For Cs-137, Table 32 provides the total, maximum 
effective dose commitment for the region and each country as well as the components of the total by 
type (i.e., ingestion, inhalation, and external exposure).  
On the basis of individual countries, the maximum, non-zero dose commitments in Table 32 for 
Cs-137 releases from the PRS can be summarized by the following rank ordering: 
 
PRS Cs-137: Regional = Russia >> Alaska (U.S.) > Aleutians (U.S.) > Japan > China > N. Korea > Mongolia  
> S. Korea. 
 
In other words, the maximum dose commitment is found in Russia (as expected), which is almost two 
orders of magnitude higher than that for any country. However, despite its proximity to the PRS, 
China will be impacted by smaller doses than either the U.S. territories or Japan, which shows the 
importance of wind circulation patterns.  It can be noted that separating the Aleutian Islands from the 
remainder of the U.S. territory (namely Alaska) considered in this study had little impact on the 
results.  
Figure 19 illustrates the frequency and cumulative percentages for the Cs-137 maximum effective 
dose commitments for the land areas in the region of study. As described above, the maximum total 
Cs-137 deposition translates into a committed dose of approximately 4 mSv (or 0.4 rem) per person, 
which can be considered a reasonably low dose commitment. It should also be noted that 95% of the 
maximum dose commitments are less than 1.6 mSv (or 0.16 rem) per person, which indicates that 
most of the dose commitments are much less than the maximum (as illustrated in Figure 19). 
Furthermore, 85% of the maximum dose commitments are less than 0.94 mSv or 0.09 rem per person. 
Finally, almost 98% of all the maximum dose commitments for CY2000 are less than the average 
annual background radiation dose of 2.4 mSv [13], and the maximum UNSCEAR dose commitment of 
4.22 mSv is less than twice that from background radiation. Thus the maximum Cs-137 dose 
commitments from the PRS releases appear to be relatively low and within the variation expected in 
background radiation doses for the area under study [13].  
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Figure 19. Frequency histogram and cumulative percentages for the PRS Cs-137 maximum effective dose 
commitments (left) and corresponding populations (right). 
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Figure 20 illustrates the results for the transboundary conditions provided in Table 32. There is a 
significant impact on the maximum dose commitment (where the maximum transboundary dose 
commitment of 0.2 mSv per person in Alaska) is more than an order of magnitude less than that for 
Russia. It is also interesting to note that the numbers of people impacted by the transboundary doses 
appear to be much higher than that in Russia. However, the maximum transboundary dose 
commitment (of approximately 0.2 mSv) is negligible when compared to the annual average 
background radiation (of 2.4 mSv) in the area of study. 
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Figure 20. Transboundary frequency histogram and cumulative percentages for the PRS Cs-137 
maximum effective dose commitments (left) and corresponding populations (right). 
 
For the Sr-90 values computed from the PRS Cs-137 results as described above, Table 33 provides the 
total, maximum effective dose commitment for the region and each country as well as the components 
of the total by type (i.e., ingestion, inhalation, and external exposure which is zero for Sr-90). Note 
that these follow the same general patterns as the PRS Cs-137 dose commitments described above.  
Figure 21 illustrates the frequency and cumulative percentages for the Sr-90 maximum effective dose 
commitments for the region of study. The maximum total Sr-90 deposition of 2.86x104 Bq m-2 from 
Table 10 translates into a maximum, committed dose of 1.6 mSv (or 0.16 rem) per person, which is 
only approximately two-thirds that of the average annual background radiation dose (2.4 mSv). It 
should be noted that 95% of the maximum dose commitments are less than 0.70 mSv (or 0.07) rem per 
person and 85% of the maximum dose commitments are less than 0.36 mSv (or 0.04) rem per person. 
This indicates that the majority of dose commitments are much less than the maximum (as illustrated 
in Figure 21). Furthermore, all the maximum dose commitments are less than the average annual 
background radiation dose (2.4 mSv). 
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Figure 21. Frequency histogram and cumulative percentages for the PRS Sr-90 maximum effective dose 
commitments (left) and corresponding populations (right). 
 
Figure 22 illustrates the results for the transboundary conditions; all the maximum dose commitments 
are less than the average annual background dose. Note that the results are necessarily similar to those 
for Cs-137. 
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Figure 22. Transboundary frequency histogram and cumulative percentages for the PRS Sr-90 
maximum effective dose commitments (left) and corresponding populations (right). 
 
For the I-131 values computed from the PRS Cs-137 results as described above, Table 34 provides the 
total, maximum effective dose commitment for the region and each country as well as the components 
of the total by type (i.e., ingestion, inhalation, and external exposure). The maximum total dose 
commitment again resides within Russia, and the maximum dose commitments for all other countries 
are lower by almost two orders of magnitude.  
Figure 23 illustrates the frequency and cumulative percentages for the I-131 maximum effective dose 
commitments for the region of study. The maximum total deposition of 4.65x104 Bq m-2 from Table 
14 translates into a committed dose of 0.18 mSv (or 0.02 rem) per person as illustrated in Table 34, 
which is less than one-tenth that of the average annual background dose [13]. It should be noted that 
95% of the maximum dose commitments are less than 0.08 mSv or 0.01 rem per person (and 85% are 
less than 0.04 mSv per person). As illustrated in Figure 23, this indicates that many of the dose 
commitments from I-131 are significantly lower than the maximum as would be expected.  
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Figure 23. Frequency histogram and cumulative percentages for the PRS I-131 maximum effective dose 
commitments (left) and corresponding populations (right). 
 
Figure 24 illustrates the results for the transboundary conditions. Note the maximum I-131 dose of 
2.4x10-3 mSv per person outside of Russia is almost two orders of magnitude less than within. This 
illustrates that the impacts of I-131 will be most significant in the areas near the risk sites for the 
conditions considered in this study. 
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Figure 24. Transboundary frequency histogram and cumulative percentages for the PRS I-131 maximum 
effective dose commitments (left) and corresponding populations (right). 
3.2.1.1 Specific Case Examples: Japan and U.S. Dose Commitments from the PRS 
As explained above, the Cs-137 results for Japan and the U.S. territories considered in this study are 
provided. Figure 25 illustrates the maximum dose commitments from the PRS for Japan. (Note the 
similarity of appearance with Figure 9 above.) Note that there are doses on only approximately 25% of 
CY2000 days and that the maximum dose commitment of 4x10-2 mSv per person appears to be an 
isolated event. The maximum dose commitments will be less than 2x10-3 mSv per person on 
approximately 95% of CY2000 days for Japan. All such dose commitments are negligible when 
compared to the average annual background dose of 2.4 mSv. 
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Figure 25. Japan Results: Frequency histogram and cumulative percentages for the PRS Cs-137 
maximum effective dose commitments (left) and corresponding populations (right). 
 
The histograms illustrating the dose commitments for the U.S. territories considered in this study are 
provided in Figure 26. Note that the dose commitments are approximately an order of magnitude 
higher than those in Japan (as illustrated in Figure 25). There is also a much higher frequency of 
deposition from the PRS for both Alaska (in Figure 26a) and the Aleutian Islands (in Figure 26b) than 
in Japan. Again the maximum dose commitments of 0.20 and 0.13 mSv per person for Alaska and the 
Aleutian Islands, respectively, appear to be isolated cases and occur within approximately three weeks 
of each other early in the year (i.e., before 18-Feb-2000) resulting from the winter winds. The 
maximum deposition in Japan, on the other hand, occurred late in April (i.e., during the shoulder 
season). Again all such maximum dose commitments are negligible when compared to the average 
annual background dose. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 26. U.S. Results: Frequency histogram and cumulative percentages for the PRS Cs-137 maximum 
effective dose commitments for Alaska (left) and the Aleutian Islands (right). 
3.2.2 Verifying the PRS Dose Commitment Estimates Using RESRAD 
The UNSCEAR-based dose commitments are checked using the RESRAD 6 [24] code. Argonne 
National Laboratory (ANL) developed the RESRAD code in support of U.S. Department of Energy 
(DOE) order (DOE Order 5400.5) establishing guidelines for residual radioactive material [25]. The 
DOE and other U.S. agencies including Environmental Protection Agency (EPA), Army Corps of 
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Engineers, Nuclear Regulatory Commission (NRC) have used RESRAD to derive cleanup criteria and 
dose calculations. The doses computed by RESRAD are the effective dose equivalent from external 
radiation (using the Federal Guidance Report No. 12, FGR-12, [26] information as default) and the 
committed effective dose equivalent from internal radiation [24]. All important exposure pathways for 
the critical population group must be considered in deriving soil guidelines. These pathways include 
the following:  Direct exposure to external radiation from the contaminated soil material;  Internal dose from inhalation of airborne radionuclides, including radon progeny, which are 
not considered in this study; and  Internal dose from ingestion of 
- Plant foods grown in the contaminated soil and irrigated with contaminated water, 
- Meat and milk from livestock fed with contaminated fodder and water, 
- Drinking water from a contaminated well or pond, 
- Fish from a contaminated pond, and 
- Contaminated soil. 
These exposure pathways are considered in RESRAD and, therefore, this code appears an appropriate 
choice for verifying the dose commitments estimated using the methodology in the UNSCEAR 1993 
Report.  
To verify the doses estimated in this report using RESRAD, a number of RESRAD default values 
were modified to be consistent with those of the UNSCEAR 1993 Report [13]. An example set of the 
input data of interest for running RESRAD is provided in Table 35 for 01-JAN-2000. For a given cell 
with total predicted deposition [6], the area, AREA, of the contaminated zone is set to be the size of the 
area of the cell as computed by MatLab [8]. The thickness, THICK0, of the contaminated zone is set to 
the same depth, 3 cm or 3x10-2 m, used in the UNSCEAR calculations for Cs-137 external exposure 
[13]. The initial radionuclide concentration, S1(1), for RESRAD was computed using the initial 
maximum deposition, in this example 4260 Bq m-2, using the following relationship: 
 
Equation 15 
( )( )( )( )( )( )( )( )
1-2
2-3-333-
2-3
3-333-
-23
g Bq 10x47.9
m 3x10m cm 100cm g .51
m Bq 10x26.4
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m Bq 10x26.4
−=
=
=
THICK0DENSCZ
S1(1)
 
 
which is the value provided in Table 35. The values in Table 35 are provided to RESRAD 6 and the 
corresponding doses obtained. A system was developed using the Microsoft® Word 2000 MailMerge 
tool (e.g., see Listing 1 in Appendix C) with a Microsoft® Excel 2000 input file (as shown in Listing 2 
in Appendix C) to generate two sets of 326 input files (or one for each day for each radionuclide) for 
the maximum total Cs-137 and Sr-90 depositions for the PRS.14 Then MatLab [8] was used as a shell 
program to process the files in RESRAD 6 (as illustrated in Listing 3 in Appendix C),15 and the results 
for Cs-137 and Sr-90 parsed into two final sets of 326 different combinations of doses (as computed in 
RESRAD 6) on a mSv per year basis. The MatLab files used to parse the RESRAD dose information 
are provided in Listings 4 and 5 in Appendix C. The resulting doses were multiplied by the 50-y 
exposure period used to make them comparable to the values computed using the UNSCEAR 1993 
Report methodology. 
The total doses from RESRAD 6 for Cs-137 and Sr-90 are compared to those obtained from the 
UNSCEAR 1993 Report methodology in Figure 27 and Figure 28, respectively. Note that although the 
values from the individual pathways vary somewhat, the total dose commitments for Cs-137 are 
                                                     
14  Note that because of its very short half-life (i.e., 8 days), I-131 is not available in RESRAD 6 and could not 
be checked for this report. 
15  The executable file, RESCALC.exe, from RESRAD 6 was used to perform the calculations for this report. 
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virtually the same and those for Sr-90 are within 56% of each other throughout the range of data. 
Much of the difference in the Sr-90 values can be explained using the following rationale. The Sr-90 
dose commitments are dominated by ingestion. As described above, the ingestion P45 transfer factor 
used in the UNSCEAR 1993 Report is 28 nSv Bq-1 for Sr-90. The default factor used in RESRAD 6 
[25] is 38.5 nSv Bq-1 from Federal Guidance Report No. 11 or FGR-11 [27]. This accounts for most of 
the difference in the dose commitments. It should be further noted that the ingestion P45 transfer 
coefficient for Cs-137 used in the UNSCEAR 1993 Report (i.e., 13 nSv Bq-1 [13]) and RESRAD 6 
(i.e., 13.5 nSv Bq-1 from [27]) are very close. Furthermore, the Cs-137 dose is dominated by external 
exposure; it is expected that these values should change little from the time of the UNSCEAR 1993 
Report and the basis [26] for the RESRAD 6 computations.  
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Figure 27. Comparison of RESRAD 6 Cs-137 Results (after multiplication by a 50-y exposure period) to 
those from the UNSCEAR 1993 Report. Values are total dose commitments in mSv person
-1
. 
 
Because of the proportional nature between the doses computed using RESRAD 6 and the UNSCEAR 
1993 Report methodology, this verification will not be repeated for subsequent dose commitment 
calculations. However, information from FGR-11 [27] will be considered below in the parameter 
variation study to assure that the dose commitments cited in this report consider all relevant sources of 
information.  
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Figure 28. Comparison of RESRAD 6 Sr-90 Results (after multiplication by a 50-y exposure period) to 
those from the UNSCEAR 1993 Report. Values are total dose commitments in mSv person
-1
. 
3.2.3 Maximum Effective Dose Commitments for the VRS 
Using the transfer factors described above, the effective dose commitments for the maximum total 
depositions for Cs-137, Sr-90, and I-131 corresponding to the values in Table 18, Table 22, and Table 
26, respectively, were computed for the VRS. For Cs-137, Table 36 provides the total, maximum 
effective dose commitment for the region and each country as well as the components of the total by 
type (i.e., ingestion, inhalation, and external exposure). Note that the maximum, non-zero total dose 
commitments for the VRS are ordered as follows: 
 
VRS Cs-137: Region = Russia > China > N. Korea > Japan > Taiwan > Alaska (U.S.) > Mongolia  
> Aleutians (U.S.) > Hong Kong > Vietnam 
 
Therefore, even though the maximum dose commitment resides in Russia (as found for the PRS 
results), the values for other surrounding countries (e.g., China, N. Korea, and Japan) are not orders of 
magnitude lower than that for Russia, but approximately four to eight times lower. This will be 
significant if the dose commitments are large enough to be of concern. 
Figure 29 illustrates the frequency and cumulative percentages for the Cs-137 maximum effective 
dose commitments for the region of study. The maximum total Cs-137 deposition of 2.64x104 Bq m-2 
from Table 18 translates into an effective dose commitment of approximately 4 mSv (or 0.4 rem) per 
person as indicated in Table 36, which is less than twice the average annual background dose of 2.4 
mSv [13] and thus within what could be considered normal variation of the background dose. It should 
also be noted that 95% of the maximum dose commitments are less than 1.35 mSv or 0.13 rem per 
person, which indicate that most of the dose commitments are much less than the maximum (as 
illustrated in Figure 29). Furthermore, 85% of the maximum dose commitments are less than 0.68 mSv 
(or 0.07 rem) per person. Finally, over 98% of all maximum dose commitments for CY2000 are less 
than the average annual background dose. 
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Figure 29. Frequency histogram and cumulative percentages for the VRS Cs-137 maximum effective dose 
commitments (left) and corresponding populations (right). 
 
Figure 30 illustrates the results for the transboundary conditions provided in Table 36. There are less 
significant impacts on the maximum dose commitment (i.e., by about a factor of four) or population 
than for the PRS. This is because of the proximity of China to the VRS as illustrated in Figure 1. For 
these conditions, N. Korea will have the next highest (to China) dose commitment of 0.65 mSv per 
person, which is considerably smaller than the average annual background dose. 
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Figure 30. Transboundary frequency histogram and cumulative percentages for the VRS Cs-137 
maximum effective dose commitments (left) and corresponding populations (right). 
 
For the Sr-90 values computed from the VRS Cs-137 results as described above, Table 37 provides the 
total, maximum effective dose commitment for the region and each country as well as the components 
of the total by type (i.e., ingestion, inhalation, and external exposure which are zero for Sr-90). Note 
that the dose commitment ordering is the same as that for the VRS Cs-137 results. 
Figure 31 illustrates the frequency and cumulative percentages for the Sr-90 maximum effective dose 
commitments for the region of study. The maximum total Sr-90 deposition of 3.26x104 Bq m-2 from 
Table 22 translates into a maximum, committed dose of 1.69 mSv (or 0.17 rem) per person (as 
indicated in Table 37), which is significantly less than the average annual background dose of 2.4 
mSv. It should be noted that 95% of the maximum dose commitments are less than 0.57 mSv (or 0.06 
rem) per person and 85% of the maximum dose commitments are less than 0.29 mSv (or 0.03 rem) per 
person. This indicates that the majority of dose commitments are much less than the maximum (as 
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illustrated in Figure 31). Figure 32 illustrates the transboundary results, which necessarily follow those 
for Cs-137 above. 
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Figure 31. Frequency histogram and cumulative percentages for the VRS Sr-90 maximum effective dose 
commitments (left) and corresponding populations (right). 
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Figure 32. Transboundary frequency histogram and cumulative percentages for the VRS Sr-90 maximum 
effective dose commitments (left) and corresponding populations (right). 
 
For the I-131 values computed from the VRS Cs-137 results as described above, Table 38 provides the 
total, maximum effective dose commitment for the region and each country as well as the components 
of the total by type (i.e., ingestion, inhalation, and external exposure). The ordering of the VRS I-131 
results generally agrees with that for the Cs-137 and Sr-90 except for those additional countries that 
have no dose commitments. 
Figure 33 illustrates the frequency and cumulative percentages for the I-131 maximum effective dose 
commitments for the region of study.  The maximum total deposition of 5.28x104 Bq m-2 from Table 
26 translates into a committed dose of 0.25 mSv (or 0.03 rem) per person as illustrated in Table 38, 
which is almost an order of magnitude lower than the average annual background dose of 2.4 mSv 
[13]. It should be noted that 95% of the maximum dose commitments are less than 0.08 mSv (or 0.01 
rem) per person. As illustrated in Figure 33, this indicates that many of the dose commitments from 
I-131 are significantly lower than the maximum. Figure 34 illustrates the transboundary results for 
I-131 from the VRS. These results again illustrate that the impact on the transboundary region for 
releases from the VRS are smaller than those from the PRS. 
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Figure 33. Frequency histogram and cumulative percentages for the VRS I-131 maximum effective dose 
commitments (left) and corresponding populations (right). 
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Figure 34. Transboundary frequency histogram and cumulative percentages for the VRS I-131 maximum 
effective dose commitments (left) and corresponding populations (right). 
3.2.3.1 Specific Case Examples: Japan and U.S. Dose Commitments from the VRS 
As explained above, the Cs-137 results for Japan and the U.S. territories considered in this study are 
provided. Figure 35 illustrates the maximum dose commitments from the VRS for Japan. The dose 
commitment frequency and magnitudes for the VRS are very different than those from the PRS. There 
are dose commitments on more than 96% of CY2000 days and the maximum dose of 0.6 mSv per 
person in December 2000 is more than an order of magnitude higher than that from the PRS. Also 
there are maximum dose commitments over 0.15 mSv per person on approximately 10% of all 
CY2000 days. Therefore, the impact from the VRS on Japan is greater than that from the PRS; 
however, all such dose commitments are significantly less than the average annual background dose of 
2.4 mSv [13]. 
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Figure 35. Japan Results: Frequency histogram and cumulative percentages for the VRS Cs-137 
maximum effective dose commitments (left) and corresponding populations (right). 
 
The dose commitment histograms for the U.S. territories considered in this study are provided in 
Figure 36. Note that the dose commitments are approximately an order of magnitude less than those in 
Japan. There is also a much lower frequency of dose commitments from the VRS for both Alaska in 
Figure 36(a) and the Aleutian Islands in Figure 36(b) than in Japan. Again the maximum doses of 
2x10-2 and 9x10-3 mSv per person for Alaska and the Aleutian Islands, respectively, appear to be 
isolated cases and occur within approximately one month of each other. The maximum deposition in 
Japan, on the other hand, occurred in December 2000. All such dose commitments are within the 
normal variation for the background dose. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 36. U.S. Results: Frequency histogram and cumulative percentages for the VRS Cs-137 maximum 
effective dose commitments for Alaska (left) and the Aleutian Islands (right). 
3.2.4 Maximum Effective Dose Commitments Summarized and Compared to 
Reference Limits 
A summary of the (non-zero) maximum effective dose commitments (incorporating the ingestion, 
inhalation, and external exposure pathways, where applicable) for the hypothetical “unit releases” 
from the PRS and VRS is presented in Exhibit 9. Note that on a regional basis that the maximum 
effective dose commitments are comparable (because these maximum values reside in Russia). 
However, the impact outside of Russia is more profound from the VRS than from the PRS. 
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Furthermore, the effects from Cs-137 releases (from either site) appear to be of more concern than 
those (for the same releases) from either Sr-90 or I-131. For example, the external exposure pathway 
for Sr-90 is negligible and only the ingestion (i.e., milk) pathway is considered for I-131. Furthermore, 
I-131 has a very short half-life and is only effective for a few weeks. 
Exhibit 9. Summary of the Maximum (Non-Zero) Effective Dose Commitments Using the UNSCEAR 
1993 Report Methodology 
PRS  VRS 
 Maximum Effective  
Dose Commitment (mSv)* 
  Maximum Effective  
Dose Commitment (mSv)* 
Region Cs-137 Sr-90 I-131  Region Cs-137 Sr-90 I-131 
Regional 4.22E+00 1.60E+00 1.79E-01  Regional 4.01E+00 1.69E+00 2.54E-01 
Transboundary** 1.95E-01 7.72E-02 2.39E-03  Transboundary** 1.05E+00 4.44E-01 6.61E-02 
China 2.96E-02 1.09E-02 2.92E-10  China 1.05E+00 4.44E-01 6.61E-02 
Hong Kong     Hong Kong 8.48E-04 1.28E-07  
Japan 4.20E-02 1.81E-02 1.81E-04  Japan 5.85E-01 2.45E-01 1.26E-02 
Mongolia 1.65E-03 6.29E-04   Mongolia 1.02E-02 4.26E-03 2.82E-09 
N. Korea 8.25E-03 3.42E-03   N. Korea 6.48E-01 2.68E-01 4.24E-02 
Russia 4.22E+00 1.60E+00 1.79E-01  Russia 4.01E+00 1.69E+00 2.54E-01 
S. Korea 6.22E-04 1.21E-04   S. Korea 1.57E-01 6.57E-02 5.94E-03 
Taiwan     Taiwan 2.91E-02 1.23E-02  
Aleutians (U.S.) 1.30E-01 4.81E-02 2.39E-03  Aleutians (U.S.) 8.91E-03 3.43E-03 3.57E-05 
Alaska (U.S.) 1.95E-01 7.72E-02 1.61E-04  Alaska (U.S.) 1.71E-02 2.36E-03 2.90E-17 
Vietnam     Vietnam 4.38E-10 2.50E-14  
 
* The effective dose commitments are comprised of the following components (based upon the UNSCEAR 1993 
Report [13] methodology):  
Cs-137: Ingestion 36.2%, Inhalation 0.1%, External Exposure 63.8% 
Sr-90: Ingestion 91.9%, Inhalation 8.1%, External Exposure 0% 
I-131: Ingestion 93.5%, Inhalation 3.8%, External Exposure 2.7%. 
** The transboundary region includes only land areas outside of Russia. 
 
Table 39 illustrates the manner in which the maximum, regional dose commitments (on a daily basis 
computed using the UNSCEAR methodology) for the PRS and VRS compare to various annual 
reference limits.16 Note the similarities amongst the various numbers of dose commitments relative to 
reference limits for the two sites. As indicated above, the main difference appears to be the numbers of 
people impacted by the VRS releases relative to those from the PRS. The information in Table 39 
indicates that all dose commitments (regardless of the radionuclide) from the two sites are below the 
10-mSv annual limit in which intervention is rarely justified [17]; approximately 98% of all maximum 
daily dose commitments are below the average annual background dose of 2.4 mSv. However, it is 
true that the majority of the Cs-137 dose commitments exceed the annual 0.15 mSv (or 15 mrem) per 
person limit proposed by the US EPA; the dose commitments for Sr-90 and I-131 are generally lower 
that those for Cs-137 for the conditions of this study. Table 40 illustrates the same information for the 
transboundary region; note that the dose commitments are significantly lower for these conditions. 
3.3 Effective UNSCEAR Collective Dose Commitments 
The final examination of the UNSCEAR dose commitment estimates is what impact might there be on 
those persons that would be exposed to the various releases described above. That is, the collective 
dose commitments will be computed for the corresponding maximum dose commitments described 
                                                     
16  It is understood that dose commitments are compared to annual dose limits; this application should be 
conservative because the dose commitments are computed for periods of 70 years for infants and 50 years for 
adults in the UNSCEAR 1993 Report [13] although they could be computed for each year. However, because 
they are used for prevention, they should not be used alone for conditions following an accident. 
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above. Furthermore, from the information above, it is apparent that many people would be exposed to 
very small doses of radiation. In the words of ICRP 82 [18]: 
 
“The unlimited aggregation of collective dose over time and space into a single value 
is unhelpful because it deprives the decision maker of much necessary information. 
The levels of individual dose and the time distribution of collective dose may be 
significant factors in making decisions.” 
 
To examine the impact that relatively small doses have on the collective dose commitments computed 
in this study, a series of threshold values (i.e., 0.1, 0.15,1.0, and 10.0 mSv per person) were selected. 
In effect, if the dose commitment at a given location does not exceed the threshold, then the dose 
commitment is ignored to compute the collective dose and to examine the resulting impact on the 
assessment. This is meant in no way to be an endorsement of the “threshold concept,” it merely allows 
assessment of the impact of small doses on collective dose assessment in keeping with the inferred 
meaning of ICRP 82 [18]. 
3.3.1 Effective UNSCEAR Collective Dose Commitments for the PRS 
The effective, maximum collective dose commitments corresponding to the total depositions for 
Cs-137, Sr-90, and I-131 in Table 4, Table 10, and Table 14, respectively, were computed for the PRS. 
For Cs-137, Figure 37 illustrates the frequency and cumulative percentages for the maximum 
collective dose commitments for the region of study assuming no threshold. Table 41 and Table 42 
provide the maximum collective dose commitment for the region as well as each country in the region 
for each of the threshold levels described above. (The collective dose commitments are also broken 
down by pathway for information purposes.) Note that the maximum collective PRS dose 
commitments (for the no threshold hypothesis) are rank-ordered as follows:17 
  
PRS Cs-137: Regional > Japan > Russia > China > Alaska (U.S.) > S. Korea > N. Korea > Aleutians (U.S.)  
> Mongolia 
 
Therefore, even though the maximum Cs-137 dose commitment was found in Russia (as indicated in 
Table 32), the maximum collective dose is found in Japan (which is not surprising based upon its high 
population density and relative proximity to the PRS in comparison to the low population density in 
Russia near the PRS). Using a mortality risk factor of 5x10-5 per mSv for all ages [19], these results 
would indicate that there might be up to 15 additional, eventual mortalities in the region based upon 
the “no threshold” results in Table 41; Japan might have as many as 14 additional mortalities while 
Russia and China might have as many as four and three, respectively.18 However, none of these 
collective dose commitments from the PRS translate into a single mortality per 100 000 persons. 
Figure 38 illustrates the results for the transboundary conditions; note there is a significant impact on 
the magnitudes of the largest maximum collective dose commitments versus those for the overall 
region in Figure 37. In other words, the total number of collective dose commitments greater than, for 
example, 40 person-Sv is much lower for the transboundary region than the overall region. 
 
                                                     
17  In this assessment, the regional value corresponds to the maximum collective dose over the whole region on 
any given day in CY2000, and thus does not correspond to either the maximum for any country or the sum of 
the maximum values for the countries. 
18  All mortality-related results in this report are based upon a value of 5x10-5 additional mortalities per mSv for 
persons of all ages [19] (which translates to 5x10-2 mortalities per person-Sv). The regional maximum of 299 
person-Sv from Table 41 gives a maximum value of 15 additional mortalities for the region. 
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Figure 37. Frequency histogram and cumulative percentages for the PRS Cs-137 effective population 
dose commitments (left) and corresponding populations (right) for CY2000. No Threshold 
Basis. 
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Figure 38. Transboundary frequency histogram and cumulative percentages for the PRS Cs-137 effective 
population dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
 
However, the above analysis ignores the inferred ICRP 82 [18] intent that collective dose estimates 
should not be made over large regions. To wit, Table 41 and Table 42 can be used to evaluate the 
impact that small doses in concert with large populations have on the collective dose estimates in this 
study. If a value of 0.1 mSv (or 10 mrem) per person is used as a threshold for the collective dose 
computation, then Japan, which had the highest collective dose commitment (and a possibility of up to 
14 additional mortalities), has a collective dose of zero. On the other hand, the collective dose 
commitment for Russia is not impacted significantly, as the individual dose commitments, in general, 
are much higher than the hypothetical 0.10 mSv per person threshold. The results using the larger 
threshold values do not add much additional information except to highlight the obvious fact that 
Russia will bear the brunt of any release of the type studied in this report. 
For Sr-90, Figure 39 illustrates the frequency and cumulative percentages for the maximum collective 
dose commitments for the region of study assuming no threshold. Table 43 and Table 44 provide the 
maximum collective dose commitment for the region as well as each country in the region as a 
function of the assumed threshold level. Note that the maximum collective PRS dose commitments 
(for the no threshold hypothesis) have the same ordering as those for the Cs-137, but are less than one-
half of the corresponding values for Cs-137. Again, even though the maximum dose commitment was 
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found in Russia (as indicated in Table 33), the maximum collective dose is found in Japan. (This 
collective dose translates into six additional mortalities [19]; however, none of the collective dose 
commitments translate into a single, additional mortality per 100 000 persons.)  
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Figure 39. Frequency histogram and cumulative percentages for the PRS Sr-90 effective collective dose 
commitments (left) and corresponding populations (right) for CY2000. No Threshold Basis. 
 
The results in Table 43 and Table 44 confirm the potential impacts of small doses in concert with large 
populations on the collective dose estimates discussed above for Cs-137. With even a relatively low 
threshold of 0.1 mSv (or 0.01 rem), the collective dose commitment and potential additional 
mortalities in Japan, which had the largest collective dose commitment under the no threshold 
condition, would be zero. Figure 40 illustrates the transboundary results for the PRS Sr-90 collective 
dose commitments; note that these results are necessarily consistent with those for Cs-137 above. This 
is a direct result of the assumed linear relationship between their depositions. 
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Figure 40. Transboundary frequency histogram and cumulative percentages for the PRS Sr-90 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
 
For I-131, Figure 41 illustrates the frequency and cumulative percentages for the maximum collective 
dose commitments for the region of study assuming no threshold. Table 45 and Table 46 provide the 
maximum collective dose commitment for the region as well as each country in the region as a 
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function of the assumed threshold level. Note that the maximum collective PRS dose commitments 
(for the no threshold hypothesis) are rank-ordered as follows: 
 
PRS I-131: Regional > Russia > Japan > Aleutians (U.S.) > Alaska (U.S.) > China 
 
Thus for I-131, the maximum dose commitment and collective dose are found in Russia (which is 
unlike the results for Cs-137 and Sr-90). This is not surprising based upon the higher deposition 
velocity of I-131 and the low dose commitments found in Japan. As a matter of fact, the results in 
Table 45 and Table 46 indicate that little I-131 from PRS impacts any countries other than Russia. 
(Even in Russia, there is not enough of a collective dose to translate into a single, additional mortality 
and none of the collective dose commitments translate into a single additional mortality per 1 000 000 
persons.) Furthermore, the impact is much smaller than that for either Cs-137 or Sr-90 releases from 
the PRS. Figure 42 illustrates the transboundary results for I-131 from the PRS. Note that there is a 
profound impact on the magnitudes of the collective dose commitments. 
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Figure 41. Frequency histogram and cumulative percentages for the PRS I-131 effective collective dose 
commitments (left) and corresponding populations (right) for CY2000. No Threshold Basis. 
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Figure 42. Transboundary frequency histogram and cumulative percentages for the PRS I-131 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
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3.3.1.1 Specific Case Examples: Japan and U.S. Collective Dose Commitments from 
the PRS 
Because it is apparent that air masses from the Asian continent can move rapidly and only slightly 
diluted across the Pacific Ocean [14,15], it has been decided to examine these areas for possible 
impacts from the nuclear risk sites. Furthermore, because the Sr-90 depositions necessarily follow 
those for Cs-137 and the I-131 depositions are smaller and will have significantly less impact on the 
transboundary region (which includes both Japan and the U.S.), it was decided to examine only 
Cs-137 for these specific examples. 
Figure 43 illustrates the collective dose results for Japan from the PRS releases for CY2000. Using a 
mortality risk factor of 5x10-5 per mSv for all ages [19], almost 97% of all maximum collective dose 
commitments will result in less than one additional, eventual mortality from the PRS releases. As 
mentioned above, the maximum collective dose commitment of 276 person-Sv, which appears from 
Figure 43 to be an isolated case, could result in as many as 14 additional mortalities.  
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Figure 43. Japan Results: Frequency histogram and cumulative percentages for the PRS Cs-137 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
 
The results for the collective dose commitments from the PRS for the U.S. territories considered in 
this report are illustrated in Figure 44 and Figure 45. Note that, when a mortality risk factor of 5x10-5 
per mSv for all ages [19] is employed, none of the collective dose commitments shown in these figures 
translate into a single, additional mortality from the PRS releases for CY2000. 
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Figure 44. Alaska (U.S.) Results: Frequency histogram and cumulative percentages for the PRS Cs-137 
effective collective dose commitments (left) and corresponding populations (right) for CY2000. 
No Threshold Basis. 
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Figure 45. Aleutian Islands (U.S.) Results: Frequency histogram and cumulative percentages for the PRS 
Cs-137 effective collective dose commitments (left) and corresponding populations (right) for 
CY2000. No Threshold Basis. 
3.3.2 Effective UNSCEAR Collective Dose Commitments for the VRS 
The effective, maximum collective dose commitments corresponding to the total depositions for 
Cs-137, Sr-90, and I-131 in Table 18, Table 22, and Table 26, respectively, were computed for the 
VRS. For Cs-137, Figure 46 and Figure 47 illustrate the frequency and cumulative percentages for the 
maximum collective dose commitments for the overall and transboundary region, respectively, 
assuming no threshold. Table 47 and Table 48 provide the maximum collective dose commitment for 
the region as well as each country in the region as a function of the assumed threshold level. (The 
collective dose commitments are also broken down by pathway for information purposes.) Note that 
the maximum collective VRS dose commitments (for the no threshold hypothesis) are rank-ordered as 
follows:19 
 
                                                     
19  In this assessment, the regional value corresponds to the maximum collective dose over the whole region on 
any given day in CY2000, and thus does not correspond to either the maximum for any country or the sum 
of the maximum values for the countries. 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 45
VRS Cs-137: Regional > Japan > China > N. Korea > S. Korea > Russia > Taiwan > Hong Kong  
> Alaska (U.S.) > Mongolia > Aleutians (U.S.) > Vietnam 
 
Therefore, even though the maximum dose commitment was found in Russia (as indicated in Table 
36), the maximum collective dose is again found in Japan (which is not surprising based upon its high 
population density and relative proximity to the VRS). However unlike the PRS results, many 
countries have collective dose commitments within an order of magnitude of that for Japan. 
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Figure 46. Frequency histogram and cumulative percentages for the VRS Cs-137 effective collective dose 
commitments (left) and corresponding populations (right) for CY2000. No Threshold Basis. 
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Figure 47. Transboundary frequency histogram and cumulative percentages for the VRS Cs-137 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
 
The effects of the VRS releases are potentially greater than those from the PRS. For example, the 
maximum collective dose commitments in Table 41 correspond to up to an additional 411 mortalities 
[19] over the entire region when a mortality risk factor of 5x10-5 per mSv for all ages [19] is used. The 
additional mortalities from the maximum collective dose commitments for Japan, China, N. Korea, S. 
Korea, Russia, and Taiwan are approximately 399, 360, 104, 102, 68, and 13, respectively. Therefore, 
even the impact on Taiwan, a country not proximate to the VRS, could be considered significant. 
However, again none of the collective dose commitments translate into a single mortality per 100 000 
persons.  
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Also unlike the results for the PRS analysis, Table 47 and Table 48 indicate that there is much less of 
an impact of magnitudes of the dose commitments in concert with large populations on the collective 
VRS dose estimates. That is, the collective dose commitments for the countries (e.g., Japan, China, N. 
Korea, S. Korea, and Russia) in the vicinity of the VRS appear relatively insensitive to the 
introduction of thresholds into the collective dose commitment computation. Furthermore, even the 
results after imposing a threshold of 0.1 mSv (or 0.01 rem) translate into 270 additional mortalities in 
Japan and significant numbers in other countries of interest. This is a result of much higher dose 
commitments in these countries resulting from the VRS releases. Only when a relatively large 
threshold (e.g., 1.0 mSv) is imposed do the releases not significantly impact countries outside of 
Russia.  
For Sr-90, Figure 48 and Figure 49 illustrate the frequency and cumulative percentages for the 
maximum collective dose commitments for the overall and transboundary region, respectively, 
assuming no threshold. Table 49 and Table 50 provide the maximum collective dose commitment for 
the region as well as each country in the region as a function of the assumed threshold level. Note that 
the maximum collective VRS dose commitments (for the no threshold hypothesis) have the same 
ordering as those for the Cs-137. Again, even though the maximum dose commitment was found in 
Russia (as indicated in Table 37), the maximum collective dose is found in Japan. The number of 
additional mortalities can be as high as 166 for the region and 146 and 164 for China and Japan, 
respectively, or less than one-half those from the VRS Cs-137 releases. The results in Table 49 and 
Table 50 confirm the insensitivity of the collective dose estimates to the imposition of thresholds 
because the relative magnitudes of the dose commitments as indicated above for Cs-137.  
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Figure 48. Frequency histogram and cumulative percentages for the VRS Sr-90 effective collective dose 
commitments (left) and corresponding populations (right) for CY2000. No Threshold Basis. 
 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 47
0
20
40
60
80
100
120
140
160
5.
77
E-
01
3.
70
E+
02
7.
39
E+
02
1.
11
E+
03
1.
48
E+
03
1.
85
E+
03
2.
22
E+
03
2.
58
E+
03
2.
95
E+
03
M
or
e
Collective dose commitment (person-Sv)
F
r
e
q
u
e
n
c
y
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
       
0
10
20
30
40
50
60
70
80
90
7.
58
E+
06
9.
34
E+
07
1.
79
E+
08
2.
65
E+
08
3.
51
E+
08
4.
37
E+
08
5.
22
E+
08
6.
08
E+
08
6.
94
E+
08
M
or
e
Total population, persons
F
r
e
q
u
e
n
c
y
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
 
Figure 49. Transboundary frequency histogram and cumulative percentages for the VRS Sr-90 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
 
For I-131, Figure 50 and Figure 51 illustrate the frequency and cumulative percentages for the 
maximum collective dose commitments for the overall and transboundary region, respectively, 
assuming no threshold. Table 51 and Table 52 provide the maximum collective dose commitment for 
the region as well as each country in the region as a function of the assumed threshold level. Note that 
the maximum collective PRS dose commitments (for the no threshold hypothesis) are rank-ordered as 
follows: 
 
VRS I-131: Regional > Japan > China > S. Korea > N. Korea > Russia > Aleutians (U.S.) > Mongolia  
> Alaska (U.S.) 
 
Thus for I-131, the maximum collective VRS dose commitment is found in Japan (which is unlike the 
results found for the corresponding PRS releases). Unlike the Cs-137 and Sr-90 results, the I-131 
releases translate into ten or fewer additional mortalities. Also unlike the VRS results for Cs-137 and 
Sr-90, the collective doses are relatively sensitive to the imposition of a threshold (because of the 
much smaller dose commitments for I-131 in countries other than Russia). This is not surprising based 
upon the higher deposition velocity of I-131. Again, the results in Table 51 and Table 52 indicate that 
little I-131 from the VRS releases impacts any countries other than Russia. Furthermore, the impact is 
much smaller than that for either Cs-137 or Sr-90 releases from the PRS. None of the collective dose 
commitments translate into a single mortality per 1 000 000 persons.  
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Figure 50. Frequency histogram and cumulative percentages for the VRS I-131 effective collective dose 
commitments (left) and corresponding populations (right) for CY2000. No Threshold Basis. 
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Figure 51. Transboundary frequency histogram and cumulative percentages for the VRS I-131 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
3.3.2.1 Specific Case Examples: Japan and U.S. Collective Dose Commitments from 
the VRS 
Figure 52 illustrates the collective dose results for Japan from the VRS releases for CY2000. Using a 
mortality risk factor of 5x10-5 per mSv for all ages [19], the maximum collective dose commitment of 
7990 person-Sv would translate into almost 400 additional mortalities or 3.2 additional mortalities per 
1 000 000 persons. However, the information in Figure 52 indicates that this would be a low-
probability event for CY2000. Over 60% of the maximum collective dose commitments are less than 
420 person-Sv, which would translate into 22 additional mortalities.  
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Figure 52. Japan Results: Frequency histogram and cumulative percentages for the VRS Cs-137 effective 
collective dose commitments (left) and corresponding populations (right) for CY2000. No 
Threshold Basis. 
 
The results for the collective dose commitments from the VRS for the U.S. territories considered in 
this report are illustrated in Figure 53 and Figure 54. Note that, when a mortality risk factor of 5x10-5 
per mSv for all ages [19] is employed, none of the collective dose commitments shown in these figures 
translate into a single, additional mortality from the VRS releases for CY2000. Furthermore, none of 
the collective dose commitments translate into a single additional mortality per 1 000 000 persons. 
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Figure 53. Alaska (U.S.) Results: Frequency histogram and cumulative percentages for the VRS Cs-137 
effective collective dose commitments (left) and corresponding populations (right) for CY2000. 
No Threshold Basis. 
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Figure 54. Aleutian Islands (U.S.) Results: Frequency histogram and cumulative percentages for the VRS 
Cs-137 effective collective dose commitments (left) and corresponding populations (right) for 
CY2000. No Threshold Basis. 
3.3.3 Summary of the Effective UNSCEAR Collective Dose Commitments 
A summary of the (non-zero) maximum effective collective dose commitments (based upon the 
UNSCEAR 1993 Report methodology and assuming no threshold) for both the PRS and VRS is 
presented in Exhibit 10. Therefore, even though the maximum effective dose commitments from the 
PRS and VRS were reasonably similar (as illustrated above), the higher populations impacted from the 
VRS releases generally resulted in significantly larger collective dose commitments. It also appears 
that the Cs-137 dose commitments will be of primary concern for either site. 
Exhibit 10. Summary of Maximum (Non-Zero) Effective Collective Dose Commitments Using the 
UNSCEAR 1993 Report Methodology 
PRS  VRS 
 Maximum Effective Collective 
Dose Commitment (person-Sv)* 
  Maximum Effective Collective 
Dose Commitment (person-Sv)* 
Region Cs-137 Sr-90 I-131  Region Cs-137 Sr-90 I-131 
Regional 2.98E+02 1.27E+02 3.78E+00  Regional 8.23E+03 3.33E+03 2.06E+02 
Transboundary** 2.76E+02 1.19E+02 7.46E-02  Transboundary** 8.22E+03 3.32E+03 2.06E+02 
China 6.96E+01 2.78E+01 4.08E-08  China 7.21E+03 2.93E+03 1.76E+02 
Hong Kong     Hong Kong 1.59E+00 3.72E-04  
Japan 2.76E+02 1.19E+02 7.46E-02  Japan 7.99E+03 3.28E+03 2.06E+02 
Mongolia 1.59E-01 5.98E-02   Mongolia 1.35E+00 4.74E-01 1.13E-07 
N. Korea 8.47E+00 3.38E+00   N. Korea 2.09E+03 8.68E+02 9.12E+01 
Russia 8.63E+01 3.76E+01 3.78E+00  Russia 1.36E+03 5.63E+02 6.68E+01 
S. Korea 9.75E+00 1.78E+00   S. Korea 2.05E+03 8.53E+02 9.82E+01 
Taiwan     Taiwan 2.67E+02 1.13E+02  
Aleutians (U.S.) 2.21E-01 8.15E-02 2.49E-03  Aleutians (U.S.) 1.39E-02 3.29E-03 4.74E-07 
Alaska (U.S.) 1.48E+01 5.20E+00 7.10E-05  Alaska (U.S.) 1.54E+00 8.66E-02 4.95E-18 
Vietnam     Vietnam 6.07E-09 3.46E-13  
 
* The effective collective dose commitments are comprised of the following components (based upon the 
UNSCEAR 1993 Report [13] methodology):  
Cs-137: Ingestion 36.2%, Inhalation 0.1%, External Exposure 63.8% 
Sr-90: Ingestion 91.9%, Inhalation 8.1%, External Exposure 0% 
I-131: Ingestion 93.5%, Inhalation 3.8%, External Exposure 2.7%. 
** The transboundary region includes only land areas outside of Russia. 
 
A study of the impact of imposing threshold values on the various collective dose commitments was 
also undertaken. Figure 55 illustrates the impact of such thresholds on the maximum collective Cs-137 
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dose commitments for those areas where the impact would be at least one additional mortality (using a 
mortality risk factor of 5x10-5 per mSv for all ages [19]). Note that only the collective doses for the 
entire region and Russia do not fall to zero using a threshold value of 0.10 mSv per person. Therefore, 
there would be a significant impact on collective doses if even a relatively small threshold (i.e., 0.10 
mSv) were imposed on the calculation.  
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Figure 55. Impact of Imposing Hypothetical Threshold Values on the UNSCEAR Maximum Effective 
Collective Cs-137 Dose Commitments for the PRS. Only those values are shown where at least 
one additional mortality would result for the no threshold case. 
 
The corresponding relationship between the maximum collective dose commitments and threshold for 
the VRS is provided in Figure 56. Notice that the impact of thresholds on the VRS collective dose 
commitments is much smaller than that for the corresponding PRS doses; however, they still appear to 
be significant for most countries impacted by the PRS releases. 
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Figure 56. Impact of Imposing Hypothetical Threshold Values on the UNSCEAR Maximum Effective 
Collective Cs-137 Dose Commitments for the VRS. Only those values are shown where at least 
one additional mortality would result for the no threshold case. 
 
4 Parameter Variation Study 
There are three major sources of potential “error” or uncertainty in the dose calculations provided in 
this report. The first is the deposition values [6] provided as the input to said calculations. The 
deposition data provided are based upon data for approximately 90% of the days in a single calendar 
year (i.e., CY2000) and, as was stated by Mahura [6], a multi-year approach would be best for 
statistical analysis of the deposition data. Furthermore, because wet deposition is related to rainfall, 
these deposition data can be highly variable as are the dry deposition velocities (whose effects were 
indicated by the differences found between Cs-137, Sr-90, and I-131 depositions for the five specific 
case studies used to generate the relationship between Cs-137 and the other radionuclides of interest). 
Thus the possible input data to this study would have had a great deal more variation if the resources 
were available to examine the possible effects such as year-to-year variation or variation in deposition 
velocities. It is thought that by examining the range of conceivable release values (as they compare to 
the “unit hypothetical release” of 8.64x1014 Bq used to generate the data [6]) and the maximum values 
on a day-to-day basis for the given time-slice represented by the CY2000 results, that a reasonable set 
of conclusions can be drawn concerning future releases from the two risk sites studied in this report. 
A second source of potential variation present in the dose calculations in this report are the UNSCEAR 
1993 Report deposition-to-dose transfer factors (i.e., P2345, P245, and P25) described above. Given a total 
deposition at a specific location, these provide an estimate of the dose commitment that would be 
imparted to an adult (except for the case of I-131 where a weighted value is instead used) under 
average or nominal conditions using information that is often decades old and not necessarily 
concerning the region of interest. The UNSCEAR methodology is sound; however, little account was 
taken for the countries of interest in this study. In this section, the parameters that constitute the 
various deposition-to-dose transfer factors will be examined to provide a more reasonable range of 
values for the region of interest. 
The third source of error applies to computing collective doses, and that is the population data used in 
this study. These data are from 1995 [7] and, therefore, are somewhat out of date. However, these data 
are used “as-is” as any adjustment of the data would be arbitrary and likely to introduce more error 
than warranted especially when considering the other sources of error that are examined below. 
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There are a number of different techniques that can be used to examine such variations in the factors 
comprising the deposition-to-dose coefficients defined above. One could set up a number of scenarios 
where the doses will be computed for each individual (i.e., infant, child, adult, etc.) of interest for each 
of the 13 countries represented in the region of interest. This would also entail defining the various 
parameters for ingestion, inhalation, and external exposure representing each selected region and 
individual. However, such a technique appears unwarranted when considering the variation inherent in 
the input data. The approach taken in this study is to define reasonable ranges for the source term and 
the various parameters used in computing the deposition-to-dose coefficients and then, using said 
ranges, compute the resulting ranges of the transfer factors and the resulting maximum dose 
commitments for both the maximum individual and adult cases. These results will be analyzed to 
determine whether accounting for reasonable variation in the source term and the parameters used to 
develop the deposition-to-dose transfer coefficients would alter the conclusions drawn from 
examination of the dose commitments computed using the UNSCEAR values for the “unit 
hypothetical release.” 
4.1 Environmental Releases from Typical Accident Scenarios 
The total release, A0, in this study consisted of a series of one-day “unit hypothetical releases” at the 
rate of 1x1010 Bq s-1 for a total release of (24 h d-1)(3600 s h-1)(1010 Bq s-1) = 8.64x1014 Bq each for 
Cs-137, Sr-90, and I-131. It will be shown how this release compares to the releases from possible 
accident scenarios of the Russian Far East nuclear risk sites. Then noting that because the depositions 
and dose commitments are proportional to the initial total release, A0, the doses that would result from 
the various accident scenarios will be considered both in light of the original UNSCEAR approach and 
then as part of the parameter variation study that takes into account the various dose pathways 
discussed above.  
The Cs-137 and Sr-90 isotopic inventories for the nuclear submarines (NS) and other facilities 
pertinent to the Russian Far East nuclear risk sites (i.e., PRS and VRS) are presented in Table 53 
[28,29,30,31,32,33,34]. However, it is implausible to consider an accident scenario consisting of both 
reactors on board a first or second generation nuclear submarine (NS) or every storage or transport 
cask in a building being involved in even the worst-case accident scenario. Therefore, the information 
in Table 53 has been summarized based upon the spent fuel assemblies (SFA’s) either in or 
hypothesized to be in (using a nominal value of 287 SFA’s per core [32]) the various reactor cores and 
storage facilities described in Table 53. These values are summarized in Table 54.   
Table 55 indicates the various configurations assumed in this study for nuclear submarines and 
transport casks whose inventories are described in Table 53 and Table 54. Note that the maximum 
Cs-137 and Sr-90 inventories for the conditions assumed for this study for the PRS and VRS are 5.67 
and 4.80 times higher, respectively, than the “unit hypothetical release” used [6] to generate the 
deposition data for this study.  
The inventory for I-131 is somewhat more straightforward as it primarily depends on the fission yield 
of the accident. Using a total number of fissions of 5.0x1018 to represent the Chazhma Bay accident 
[35], the inventory of I-131 was estimated to be 1.45x1011 Bq. A NATO report [34] concerning two 
defense-related cross-border problems examined a hypothetical criticality accident involving 1x1020 
fissions (considered bounding [36]) in which the I-131 inventory is between 1.3x1010 Bq (at the time 
of the accident) and 4.3x1012 Bq (one day after the accident corresponding to the end of the releases 
modeled in this study). This information is also found in Table 55; note that even the maximum I-131 
inventory in this table is more than 200 times lower than the “unit hypothetical release” of 8.64x1014 
Bq used to generate the data for this study. 
However, the release fraction (i.e., the fraction of the inventory that is released into the atmosphere) 
for a given accident scenario also determines the environmental release, A0. Table 56 provides a 
summary of the release fractions for a series of accident scenarios [36,37,38,39,40,41]. Note that the 
release fractions for each element considered in this study can vary over several orders of magnitude 
depending upon the severity of the accident scenario. Also note that, depending upon the accident 
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scenario, almost all the Cs-137 or I-131 can be released into the atmosphere, whereas the Sr-90 tends 
to stay within the fuel assemblies even during the most severe accident scenarios. 
By combining the various values from the inventories in Table 55 and the release fractions in Table 
56, the potential environmental source terms pertinent to this study can be estimated. These are 
provided in Table 57. Note that the “unit hypothetical release” used to generate the deposition data 
used in this report is significantly greater than the median values examined but less than the maximum 
values for Cs-137, greater than the maximum values for Sr-90, and more than 250 times greater than 
the maximum value for I-131. Therefore, the choice of a “unit hypothetical release” of 8.64x1014 Bq 
used in this study appears to be representative for Cs-137, conservative for Sr-90, and grossly 
conservative for I-131.  This information will be factored into the parameter variation study below. 
4.2 Ingestion Transfer Coefficients 
As stated above, the UNSCEAR P25 transfer coefficient is computed using Equation 3: P2345 = 
P23P34P45 where P23 represents the deposition to diet transfer, P34 links the concentrations of 
radionuclides in diet to those in the body, and P45 the concentrations in body to dose. This will be the 
basis for the ingestion “design” for Sr-90 and Cs-137. The P2345 transfer factor for I-131 will be 
discussed below as only the milk pathway is considered. 
The transfer, represented by the coefficient P23 in units mBq a kg
-1 per Bq m-2, of Sr-90 and Cs-137 
from deposition to diet was modeled in the 1993 UNSCEAR Report using a three-component model 
considering transfer in the first year from mainly direct deposition, transfer in the second year from 
lagged use of stored foods and uptake from the surface deposits, and transfer via root uptake from the 
accumulated deposits [13]. The data provided in the UNSCEAR report were obtained from regression 
analysis for data from Argentina, Denmark, and the United States. These values appear to have not 
changed in the 2000 UNSCEAR Report [16]. No comparable data were discovered for the countries 
considered in our study so the range of results for these three countries will be used to represent the 
range of values for our study after adjusting by an arbitrary 10% on either side to provide some degree 
of safety margin and variability. Said P23 ranges are provided in Table 58.  
To derive values for the UNSCEAR P34 transfer coefficient, the fractional amounts by weight 
consumed provided in the report (based again upon Argentina, Denmark, and the United States) were 
used assuming an average food consumption rate of 500 kg a-1 [13]. These values are provided in 
Table 59. However, because the region of interest in our study is not well-covered by the three 
countries considered in the UNSCEAR 1993 Report, it was decided to include other dietary data in 
defining the P34 range as opposed to adjusting the ranges presented in Table 59 by some arbitrary 
factor as was found necessary for the P23 coefficient. Note that Table 59 provides information (i.e., 
minimum and maximum values) that was not provided in Table 29. 
Additional consumption rate values were taken from a number of sources including:   the values of milk consumption provided on a “by age” basis in the UNSCEAR 1993 Report 
[13],   a 1982 UNSCEAR report [42] on the effects of atomic radiation,   a study [43] concerned with diet and disease in Asia,   the UNFAO food balance sheets [44],   a United Nations report [45] on the effects of ionizing radiation, and  the NRC 1.109 [46] values for the “maximum exposed individual.” 
The following milk consumptions: 330, 180, 150, and 90 L a-1 for age groups 0-1, 1-9, 9-19, and adult, 
respectively, were provided in the UNSCEAR 1993 Report [13]. When converted to a kg a-1 basis 
(using a milk specific gravity of 1.03), they correspond to 339.9, 185.4, 154.5, and 92.7 kg a-1, 
respectively. Note that these values do not appear to be represented by the corresponding values in 
Table 59, which are not age-dependent in nature, and thus the age-dependent values will be considered 
below for the milk pathway where applicable. 
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The values provided in the 1982 UNSCEAR report [42] for age-dependent dietary intakes are 
provided in Table 60. (Note the total is 500 kg a-1 per adult as in Table 59; however, the age-dependent 
1982 UNSCEAR Report values for milk consumption are again different from those used in the 
UNSCEAR 1993 Report.) The Asian dietary report [43] gave a breakdown of food available for 
consumption (which is considered a limit for the purposes of this study) per income level. The P34 
values derived from these data are provided in Table 61. Similar values derived from the UNFAO 
food balance sheets database [44] are provided in Table 62.  
Another source considered for consumption rates was provided in the United Nations report [45] on 
the effects of ionizing radiation; these values are presented in Table 63. However, two of the values 
were cited as being unusually high or low [45] and, therefore, were not used to define the design space 
for the consumption parameters although it would have little impact on the worst-case results that will 
be presented below. So, in effect, the only value from this source that was used was the United States 
meat consumption rate. (Also note that the vegetable and fruit categories were grouped differently 
than in the other tables.) Note this report is the source of the consumption information used in the 
2000 UNSCEAR Report and, therefore, no additional reference pertaining to the consumption rates 
used in the 2000 UNSCEAR Report will be made. 
The final source of consumption information considered was NRC 1.109 [46]. The data for the 
average individual and the “maximum exposed individual”20 are provided in Table 64 and Table 65, 
respectively. The ranges for all pathways considered using the information in Table 58 through Table 
65 are summarized in Table 66.  
Therefore, for the consumption data gathered for this study, there are data (i.e., those in Table 59, 
Table 62, and Table 63) that represent average consumption values, there are also data (i.e., the 
UNSCEAR 1993 Report [13] milk consumption values, Table 60, Table 64, and Table 65) that are 
characterized by age, and even data that are characterized by income level for the region of interest. 
The age-dependent extreme values, as they relate to the adult consumption values, are summarized in 
Table 67. Furthermore, it will be assumed that for the purposes of this study that the non-age-specific 
consumption rates provided elsewhere can be considered adult consumption rates.21 The range of these 
“adult” consumption rates and those obtained using the age-specific factors in Table 67 are provided 
in Table 68. 
Note the minimum and maximum totals in Table 68 are between less than one-tenth and three and 
one-half times that of the average annual consumption (i.e., assumed to be 500 kg a-1) in the 
UNSCEAR 1993 Report. It was decided to follow the example set by the NRC 1.109 “maximum 
exposed individual” [46] where the totals of the consumption values ranged between 339.9 and 1149 
kg a-1 (or between 68% and 230% of the assumed average value of 500 kg a-1). Furthermore, 
representing the consumption rates in this manner allows the unit-sum type constraint22 that would 
otherwise be on this parameter to be omitted making the design study to be executed in a much more 
straightforward manner. Furthermore, a constrained design tends to decrease variation (i.e., a 
constraint is imposed) in the resulting parameters, which is not desirable when attempting to examine 
the worst-case scenario. Thus the ranges in Table 68 are considered to be broad enough to not warrant 
any additional safety margin or more complex design structure. 
As described above, the UNSCEAR P45 transfer coefficients representing the effective committed dose 
per unit intake (in nSv Bq-1) for the ingestion of Sr-90 and Cs-137 were given as 28 and 13, 
respectively [13]. (These values are for the committed equivalent doses for a period of 50 years after 
intake for adults). However, not all the people that will be exposed will be adults; this can be 
                                                     
20  Such individuals are “characterized with regard to food consumption, occupancy, and other usage of the 
region in the vicinity of the plant site and as such represent individuals with habits representing reasonable 
deviations from the average for the population in general.” [46] 
21  From inspection of the available population distribution information, the majority of the impacted persons 
will be adults. Furthermore, it is likely that any bias resulting from this assumption will be more than 
compensated for by the wide range of consumption rates considered. 
22  A unit-sum type constraint is one where the sum of the proportions (e.g., the fractions of an average 
consumption rate) must equal one and are thus constrained. 
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accommodated by computing the P2345 transfer coefficient for ingestion in the same manner as was 
done for I-131 in Equation 6. The ingestion P45 transfer coefficients considered in this study are 
provided in Table 69 [27,46,47].  
Note that the NRC 1.109 [46] values for Sr-90 in Table 69 are more than an order of magnitude higher 
than any of the others. The values in the NRC 1.109 guide are based upon ICRP-2 [48] models; 
whereas, the other values are based upon models using assumptions in ICRP-26 [49] and later. The 
ICRP-2 models used the assumption that a single organ could be considered critical and doses were 
limited to a specified annual dose to said critical organ. The other three sets of P45 values (i.e., NRPB 
[20] used in the UNSCEAR 1993 Report [13], FGR-11 [27], and ICRP-72 [47]) in Table 69 involve 
the concept of tissue weighting factors, which represent the ratio of the risk for the effect in an organ 
to the risk for whole body upon irradiation. Because the NRC 1.109 P45 coefficients are based upon an 
older (and, in a great many cases, superceded) model for dose effects, these coefficients (for both 
ingestion and, later, inhalation) will not be considered for this study. However, they have been 
presented for completeness. 
Population information was used above to weight the I-131 ingestion values found in the UNSCEAR 
1993 Report [13]; however, the population information is not strictly applicable to the region of 
interest in this study. Additional, and more pertinent, population information from the United States 
2000 Census for Alaska [50], the Japanese Ministry of Public Management, Home Affairs, Posts and 
Telecommunications [51], and the Republic of Korea National Statistical Office [52] is provided in 
Table 70. This is considered a reasonable coverage for the region of interest. These population data 
have a constraint upon them; that is, they must sum to 100% (or their corresponding fractions must 
sum to unity). To better represent the possible values, the lower and upper ranges representing the 
values in Table 70 were used to define an extreme vertex design; the ten vertices representing the 
design and the centroid are provided in Table 71. The extreme vertices will be considered in any 
calculation using the population data to assure that representative variation has been included. 
If the resources and time were available, it would be possible to generate a very large design space 
covering all the various parameters that comprise the P23, P34, and P45 transfer coefficients for the 
ingestion pathways.  However such resources are not available and not warranted because of the 
nature and uncertainties inherent in the input data. Therefore, for the purposes of this study, it will be 
considered to be of equivalent value to generate reasonable ranges for the P2345 coefficients for each of 
the five ingestion pathways considered using the ranges of the P23, P34, and P45 factors and populations 
described above. Considering the variations involved, a defensible case can be made that the resulting 
design in P2345 space will provide the appropriate information because the results can be transformed 
back into the component parameters important to each pathway.  
An age-weighted P2345 transfer coefficient accounting for the five pathways noted above is computed 
using the following relationship (where pi,j is again the population fraction for the i
th pathway and jth 
age group): 
 
Equation 16 ( )[ ] groups, age 1,...,4i and pathways 1,...,5jfor   PpPPP
ji453442352345
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which is analogous to that used to compute the I-131 ingestion P2345 transfer coefficient in Equation 6, 
in which only the milk pathway was considered. For example, using the UNSCEAR 1993 Report 
values (instead including the age-specific P45 transfer factors from Reference 20), the Cs-137 P25 
transfer coefficient would be: 
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versus a value of 56 nSv per Bq m-2 computed previously in Equation 4 or the value of 55 nSv per 
Bq m-2 provided in the UNSCEAR 1993 Report [13] (and also computed using Equation 3 in Section 
3.1.1). Therefore, the age-specific P45 values have very little impact on the calculation for this specific 
case where the P45 values vary between 10 and 15.5 nSv Bq
-1.  
A very large set of possible P2345 transfer coefficients for Cs-137 and Sr-90 can be obtained by 
substituting the various possible values of P23, p, P34, and P45 into Equation 17. The ranges describing 
the possible transfer coefficients by both age23 and pathway (including the weighted values obtained 
using Equation 17) are provided in Table 72 and Table 73 for Cs-137 and Sr-90, respectively. The 
corresponding values from the UNSCEAR 1993 Report [13] are 55 and 52 nSv Bq-1 for Cs-137 and 
Sr-90, respectively; therefore, there is the possibility of very different dose estimates from those 
                                                     
23  In estimating the values for Table 72 and Table 73, if only adult values are provided (e.g., the UNSCEAR 
1993 Report consumption values for pathways other than milk and the FGR-11 [27] P45 coefficients), then 
the adult values are substituted for the missing values. This will provide conservative minimum and 
maximum values for the coefficients desired in this study. 
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obtained using the UNSCEAR 1993 Report values. The Cs-137 and Sr-90 P2345 coefficients for adults, 
which were the values computed in the UNSCEAR 1993 Report [13], are between 0.13 and 4.6 times 
and 0.12 to 7.4 times, respectively, the values provided in the UNSCEAR 1993 Report. For the 
“maximum individual”24, or that age group with the highest deposition-to-dose P2345 ingestion 
coefficient, the values in Table 72 and Table 73 for Cs-137 (for teens) and Sr-90 (for infants) are 
between 0.13 and 6.0 times and between 0.014 and 34.3 times, respectively, the values provided in the 
UNSCEAR 1993 Report. 
4.2.1 I-131 Ingestion Design Space Definition 
For I-131, only the milk pathway was assumed significant in the UNSCEAR 1993 Report (which 
appears a reasonable assumption). The P23 value used for I-131 is 0.63 mBq a L
-1 per Bq m-2 [21], 
which was derived for an average milk consumption rate of 0.3 L d-1 (or 109.5 L a-1). Use of these 
values provides a nominal P234 = P23P34 coefficient for I-131 of 0.07 Bq per Bq m
-2. As illustrated in 
Equation 6, the population information in Table 70 was used with the following milk consumptions: 
330, 180, 150, and 90 L a-1 for age groups 0-1, 1-9, 9-19, and adult, respectively, to derive an overall 
P2345 coefficient for I-131 of 4.2 nSv per Bq m
-2.  
Defining a design space for the I-131 P25 coefficients requires information concerning the ranges for 
the P23, P34, and P45 parameters resulting from site specific criteria, updated information, etc. As in the 
case of the P23 parameters for Sr-90 and Cs-137, the basic information as to how this value used was 
obtained is not available; therefore, an arbitrary factor of 10% on either side of the UNSCEAR P23 
value was employed. The P34 design range from Table 68 for milk converted to a L a
-1 basis will be 
used. The P45 coefficients for I-131 are provided in Table 69 (where a value of 61 nSv Bq-1 will be 
examined as this is the age-weighted value used in the UNSCEAR 1993 Report [13]). As above, the 
NRC 1.109 values were not used as they are based upon a different assumption than the other three 
sets of information. Using the aforementioned information, the ranges describing the resulting I-131 
P2345 coefficients for ingestion are provided in Table 74; the value used in the UNSCEAR 1993 Report 
is 4.2 nSv per Bq m-2. Note that the weighted values, which are analogous to those computed in the 
UNSCEAR 1993 Report, are between 0.008 and 4.4 times the value provided in the UNSCEAR 1993 
Report, and the “maximum individual” values (for infants) are between 0.008 and 39.4 times the 
UNSCEAR 1993 Report value. 
4.3 Inhalation Transfer Coefficients 
Per the UNSCEAR 1993 report, the deposition-to-dose transfer coefficient for the inhalation pathway 
is computed using the form described in Equation 8: 
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where P14 is the average breathing rate (e.g., 7300 m
3 a-1 [13]), P45 is the dose per unit intake factor in 
nGy Bq-1, and P12 is the deposition velocity (e.g., 1.76 cm s
-1 [13]). The above relationship provides a 
P245 transfer factor with units of nGy Bq
-1 instead of nSv Bq-1, which is desired for this study. From 
inspection of the results in the UNSCEAR 1993 Report [13], it appears that a factor of 1 nSv nGy-1 
was used to convert from the values provided using the relationship in Equation 8 to the P245 values 
provided in nSv Bq-1 that were subsequently used to estimate doses. 
Various average breathing rates (P14) are provided in Table 60, Table 64, and Table 65; whereas, a 
value of 7300 m3 a-1 was used in the UNSCEAR 1993 Report [13]. Additional values obtained from 
                                                     
24  It is sufficient to define the “maximum individual” based upon the ingestion P2345 coefficients because 1) 
inhalation is a very small part of the total deposition to dose factor and 2) external exposure is not age-
dependent. 
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the 2000 UNSCEAR Report [16,53] are provided in Table 75. The breathing rate values for use in this 
study are summarized in Table 76.  
A single value (i.e., 1.76 cm s-1 or 5.54x105 m a-1) of the P12 parameter was used in the UNSCEAR 
1993 Report [13] for all radionuclides. However, the dry deposition values [6] are 0.2, 0.15, and 0.6 
cm s-1 for Sr-90, Cs-137, and I-131, respectively. Thus these deposition velocities will be used with 
the UNSCEAR P12 value of 1.76 cm s
-1 to bracket the likely values of P12 for definition of the P245 
inhalation design space.  
The final parameter used in the definition of the UNSCEAR P245 factor for inhalation is the effective, 
committed dose per unit intake, P45, in units of nSv Bq
-1. The relevant information concerning the 
possible values for the effective P45 transfer coefficient is summarized in Table 77.  When age-
dependent values for P14 and P45 are available, then the P245 should be weighted as follows: 
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where P12 is the deposition velocity (which is not population dependent) and pi, P14,i, and P45,i are the 
appropriate population fraction (e.g., as provided in Table 70), breathing rate (e.g., Table 60 and Table 
76), and exposure-to-dose coefficient (from Table 77) for the ith age group, respectively. For example, 
the original Cs-137 P245 coefficient for adults was provided using Equation 8: 
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When the appropriate age-dependent values are used including the age-dependent P45 values [20], the 
P245 value becomes: 
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or there is little change in the P245 transfer factor for this specific case.  
Using the information above for P14 and P12 as well as the P45 information in Table 77, the P245 design 
space for inhalation can be defined as shown in Table 78. The Cs-137 and Sr-90 P245 transfer factors 
for adults, which correspond to the values computed in the UNSCEAR 1993 Report, are between 0.55 
and 13.4 times and 0.46 to 9.8 times, respectively, the original UNSCEAR values. For the “maximum 
individual”, or that age group with the highest overall deposition-to-dose transfer coefficient, the 
values for Cs-137 (for teens) and Sr-90 (for infants) are between 0.40 and 13.3 times and between 0.14 
and 8.4 times, respectively, the original UNSCEAR transfer factors. For I-131, the age-weighted P245 
values, which correspond to those in the UNSCEAR Report, are between 0.56 and 4.9 times the 
original value, and the “maximum individual” values (for infants) are between 0.10 and 5.7 times the 
original UNSCEAR value. Thus the three parameters used in the definition of P245 for inhalation were 
lumped into a single P245 design parameter to simplify the design. Any significant effects of the 
inhalation parameter can easily be deconvoluted to identify specific inhalation parameters. 
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4.4 External Exposure Transfer Coefficients 
In addition to internal radiation from inhaled or ingested radionuclides, persons are also irradiated 
externally from gamma-emitting nuclides dispersed in air and on the ground. As the contamination 
normally spends much more time on the ground than in the air, the external dose due to irradiation 
from the earth’s surface is normally significantly higher than the dose due to irradiation while the 
cloud of contamination passes [13]. Therefore, as described above, the external exposure due to 
radioactive cloud passage will be assumed negligible for the purpose of this study.  
As described above, the UNSCEAR P25 transfer coefficients for external irradiation due to ground 
contamination were computed by multiplying the appropriate dose rate conversion factors by the mean 
lifetime of the radionuclide (i.e., half-life divided by ln(2)) and then by an average factor assuming 
80% indoor occupancy with a shielding factor of 0.2. A factor of 0.7 Sv per Gy (i.e., equivalent dose 
rate in the body per unit absorbed dose rate in air) was also used [54].25 For I-131 the dose rate 
conversion factor applying to a plane source was used. For Cs-137, the dose-rate conversion factor 
applying to an exponential concentration profile in the ground with a mean depth of 3 cm was used. 
No value was given for Sr-90 (likely because it is a pure beta emitter). Thus the UNSCEAR 1993 
values for the external exposure P25 coefficients for Cs-137, Sr-90 and I-131 were 97, 0, and 0.12 nSv 
per Bq m-2, respectively. 
To better represent the range of values that might influence the estimation of external exposure, the 
various factors used to represent daily exposure were considered as illustrated in Table 79.The values 
provided in Federal Guidance Report No. 12 (FGR-12) [26] are already provided in Sv Bq-1 and thus 
no absorption value is needed. Furthermore, the maximum exposure will be when the person spends all 
their time outside. (Even though this scenario is implausible, it provides an upper limit for this study.) 
This scenario renders the indoor occupancy and shielding factors moot for the maximum exposure 
case.  
Using the values from Table 79 which will provide maximum dose transfer coefficients (i.e., the case 
where all time is spent outdoors) and the FGR-12 dose coefficients (i.e., 2.84x10-10 and 3.76x10-7 Sv 
per Bq s m-2 for Sr-90 and I-131, respectively) for exposure to contaminated ground surface [26], 
maximum values for P25 can be obtained:
26 
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25  It is assumed that this factor is used because the dose factors are those based upon soft tissue near the body 
surface. Because of energy absorption in the body, the interior doses are about 70% of the values measured 
near the body surface [54]. 
26  Note that the quantity, (1-Ri) + (Ri)(Sh), is referred to as Sf in NRC 1.109 and has values of 0.5 and 0.7 for 
the general population and maximum individual exposures, respectively. Using the values in Table 79 gives a 
range of Sf for this study from 0.36 to 1.0; therefore, the NRC 1.109 values will not be explicitly mentioned 
in this study (as they are represented in the range computed). 
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where the half-lives of I-131 and Sr-90 are 6.948x105 and 9.1764x108 s, respectively [6]. Note that the 
Gy to Sv conversion factor of 0.7 was unnecessary in the above equations. Substituting the external 
exposure value from NRC 1.109 [46] of 2.10x10-7 Sv per Bq s m-2 for I-131 provides a value of 0.21 
nSv per Bq m-2 for I-131. The value provided in NRC 1.109 for Sr-90 is 0 nSv per Bq m-2 [46]. Thus 
the lower values for the P25 ranges for Sr-90 and I-131 will be those from the UNSCEAR 1993 Report 
[13]. The fact that the P25 factor for Sr-90 is non-zero may cause some consternation; however, two 
facts must be taken into consideration: 1) the appropriate coefficient from FGR-12 is non-zero and 2) 
the Sr-90 dose commitments will be dominated by the ingestion pathway.  
As described above, the P25 coefficient (i.e., 97 nSv per Bq m
-2) for Cs-137 was computed in a 
different fashion than those for Sr-90 and I-131; the dose-rate conversion factor corresponding to an 
exponential concentration profile in the ground with mean depth of 3 cm was used [13]. However, it 
appears that the Cs-137 was assumed to be in secular equilibrium with Ba-137m (which is a valid 
assumption) and that the dose-rate conversion factor for Ba-137m was used to determine the external 
irradiation factor for Cs-137.  
For example, employing the FGR-12 Cs-137 dose coefficients (i.e., 1.34x10-12 Sv s-1 per Bq m-3 and 
3.07x10-12 Sv s-1 per Bq m-3 [26]) for 20% outdoor exposure (i.e., the complement of an 80% indoor 
exposure) to soil contaminated to depths of 1 cm and 5 cm, respectively (because coefficients for 3 cm 
were not provided) provides the following P25 values: 
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Cs-137 at 5 cm 
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If, on the other hand, the FGR-12 values (i.e., 3.76x10-9 Sv s-1 per Bq m-3 and 1.09x10-8 Sv s-1 per Bq 
m-3 at 1 cm and 5 cm, respectively [26]) for Ba-137m are used, the following P25 values are obtained: 
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+− 
=
−
−
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Ba-137m at 5 cm 
( )( ) ( ) ( )( )[ ]( )( ) ( ) ( )( ) ( )( )[ ]
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for a value (based upon an exponential concentration profile) at 3 cm of 141.3 nSv per Bq m-2, which 
is larger than the UNSCEAR value of 97 nSv per Bq m-2. This will be used as one way to obtain an 
upper bound for Cs-137 because it will be assumed that the Ba-137m is in secular equilibrium with 
Cs-137. 
The upper bound for Cs-137 will thus be the value P25 (with 100% outdoor occupancy and no quality 
factor adjustment) corresponding to 3 cm based upon the following: 
 
Ba-137m at 1 cm 
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=
−
−
 
Ba-137m at 5 cm 
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=
−
−
 
 
The value at 3 cm is 392.6 nSv per Bq m-2 based upon a logarithmic profile. 
In NRC 1.109 [46], the external exposures are not given as a function of depth. Following the 
computations for I-131 and Sr-90, the minimum and maximum external exposures from Cs-137 for an 
individual standing on contaminated ground based upon the value of 4.20x10-9 mrem h-1 per pCi m-2 
(which converts to a value of 3.15x10-7 Sv s-1 per Bq m-2) would be: 
 
Minimum Cs-137 
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and 
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Maximum Cs-137 
( )( ) ( ) ( )[ ]( )( ) ( ) ( ) ( )( )[ ]
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The minimum design value will be that (i.e., 97 nSv per Bq m-2) from the UNSCEAR 1993 Report 
[13] because it is lowest of those computed for Cs-137. The upper value for Cs-137 will be the largest 
computed from the NRC 1.109 [46] values. Although the assumptions for which it was computed are 
somewhat different than those used in the UNSCEAR 1993 Report, the NRC 1.109 value is 
considered appropriate for use under scenarios such as those postulated in this study and, therefore, the 
value will be included here as the maximum value for Cs-137. Note that, unlike the NRC 1.109 
ingestion and inhalation coefficients, the fundamental assumptions have not changed since its 
publication and, therefore, these values have been included in this study. Any issues (e.g., secular 
equilibrium between Ba-137m and Cs-137) used to compute the Cs-137 P25 coefficients using the 
FGR-12 information are less important as said values fall within the range that will be used in this 
study; they are not used to directly define the range of P25 coefficients that will be used. 
4.5 Transfer Coefficient Summary Based upon the UNSCEAR Methodology 
The design spaces for Cs-137, Sr-90, and I-131 are summarized by the various deposition-to-dose 
transfer coefficients defined in this memorandum (which will then be multiplied by the pertinent, 
scaled deposited radiation levels in Bq m-2 to provide dose commitment estimates). The deposition-to-
dose coefficients for Cs-137, Sr-90, and I-131 are summarized in Table 80, Table 81, and Table 82, 
respectively, and the factors needed to scale the “unit hypothetical release” of 8.64x1014 Bq to values 
representing various accident scenarios are provided in Table 57. Note that like the UNSCEAR 1993 
Report values, the majority of the Cs-137 dose commitment is from the external exposure pathway 
(although the ingestion pathway can be significant), and the Sr-90 and I-131 dose commitments will 
be dominated by the ingestion pathway. 
Initially “worst-case” scenarios will be examined to indicate whether additional study is necessary. By 
“worst-case,” it is meant that the values associated with those coefficients described above that result 
in the largest dose commitment for the individual in question will be used. The scenarios the will be 
considered in this study are the following:  “maximum individual” dose commitment or that dose resulting from the coefficients 
corresponding to the maximum coefficients in Table 80 (or the teen group for Cs-137), Table 
81 (or the infant group for Sr-90), and Table 82 (or the infant group for I-131),  maximum adult dose commitments for Cs-137 and Sr-90 and age-weighted dose commitment 
for I-131, and   maximum collective dose commitment corresponding to the age-weighted values in Table 80. 
The above scenarios appear appropriate because the “maximum individual” dose commitment will 
illustrate the maximum impact on those persons most effected by the depositions considered in this 
study. The maximum, adult dose commitments for Cs-137 and Sr-90 and the age-weighted dose 
commitment for I-131 will show impact that varying the parameters in this study have relative to the 
UNSCEAR 1993 Report values. The maximum, collective dose commitments will only be computed 
using the population-weighted values from Table 80, Table 81, and Table 82 as the weighting takes 
into account the varying ages in the affected population. 
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4.6 Adjusted Total Deposition Data Analysis 
In this part of the study, the deposition data will be adjusted to be more representative of the types of 
accidents that can occur. Examination of the adjusted total deposition data for a given site requires 
adjustment of the original total depositions [6] by the maximum ratio from Table 57 for the site in 
question. In essence, the source term would be adjusted by the appropriate ratio from Table 57, which 
would then result in each deposition from Mahura [6] to be adjusted by the same factor. Therefore, it 
is equivalent to merely adjust the depositions to reflect the result of the new source term. Adjustment 
of the source term and resulting depositions will have the greatest impact on the Cs-137 results; these 
values can increase by a factor of more than five for both the PRS and VRS when the maximum 
values from Table 57 are considered. The impact on the Sr-90 deposition values will be negative; the 
PRS and VRS values for Sr-90 will be less than 30% of the original “unit hypothetical” value. The 
largest impact will be on the total I-131 depositions; the resulting depositions for both the PRS and 
VRS will decrease by more than a factor of 250. 
4.6.1 Maximum Adjusted Total Depositions from the PRS 
Using the appropriate values from Table 57, the maximum adjusted total deposition values for the 
releases from the PRS are provided in Table 83, Table 84, and Table 85 for Cs-137, Sr-90, and I-131, 
respectively. Note that, not surprisingly, the maximum adjusted Cs-137 depositions are now more than 
an order of magnitude larger than the corresponding maximum Sr-90 values and almost three orders of 
magnitude larger than the corresponding I-131 depositions. When considering the deposition-to-dose 
coefficients in Table 80, Table 81, and Table 82 for Cs-137, Sr-90, and I-131, respectively, it is 
apparent that the radionuclide of primary interest will be Cs-137. This should be obvious when 
comparing the resulting Cs-137 and I-131 dose commitments because both the Cs-137 maximum 
depositions and deposition-to-dose factors are orders of magnitude larger for Cs-137 than for I-131. 
For Sr-90, even though the deposition-to-dose coefficients are larger than their Cs-137 counterparts by 
a factor of up to 2.5, the maximum Cs-137 depositions will be larger than those for Sr-90 by more than 
an order of magnitude. Thus the Cs-137 depositions and resulting dose commitments are of primary 
concern for releases from the PRS. 
The distribution of maximum daily total depositions corresponding to the adjusted Cs-137 releases 
from the PRS for the entire region of interest and the transboundary region (i.e., including all areas 
outside of Russia including ocean) are provided in Figure 57(a) and Figure 57(b), respectively. The 
maximum depositions for the adjusted releases from the PRS are 1.39x105 and 1.10x105 Bq m-2 for the 
entire region and transboundary region, respectively. Thus even though there is little impact on the 
maximum deposition (and thus the corresponding dose commitment) between these two regions, the 
information in Figure 57 indicates that there are fewer large depositions (i.e., greater than 5x104 Bq 
m-2) in the transboundary region.  
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(a) Regional 
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(b) Transboundary 
Figure 57. Frequency histogram and cumulative percentages for the adjusted PRS Cs-137 total 
deposition (tdep) maximum values for (a) the entire region of interest and (b) the 
transboundary region. 
 
To complete the picture, the distributions for the maximum Sr-90 and I-131 depositions resulting from 
the adjusted releases from the PRS are provided in Figure 58 and Figure 59, respectively. As indicated 
above, the deposition and dose commitments resulting for these two radionuclides from the adjusted 
releases from the PRS are much less significant than those for Cs-137. 
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(a) Regional 
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(b) Transboundary 
Figure 58. Frequency histogram and cumulative percentages for the adjusted PRS Sr-90 total deposition 
(tdep) maximum values for (a) the entire region of interest and (b) the transboundary region. 
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(a) Regional 
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(b) Transboundary 
Figure 59. Frequency histogram and cumulative percentages for the adjusted PRS I-131 total deposition 
(tdep) maximum values in for (a) the entire region of interest and (b) the transboundary 
region. 
4.6.1.1 Specific Case Examples: Japan and U.S. Depositions from the PRS 
For the specific examples in this study, only the Cs-137 depositions will be examined as they represent 
the largest impact of the three radionuclides considered. The distribution of maximum total Cs-137 
depositions for Japan resulting from the adjusted PRS releases is illustrated in Figure 60. Note that 
even though the maximum value is 1380 Bq m-2 (from Table 83), 95% of all such depositions in Japan 
are less than 156 Bq m-2 and there are no depositions on 75% of all days in CY2000. Therefore, the 
impact on Japan from even the maximum adjusted releases from the PRS appears to be minimal when 
compared to the rest of the transboundary region.  
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Figure 60. Japan Results: Frequency histogram and cumulative percentages for the PRS Cs-137 total 
deposition (tdep) adjusted values. 
 
The distributions of the maximum total Cs-137 depositions resulting from the adjusted PRS releases 
for Alaska and the Aleutian Islands are provided in Figure 61(a) and Figure 61(b), respectively. It 
should be noted that 1) the impact on both of these U.S. territories is similar and 2) that the impact on 
these U.S. territories is generally larger than that on Japan. Both the maximum values for the U.S. 
territories (as illustrated in Table 83) are larger by a factor of at least 3.5, but there are depositions on 
the U.S. territories considered on many more days than in Japan. Therefore, the adjusted Cs-137 
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releases from the PRS are more significant to the people living in the U.S. territories than in Japan; 
however, it is also true that many more people will be impacted by the depositions on Japan than in 
either U.S. territory considered here. This impact will be addressed below when collective doses are 
computed. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 61. U.S. Results: Frequency histogram and cumulative percentages for the PRS Cs-137 total 
deposition (tdep) adjusted values for (a) Alaska and (b) the Aleutian Islands. 
4.6.2 Maximum Adjusted Total Depositions from the VRS 
Using the appropriate values from Table 57, the maximum total deposition values obtained for the 
adjusted VRS releases are provided in Table 86, Table 87, and Table 88 for Cs-137, Sr-90, and I-131, 
respectively. Note that, like those for the corresponding PRS releases, the adjusted Cs-137 depositions 
are more than an order of magnitude larger than the corresponding maximum Sr-90 values and 
approximately three orders of magnitude larger than the corresponding I-131 depositions. When 
considering the deposition-to-dose coefficients, it is apparent that the radionuclide of primary interest 
will be Cs-137.  
The distribution of maximum daily total depositions corresponding to the adjusted Cs-137 releases 
from the VRS for the entire region of interest and the transboundary region are provided in Figure 
62(a) and Figure 62(b), respectively. The maximum depositions for the adjusted VRS releases are 
3.91x105 and 1.34x105 Bq m-2 for the entire region and transboundary region, respectively. Thus even 
though there is little impact on the maximum deposition (and thus dose commitment) between these 
two regions, the information in Figure 62 indicates that there are many fewer large depositions in the 
transboundary region.  
 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 68 
0
20
40
60
80
100
120
140
160
4.
56
E+
02
1.
54
E+
04
3.
03
E+
04
4.
52
E+
04
6.
01
E+
04
7.
50
E+
04
8.
99
E+
04
1.
05
E+
05
1.
20
E+
05
M
or
e
F
r
e
q
u
e
n
c
y
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
Total deposition (Bq m -2)  
 
(a) Regional 
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(b) Transboundary 
Figure 62. Frequency histogram and cumulative percentages for the adjusted VRS Cs-137 total 
deposition (tdep) maximum values for (a) the entire region of interest and (b) the 
transboundary region. 
 
The distributions for the maximum Sr-90 and I-131 depositions resulting from the adjusted VRS 
releases are provided in Figure 63 and Figure 64, respectively. As indicated above, the deposition and 
dose commitments resulting for these two radionuclides from the adjusted PRS releases are much less 
significant than those for Cs-137. 
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(a) Regional 
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(b) Transboundary 
Figure 63. Frequency histogram and cumulative percentages for the adjusted VRS Sr-90 total deposition 
(tdep) maximum values for (a) the entire region of interest and (b) the transboundary region. 
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(b) Transboundary 
Figure 64. Frequency histogram and cumulative percentages for the adjusted VRS I-131 total deposition 
(tdep) maximum values for (a) the entire region of interest and (b) the transboundary region. 
4.6.2.1 Specific Case Examples: Japan and U.S. Depositions from the VRS 
For the specific examples in this study, only the Cs-137 depositions will be examined for the adjusted 
VRS releases as they represent the largest impact of the three radionuclides considered. The 
distribution of maximum total Cs-137 depositions for Japan resulting from the adjusted VRS releases 
is illustrated in Figure 65. Note that the impact on Japan from releases at the VRS is generally much 
larger than those from the PRS. The maximum deposition resulting from the adjusted VRS release is 
5.70x104 Bq m-2 or more than 40 times that from the corresponding adjusted release from the PRS. 
Furthermore, the majority of the maximum daily depositions in Japan from the adjusted VRS release 
are greater than the maximum of all such releases from the PRS. The maximum such value for Japan 
corresponds to approximately one-half the value for China, a country proximate to the VRS. 
Therefore, the impact on Japan from the adjusted VRS releases appears to warrant greater 
consideration. This will be considered in detail below when dose commitments are estimated. 
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Figure 65. Japan Results: Frequency histogram and cumulative percentages for the VRS Cs-137 total 
deposition (tdep) adjusted values. 
 
The distributions of the maximum total Cs-137 depositions resulting from the adjusted PRS releases 
for Alaska and the Aleutian Islands are provided in Figure 66(a) and Figure 66(b), respectively. It 
should be noted that the impact on both of these U.S. territories is again similar (as found for the 
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corresponding releases from the PRS). However, unlike the VRS, the maximum impact on these U.S. 
territories is generally smaller than that on Japan by an order of magnitude and there are depositions 
on approximately half the number of CY2000 days as there are for Japan. Therefore, the adjusted 
Cs-137 releases from the VRS are more significant to the people living in Japan than those living in 
the U.S. territories; this is compounded by the fact that many more people will be impacted by the 
depositions on Japan than in either U.S. territory considered. This impact will be addressed below 
when collective doses are computed. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 66. U.S. Results: Frequency histogram and cumulative percentages for the VRS Cs-137 total 
deposition (tdep) adjusted values for (a) Alaska and (b) the Aleutian Islands. 
4.6.3 Summary of the Adjusted Total Depositions 
A summary of the maximum (non-zero) adjusted total depositions for the PRS and VRS is presented 
in Exhibit 11. Note that the maximum total depositions for Russia (and thus the region) are 
comparable; however, the total depositions outside of Russia are much larger for the VRS releases 
than for those from the PRS. Furthermore, the impacts from Cs-137 releases are much larger than their 
Sr-90 counterparts and orders of magnitude larger than those for I-131. Thus the Cs-137 will be of 
primary concern under the conditions studied in this report. 
Exhibit 11. Summary of Maximum Adjusted Total Depositions (tdep) 
PRS  VRS 
 Maximum Total 
Deposition (Bq m
-2
) 
  Maximum Total 
Deposition (Bq m
-2
) 
Region Cs-137 Sr-90 I-131  Region Cs-137 Sr-90 I-131 
Regional 1.42E+05 8.25E+03 1.85E+02  Regional 1.35E+05 9.38E+03 2.10E+02 
Transboundary* 1.12E+05 6.63E+03 1.23E+02  Transboundary* 4.62E+04 3.13E+03 7.01E+01 
China 9.93E+02 5.58E+01 2.47E-07  China 3.54E+04 2.27E+03 6.53E+01 
Hong Kong     Hong Kong 2.84E+01 6.52E-04  
Japan 1.41E+03 9.19E+01 1.53E-01  Japan 1.96E+04 1.27E+03 1.04E+01 
Mongolia 5.54E+01 3.20E+00   Mongolia 3.42E+02 2.17E+01 2.33E-06 
N. Korea 2.77E+02 1.74E+01   N. Korea 2.18E+04 1.49E+03 3.93E+01 
Russia 1.42E+05 8.25E+03 1.85E+02  Russia 1.35E+05 9.38E+03 2.10E+02 
S. Korea 2.09E+01 6.16E-01   S. Korea 5.28E+03 3.44E+02 4.55E+00 
Taiwan     Taiwan 9.77E+02 6.27E+01  
Aleutians (U.S.) 4.37E+03 2.45E+02 2.01E+00  Aleutians (U.S.) 2.99E+02 1.74E+01 2.62E-02 
Alaska (U.S.) 6.54E+03 3.93E+02 1.36E-01  Alaska (U.S.) 5.74E+02 1.20E+01 2.13E-14 
Vietnam     Vietnam 1.47E-05 1.27E-10  
 
* The transboundary region includes all land areas (i.e., including ocean) outside of Russia. 
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4.7 Worst-Case Scenario Maximum Effective Dose Commitment Estimates 
Estimation of the maximum dose commitments corresponding to the worst-case scenario for a given 
site requires multiplying the maximum adjusted total deposition described above by the appropriate 
deposition-to-dose factor from either Table 80, Table 81, or Table 82 for the radionuclide in question. 
Results for two specific cases will be computed for each radionuclide corresponding to the UNSCEAR 
1993 Report results; these are:  the maximum individual (i.e., teen) and adult dose commitments for Cs-137,  the maximum individual (i.e., infant) and adult dose commitments for Sr-90, and  the maximum individual (i.e., infant) and age-weighted (or person) dose commitments for 
I-131. 
Such adjustments of the deposition-to-dose factors will have the greatest impact on the Sr-90 and 
I-131 results; these values can increase by factors of more than 30 depending upon the age group in 
question. The impact on the Cs-137 results will be significantly smaller (i.e., an increase by a factor of 
five or less). However, because the adjusted Cs-137 depositions can be much larger than those for 
either Sr-90 or I-131, the Cs-137 dose commitments resulting from the adjusted releases from both 
sites will be significantly larger than those from either Sr-90 or I-131. 
4.7.1 Worst-Case Dose Commitments from the PRS 
Despite the fact that the Cs-137 dose commitments will be largest for the conditions considered in this 
study, the maximum Sr-90 and I-131 dose commitments resulting from the adjusted release from the 
PRS will also be computed for completeness and as points of comparison. To compute the pertinent 
dose commitment, the maximum deposition for Cs-137, Sr-90, or I-131 described above will be 
multiplied by the deposition-to-dose factor obtained by adjusting the UNSCEAR 1993 factor by the 
following factor:  5.01 for teens, the “maximum individual” group, and 4.51 for adults for Cs-137 from Table 
80, or  31.87 for infant, the “maximum individual” group, and 7.65 for adults for Sr-90 from Table 
81, or  37.15 for infant, the “maximum individual” group, and 4.34 for the age-weighted value for 
I-131 from Table 82. 
Using the maximum total deposition values for the adjusted releases from the PRS and the appropriate 
factors from Table 80, Table 81, and Table 82, the maximum dose commitments were computed; for 
the maximum individual dose commitments, these are provided in Table 89, Table 91, and Table 93 
for Cs-137, Sr-90, and I-131, respectively, and the corresponding adult (for Cs-137 and Sr-90) and 
age-weighted (for I-131) doses are provided in Table 90, Table 92, and Table 94. As predicted above, 
the worst-case Cs-137 dose commitments for the maximum individual are, in general, more than a 
factor of five larger than the corresponding Sr-90 values and more than three orders of magnitude 
larger than the corresponding I-131 values. The adult and age-weighted dose commitments for Cs-137 
are even larger than their corresponding Sr-90 and I-131 values. Thus the Cs-137 dose commitments 
are of primary concern for the adjusted releases from the PRS. 
The distribution of maximum daily dose commitments corresponding to the adjusted Cs-137 releases 
from the PRS for the entire region of interest and the transboundary region (i.e., including all areas 
outside of Russia excluding oceans) are provided in Figure 67 and Figure 68, respectively, for both the 
maximum individual (in this case, the teen group) and adult categories. The maximum dose 
commitments for the adjusted releases from the PRS for the entire region are 108 and 97.3 mSv per 
person for the maximum individual (or teen) and adult categories, respectively. For the transboundary 
region, the corresponding dose commitments are 4.98 and 4.49 mSv per person for the maximum 
individual and adult categories, respectively. Note that by accounting for possible variation in the 
source term and the parameters used to define the deposition-to-dose transfer coefficients as well as 
 72 
considering the maximum exposed individual, the Cs-137 dose commitments can increase by a factor 
of approximately 25. 
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(a) Maximum Individual (Teen) 
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(b) Adult 
Figure 67. Frequency histogram and cumulative percentages for the PRS Cs-137 maximum effective dose 
commitments for (a) the maximum individual and (b) adult. 
 
These results illustrate a very interesting fact concerning the maximum dose commitments resulting 
from the adjusted releases from the PRS for Cs-137. On a regional basis, the majority of the Cs-137 
dose commitments to either the maximum individual or adult are larger than the annual 10 mSv per 
person level below which interventions are rarely justified [17], and there is a single maximum daily 
value for the maximum individual that exceeds the annual 100 mSv per person level in which 
interventions are almost always justifiable [17] (although this maximum value is less than the total 
dose that would be imparted by background radiation over the lifetime of the individual). Examination 
of the transboundary results indicate that even the worst-case values are all less than the annual 10 
mSv per person level below which interventions are rarely justified [17], and over 40% are less than 
the average annual background dose of 2.4 mSv [13]. Thus even though the impact to Russia from the 
adjusted PRS release may be large as anticipated, the transboundary implications are much less 
significant even for the worst-case scenario. 
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(a) Maximum Individual (Teen) 
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(b) Adult 
Figure 68. Transboundary frequency histogram and cumulative percentages for the PRS Cs-137 
maximum effective dose commitments for (a) the maximum individual and (b) adult. 
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The distribution of maximum daily dose commitments corresponding to the adjusted Sr-90 releases 
from the PRS for the entire region of interest and the transboundary region (i.e., including all areas 
outside of Russia excluding oceans) are provided in Figure 69 and Figure 70, respectively, for both the 
maximum individual (in this case, the infant group) and adult categories. The maximum dose 
commitments for the adjusted releases from the PRS for the entire region are 14.7 and 3.53 mSv per 
person for the maximum individual (or infant) and adult categories, respectively. For the 
transboundary region, the corresponding dose commitments are 0.71 and 0.17 mSv per person for the 
maximum individual and adult categories, respectively. Note that by accounting for possible variation 
in the source term and the parameters used to define the deposition-to-dose transfer coefficients as 
well as considering the maximum exposed individual, the Sr-90 dose commitments can increase by a 
factor of almost an order of magnitude. 
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(a) Maximum Individual (Infant) 
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(b) Adult 
Figure 69. Frequency histogram and cumulative percentages for the PRS Sr-90 maximum effective dose 
commitments for (a) the maximum individual and (b) adult. 
 
On a regional basis, less than 2% of the Sr-90 dose commitments to the maximum individual exceed 
the annual 10 mSv per person level below which interventions are rarely justified [17], and there are 
no values for the maximum individual that exceed the annual 100 mSv per person level in which 
interventions are almost always justifiable [17]. All the adult dose commitments from Sr-90 are less 
than the 10 mSv per person level below which interventions are rarely justified [17], and more than 
98% of these dose commitments are less than the average annual background dose of 2.4 mSv [13]. 
Examination of the transboundary results indicates that all the worst-case values are less than the 
international annual reference level of 1 mSv per person [17]. Thus the impact to Russia from the 
adjusted release from the PRS may be significant (although apparently within the variation expected in 
background doses [13]); the transboundary implications are much less so. 
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(a) Maximum Individual (Infant) 
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(b) Adult 
Figure 70. Transboundary frequency histogram and cumulative percentages for the PRS Sr-90 maximum 
effective dose commitments for (a) the maximum individual and (b) adult. 
 
The distribution of maximum daily dose commitments corresponding to the adjusted I-131 releases 
from the PRS for the entire region of interest and the transboundary region (i.e., including all areas 
outside of Russia excluding oceans) are provided in Figure 71 and Figure 72, respectively, for both the 
maximum individual (in this case, the infant group) and age-weighted categories. The maximum dose 
commitments for the adjusted releases from the PRS for the entire region are 3.30x10-2 and 3.86x10-3 
mSv per person for the maximum individual (or infant) and age-weighted categories, respectively. For 
the transboundary region, the corresponding dose commitments are 4.41x10-4 and 5.16x10-5 mSv per 
person for the maximum individual and adult categories, respectively. Note that by accounting for 
possible variation in the source term and the parameters used to define the deposition-to-dose transfer 
coefficients as well as considering the maximum exposed individual, the I-131 dose commitments can 
decrease by a factor of more than 46. 
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(a) Maximum Individual (Infant) 
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(b) Age-Weighted 
Figure 71. Frequency histogram and cumulative percentages for the PRS I-131 maximum effective dose 
commitments for (a) the maximum individual and (b) the age-weighted individual. 
 
On both a regional and transboundary basis, the I-131 dose commitments are less than the 
international annual reference level of 1 mSv per person [17] (and thus the average annual background 
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dose) by at least a factor of 30. Thus the impact from I-131 based upon the conditions in this study 
will be small.  
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(a) Maximum Individual (Infant) 
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(b) Age-Weighted 
Figure 72. Transboundary frequency histogram and cumulative percentages for the PRS I-131 maximum 
effective dose commitments for (a) the maximum individual and (b) the age-weighted 
individual. 
4.7.1.1 Specific Case Examples: Japan and U.S. Dose Commitments from the PRS 
For the specific examples in this study, only the maximum Cs-137 dose commitments from the 
adjusted release from the PRS will be examined as they represent the largest impact of the three 
radionuclides considered. The distribution of maximum Cs-137 dose commitments for Japan resulting 
from the adjusted PRS releases is illustrated in Figure 73. Note that only a single maximum value for 
the worst-case scenario (and maximum individual) exceeds the international annual reference level of 
1 mSv per person [17]; however, this maximum value is significantly less than the average annual 
background dose. Therefore, the impact on Japan from even the adjusted PRS releases appears to be 
minimal from an intervention perspective.  
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(b) Adult 
Figure 73. Japan Results: Frequency histogram and cumulative percentages for the worst-case PRS 
Cs-137 maximum effective dose commitments for (a) the maximum individual and (b) adult. 
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The distribution of maximum Cs-137 dose commitments for Alaska resulting from the adjusted PRS 
releases is illustrated in Figure 74. Note that none of the maximum values for the worst-case scenario 
exceed the annual 10 mSv per person level below which interventions are rarely justified [17]. 
Approximately 95% of all maximum values for the worst-case scenario (and either the maximum 
individual or adult categories) are less than the international reference level of 1 mSv per person [17], 
and 99% are less than the average annual background dose of 2.4 mSv [13]. Therefore, the impact on 
Alaska, although larger than that for Japan, from the adjusted PRS releases appears again to be 
minimal from an intervention perspective. 
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(b) Adult 
Figure 74. Alaska (U.S.) Results: Frequency histogram and cumulative percentages for the worst-case 
PRS Cs-137 maximum effective dose commitments for (a) the maximum individual and (b) 
adult. 
 
The distribution of maximum Cs-137 dose commitments for the Aleutian Islands resulting from the 
adjusted PRS releases is illustrated in Figure 75. Note the similarity to the Alaska results provided 
above. Again none of the maximum values for the worst-case scenario exceed the annual 10 mSv per 
person level below which interventions are rarely justified [17]. More than 96% of all maximum 
values for the worst-case scenario (and either the maximum individual or adult categories) are less 
than the international annual reference level of 1 mSv per person [17], and all but a single value is less 
than the average annual background dose of 2.4 mSv [13]. Therefore, the impact on the Aleutian 
Islands—like that for Alaska—appears to be minimal from an intervention perspective. 
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(b) Adult 
Figure 75. Aleutian Islands (U.S.) Results: Frequency histogram and cumulative percentages for the 
worst-case PRS Cs-137 maximum effective dose commitments for (a) the maximum individual 
and (b) adult. 
4.7.2 Worst-Case Dose Commitments from the VRS 
Despite the fact that the Cs-137 dose commitments will be largest for the conditions considered in this 
study, the maximum Sr-90 and I-131 dose commitments resulting from the adjusted VRS release will 
also be computed for completeness. To compute the pertinent dose commitment, the maximum 
deposition for Cs-137, Sr-90, or I-131 described above will be multiplied by the deposition-to-dose 
factor obtained by adjusting the UNSCEAR 1993 factor by the appropriate factor from Table 80, 
Table 81, or Table 82, respectively.  
Using the maximum total deposition values for the adjusted VRS releases and the appropriate factors 
from Table 80, Table 81, and Table 82, the maximum dose commitments were computed; for the 
maximum individual dose commitments, these are provided in Table 95, Table 97, and Table 99 for 
Cs-137, Sr-90, and I-131, respectively, and the corresponding adult (for Cs-137 and Sr-90) and age-
weighted (for I-131) doses are provided in Table 96, Table 98, and Table 100. As with the PRS results, 
the worst-case Cs-137 dose commitments for the maximum individual are, in general, more than a 
factor of five larger than the corresponding Sr-90 values and more than three orders of magnitude 
larger than the corresponding I-131 values. The adult dose commitments for Cs-137 are even larger 
than their corresponding Sr-90 and I-131 (age-weighted) values. Thus, similar to the results for the 
PRS, the Cs-137 dose commitments are of primary concern for the adjusted VRS releases. 
The distribution of maximum daily dose commitments corresponding to the adjusted Cs-137 releases 
from the PRS for the entire region of interest and the transboundary region (i.e., including all areas 
outside of Russia excluding oceans) are provided in Figure 76 and Figure 77, respectively, for both the 
maximum individual (in this case, the teen group) and adult categories. The maximum dose 
commitments for the adjusted VRS releases for the entire region are 102 and 92.4 mSv per person for 
the maximum individual (or teen) and adult categories, respectively. For the transboundary region, the 
corresponding dose commitments are 26.9 and 24.3 mSv per person for the maximum individual and 
adult categories, respectively. Note that by accounting for possible variation in the source term and the 
parameters used to define the deposition-to-dose transfer coefficients as well as considering the 
maximum exposed individual, the Cs-137 dose commitments can increase by more than a factor of 25.  
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(b) Adult 
Figure 76. Frequency histogram and cumulative percentages for the VRS Cs-137 maximum effective dose 
commitments for (a) the maximum individual and (b) adult. 
 
These results illustrate a very interesting fact concerning the maximum dose commitments resulting 
from the adjusted VRS releases for Cs-137. On a regional basis, more than 30% of the Cs-137 dose 
commitments to either the maximum individual or adult are larger than the annual 10 mSv per person 
level below which interventions are rarely justified [17]. Furthermore, two of the maximum dose 
commitments for the maximum individuals exceed the annual 100 mSv per person level in which 
interventions are almost always justifiable [17]; none of the maximum dose commitments for the adult 
group exceed this annual limit. Examination of the transboundary results illustrated in Figure 77 
indicate that even the worst-case values are all less than the annual 100 mSv per person level below 
which interventions are almost always justifiable [17]. Therefore, the impact to Russia from the 
adjusted VRS release may be large as anticipated; however, the transboundary implications are less 
significant; however, they may still be important as over 7% of the maximum individual dose 
commitments are greater than the annual 10 mSv per person level below which interventions are rarely 
justified [17], and at least 40% are greater than the average annual background dose of 2.4 mSv [13].  
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(b) Adult 
Figure 77. Transboundary frequency histogram and cumulative percentages for the VRS Cs-137 
maximum effective dose commitments for (a) the maximum individual and (b) adult. 
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The distribution of maximum daily dose commitments corresponding to the adjusted Sr-90 releases 
from the VRS for the entire region of interest and the transboundary region are provided in Figure 78 
and Figure 79, respectively, for both the maximum individual (in this case, the infant group) and adult 
categories. The maximum dose commitments for the adjusted VRS releases for the entire region are 
15.5 and 3.73 mSv per person for the maximum individual (or infant) and adult categories, 
respectively. For the transboundary region, the corresponding dose commitments are 4.08 and 0.98 
mSv per person for the maximum individual and adult categories, respectively. Note that by 
accounting for possible variation in the source term and the parameters used to define the deposition-
to-dose transfer coefficients as well as considering the maximum exposed individual, the Sr-90 dose 
commitments can increase by almost an order of magnitude. 
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(a) Maximum Individual (Infant) 
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(b) Adult 
Figure 78. Frequency histogram and cumulative percentages for the VRS Sr-90 maximum effective dose 
commitments for (a) the maximum individual and (b) adult. 
 
On a regional basis, less than 2% of the Sr-90 dose commitments to the maximum individual are larger 
than the annual 10 mSv per person level below which interventions are rarely justified [17], and there 
are no values for the maximum individual that exceed the annual 100 mSv per person level in which 
interventions are almost always justifiable [17]. For the adult dose commitments from Sr-90, all are 
less than the annual 10 mSv per person level below which interventions are rarely justified [17], and 
almost 99% are less than the average annual background dose of 2.4 mSv [13]. Examination of the 
transboundary results indicates that all of the maximum individual dose commitments are less than the 
10 mSv per person level below which interventions are rarely justified [17] and more than 96% are 
less than the average annual background dose. Also all of the adult dose commitments are below the 
international annual reference level of 1 mSv per person [17]. Thus the impact to Russia from the 
adjusted VRS release may be significant in a few cases; however, the transboundary implications are 
much less. 
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(a) Maximum Individual (Infant) 
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(b) Adult 
Figure 79. Transboundary frequency histogram and cumulative percentages for the VRS Sr-90 
maximum effective dose commitments for (a) the maximum individual and (b) adult. 
 
The distribution of maximum daily dose commitments corresponding to the adjusted I-131 releases 
from the VRS for the entire region of interest and the transboundary region are provided in Figure 80 
and Figure 81, respectively, for both the maximum individual (in this case, the infant group) and age-
weighted categories. The maximum dose commitments for the adjusted VRS releases for the entire 
region are 4.70x10-2 and 5.49x10-3 mSv per person for the maximum individual (or infant) and age-
weighted categories, respectively. For the transboundary region, the corresponding dose commitments 
are 1.22x10-2 and 1.43x10-3 mSv per person for the maximum individual and adult categories, 
respectively. Note that by accounting for possible variation in the source term and the parameters used 
to define the deposition-to-dose transfer coefficients as well as considering the maximum exposed 
individual, the I-131 dose commitments can decrease by a factor of more than 46. 
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(a) Maximum Individual (Infant) 
0
50
100
150
200
250
5.
84
E-
06
4.
93
E-
04
9.
81
E-
04
1.
47
E-
03
1.
96
E-
03
2.
44
E-
03
2.
93
E-
03
3.
42
E-
03
3.
91
E-
03
M
or
e
Dose commitment (mSv per person)
F
r
eq
u
e
n
c
y
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
 
 
(b) Age-Weighted 
Figure 80. Frequency histogram and cumulative percentages for the VRS I-131 maximum effective dose 
commitments for (a) the maximum individual and (b) the age-weighted individual. 
 
On both a regional and transboundary basis, the I-131 dose commitments are less than the 
international annual reference level of 1 mSv per person [17] by at least a factor of 20. Thus the 
impact from I-131 based upon the conditions in this study will be small.  
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(a) Maximum Individual (Infant) 
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(b) Age-Weighted 
Figure 81. Transboundary frequency histogram and cumulative percentages for the VRS I-131 
maximum effective dose commitments for (a) the maximum individual and (b) the age-
weighted individual. 
4.7.2.1 Specific Case Examples: Japan and U.S. Dose Commitments from the VRS 
For the specific examples in this study, only the maximum Cs-137 dose commitments from the 
adjusted VRS release will be examined as they represent the largest impact of the three radionuclides 
considered. The distribution of maximum Cs-137 dose commitments for Japan resulting from the 
adjusted VRS releases is illustrated in Figure 82. More than 98% of the maximum individual and adult 
dose commitments are less than the annual 10 mSv per person level below which interventions are 
rarely justified [17] and approximately 60% of both are less than the international annual reference 
level of 1 mSv per person [17]. More than 80% of the maximum dose commitments are less than the 
average annual background dose of 2.4 mSv [13]. Therefore, the impact on Japan from even the 
adjusted VRS releases appears to be small from an intervention perspective although there may be 
isolated cases where intervention may be considered.  
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(a) Maximum Individual (Teen) 
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(b) Adult 
Figure 82. Japan Results: Frequency histogram and cumulative percentages for the worst-case VRS 
Cs-137 maximum effective dose commitments for (a) the maximum individual and (b) adult. 
 
The distribution of maximum Cs-137 dose commitments for Alaska resulting from the adjusted VRS 
releases is illustrated in Figure 83. Note that all of the maximum values for the worst-case scenario are 
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less than the international annual reference level of 1 mSv per person [17]. Therefore, the impact on 
Alaska from the adjusted VRS releases are less than those for Japan and appear to be minimal from an 
intervention perspective. 
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(b) Adult 
Figure 83. Alaska (U.S.) Results: Frequency histogram and cumulative percentages for the worst-case 
VRS Cs-137 maximum effective dose commitments for (a) the maximum individual and (b) 
adult. 
 
The distribution of maximum Cs-137 dose commitments for the Aleutian Islands resulting from the 
adjusted VRS releases is illustrated in Figure 84. Note the similarity to Alaska results illustrated in 
Figure 83. All of the maximum values for the worst-case scenario (and either the maximum individual 
or adult categories) are less than the international annual reference level of 1 mSv per person [17]. 
Therefore, the impact on the Aleutian Islands—like that for Alaska—appears to be small from an 
intervention perspective. 
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(b) Adult 
Figure 84. Aleutian Islands (U.S.) Results: Frequency histogram and cumulative percentages for the 
worst-case VRS Cs-137 maximum effective dose commitments for (a) the maximum individual 
and (b) adult. 
 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 83
4.7.3 Worst-Case Dose Commitments Summarized and Compared to 
Reference Levels 
A summary of the (non-zero) worst-case maximum effective dose commitments for the maximum 
individual (i.e., teens for Cs-137 and infants for Sr-90 and I-131) for both the PRS and VRS is 
presented in Exhibit 12. Note that on a regional basis that the worst-case maximum effective dose 
commitments are again comparable (because these maximum values reside in Russia). However, the 
impact outside of Russia is more profound from the VRS than from the PRS. Furthermore, the effects 
from Cs-137 releases (from either site) appear to be of more concern than those (for the same releases) 
from either Sr-90 or I-131. A small number of the worst-case case dose commitments for Cs-137 
exceed 100 mSv per person, which will be described in more detail below. 
Exhibit 12. Summary of the Maximum (Non-Zero) Effective Dose Commitments for the Maximum 
Individual Using the Worst-Case Scenario 
PRS  VRS 
 Maximum Effective  
Dose Commitment (mSv)* 
  Maximum Effective  
Dose Commitment (mSv)* 
 
Region 
Cs-137 
(Teen) 
Sr-90 
(Infant) 
I-131 
(Infant) 
  
Region 
Cs-137 
(Teen) 
Sr-90 
(Infant) 
I-131 
(Infant) 
Regional 1.08E+02 1.47E+01 2.64E-02  Regional 1.02E+02 1.55E+01 3.76E-02 
Transboundary** 4.98E+00 7.09E-01 3.53E-04  Transboundary** 2.69E+01 4.08E+00 9.78E-03 
China 7.56E-01 1.01E-01 4.32E-11  China 2.69E+01 4.08E+00 9.78E-03 
Hong Kong  0.00E+00   Hong Kong 2.17E-02 1.18E-06  
Japan 1.07E+00 1.66E-01 2.68E-05  Japan 1.49E+01 2.25E+00 1.86E-03 
Mongolia 4.22E-02 5.78E-03   Mongolia 2.60E-01 3.91E-02 4.17E-10 
N. Korea 2.11E-01 3.14E-02   N. Korea 1.66E+01 2.46E+00 6.27E-03 
Russia 1.08E+02 1.47E+01 2.64E-02  Russia 1.02E+02 1.55E+01 3.76E-02 
S. Korea 1.59E-02 1.11E-03   S. Korea 4.02E+00 6.04E-01 8.78E-04 
Taiwan     Taiwan 7.44E-01 1.13E-01  
Aleutians (U.S.) 3.33E+00 4.42E-01 3.53E-04  Aleutians (U.S.) 2.28E-01 3.15E-02 5.27E-06 
Alaska (U.S.) 4.98E+00 7.09E-01 2.38E-05  Alaska (U.S.) 4.37E-01 2.17E-02 4.29E-18 
Vietnam     Vietnam 1.12E-08 2.29E-13  
 
* The effective dose commitments are comprised of the following components (based upon the UNSCEAR 1993 
Report [13] methodology):  
Cs-137: Ingestion 43.0%, Inhalation 0.2%, External Exposure 56.8% 
Sr-90: Ingestion 97.8%, Inhalation 2.2%, External Exposure 0.02% 
I-131: Ingestion 99.2%, Inhalation 0.6%, External Exposure 0.2%. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia. 
 
The values for the maximum individual dose commitments in Exhibit 12 can be compared to the 
worst-case values for adults (for Cs-137 and Sr-90) and the weighted values (for I-131) that 
correspond to those computed above using the UNSCEAR 1993 Report methodology. These values 
are summarized in Exhibit 13. Note that these values are smaller than their maximum individual 
counterparts, and that, once again, the Cs-137 values would have the largest impact on the area under 
study. Furthermore, none of these values exceed 100 mSv per person. 
Exhibit 13. Summary of the Maximum (Non-Zero) Effective Dose Commitments for the Individuals 
Corresponding to those in the UNSCEAR 1993 Report Using the Worst-Case Scenario 
PRS  VRS 
 Maximum Effective  
Dose Commitment (mSv)* 
  Maximum Effective  
Dose Commitment (mSv)* 
 
Region 
Cs-137 
(Adult) 
Sr-90 
(Adult) 
I-131 
(Weighted) 
  
Region 
Cs-137 
(Adult) 
Sr-90 
(Adult) 
I-131 
(Weighted) 
Regional 9.73E+01 3.53E+00 3.09E-03  Regional 9.24E+01 3.73E+00 4.39E-03 
Transboundary** 4.49E+00 1.70E-01 4.13E-05  Transboundary** 2.43E+01 9.80E-01 1.14E-03 
China 6.82E-01 2.42E-02 5.05E-12  China 2.43E+01 9.80E-01 1.14E-03 
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PRS  VRS 
 Maximum Effective  
Dose Commitment (mSv)* 
  Maximum Effective  
Dose Commitment (mSv)* 
 
Region 
Cs-137 
(Adult) 
Sr-90 
(Adult) 
I-131 
(Weighted) 
  
Region 
Cs-137 
(Adult) 
Sr-90 
(Adult) 
I-131 
(Weighted) 
Hong Kong     Hong Kong 1.95E-02 2.83E-07  
Japan 9.67E-01 3.99E-02 3.13E-06  Japan 1.35E+01 5.41E-01 2.17E-04 
Mongolia 3.80E-02 1.39E-03   Mongolia 2.35E-01 9.40E-03 4.88E-11 
N. Korea 1.90E-01 7.55E-03   N. Korea 1.49E+01 5.91E-01 7.33E-04 
Russia 9.73E+01 3.53E+00 3.09E-03  Russia 9.24E+01 3.73E+00 4.39E-03 
S. Korea 1.43E-02 2.67E-04   S. Korea 3.63E+00 1.45E-01 1.03E-04 
Taiwan     Taiwan 6.71E-01 2.72E-02  
Aleutians (U.S.) 3.00E+00 1.06E-01 4.13E-05  Aleutians (U.S.) 2.05E-01 7.56E-03 6.17E-07 
Alaska (U.S.) 4.49E+00 1.70E-01 2.78E-06  Alaska (U.S.) 3.94E-01 5.21E-03 5.01E-19 
Vietnam     Vietnam 1.01E-08 5.51E-14  
 
* The effective dose commitments are comprised of the following components (based upon the UNSCEAR 1993 
Report [13] methodology):  
Cs-137: Ingestion 36.8%, Inhalation 0.2%, External Exposure 63.0% 
Sr-90: Ingestion 89.5%, Inhalation 10.4%, External Exposure 0.09% 
I-131: Ingestion 93.8%, Inhalation 4.3%, External Exposure 1.9%. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia. 
 
The information in Table 101 through Table 104 illustrates the manner in which the maximum worst-
case dose commitments (on a day-to-day basis) for the PRS and VRS compare to various reference 
limits for both the regional and transboundary conditions. As indicated previously, this information 
indicates that the dose commitments resulting from the adjusted releases of Cs-137 are more 
problematic than those for Sr-90 or I-131. Furthermore, the impacts from the adjusted VRS releases 
are more significant than those from the PRS. This is especially true for the transboundary region 
although there are no maximum dose commitments from the worst-case PRS and VRS releases in this 
region that exceed the annual 100 mSv per person level in which interventions are almost always 
justifiable [17]. The more significant impact of the VRS releases is compounded by the fact that many 
more people are impacted than are from the PRS releases. 
4.8 Worst-Case Collective Dose Commitments 
The final examination of the dose commitment estimates is what impact might there be on the persons 
that would be exposed to the adjusted releases described above. That is, the population or collective 
dose commitments will be computed for the corresponding maximum dose commitments described 
above. However, unlike the corresponding UNSCEAR analyses for Cs-137 and Sr-90 where only 
adult deposition-to-dose factors were used, the maximum age-weighted factors will be used in this 
portion of the variation study because not only adults are impacted by the depositions in the region of 
interest.  
Furthermore, it is likely that a great many people will be exposed to very small doses of radiation. To 
examine the impact that relatively small doses have on the collective dose, a series of threshold values 
(i.e., 0.1, 0.15,1.0, and 10.0 mSv per person) were defined above and their potential impacts will be 
examined. In effect, if the dose commitment at a given location does not exceed the threshold, then the 
corresponding dose commitment is ignored when computing the collective dose to examine the 
resulting impact on the earlier assessment using the UNSCEAR results. This is meant in no way to be 
an endorsement of the “threshold concept,” it merely allows assessment of the impact of small doses 
on collective dose assessment. 
4.8.1 Worst-Case Collective Dose Commitments for the PRS 
The effective, maximum collective dose commitments corresponding to the adjusted total depositions 
for Cs-137, Sr-90, and I-131 in Table 83, Table 84, and Table 85, respectively, were computed for the 
 85
PRS. For Cs-137, Figure 85(a) illustrates the frequency and cumulative percentages for the maximum 
collective dose commitments for the region of study assuming no threshold. Table 105 and Table 106 
provide the maximum collective dose commitment for the region as well as each country in the region 
as a function of the assumed threshold value. Note that the maximum collective dose commitments 
(for the PRS no threshold case) are again rank-ordered as follows: 
 
PRS Cs-137: Regional > Japan > Russia > China > Alaska (U.S.) > S. Korea > N. Korea > Aleutians (U.S.)  
> Mongolia 
 
Therefore, even though the maximum dose commitment was found in Russia, the maximum collective 
dose is found in Japan (which is not surprising based upon its high population density and relative 
proximity to the PRS). Using a mortality risk factor of 5x10-5 per mSv for all ages [19], these results 
would indicate that there might be up to 355 additional, eventual mortalities in the region based upon 
the “no threshold” results in Table 105; Japan might have as many as 329 additional mortalities while 
Russia and China might have as many as 103 and 83, respectively. North and South Korea and Alaska 
are the other areas with a significant impact of between 10 and 18 additional, eventual mortalities. 
However, it should be noted that even the mortality impact on Japan is one person out of 
approximately 300 000 persons impacted by the maximum deposition and dose from the PRS. For 
comparison, the mortality impact on Russia is one person out of fewer than 10 000 persons impacted 
by the deposition. Figure 85(b) illustrates the results for the transboundary conditions; note there is a 
significant impact on the magnitude of the collective dose commitments versus those for the overall 
region in Figure 85(a). 
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(b) Transboundary 
Figure 85. Frequency histogram and cumulative percentages for the PRS Cs-137 effective population 
dose commitments for the (a) Regional and (b) Transboundary areas for CY2000. No 
Threshold Basis. The corresponding population information is presented in Figure 37 and 
Figure 38. 
 
Table 105 and Table 106 can also be used to evaluate the impact that small doses in concert with large 
populations have on the worst-case collective dose estimates. If a value of 0.1 mSv (or 10 mrem) per 
person is used as a threshold for the collective dose computation, then Japan, which had the highest 
collective dose commitment (and a possibility of up to 329 additional mortalities), has a collective 
dose approximately 40% lower than that without a threshold imposed. When a threshold of 0.15 mSv 
(or 15 mrem) is imposed, the collective dose decreases by approximately 65%. It requires a threshold 
of 1.0 mSv (or 100 mrem) to result in a collective dose of zero, or, in other words, to have the same 
impact as a 0.1 mSv threshold on the original UNSCEAR values. Again the impact of such thresholds 
on the Russian collective doses is negligible. 
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For Sr-90, Figure 86(a) illustrates the frequency and cumulative percentages for the maximum 
collective dose commitments for the region of study from the PRS assuming no threshold. Table 107 
and Table 108 provide the maximum collective dose commitment for the region as well as each 
country in the region as a function of the assumed threshold level. Note that the maximum collective 
PRS dose commitments (for the no threshold hypothesis) have the same ordering as those for the 
Cs-137. Again, even though the maximum dose commitment was found in Russia, the maximum 
collective dose is found in Japan (which translates into 17 additional mortalities). The results in Table 
107 and Table 108 confirm the potential impacts of small doses in concert with large populations on 
the collective dose estimates discussed above for Cs-137. With a relatively low threshold of 0.1 mSv 
(or 10 mrem), the collective dose commitment and potential additional mortalities in Japan become 
zero, and, other than Russia, only the US territories have non-zero collective dose commitments. 
Figure 86(b) illustrates the transboundary results for the PRS Sr-90 collective dose commitments; note 
that these results are necessarily consistent with those for Cs-137 above. 
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(b) Transboundary 
Figure 86. Frequency histogram and cumulative percentages for the PRS Sr-90 effective population dose 
commitments for the (a) Regional and (b) Transboundary areas for CY2000. No Threshold 
Basis. The corresponding population information is presented in Figure 39 and Figure 40. 
 
For I-131, Figure 87(a) illustrates the frequency and cumulative percentages for the maximum 
collective dose commitments for the region of study assuming no threshold. Table 109 and Table 110 
provide the maximum collective dose commitment for the region as well as each country as a function 
of the assumed threshold level. Note that the maximum collective PRS dose commitments (for the no 
threshold hypothesis) are rank-ordered as follows: 
 
PRS I-131: Regional > Russia > Japan > Aleutians (U.S.) > Alaska (U.S.) > China 
 
Thus for I-131, the maximum dose commitment and collective dose are found in Russia (which is 
unlike the results for Cs-137 and Sr-90). This is not surprising based upon the higher deposition 
velocity of I-131. As a matter of fact, the results in Table 109 and Table 110 indicate that little I-131 
from PRS impacts any country including Russia. (Even in Russia, there is not enough of a collective 
dose to translate into a single, additional mortality.) Furthermore, the impact is much smaller than that 
for either Cs-137 or Sr-90 releases from the PRS. Figure 87(b) illustrates the transboundary results for 
I-131 from the PRS, which are also negligible for all the countries studied. 
 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 
F
r
e
q
u
e
n
c
y
, 
N
u
m
b
e
r
 o
f 
D
a
y
s 
 87
0
50
100
150
200
250
0.
00
E+
00
7.
27
E-
03
1.
45
E-
02
2.
18
E-
02
2.
91
E-
02
3.
63
E-
02
4.
36
E-
02
5.
09
E-
02
5.
81
E-
02
M
or
e
Collective dose commitment (person-Sv)
F
r
e
q
u
e
n
c
y
0
20
40
60
80
100
120
C
u
m
u
la
ti
v
e
(%
)
 
(a) Regional 
0
50
100
150
200
250
300
0.
00
E+
00
1.
43
E-
04
2.
87
E-
04
4.
30
E-
04
5.
73
E-
04
7.
17
E-
04
8.
60
E-
04
1.
00
E-
03
1.
15
E-
03
M
or
e
Collective dose commitment (person-Sv)
F
r
e
q
u
e
n
c
y
75
80
85
90
95
100
105
C
u
m
u
la
ti
v
e
(%
)
 
(b) Transboundary 
Figure 87. Frequency histogram and cumulative percentages for the PRS I-131 effective population dose 
commitments for the (a) Regional and (b) Transboundary areas for CY2000. No Threshold 
Basis. The corresponding population information is presented in Figure 41 and Figure 42. 
4.8.1.1 Specific Case Examples: Japan and U.S. Collective Dose Commitments from 
the PRS 
Because it is apparent that air masses from the Asian continent can move rapidly and only slightly 
diluted across the Pacific Ocean [14,15], it has been decided to examine these areas for possible 
impacts from the nuclear risk sites. Furthermore, because the Sr-90 depositions necessarily follow 
those for Cs-137 and the I-131 depositions are smaller and will have significantly less impact on the 
transboundary region (which includes both Japan and the U.S.), it was decided to examine only 
Cs-137 for these specific examples. 
Figure 88 illustrates the collective dose results for Japan from the PRS releases for CY2000. Using a 
mortality risk factor of 5x10-5 per mSv for all ages [19], almost 97% of all maximum collective dose 
commitments will result in fewer than 18 additional, eventual mortalities from the PRS releases. As 
mentioned above, the maximum collective dose commitment of 6570 person-Sv, which appears from 
Figure 88 to be very much an isolated case, would result in as many as 329 additional eventual 
mortalities.  
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Figure 88. Japan Results: Frequency histogram and cumulative percentages for the weighted PRS Cs-137 
effective collective dose commitments for CY2000. No Threshold Basis. The corresponding 
populations are provided in Figure 43.  
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The results for the weighted collective dose commitments from the PRS for the U.S. territories 
considered in this report are illustrated in Figure 89. Note that, when a mortality risk factor of 5x10-5 
per mSv for all ages [19] is employed, approximately 94% of the maximum collective doses for 
Alaska would result in fewer than one additional mortality and none of the maximum collective dose 
commitments for the Aleutian Islands would translate into a single, additional mortality from the 
adjusted PRS releases for CY2000. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 89. Alaska (U.S.) Results: Frequency histogram and cumulative percentages for the PRS Cs-137 
effective collective dose commitments for (a) Alaska and (b) the Aleutian Islands for CY2000. 
No Threshold Basis. The corresponding population information is found in Figure 44 and 
Figure 45. 
4.8.2 Worst-Case Collective Dose Commitments for the VRS 
The effective, maximum collective dose commitments corresponding to the total depositions for 
Cs-137, Sr-90, and I-131 in Table 86, Table 87, and Table 88, respectively, were computed for the 
VRS. For Cs-137, Figure 90 illustrates the frequency and cumulative percentages for the maximum 
collective dose commitments for the overall and transboundary region assuming no threshold. Table 
111 and Table 112 provide the maximum collective dose commitment for the region as well as each 
country in the region as a function of the assumed threshold level. (The collective dose commitments 
are also broken down by pathway for information purposes.) Note that the maximum collective VRS 
dose commitments (for the no threshold hypothesis) are rank-ordered as follows: 
 
VRS Cs-137: Regional > Japan > China > N. Korea > S. Korea > Russia > Taiwan > Hong Kong  
> Alaska (U.S.) > Mongolia > Aleutians (U.S.) > Vietnam 
 
Therefore, even though the maximum dose commitment was found in Russia, the maximum collective 
dose is found in Japan (which is not surprising based upon its high population density and relative 
proximity to both the VRS and the PRS). Furthermore, unlike the PRS results, other countries have 
collective dose commitments within an order of magnitude of that for Japan, and there are many more 
countries with non-zero collective dose commitments. 
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(b) Transboundary 
Figure 90. Frequency histogram and cumulative percentages for the VRS Cs-137 effective population 
dose commitments for the (a) Regional and (b) Transboundary areas for CY2000. No 
Threshold Basis. The corresponding population information is presented in Figure 46 and 
Figure 47. 
 
The effects of the VRS releases are potentially much more profound than those from the PRS. For 
example, the maximum collective dose commitments in Table 111 (for the no threshold case) 
correspond to up to an additional 9783 mortalities [19] over the entire region and 9771 additional over 
the transboundary region (using a factor of 5x10-5 mortality per mSv for all ages). The additional 
mortalities from the maximum collective dose commitments for Japan, China, N. Korea, S. Korea, 
Russia, and Taiwan are 9501, 8575, 2485, 2436, 1614, and 318, respectively. Therefore, even the 
impact on Taiwan, a country not proximate to the VRS, could be considered significant. The State of 
Alaska, the Aleutian Islands, and Hong Kong might have an additional two mortalities each from the 
adjusted releases and worst-case deposition-to-dose factors.  
Also unlike the results for the PRS analysis, Table 111 and Table 112 indicate that there is much less 
of an impact on the magnitudes of the dose commitments in concert with large populations on the 
collective VRS dose estimates. That is, the collective dose commitments for the countries (e.g., Japan, 
China, N. Korea, S. Korea, and Russia) in the vicinity of the VRS are relatively insensitive to the 
introduction of thresholds into the collective dose commitment computation. For example, the results 
after imposing a threshold of 0.1 mSv (or 0.01 mrem) translate into over 9488 additional mortalities in 
Japan and significant numbers in other countries of interest. This is a result of much higher dose 
commitments in these countries from the VRS releases. Even the introduction of a relatively large 
threshold (e.g., 1.0 mSv) only reduces the impact of the Cs-137 depositions to 8423 additional 
mortalities.  
Unlike the earlier UNSCEAR results, the additional mortalities described above do not appear to be 
significantly mitigated by being small fractions of very large, affected populations. Said additional 
mortalities are 1 in 13 105 (or 8 per 100 000) for Japan and 1 in 11 112 (or 9 per 100 000) persons 
affected by the maximum releases from the VRS. 
For Sr-90, Figure 91 illustrates the frequency and cumulative percentages for the maximum collective 
dose commitments for the overall and transboundary region assuming no threshold. Table 113 and 
Table 114 provide the maximum collective dose commitment for the region as well as each country in 
the region as a function of the assumed threshold level. Note that the maximum collective VRS dose 
commitments (for the no threshold hypothesis) have the same ordering as those for the Cs-137. Again, 
even though the maximum dose commitment was found in Russia (as indicated in Table 113), the 
maximum collective dose is found in Japan. The number of additional mortalities can be as high as 
484 for the region (and 483 for the transboundary region) and 426 and 477 for China and Japan, 
respectively, or between 18 and 20 times less than those from the comparable VRS Cs-137 releases. 
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The results in Table 113 and Table 114 confirm the insensitivity of the collective dose estimates to the 
magnitudes of the dose commitments as indicated above for Cs-137.  
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(a) Regional 
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(b) Transboundary 
Figure 91. Frequency histogram and cumulative percentages for the VRS Sr-90 effective population dose 
commitments for the (a) Regional and (b) Transboundary areas for CY2000. No Threshold 
Basis. The corresponding population information is presented in Figure 48 and Figure 49. 
        
For I-131, Figure 92 illustrates the frequency and cumulative percentages for the maximum collective 
dose commitments for the overall and transboundary region, respectively, assuming no threshold. 
Table 115 and Table 116 provide the maximum collective dose commitment for the region as well as 
each country in the region as a function of the assumed threshold level. Note that the maximum 
collective PRS dose commitments (for the no threshold hypothesis) are rank-ordered as follows: 
 
PRS I-131: Regional > Japan > China > S. Korea > N. Korea > Russia > Aleutians (U.S.) > Mongolia 
   > Alaska (U.S.) 
 
Thus for I-131, the maximum collective VRS dose commitment is found in Japan (which is unlike the 
results found for the corresponding PRS releases). Unlike the Cs-137 and Sr-90 results, the I-131 
releases translate into no additional mortalities. Also unlike the VRS results for Cs-137 and Sr-90, the 
collective doses are sensitive to the imposition of a threshold (because of the much smaller dose 
commitments for I-131 in countries other than Russia). Again, the results in Table 115 and Table 116 
indicate that the I-131 from the VRS releases will have an insignificant impact on any country, 
including Russia.  
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(b) Transboundary 
Figure 92. Frequency histogram and cumulative percentages for the VRS I-131 effective population dose 
commitments for the (a) Regional and (b) Transboundary areas for CY2000. No Threshold 
Basis. The corresponding population information is presented in Figure 50 and Figure 51. 
4.8.2.1 Specific Case Examples: Japan and U.S. Collective Dose Commitments from 
the VRS 
Figure 93 illustrates the collective dose results for Japan from the VRS releases for CY2000. Using a 
mortality risk factor of 5x10-5 per mSv for all ages [19], the maximum collective dose commitment of 
1.90x105 person-Sv (as shown in Table 111) would translate into more than 9500 additional 
mortalities or 8 additional mortalities for every 100 000 persons. However, the information in Figure 
93 indicates that this would be a low-probability event for CY2000. Over 60% of the maximum 
collective dose commitments are less than 3.17x104 person-Sv, which would translate into 1538 
additional mortalities (or between 1 and 2 per 100 000 persons).  
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Figure 93. Japan Results: Frequency histogram and cumulative percentages for the weighted VRS Cs-
137 effective collective dose commitments for CY2000. No Threshold Basis. The corresponding 
populations are provided in Figure 52.  
 
The results for the collective dose commitments from the PRS for the U.S. territories considered in 
this report are illustrated in Figure 94. Note that, when a mortality risk factor of 5x10-5 per mSv for all 
ages [19] is employed, the maximum collective dose commitments shown in these figures translate 
into two and zero additional mortalities for Alaska and the Aleutian Islands, respectively, from the 
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VRS releases for CY2000. These can be considered negligible when compared to both background 
radiation doses and other causes of death. 
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(a) Alaska (U.S.) 
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(b) Aleutian Islands (U.S.) 
Figure 94. Alaska (U.S.) Results: Frequency histogram and cumulative percentages for the VRS Cs-137 
effective collective dose commitments for (a) Alaska and (b) the Aleutian Islands for CY2000. 
No Threshold Basis. The corresponding population information is found in Figure 53 and 
Figure 54. 
4.8.3 Summary of the Effective Collective Worst-Case Dose Commitments 
A summary of the (non-zero) maximum effective collective dose commitments (based upon the worst-
case methodology described above and assuming no threshold) for both the PRS and VRS is presented 
in Exhibit 14. Therefore, even though the maximum effective dose commitments from the PRS and 
VRS were reasonably similar (as illustrated in Exhibit 12 and Exhibit 13), the higher populations 
impacted from the VRS releases generally resulted in significantly larger collective dose 
commitments. It again appears that the Cs-137 dose commitments will be of primary concern for 
either site. 
Exhibit 14. Summary of the Maximum (Non-Zero) Collective Effective Dose Commitments for 
Individuals Corresponding to those in the UNSCEAR 1993 Report Using the Worst-Case 
Scenario 
PRS  VRS 
 Maximum Effective Collective 
Dose Commitment (person-Sv)* 
  Maximum Effective Collective 
Dose Commitment (person-Sv)* 
Region Cs-137 Sr-90 I-131  Region Cs-137 Sr-90 I-131 
Regional 7.09E+03 3.69E+02 6.54E-02  Regional 1.96E+05 9.68E+03 3.56E+00 
Transboundary** 6.57E+03 3.45E+02 1.29E-03  Transboundary** 1.95E+05 9.67E+03 3.56E+00 
China 1.66E+03 8.10E+01 7.05E-10  China 1.72E+05 8.53E+03 3.05E+00 
Hong Kong     Hong Kong 3.78E+01 1.08E-03  
Japan 6.57E+03 3.45E+02 1.29E-03  Japan 1.90E+05 9.55E+03 3.56E+00 
Mongolia 3.79E+00 1.74E-01   Mongolia 3.21E+01 1.38E+00 1.96E-09 
N. Korea 2.02E+02 9.82E+00   N. Korea 4.97E+04 2.53E+03 1.58E+00 
Russia 2.05E+03 1.09E+02 6.54E-02  Russia 3.23E+04 1.64E+03 1.15E+00 
S. Korea 2.32E+02 5.18E+00   S. Korea 4.87E+04 2.48E+03 1.70E+00 
Taiwan     Taiwan 6.35E+03 3.28E+02  
Aleutians (U.S.) 5.26E+00 2.37E-01 4.31E-05  Aleutians (U.S.) 3.31E-01 9.57E-03 8.20E-09 
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PRS  VRS 
 Maximum Effective Collective 
Dose Commitment (person-Sv)* 
  Maximum Effective Collective 
Dose Commitment (person-Sv)* 
Region Cs-137 Sr-90 I-131  Region Cs-137 Sr-90 I-131 
Alaska (U.S.) 3.53E+02 1.51E+01 1.23E-06  Alaska (U.S.) 3.67E+01 2.52E-01 8.57E-20 
Vietnam     Vietnam 1.44E-07 1.01E-12  
 
* The effective collective dose commitments are comprised of the following components (based upon the 
UNSCEAR 1993 Report [13] methodology):  
Cs-137: Ingestion 38.8%, Inhalation 0.2%, External Exposure 61.0% 
Sr-90: Ingestion 90.9%, Inhalation 9.1%, External Exposure 0.1% 
I-131: Ingestion 93.8%, Inhalation 4.3%, External Exposure 1.9%. 
** The transboundary region includes only land areas outside of Russia. 
 
A study of the impact of imposing threshold values on the various collective dose commitments for the 
worst-case scenario was also undertaken. Figure 95 illustrates the impact of such thresholds on the 
maximum collective Cs-137 dose commitments for those areas where the impact would be at least one 
additional mortality (using a mortality risk factor of 5x10-5 per mSv for all ages [19]). Note that only 
the collective doses for the entire region, transboundary area, and Russia do not fall to zero using a 
threshold value of 1.0 mSv per person. Therefore, there would be a significant impact on collective 
doses if a relatively small threshold of 1.0 mSv is imposed on the calculation. This is analogous to the 
results when a 0.1 mSv threshold was applied to the corresponding UNSCEAR collective dose 
commitments as illustrated in Figure 55. 
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Figure 95. Impact of Imposing Hypothetical Threshold Values on the Worst-Case Maximum Effective 
Collective Cs-137 Dose Commitments for the PRS. Only those values are shown where at least 
one additional mortality would result for the no threshold case. 
 
The corresponding relationship between the maximum collective dose commitments and threshold for 
the VRS is provided in Figure 96 (where the maximum value of the abscissa has been increased to 10 
mSv). Notice that the impact of thresholds on the VRS collective dose commitments is much smaller 
than that for the corresponding PRS doses; in fact, the imposition of thresholds up to 1 mSv appears to 
have little impact for most countries impacted by the VRS releases. 
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Figure 96. Impact of Imposing Hypothetical Threshold Values on the Worst-Case Maximum Effective 
Collective Cs-137 Dose Commitments for the VRS. Only those values are shown where at least 
one additional mortality would result for the no threshold case. 
 
5 Summary and Conclusions 
The main purpose of this study was to estimate the worst-case dose commitments and potential 
consequences of accidental releases at nuclear risk sites in the Russian Far East. The nuclear risk sites 
of concern for this study are at Petropavlovsk (52°55'N & 158°30'E) and Vladivostok (42°55'N & 
132°25'E). The region of interest includes the territories of the Russia Far East, China, Japan, North 
and South Korea, State of Alaska, the Aleutian Islands, Mongolia, Burma, Hong Kong, Laos, Taiwan, 
Thailand, and Vietnam. In this study, those regions that are at highest risk from the hypothetical 
accidental releases at the nuclear risk sites will be determined as well as the potential impact of the 
releases. The transboundary region (i.e., that outside of Russia) is of primary interest because it is 
likely that the highest doses will reside in Russia and these would be examined using site specific 
information and detailed models unavailable for this study. However, the transboundary region can be 
examined, in general, using existing information and models. The methodology from the UNSCEAR 
1993 Report was used in this study. 
The research tool used to generate the deposition data used as the basis for this study is a long-range 
transport model—the Danish Emergency Response Model of the Atmosphere (DERMA)—which was 
used to simulate the 5-d atmospheric transport, dispersion and deposition of Cs-137 for a one-day 
release at a rate of 1010 Bq s-1 for a total “unit hypothetical release” of 8.64x1014 Bq. The 
meteorological data from the European Center for Medium-Range Weather Forecasts (ECMWF, 
Reading, UK) based on the ECMWF global model forecast and analysis were used as input data for 
the model simulation. Using the DERMA model, several Cs-137 indicators were computed for over 
90% of the days in calendar year 2000 including: 1) surface air concentration, 2) time-integrated 
surface concentration, 3) dry deposition, and 4) wet deposition. The meteorological data was missing 
for the remaining days.  
5.1 Maximum Total Deposition Results 
The main conclusions that can be drawn for the deposition data, which are those used to estimate 
doses, is that the dry deposition values are high in the vicinity of the risk sites and decrease 
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significantly with increasing distance from the release point. The wet deposition values can also be 
high near the risk sites; however, they are irregular as they are dependent upon the rainfall pattern. 
Some of these values can exceed the corresponding dry deposition value by an order of magnitude. 
However, it is the total deposition values (i.e., the sum of the wet and dry depositions at a given time 
and locale) that are of primary interest in this report because they are used to estimate effective dose 
commitments. The other indicators are summarized in the body of the report for completeness.  
Radionuclides other than Cs-137 can be of concern depending upon the inventory of the risk site and 
conditions under which the release is made. In this report, Sr-90 and I-131 were such radionuclides. 
However, because of a lack of time and resources, the necessary indicators above were not computed 
for these radionuclides for all calendar year 2000 days with full meteorological data. There were Sr-90 
and I-131 concentration and deposition data provided for five days considered representative of the 
variation of the climactic conditions for the region for year 2000. These data were used to generate 
simple, linear relationships between the unavailable Sr-90 and I-131 concentration and deposition data 
and the corresponding Cs-137 data [6]. These relationships were found to be sufficiently accurate for 
the general examination undertaken in this report. 
For the Petropavlovsk nuclear risk site, the original Cs-137, Sr-90, and I-131 total depositions had 
maximum values of 2.78x104, 2.86x104, and 4.65x104 Bq m-2, respectively, and were located in 
Russia. For the transboundary region (i.e., that outside of Russia including oceans), the maximum total 
deposition values for Cs-137, Sr-90, and I-131 were 2.20x104, 2.30x104, and 3.09x104 Bq m-2, 
respectively. However, the maximum total transboundary depositions were located in the ocean 
surrounding the Petropavlovsk risk site. The maximum total transboundary depositions found on land 
for Cs-137, Sr-90, and I-131 were 1280, 1360, and 506 Bq m-2, respectively. These were located in the 
U.S. territories (i.e., State of Alaska for Cs-137 and Sr-90 and the Aleutian Islands for I-131) 
examined in this study. Note that the total depositions in the U.S. territories were generally three to 
four times higher than those in Japan, the transboundary country with the next highest maximum total 
depositions resulting from accidental releases from the Petropavlovsk risk site. 
For the Vladivostok site, the original Cs-137, Sr-90, and I-131 total depositions had maximum values 
of 2.64x104, 3.26x104, and 5.28x104 Bq m-2, respectively, and were again located in Russia. For the 
transboundary region, the maximum total deposition values for Cs-137, Sr-90, and I-131 were 9060, 
1.09x104, and 1.76x104 Bq m-2, respectively. The maximum total transboundary depositions were 
again located in the ocean surrounding the risk site. The maximum total transboundary depositions 
found on land for Cs-137, Sr-90, and I-131 were 6930, 7870, and 1.64x104 Bq m-2, respectively. 
Unlike the maximum values for the Petropavlovsk releases, these maximum values were located in 
China, which is proximate to the Vladivostok site. The maximum total depositions for Japan and N. 
Korea were approximately the same (i.e., within a factor of two) as that for China. Note that the total 
depositions in the U.S. territories were generally more than a factor of 60 lower than those in China, 
the transboundary country with the highest maximum total depositions resulting from accidental 
releases from the Vladivostok risk site. 
5.2 UNSCEAR Maximum Effective Dose Commitment Results 
The initial portion of this study was concerned with estimating effective dose commitments from the 
deposition data either provided by Mahura [6] (for Cs-137) or derived from said data (for Sr-90 and 
I-131) and the methodology described in the UNSCEAR 1993 Report. It is recognized that this 
methodology is not the only acceptable manner in which to estimate such doses; the methodology was 
selected because it is independent, defensible, and, because it is based upon a multiplicative model, 
lends itself to a facile examination of parameter variation, the results of which will be described 
below.  
For the Petropavlovsk nuclear risk site, the maximum Cs-137, Sr-90, and I-131 total depositions 
translated into maximum effective dose commitments of 4.22, 1.60, and 0.18 mSv per person, 
respectively, and were located in Russia. For the transboundary region (i.e., that area outside of Russia 
over land), the maximum effective dose commitments for Cs-137, Sr-90, and I-131 were much 
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smaller—0.20, 0.08, and 2x10-3 mSv per person, respectively. These were located in U.S. territory 
(i.e., State of Alaska for Cs-137 and Sr-90 and the Aleutian Islands for I-131). The maximum effective 
dose commitments in the U.S. territories were generally three to four times higher than those in Japan, 
the transboundary country with the next highest dose commitments resulting from accidental releases 
from the Petropavlovsk risk site. The results of this study indicate that the Cs-137 dose commitments 
will dominate for the conditions studied in this report. Thus only the Cs-137 results will be discussed 
in this section; however, complete results are provided in the body of the report. 
For the Vladivostok site, the maximum Cs-137 total deposition translated into a maximum effective 
dose commitment of 4.01 mSv per person, which was located in Russia. For the transboundary region, 
the maximum effective dose commitment for Cs-137 was 1.05 mSv per person, which was located in 
China. The maximum effective dose commitments for Japan and N. Korea were approximately the 
same (i.e., within a factor of two) as that for China. Note that the maximum effective dose 
commitments in the U.S. territories were generally more than a factor of 60 lower than those in China, 
the transboundary country with the highest maximum dose commitments resulting from accidental 
releases from the Vladivostok risk site. 
5.3 UNSCEAR Maximum Collective Effective Dose Commitment Results 
Collective dose commitments were also computed and examined for hypothetical accidental releases 
from the Petropavlovsk and Vladivostok sites. Even though the maximum effective dose commitments 
from Petropavlovsk and Vladivostok releases were reasonably similar, the higher populations 
impacted from the Vladivostok releases generally resulted in significantly larger collective dose 
commitments. The Cs-137 dose commitments were again of primary concern for either site and will be 
the only collective dose commitments described here. The doses for the other radionuclides are 
provided in the body of the report. 
For the Petropavlovsk nuclear risk site, the maximum collective effective dose commitment was 298 
person-Sv for the entire region using the UNSCEAR 1993 Report methodology (although such an 
aggregation of doses over a very large area is contrary to ICRP recommendations as indicated in ICRP 
Publication 82). The maximum transboundary collective dose commitment of 276 person-Sv was 
located in Japan (which would translate into 14 additional mortalities); this value was more than an 
order of magnitude greater than that found in the U.S. territories examined in this study.  
For the Vladivostok nuclear risk site, the maximum collective effective dose commitment was 8230 
person-Sv for the entire region. The maximum transboundary collective dose commitment of 7990 
person-Sv was again located in Japan, which would translate into an additional 399 mortalities. China, 
N. Korea, and S. Korea also had similar collective dose commitments; however, it should be noted that 
none of the collective dose commitments (including those for the releases from the Petropavlovsk site) 
translated into a single additional mortality per 100 000 persons in the impacted area. Furthermore, the 
maximum collective doses in the U.S. territories studied in this report were more than three orders of 
magnitude lower than those for Japan. 
5.3.1 Examination of the Impact of Small Doses on Large Populations 
Because the aggregation of doses over large areas is contrary to ICRP recommendations, the impact of 
aggregating small doses in this manner on any conclusions was examined by imposing a series of 
threshold limits on the collective dose computations to determine whether the conclusions would 
change dramatically. This is intended in no way to endorse the “threshold concept,” it merely allows 
assessment of the impact of small doses on the collective dose computations. The results of this 
examination indicated that the collective effective dose commitments for the transboundary region 
associated with releases from the Petropavlovsk site were very sensitive to the imposition of such a 
threshold. For example, all collective dose commitments in the transboundary region (including Japan) 
were zero if a threshold of 0.1 mSv per person was used.  
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On the other hand, the collective dose commitments in the transboundary region associated with 
releases from the Vladivostok site were much less sensitive. For example, the imposition of a 
threshold of 0.1 mSv per person resulted in the approximate halving of the collective dose for many 
affected countries; however, it required a threshold of 1.0 mSv per person to result in collective doses 
of zero for the transboundary region. That is, the threshold limit must be an order of magnitude larger 
for the Vladivostok results to have the same impact as was found on the collective doses resulting 
from hypothetical releases from the Petropavlovsk site. 
5.4 Parameter Variation Study and Worst-Case Study 
The total depositions from Mahura and the dose commitments associated with the UNSCEAR 1993 
Report were computed to provide a baseline for comparing worst-case values. The original total 
depositions [6] were available for 90% of the days from a single calendar year (2000) and thus do not 
provide a rigorously defensible basis for projecting the results from this study to other years. However, 
the maximum values for all depositions and dose commitments were analyzed which should provide 
meaningful worst-case information for other years. Also the “hypothetical unit release” term used to 
generate the original deposition data was examined in light of known inventories and possible release 
fractions to better gauge the magnitudes of the deposition values. It is thought that by using the 
maximum values on a day-to-day basis and adjusting the total depositions based upon possible source 
terms that meaningful, general conclusions can be drawn from the year 2000 data for the two risk 
sites. 
Other sources of potential variation were the UNSCEAR 1993 Report deposition-to-dose transfer 
factors. Given a total deposition at a specific location, these factors provide an estimate of the effective 
dose commitment that would be imparted to an adult (except for the case of I-131 where an age-
weighted value is used) under average or nominal conditions using information that is dated and not 
necessarily concerning the region of interest. The UNSCEAR methodology is sound; however, little 
account was taken for the countries of interest in the UNSCEAR Report. The parameters used to 
define the necessary deposition-to-dose transfer factors were adjusted to provide worst-case factors, 
which were those factors providing the largest effective dose commitments for the range of parameters 
defined in this report. These worst-case transfer factors were then used to estimate dose commitments 
associated with the adjusted total depositions. 
The final source of variation primarily impacted the collective dose commitment estimates; this was 
the population information used in the study. The population data used in this study are from 1995 
and, therefore, are somewhat dated. However, these data were used “as-is” as any adjustment of the 
data would be arbitrary and likely to introduce more error than warranted in the type of general 
examination being made in this study. 
The approach taken in this study was to define reasonable ranges for the source term and various 
parameters used in defining the deposition-to-dose coefficients and then, using these values, compute 
the resulting transfer factor ranges and maximum effective dose commitments for both the maximum 
individual case and that case corresponding to the UNSCEAR results (i.e., adults for Cs-137 and Sr-90 
and age-weighted for I-131). These results were analyzed to determine whether accounting for 
reasonable variation in the source term and deposition-to-dose transfer coefficients would alter the 
conclusions drawn from examination of the dose commitments computed using the UNSCEAR values 
for the “unit hypothetical release.” 
5.4.1 Source Term Examination and Adjusted Total Depositions 
For Cs-137 and Sr-90, the isotopic inventories for the nuclear submarines and other facilities pertinent 
to the Russian Far East nuclear risk sites were examined on a spent fuel assembly basis. The maximum 
Cs-137 and Sr-90 inventories for conceivable accident scenarios were 5.67 and 4.80 times higher than 
the “unit hypothetical release” of 8.64x1014 Bq used to generate the data for this study. The potential 
inventory for I-131 is more straightforward to determine as it primarily depends on the fission yield of 
the accident. Using a bounding total number of fissions of 1x1020, the maximum inventory of I-131 
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was estimated to be 4.3x1012 Bq. Even the maximum I-131 inventory is more than 200 times lower 
than the “unit hypothetical release” used to generate the data for this study.  
However, the release fraction (i.e., the fraction of the inventory that is released into the atmosphere) 
for a given accident scenario also determines the environmental release source term. The release 
fractions for each radionuclide considered in this study can vary over several orders of magnitude 
depending upon the severity and type of accident scenario. Also note that, depending upon the 
accident scenario, almost all the Cs-137 or I-131 can be released into the atmosphere, whereas the 
Sr-90 tends to stay within the fuel assemblies even during the most severe accident scenarios. 
By combining the various inventories and release fractions, the potential maximum environmental 
source terms pertinent to this study were estimated. The “unit hypothetical release” used to generate 
the deposition data used in this report is significantly greater than the median values examined but less 
than the maximum values for Cs-137, greater than the maximum values for Sr-90, and more than 250 
times greater than the maximum value for I-131. Therefore, the choice of the  “unit hypothetical 
release” appeared to be representative for Cs-137, conservative for Sr-90, and overly conservative for 
I-131. The adjusted total depositions values for Cs-137, Sr-90, and I-131 were obtained by scaling the 
original values by 5.10, 0.29, and 4x10-3, respectively, the ratios of the appropriate maximum source 
terms to the “unit hypothetical release” used to provide the original deposition data.  
The adjusted total Cs-137 depositions were more than an order of magnitude larger than the 
corresponding maximum Sr-90 values and almost three orders of magnitude larger than the 
corresponding I-131 depositions. When considering the appropriate deposition-to-dose coefficients 
(provided in the report), it was apparent that the radionuclide of primary interest was Cs-137. For 
example, both the Cs-137 maximum total depositions and the worst-case deposition-to-dose factors 
are orders of magnitude larger for Cs-137 than for I-131. For Sr-90, even though the worst-case 
deposition-to-dose coefficients were larger than their Cs-137 counterparts by a factor of up to 2.5, the 
maximum total Cs-137 depositions will be larger than those for Sr-90 by more than an order of 
magnitude. Thus the Cs-137 depositions and resulting dose commitments were of primary concern for 
releases from both risk sites. 
5.4.2 Worst-Case Maximum Effective Dose Commitments 
The UNSCEAR 1993 Report methodology employed a multiplicative model to estimate effective dose 
commitments. Three pathways (i.e., ingestion, inhalation, and external exposure from ground 
deposition) were found dominant when computing effective dose commitments for the conditions 
considered in the UNSCEAR 1993 Report; these were also found to be dominant for this study. The 
various components used to derive the deposition-to-dose transfer factors for these pathways were 
examined in light of the region of interest, and reasonable ranges were computed using more relevant 
data. These were then used to compute worst-case effective dose commitments from the adjusted 
deposition results. 
For the ingestion pathway, the Cs-137 and Sr-90 deposition-to-dose transfer coefficients for adults, 
which correspond to the values computed in the UNSCEAR 1993 Report, were between 0.13 and 4.6 
times and 0.12 to 7.4 times, respectively, the original UNSCEAR values. For the “maximum 
individual”, or that age group with the highest deposition-to-dose transfer coefficient, the values for 
Cs-137 (for teens) and Sr-90 (for infants) were between 0.13 and 6.0 times and between 0.014 and 
34.3 times, respectively, the original UNSCEAR coefficients. For I-131, the age-weighted values, 
which correspond to those in the UNSCEAR 1993 Report, were between 0.008 and 4.4 times the 
original value, and the “maximum individual” values (for infants) are between 0.008 and 39.4 times 
the original UNSCEAR value. 
For the inhalation pathway, the Cs-137 and Sr-90 deposition-to-dose transfer factors for adults, which 
correspond to the original UNSCEAR values, were between 0.55 and 13.4 times and 0.46 to 9.8 times, 
respectively, the UNSCEAR values. For the maximum individual, the values for Cs-137 (for teens) 
and Sr-90 (for infants) were between 0.40 and 13.3 times and between 0.14 and 8.4 times, 
respectively, the original UNSCEAR transfer factors. For I-131, the age-weighted values, which 
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correspond to those in the UNSCEAR Report, were between 0.56 and 4.9 times the original value, and 
the maximum individual values (for infants) were between 0.10 and 5.7 times the original UNSCEAR 
value. 
For the external exposure (from ground deposition) pathway, the lower bounding values were those 
provided in the UNSCEAR 1993 Report (where a deposition-to-dose coefficient for Sr-90 of zero was 
provided; likely because it is a pure beta-emitter). The upper bounds for the external exposure transfer 
factor for Cs-137 and I-131 were 4.5 and 3.2 times larger, respectively, than their UNSCEAR 
counterparts. The upper bound computed for Sr-90 was approximately the same as that for I-131 
(which occurred by happenstance).   
It should be noted, however, that only the overall Cs-137 deposition-to-dose transfer factor had a 
significant contribution from the external exposure pathway (although there was significant 
contribution from the ingestion pathway). The Sr-90 and I-131 dose commitments were dominated by 
the ingestion pathway. The worst-case overall deposition-to-dose transfer factors for Cs-137, Sr-90, 
and I-131 corresponding to those in the UNSCEAR Report were 4.5 (for adults), 7.7 (for adults), and 
4.3 (age-weighted) times higher, respectively, than the corresponding UNSCEAR values. For the 
maximum individual groups, the worst-case overall transfer factors were 5.0 (for teens), 31.9 (for 
infants), and 37.1 (for infants) times higher, respectively, than the corresponding UNSCEAR values. 
However, even though the relative changes in the overall Sr-90 and I-131 deposition-to-dose transfer 
factors are much larger than those for Cs-137, when the adjusted total deposition values are taken into 
account, the impact of Cs-137 will dominate (which also applies to collective doses). Thus only the 
Cs-137 results will be provided below; the corresponding Sr-90 and I-131 values were provided in the 
body of the report for completeness. 
For the Petropavlovsk nuclear risk site, the maximum adjusted Cs-137 total deposition (located in 
Russia) translated into worst-case maximum effective dose commitments of 97 and 108 mSv per 
person for adults and maximum individuals (or teens), respectively. For the transboundary region (i.e., 
that area outside of Russia over land), the maximum effective dose commitments for Cs-137 were 4.5 
and 5.0 mSv per person for adults and teens, respectively. These maximum values were located in the 
U.S. territories (i.e., State of Alaska); the maximum effective dose commitments for the Aleutian 
Islands were 3.0 and 3.3 mSv per person for adults and teens, respectively. The maximum effective 
dose commitments in the U.S. territories were generally three to four times higher than those in Japan, 
the transboundary country with the next highest maximum dose commitments resulting from 
accidental releases from the Petropavlovsk risk site.  
For the Vladivostok site, the maximum adjusted Cs-137 total deposition (located again in Russia) 
translated into worst-case maximum effective dose commitments of 92 and 102 mSv per person for 
adults and maximum exposed individuals (or teens), respectively. For the transboundary region, the 
maximum effective dose commitments for Cs-137 were 24 and 27 mSv per person for adults and 
teens, respectively. These maximum values were located in China, which is proximate to the 
Vladivostok site. The maximum effective dose commitments for Japan and N. Korea are 
approximately the same (i.e., within a factor of two) as that for China. Note that the maximum 
effective dose commitments in the U.S. territories are generally more than a factor of 60 lower than 
those in China, the transboundary country with the highest maximum dose commitments resulting 
from accidental releases from the Vladivostok risk site. 
The maximum worst-case dose commitments (on a day-to-day basis) corresponding to the 
Petropavlovsk and Vladivostok releases for both the regional and transboundary conditions were also 
compared to various annual reference levels (i.e., 0.15, 1.0, 10, and 100 mSv per person) discussed in 
the ICRP 82 Report pertaining to practices and interventions and the annual background radiation dose 
(i.e., 2.4 mSv per person) provided in the UNSCEAR 1993 Report. These comparisons are 
conservative because the effective dose commitments computed in this report are being compared to 
annual reference values and background doses. The body of the report should be referred to for 
specific results; however, it should be noted that the worst-case maximum dose commitments for the 
transboundary region on over 99% of all year 2000 days studied for the releases from the 
Petropavlovsk site are less than the average annual background radiation dose. For the corresponding 
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Vladivostok releases, the worst-case maximum dose commitments are less than the average annual 
background radiation dose for over 44% of all year 2000 days studied. Furthermore, the maximum 
dose commitments corresponding to the adjusted Vladivostok releases are less than the annual 10 mSv 
per person level in which interventions are rarely justified for more than 90% of all year 2000 days 
studied and are all less than the annual 100 mSv per person level in which interventions are almost 
always justifiable according to ICRP 82. Therefore, the impacts from the adjusted Vladivostok 
releases were more significant than those from Petropavlovsk, which could be considered negligible 
when compared to average annual background doses. The more significant impact of the adjusted 
Vladivostok releases were compounded by the fact that many more people were impacted than from 
the corresponding hypothetical Petropavlovsk releases. 
5.4.3 Worst-Case Maximum Collective Effective Dose Commitment Results 
The final examination of the dose commitment estimates was the potential impact on those persons 
exposed to the depositions resulting from the accidental releases. That is, the maximum collective dose 
commitments corresponding to the worst-case dose commitments were computed. However, unlike 
the corresponding UNSCEAR analysis, only the maximum age-weighted deposition-to-dose factors 
were used in this portion of the variation study because not only adults were impacted by the 
depositions in the region of interest. 
The results indicate that even though the maximum effective dose commitments from the 
Petropavlovsk and Vladivostok releases were reasonably similar, the higher populations impacted by 
the Vladivostok releases generally resulted in significantly larger collective dose commitments and 
thus potential mortalities than those for the Petropavlovsk releases. For example, the maximum 
number of additional mortalities on a regional basis resulting from the adjusted Petropavlovsk releases 
would be 355; there would be as many as 329 in Japan, 83 in China, 18 in the State of Alaska, and 10 
in S. Korea. However, for the Vladivostok releases, there might be as many as 9771 additional 
mortalities on a regional basis, and the additional mortalities for Japan, China, N. Korea, S. Korea, 
Russia, and Taiwan would be 9501, 8575, 2485, 2436, 1614, and 318, respectively. The U.S. 
territories and Hong Kong might have an additional two mortalities each from the adjusted 
Vladivostok releases and worst-case deposition to dose factors. However, even though these mortality 
numbers may appear large, it should be noted that none of the transboundary values exceed 9 
mortalities per 100 000 persons, found in N. Korea resulting from the worst-case deposition-to-dose 
coefficients applied to the maximum adjusted Cs-137 total deposition values from the Vladivostok 
releases.  
Because the aggregation of doses over large areas is contrary to the recommendation of the ICRP, a 
series of threshold values were imposed on the worst-case results to determine whether the 
conclusions would change dramatically. The impact on the maximum worst-case collective dose 
commitments for the Petropavlovsk releases would remain significant although a larger threshold (i.e., 
1.0 mSv per person) would have to be imposed to have an impact corresponding to that found for the 
analogous UNSCEAR values. However, the impact of imposing such thresholds on the maximum 
collective dose commitments from the hypothetical Vladivostok releases was much less profound than 
that for the corresponding Petropavlovsk dose commitments; in fact, the imposition of thresholds up to 
1 mSv per person had little impact on the collective dose commitments for most countries that would 
have been impacted by the Vladivostok releases. Even though the impact on the collective doses 
related to the Vladivostok releases was small, it remains true that the worst-case impacts of the 
effective dose commitments for the releases from both the Vladivostok and Petropavlovsk sites were 
negligible when compared to metrics such as the average annual background dose and other causes of 
death in the affected countries. 
6 Recommendation and Future Studies 
The results of this work were general in nature and should only be used as an initial indication of the 
location and magnitude of potential problems associated with accidental releases from the two Russian 
Far East nuclear sites considered. The conclusions of this report indicate that the potential impact of 
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the accidental releases from these sites will be small when compared to background radiation although 
some individuals could get a dose commitment that is larger than that from annual background 
radiation. It is recognized that it is prudent to apply site-specific information wherever possible to 
determine risks for areas of primary concern, such as Russia, not covered in this report. It is 
conceivable that there might be cases where significant impacts are possible for the accident scenarios 
examined in this report; however, every attempt was made to make the conclusions of this report as 
conservative and meaningful as warranted.  
Despite the successful attempts to make the conclusions meaningful, there are a number of areas that 
could be further investigated: ♦ The concentration and deposition data were generated for a single calendar year (2000). It 
would provide a more rigorous basis of analysis if the concentration and deposition data used 
as the basis for the conclusions of this report were generated over as many years as possible. 
Then a statistical analysis could be applied to the results instead of merely examining the 
maximum values for the data provided. ♦ The potential source term information (i.e., inventories and potential release fractions) 
available for the Russian Far East nuclear sites will continue to improve. Such information has 
a direct bearing on the conclusions of a study such as this one and should be incorporated 
when available. ♦ The population information used in this study was from 1995. When updated population 
information is available, the information in this report should be updated. ♦ The parameters and methodology provided in the UNSCEAR 1993 Report were used ato 
compute the baseline case and then updated using area-specific information where available. 
However, such area-specific information was not available for all parameters (e.g., the 
deposition-to-diet transfer factors for the ingestion pathway), and these parameters were 
merely adjusted by 10% to provide some measure of variation for the parameter study. When 
such specific data are available, they can be incorporated into the study.  ♦ The information in the UNSCEAR 2000 Report was examined, and it was determined that 
there would be no significant impact on the conclusions of this study if the minor differences 
in methodology were incorporated into this study. Any pertinent pathway information was 
incorporated into this report; however, it would seem prudent to update the report to reflect the 
latest methodology. ♦ Other, more concrete assessments of the potential impacts can be made. For example, 
restrictions on the slaughter and distribution of sheep and reindeer are still in force in some 
Nordic countries [55]. A limit such as that used for reindeer removal can be applied to the 
results of this study. ♦ The analysis in this report could be applied to the other nuclear risk sites in the North Pacific 
region including nuclear-weapon related facilities in the northern regions of China and nuclear 
fuel reprocessing facilities located in the northern regions of both China and Japan. ♦ The approach for those regions proximate to the risk sites (e.g., Russia, China, Japan, the 
Koreas, etc.) could be modified to reflect the localized scale. ♦ The initiating event could be investigated to determine if other, co-located energy sources 
could send the plume higher into the atmosphere and, therefore, reach distant sites more 
quickly. ♦ The impact onregional fisheries and dosages to fish consumers could be determined. 
The above additions and changes to the report could only make the conclusions drawn from this study 
more meaningful. 
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8.1 Appendix A 
Detailed Report Figures 
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Figure A 1. This figure represents the region of interest for this study. Both the Petropavlovsk (PRS) and Vladivostok (VRS) Nuclear Risk Sites are shown. The 
inset illustrates the lower left-hand corner of this region where the countries of Burma, Thailand, Laos, and Vietnam are located. 
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Figure A 2. This figure illustrates a contour plot (employing 150 equally-spaced lines) of the original population data (i.e., 12 cells per degree) used in this study.   
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Figure A 3. This figure illustrates a contour plot (employing 75 equally-spaced lines) of the converted population data (i.e., 2 cells per degree) used in this study. 
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8.2 Appendix B 
Alternative Development of the I-131 Ingestion Coefficient 
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A different representation of the P2345 ingestion transfer coefficient for I-131 from that above can be  
developed by using the population-weighted value for milk consumption, or: 
Equation 22 
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versus an average value of 109.5 L a-1 used in the UNSCEAR 1993 Report. It can be show to be 
mathematically identical to then use the following milk consumption-weighted I-131 P45 value: 
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to compute the P2345 transfer coefficient. In other words, the overall ingestion transfer coefficient 
obtained using the consumption-weighted values is: 
 
Equation 24 
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Ifor  m Bqper  nSv 2.4
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1-1-2-1-3
c
45
c
34232345
==
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or the same value as obtained above.  
If, on the other hand, a population-weighted value of the P45 coefficient is desired, then the necessary 
P34 coefficient must be weighted using the population for the P45 coefficients in a manner analogous to 
that above. These coefficients would be: 
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Equation 25 
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and 
Equation 26 
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where 
Equation 27 
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Therefore, there are a number of equivalent ways to compute the ingestion transfer coefficient for 
I-131 when using population or age-weighted values. However, note that using the two population-
weighted values does not provide the correct transfer coefficient: 
 
Equation 28 
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In fact, the transfer factor is significantly lower than the one computed above; therefore, simply 
multiplying the population-weighted values will not provide the appropriate transfer coefficient. 
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8.3 Appendix C 
RESRAD Verification Information and Files 
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Listing 1. Microsoft Word 2000 MailMerge File Site2_RAD_template2.doc 
 &DB 
 IHAFTIM = «IHAFTIM», 
 DFFILE = 'FGR 13 Morbidity', 
 RISKLIB= 'FGR 13 Morbidity', 
 NANUC =  «NANUC» , 
 NIY =  8 , 
 NPD =  «NANUC» , 
 NPTS =  1024 , 
 NS =  1 , 
 NPDS =  «NANUC» , 
 U_activity = 'Bq' , 
 U_dose_unit = 'mSv' , 
 &END 
 &INDATA 
 TITLE = «TITLE», 
 NPTS = 1024 , 
 TDISK = '', VERS = '6.2', 
 XSPACE = 'LOG', 
 FINDPEAK = 1 , 
 LYMAX = 17 , 
 KYMAX = 513 , 
 COVER0 = 0, 
 DENSCV = 1.5, 
 VCV = .001, 
 DENSCZ = 1.5, 
 VCZ = .001, 
 TPCZ = .4, 
 FCCZ = .2, 
 HCCZ = 10, 
 BCZ = 5.3, 
 HUMID = 8, 
 EVAPTR = .5, 
 PRECIP = 1, 
 RI = .2, 
 IDITCH = 0, 
 RUNOFF = .2, 
 WAREA = 1000000, 
 EPS = .001, 
 NS = 1, 
 TI = 0, 
 DENSAQ = 1.5, 
 TPSZ = .4, 
 EPSZ = .2, 
 FCSZ = .2, 
 HCSZ = 100, 
 HGWT = .02, 
 BSZ = 5.3, 
 VWT = .001, 
 DWIBWT = 10, 
 MODEL = 0, 
 UW = 250, 
 AREA = «AREA», 
 THICK0 = «THICK0», 
 LCZPAQ = «LCZPAQ», 
 BRDL = «BRDL», 
 T(1) = 0, 
 T(2) = 1, 
 T(3) = 3, 
 T(4) = 10, 
 T(5) = 30, 
 T(6) = 100, 
 T(7) = 300, 
 T(8) = 1000, 
 T(9) = 0, 
 T(10) = 0, 
 INHALR = 8400, 
 MLINH = .0001, 
 ED = «ED», 
 SHF1 = «SHF1», 
 SHF3 = «SHF3», 
 FIND = «FIND», 
 FOTD = «FOTD», 
 FS = 1, 
 RAD_SHAPE(1) = 50.000000, 
 RAD_SHAPE(2) = 70.710680, 
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 RAD_SHAPE(3) = 0.000000, 
 RAD_SHAPE(4) = 0.000000, 
 RAD_SHAPE(5) = 0.000000, 
 RAD_SHAPE(6) = 0.000000, 
 RAD_SHAPE(7) = 0.000000, 
 RAD_SHAPE(8) = 0.000000, 
 RAD_SHAPE(9) = 0.000000, 
 RAD_SHAPE(10) = 0.000000, 
 RAD_SHAPE(11) = 0.000000, 
 RAD_SHAPE(12) = 0.000000, 
 FRACA(1) = 1.000000, 
 FRACA(2) = 0.273240, 
 FRACA(3) = 0.000000, 
 FRACA(4) = 0.000000, 
 FRACA(5) = 0.000000, 
 FRACA(6) = 0.000000, 
 FRACA(7) = 0.000000, 
 FRACA(8) = 0.000000, 
 FRACA(9) = 0.000000, 
 FRACA(10) = 0.000000, 
 FRACA(11) = 0.000000, 
 FRACA(12) = 0.000000, 
 DIET(1) = «Dnl», 
 DIET(2) = «Dl», 
 DIET(3) = «Dmk», 
 DIET(4) = «Dmt», 
 DIET(5) = 0.000000, 
 DIET(6) = 0.000000, 
 SOIL = 36.5, 
 DWI = 510, 
 FDW = 1, 
 FHHW = 1, 
 FLW = 1, 
 FIRW = 1, 
 FR9 = «FR9», 
 FPLANT =-1, 
 FMEAT =-1, 
 FMILK =-1, 
 LFI5 = 68, 
 LFI6 = 55, 
 LWI5 = 50, 
 LWI6 = 160, 
 LSI = .5, 
 MLFD = .0001, 
 DM = .15, 
 DROOT = «DROOT», 
 FGWDW = 1, 
 FGWHH = 1, 
 FGWLW = 1, 
 FGWIR = 1, 
 STOR_T(1) = 14, 
 STOR_T(2) = 1, 
 STOR_T(3) = 1, 
 STOR_T(4) = 20, 
 STOR_T(5) = 7, 
 STOR_T(6) = 7, 
 STOR_T(7) = 1, 
 STOR_T(8) = 1, 
 STOR_T(9) = 45, 
 FLOOR1 = .15, 
 DENSFL = 2.4, 
 TPCV = .4, 
 TPFL = .1, 
 PH2OCV = .05, 
 PH2OFL = .03, 
 DIFCV = .000002, 
 DIFFL = .0000003, 
 DIFCZ = .000002, 
 HMIX = 2, 
 WIND = 2, 
 REXG = .5, 
 HRM = 2.5, 
 FAI = 0, 
 DMFL =-1, 
 EMANA(1) = 0.250000, 
 EMANA(2) = 0.150000, 
 C12WTR = .00002, 
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 C12CZ = .03, 
 CSOIL = .02, 
 CAIR = .98, 
 DMC = .3, 
 EVSN = .0000007, 
 REVSN = 1E-10, 
 AVFG4 = .8, 
 AVFG5 = .2, 
 CO2F = 88.94, 
 H(1) = «H1», 
 H(2) = 4.000000, 
 H(3) = 4.000000, 
 H(4) = 4.000000, 
 H(5) = 4.000000, 
 DENSUZ(1) = 1.500000, 
 DENSUZ(2) = 1.500000, 
 DENSUZ(3) = 1.500000, 
 DENSUZ(4) = 1.500000, 
 DENSUZ(5) = 1.500000, 
 TPUZ(1) = 0.400000, 
 TPUZ(2) = 0.400000, 
 TPUZ(3) = 0.400000, 
 TPUZ(4) = 0.400000, 
 TPUZ(5) = 0.400000, 
 EPUZ(1) = 0.200000, 
 EPUZ(2) = 0.200000, 
 EPUZ(3) = 0.200000, 
 EPUZ(4) = 0.200000, 
 EPUZ(5) = 0.200000, 
 FCUZ(1) = 0.200000, 
 FCUZ(2) = 0.200000, 
 FCUZ(3) = 0.200000, 
 FCUZ(4) = 0.200000, 
 FCUZ(5) = 0.200000, 
 BUZ(1) = 5.300000, 
 BUZ(2) = 5.300000, 
 BUZ(3) = 5.300000, 
 BUZ(4) = 5.300000, 
 BUZ(5) = 5.300000, 
 HCUZ(1) = 10.000000, 
 HCUZ(2) = 10.000000, 
 HCUZ(3) = 10.000000, 
 HCUZ(4) = 10.000000, 
 HCUZ(5) = 10.000000, 
 INDPOPFLAG = 0, 
 OFFDISTANCE(1) = 250, 
 NUMDISTANCES = 0, 
 AMBIENTTEMP = 10, 
 LIDHEIGHT = 1000, 
 SOURCEHEIGHT = 10, 
 AGVEG(1) = 0.000000, 
 AGVEG(2) = 0.500000, 
 AGVEG(3) = 0.500000, 
 AGMILK(1) = 0.000000, 
 AGMILK(2) = 0.500000, 
 AGMILK(3) = 0.500000, 
 AGMEAT(1) = 0.000000, 
 AGMEAT(2) = 0.500000, 
 AGMEAT(3) = 0.500000, 
 BEEFDENSITY = .164, 
 MILKDENSITY = .0207, 
 VEGLANDFRACTION = .0185, 
 YV(1) = 0.700000, 
 YV(2) = 1.500000, 
 YV(3) = 1.100000, 
 TE(1) = 0.170000, 
 TE(2) = 0.250000, 
 TE(3) = 0.080000, 
 TIV(1) = 0.100000, 
 TIV(2) = 1.000000, 
 TIV(3) = 1.000000, 
 WLAM = 20, 
 RWET(1) = 0.250000, 
 RWET(2) = 0.250000, 
 RWET(3) = 0.250000, 
 RDRY(1) = 0.250000, 
 RDRY(2) = 0.250000, 
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 RDRY(3) = 0.250000, 
 NUCNAM = «NUC_1», «NUC_2», «NUC_3», 'LAST', 
 S = «S_1», «S_2», «S_3», 
 W = , «NANUC»*0, 
 DCACTC = «DCACT_1», «DCACT_2», «DCACT_3», 
 DCACTU1 = «DCACT_1», «DCACT_2», «DCACT_3», 
 DCACTS = «DCACT_1», «DCACT_2», «DCACT_3», 
 RLEACH = , «NANUC»*0, 
 SOLUBK0 = , «NANUC»*0, 
 NSENA = 0, 
 NUM_SAMPS = 0, NUMVAR = 0, 
 UNCPPD = 1 , 
 UNCPND = 1 , 
 SELPATH = 255, 
 &END 
 &DCF 
 T_DCF2= «T_DCF2_1», «T_DCF2_2», «T_DCF2_3», 
 T_DCF3= «T_DCF3_1», «T_DCF3_2», «T_DCF3_3», 
 BIOFAC2= «BIOFAC2_1», «BIOFAC2_2», «BIOFAC2_3», 
 BIOFAC1= «BIOFAC1_1», «BIOFAC1_2», «BIOFAC1_3», 
 RTF2= «RTF2_1», «RTF2_2», «RTF2_3», 
 RTF3= «RTF3_1», «RTF3_2», «RTF3_3», 
 RTF1= «RTF1_1», «RTF1_2», «RTF1_3», 
 SLPF1= «SLPF1_1», «SLPF1_2», «SLPF1_3», 
 SLPF2= «SLPF2_1», «SLPF2_2», «SLPF2_3», 
 SLPF3= «SLPF3_1», «SLPF3_2», «SLPF3_3», 
 SLPF4= «SLPF4_1», «SLPF4_2», «SLPF4_3», 
 SLPF5= «SLPF5_1», «SLPF5_2», «SLPF5_3», 
 T_SLPFRN=  1.8E-12,  1.9E-13,  3.7E-12,  3E-15,  6.2E-12,  3.9E-11, 
  1.5E-11,  3.7E-11, 
 T_KFACTR= 760,  150,  570,  250, 
 S_NUCNAM = 'Po-210','Te-125m', 
 S_DCF2 =  .0094,  7.29E-06, 
 S_DCF3 =  .0019,  3.67E-06, 
 S_SLPF1=  3.95E-11,  6.98E-09, 
 S_SLPF2=  1.45E-08,  1.45E-11, 
 S_SLPF3=  2.25E-09,  4.7E-12, 
 S_SLPF4=  1.77E-09,  3.33E-12, 
 S_SLPF5=  2.25E-09,  4.7E-12, 
 &END 
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Listing 2. Partial Listing of MS Excel 2000 Data File, 2000_krs_Cs137_RESRAD.xls, for Input to the MS Word 2000 MailMerge Tool 
IHAFTIM NANUC TITLE AREA THICK0 LCZPAQ BRDL H1 ED SHF3 SHF1 FIND FOTD FR9 DROOT Dnl Dl Dmk Dmt NUC_1 S_1 DCACT_1
0 1 'January 01, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 2.55884 1000
0 1 'January 02, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 2.067434564 1000
0 1 'January 03, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.443952729 1000
0 1 'January 04, 2000' 1824722000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.146256311 1000
0 1 'January 05, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.131936427 1000
0 1 'January 06, 2000' 1824722000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.320926063 1000
0 1 'January 07, 2000' 1824722000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.568941254 1000
0 1 'January 08, 2000' 1758936000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.175935271 1000
0 1 'January 09, 2000' 1824722000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.177857396 1000
0 1 'January 10, 2000' 1867857000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.108600541 1000
0 1 'January 11, 2000' 1824722000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.588292799 1000
0 1 'January 12, 2000' 1824722000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.213717208 1000
0 1 'January 13, 2000' 1802936000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.229046232 1000
0 1 'January 16, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.818107921 1000
0 1 'January 17, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.605472079 1000
0 1 'January 18, 2000' 1867857000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.909529617 1000
0 1 'January 19, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.157484785 1000
0 1 'January 20, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.388090729 1000
0 1 'January 21, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.282493521 1000
0 1 'January 22, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.667340627 1000
0 1 'January 23, 2000' 1736726000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.297209875 1000
0 1 'January 24, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.513930337 1000
0 1 'January 25, 2000' 1867857000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.578321835 1000
0 1 'January 26, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 2.579863136 1000
0 1 'January 27, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 2.426092706 1000
0 1 'January 28, 2000' 1910399000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.026358455 1000
0 1 'January 29, 2000' 1910399000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.098124908 1000
0 1 'January 30, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.920221254 1000
0 1 'January 31, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.819309175 1000
0 1 'February 01, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 3.516302509 1000
0 1 'February 02, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 3.295858118 1000
0 1 'February 03, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.645826667 1000
0 1 'February 04, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.839841882 1000
0 1 'February 05, 2000' 1910399000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.232037521 1000
0 1 'February 06, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.053569175 1000
0 1 'February 07, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 6.240927062 1000
0 1 'February 08, 2000' 1802936000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.965812056 1000
0 1 'February 09, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 11.45482904 1000
0 1 'February 10, 2000' 1910399000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 0.187473868 1000
0 1 'February 11, 2000' 1867857000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 1.664399117 1000
0 1 'February 12, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 2.203248177 1000
0 1 'February 13, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 4.477969803 1000
0 1 'February 14, 2000' 1889203000 0.15 100 25 4 50 0 0.2 0.8 0.2 0.5 0.9 155 123.333 148.8669903 66.667 'Cs-137' 2.308962509 1000
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Listing 3. MatLab File, test_run_3.m, used to generate RESRAD dose estimates from files generated using the MS Word 2000 
MailMerge tool 
% An MS Word MailMerge tool has been used to produce the appropriate files. 
close all; 
clear all; 
% The files (of form Site##.txt) are contained in the following directory: 
testdirname = 'D:\kgb\RESRAD\Test Folder'; 
% and the result files (i.e., SUMMARY##.REP will be placed this directory as well). 
% NOTE: It is assumed that only test files--AND NOT SUMMARY.REP files--are located in this irectory to start. 
% The RESRAD directory is: 
resraddirname = 'D:\Program Files\RESRAD_Family\RESRAD'; 
% Save current directory 
fid0 = pwd; 
% Put the file information into the following variable: 
files = dir(testdirname); 
% The first two represent directories--so skip 
for i = 3:length(files) 
    cd(testdirname); 
    copyfile(files(i).name, strcat(resraddirname, '\Site2.RAD')); 
    cd(resraddirname); 
    % Run the calculation using RESCALC.EXE 
    !rescalc Site2.RAD 0 >nul 
    % Copy the results placed in SUMMARY.REP back to the Test Folder defined above 
    copyfile('SUMMARY.REP', strcat(testdirname, '\SUMMARY', sprintf('%04d',i-2), '.REP')); 
    % as well as the other files that may be of interest later 
    copyfile('DETAILED.REP', strcat(testdirname, '\DETAILED', sprintf('%04d',i-2), '.REP')); 
    copyfile('DAUDOSE.REP', strcat(testdirname, '\DAUDOSE', sprintf('%04d',i-2), '.REP')); 
    copyfile('CONCENT.REP', strcat(testdirname, '\CONCENT', sprintf('%04d',i-2), '.REP')); 
    copyfile('INTRISK.REP', strcat(testdirname, '\INTRISK', sprintf('%04d',i-2), '.REP')); 
    copyfile('DEBUG.OUT', strcat(testdirname, '\DEBUG', sprintf('%04d',i-2), '.OUT')); 
end; 
% And back to the original directory .... 
cd(fid0); 
clear testdirname resraddirname fid0 files i; 
% You can summarize the results from all the files using summarypp.m 
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Listing 4. MatLab File, summarypp3.m, used to collect RESRAD dose information after processing through MatLab with test_run_3.m 
% Now postprocess the various SUMMARY##.REP files to gather the desired information. 
close all; 
clear all; 
% The results files (of form SUMMARY##.REP) are contained in the following directory: 
testdirname = 'D:\kgb\RESRAD\Test Folder'; 
% NOTE: There will likely also be test files located in this directory so they should be excluded from the following. 
fid0 = pwd; 
% Put the file information (containing directories and SUMMARY and test files) into the following variable: 
files = dir(testdirname); 
cd(testdirname); 
counter = 0; 
for i = 3:length(files) 
    ycount = 1; 
    ids0 = ''; 
    allconcs = []; 
    if strfind(files(i).name, 'SUMMARY') 
        fid = fopen(files(i).name); 
        counter = counter+1; 
        while 1 
            tline = fgetl(fid); 
            if ~ischar(tline), break, end % end if string is empty 
            % Get the contaminated zone area (AREA) 
            front = ' R011 | Area of contaminated zone (m**2)'; 
            if strfind(tline, front) 
                init(counter).area = getthing(front, tline); 
            end 
            % Get the contaminated zone thickness (THICK0) 
            front = ' R011 | Thickness of contaminated zone (m)'; 
            if strfind(tline, front) 
                init(counter).thick0 = getthing(front, tline); 
            end 
            % Get the length parallel to aquifer flow (LCZPAQ) 
            front = ' R011 | Length parallel to aquifer flow (m)'; 
            if strfind(tline, front) 
                init(counter).lczpaq = getthing(front, tline); 
            end 
            % Get the basic radiation dose limit (BRDL) 
            front = ' R011 | Basic radiation dose limit (mSv/yr)'; 
            if strfind(tline, front) 
                init(counter).brdl = getthing(front, tline); 
            end 
            % Get the Unsaturated zone 1 thickness (H(1)) 
            front = ' R015 | Unsat. zone 1, thickness (m)'; 
            if strfind(tline, front) 
                init(counter).h1 = getthing(front, tline); 
            end 
            % Get the Exposure Duration (ED) 
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            front = ' R017 | Exposure duration'; 
            if strfind(tline, front) 
                init(counter).ed = getthing(front, tline); 
            end 
            % Get the Inhalation Shielding Factor (SHF3) 
            front = ' R017 | Shielding factor, inhalation'; 
            if strfind(tline, front) 
                init(counter).shf3 = getthing(front, tline); 
            end 
            % Get the External Gamma Shielding Factor (SHF1) 
            front = ' R017 | Shielding factor, external gamma'; 
            if strfind(tline, front) 
                init(counter).shf1 = getthing(front, tline); 
            end 
            % Get the Fraction Spent Indoors (FIND) 
            front = ' R017 | Fraction of time spent indoors'; 
            if strfind(tline, front) 
                init(counter).find = getthing(front, tline); 
            end 
            % Get the Fraction Spent Outdoors (FOTD) 
            % Should there not be a unit sum or just a maximum constraint on FIND+FOTD???  
            front = ' R017 | Fraction of time spent outdoors (on site)'; 
            if strfind(tline, front) 
                init(counter).fotd = getthing(front, tline); 
            end 
            % Get the Aquatic Food Contamination Factor (FR9) 
            front = ' R018 | Contamination fraction of aquatic food'; 
            if strfind(tline, front) 
                init(counter).fr9 = getthing(front, tline); 
            end 
            % Get the Depth of Roots (DROOT) 
            front = ' R019 | Depth of roots (m)'; 
            if strfind(tline, front) 
                init(counter).droot = getthing(front, tline); 
            end 
            % Get the Non-leafy Vegetable Consumption (DIET(1)) 
            front = ' R018 | Fruits, vegetables and grain consumption (kg/yr)'; 
            if strfind(tline, front) 
                init(counter).diet(1) = getthing(front, tline); 
            end 
            % Get the Leafy Vegetable Consumption (DIET(2)) 
            front = ' R018 | Leafy vegetable consumption (kg/yr)'; 
            if strfind(tline, front) 
                init(counter).diet(2) = getthing(front, tline); 
            end 
            % Get the Milk Consumption (DIET(3)) 
            front = ' R018 | Milk consumption (L/yr)'; 
            if strfind(tline, front) 
                init(counter).diet(3) = getthing(front, tline); 
            end 
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            % Get the Meat Consumption (DIET(4)) 
            front = ' R018 | Meat and poultry consumption (kg/yr)'; 
            if strfind(tline, front) 
                init(counter).diet(4) = getthing(front, tline); 
            end 
            % I am not currenlty concerned with the Fish and Other Seafood consumption values in DIET(5) and DIET(6), respectively. 
            % Get the density of the contaminated zone (DENSCZ) 
            front = ' R013 | Density of contaminated zone (g/cm**3)'; 
            if strfind(tline, front) 
                init(counter).denscz = getthing(front, tline); 
            end 
            % Get the Soil Ingestion Rate (SOIL) 
            front = ' R018 | Soil ingestion rate (g/yr)'; 
            if strfind(tline, front) 
                init(counter).soil = getthing(front, tline); 
            end 
            % Get the radionuclide ID's and concentrations 
            if strfind(tline, 'R012 | Initial principal radionuclide (Bq/g):') 
                [id0, conc] = getconc(tline); 
                ids0 = strvcat(ids0, id0); 
                allconcs = [allconcs, conc]; 
            end 
            % Process doses and fractions for each year considered 
            if strfind(tline, 'As mSv/yr and Fraction of Total Dose At t = 0.000E+00 years') % had to add the 0.000E+00 years to prevent error 
                tlinep1 = fgetl(fid); % get the next line to see if the path is water independent 
                    if strfind(tlinep1, 'Water Independent Pathways') 
                        year = getyear(tline); 
                        % disp(num2str(year)); 
                        % Now go to the beginning of the results by skipping the next four (4) lines 
                        for j = 1:4 
                            fgetl(fid); 
                        end 
                        count = 1; 
                        ids = ''; 
                        alldoses = []; 
                        allfractions = []; 
                        while 1 
                            tline = fgetl(fid); 
                            [id, tline] = strtok(tline); 
                            if strcmp(id, '======='), break, end % the line above the totals 
                            ids = strvcat(ids, id); 
                            % now get doses 
                            [doses, fractions] = getdoses(tline); 
                            alldoses = [alldoses; doses]; 
                            allfractions = [allfractions; fractions]; 
                        end 
                        results(counter, ycount).year = year; 
                        results(counter, ycount).ids = ids; 
                        results(counter, ycount).doses = alldoses; 
                        results(counter, ycount).fractions = allfractions; 
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                        ycount = ycount + 1; 
                    end 
            end 
        end 
        fclose(fid); 
        init(counter).ids = ids0; 
        init(counter).concs = allconcs; 
        % Now compute the initial radionuclide loadings 
        %init(counter).loadings = (1000*allconcs)*(1000*init(counter).denscz)*init(counter).thick0; 
        % But let's try it in Bq/g instead 
        init(counter).loadings = allconcs; 
    end 
end 
cd(fid0); 
clear testdirname fid0 files i ids0 allconcs fid tline front id0 conc ycount; 
clear tlinep1 year j count ids doses fractions alldoses allfractions id; 
% Now process the results using process_results.m to return the dose conversion factors in the variable dosefactors 
% and save them into a tab-delimited file 
% process_results 
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Listing 5. MatLab File, process_results3.m, used to generate a file containing the RESRAD dose information after generating the 
summary information with summarypp3.m 
% M-file to process results (in both init and results variables) from summarypp.m run 
% and generate dose factors at time zero (0) 
% This m-file will also write the results from processing a series of SUMMARY reports from  
% RESRAD 6.2 to a tab-delimited files for input to Excel or similar 
% The variables are contained in the original Excel files used to generate the runs 
% and thus only the results will be placed in the file 
% There are r files and c times in years in the results files 
[r, cc] = size(results); 
% For now, pick the values at zero (0) years corresponding to c = 1 
yindex = 1; % corresponding to results(:,yindex).year value 
year = results(1,yindex).year 
% The directory name to put the results file: 
dirname = 'D:\kgb\RESRAD'; 
% Save current directory 
fid0 = pwd; 
% Go to directory where you want the results. 
cd(dirname); 
% Use clock function to make a new (and likely unique) filename.... 
c = clock; 
filename = strcat('t', num2str(results(1,yindex).year), '-', num2str(c(3)), '-', num2str(c(2)), '-', num2str(c(1))); 
filename = strcat(filename, '-', num2str(c(4)), '-', num2str(c(5)), '-', num2str(round(c(6))), '.txt'); 
fid = fopen(filename, 'w'); 
% Now generate the heading string 
heading = '%s\tGround\tInhalation\tRadon\tPlant\tMeat\tMilk\tSoil'; 
fprintf(fid, heading, 'Dose'); fprintf(fid, '\t'), fprintf(fid, heading, 'DCF'); fprintf(fid, '\t'); 
fprintf(fid, heading, 'Dose'); fprintf(fid, '\t'), fprintf(fid, heading, 'DCF'); fprintf(fid, '\t'); 
fprintf(fid, heading, 'Dose'); fprintf(fid, '\t'), fprintf(fid, heading, 'DCF'); fprintf(fid, '\n'); 
for i = 1:r 
    ids = results(i,yindex).ids; 
    doses = results(i,yindex).doses; 
    [dr, dc] = size(doses); 
    diet = init(i).diet; 
    loadings = init(i).loadings; 
    dosefactors(i).ids = init(i).ids; % I think this is already available above in ids 
    % Factors for Ground, Inhalation, Radon, Plant, Meat, Milk, and Soil 
    factors = [365*24, 365*24, 1, diet(1)+diet(2), diet(4), diet(3), init(i).soil]; 
    for j = 1:dr 
        fprintf(fid,'%s\t', ids(j,:)); 
        % Write out the doses 
        for k = 1:dc 
            fprintf(fid,'%6.3E\t', doses(j,k)); 
        end 
        % Compute and write the dose conversion factors (DCF's)--check summarypp3.m for denominator used 
        fprintf(fid,'%s\t', ids(j,:)); 
        for k = 1:dc 
            % Check for division(s) by zero 
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            if (loadings(j) * factors(k)) > 0 
                dosefactors(i).factors(j,k) = doses(j,k) / loadings(j) / factors(k); 
            else 
                dosefactors(i).factors(j,k) = NaN 
            end 
            fprintf(fid,'%6.3E\t', dosefactors(i).factors(j,k)); 
        end 
    end 
    fprintf(fid, '\n'); 
end 
% and now close the file 
fclose(fid); 
% And back to the original directory .... 
cd(fid0); 
clear r cc i doses dr dc diet loadings factors j k ids filename heading fid fid0 dirname; 
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9 Tables 
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Table 1.  Correlations for I-131 versus Cs-137 “raw” Dry Deposition (ddep) results (in Bq m
-2
)  
for the PRS 
 I-131(td hr) 
Cs-137(tp hr) Max 144 120 096 072 048 024 
Cs-137(Max) 0.868 0.888 0.888 0.887 0.885 0.865 0.514 
Cs-137(144) 0.868 0.888 0.888 0.887 0.885 0.865 0.514 
Cs-137(138) 0.868 0.889 0.888 0.887 0.885 0.865 0.514 
Cs-137(132) 0.868 0.889 0.889 0.888 0.886 0.865 0.514 
Cs-137(126) 0.869 0.890 0.890 0.888 0.887 0.866 0.515 
Cs-137(120) 0.870 0.891 0.891 0.890 0.888 0.867 0.515 
Cs-137(114) 0.871 0.892 0.892 0.891 0.889 0.869 0.516 
Cs-137(108) 0.872 0.893 0.893 0.892 0.891 0.870 0.517 
Cs-137(102) 0.873 0.893 0.893 0.893 0.891 0.871 0.518 
Cs-137(096) 0.873 0.894 0.894 0.894 0.892 0.871 0.518 
Cs-137(090) 0.874 0.895 0.895 0.895 0.893 0.873 0.519 
Cs-137(084) 0.875 0.895 0.895 0.896 0.895 0.874 0.520 
Cs-137(078) 0.876 0.896 0.896 0.896 0.896 0.875 0.521 
Cs-137(072) 0.877 0.897 0.897 0.898 0.897 0.877 0.522 
Cs-137(066) 0.879 0.899 0.899 0.899 0.899 0.880 0.524 
Cs-137(060) 0.884 0.904 0.904 0.904 0.904 0.887 0.531 
Cs-137(054) 0.892 0.910 0.910 0.910 0.911 0.898 0.543 
Cs-137(048) 0.909 0.925 0.925 0.925 0.925 0.916 0.573 
Cs-137(042) 0.963 0.972 0.972 0.972 0.972 0.969 0.695 
Cs-137(036) 0.962 0.955 0.955 0.956 0.956 0.963 0.858 
Cs-137(030) 0.879 0.861 0.861 0.862 0.862 0.877 0.907 
Cs-137(024) 0.869 0.848 0.848 0.848 0.848 0.863 0.986 
Cs-137(018) 0.660 0.638 0.638 0.638 0.638 0.648 0.881 
Cs-137(012) 0.287 0.271 0.271 0.271 0.271 0.276 0.422 
Cs-137(006) 0.198 0.184 0.184 0.184 0.184 0.188 0.290 
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Table 2.  PRS Dry Deposition (ddep) Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 09-Feb 326 100.0 1.91E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.91E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.91E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 1.56E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.56E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.56E+04 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 07-Jan 58 17.8 6.75E+01 43.50 130.50 2306 2.25E+09 70383 07-Jan 17.8 6.75E+01 43.50 130.50 2306 2.25E+09 70383 04-Dec 1.5 5.45E-04 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 82 25.2 2.76E+02 43.50 142.50 1581 2.25E+09 155808 26-Apr 25.2 2.76E+02 43.50 142.50 1581 2.25E+09 155808 02-Jan 3.1 4.42E+01 44.50 145.50 1338 2.21E+09 2136
Laos None      None  None
Mongolia 04-Jan 13 4.0 4.13E+00 46.50 119.50 2855 2.13E+09 1835 04-Jan 4.0 4.13E+00 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 18 5.5 4.24E+01 43.00 130.00 2372 2.26E+09 175327 07-Jan 5.5 4.24E+01 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 9.93E-13 43.00 130.00 2372 2.26E+09 175327
Russia 09-Feb 326 100.0 1.91E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.91E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.91E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 06-Jan 5 1.5 3.04E+00 37.50 129.50 2818 2.45E+09 1434 06-Jan 1.5 3.04E+00 37.50 129.50 2818 2.45E+09 1434 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 20-May 273 83.7 4.76E+02 52.50 174.00 1043 1.89E+09 0 20-May 83.7 4.76E+02 52.50 174.00 1043 1.89E+09 0 20-May 32.5 3.60E+02 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 229 70.2 7.00E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 70.2 7.00E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 5.27E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 3.  PRS Wet Deposition (wdep) Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 21-Mar 326 100.0 1.79E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 1.79E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 98.8 1.79E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 326 100.0 1.55E+04 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 1.55E+04 52.50 159.00 65 1.89E+09 0 05-Nov 98.8 1.55E+04 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 05-Jan 45 13.8 1.43E+02 52.50 126.00 2169 1.89E+09 7721 05-Jan 13.8 1.43E+02 52.50 126.00 2169 1.89E+09 7721 04-Dec 1.2 4.71E-04 52.50 121.50 2463 1.89E+09 17115
Hong Kong None      None  None
Japan 01-Jan 45 13.8 4.05E+01 45.00 142.50 1462 2.19E+09 71857 01-Jan 13.8 4.05E+01 45.00 142.50 1462 2.19E+09 71857 01-Jan 1.8 4.05E+01 45.00 142.50 1462 2.19E+09 71857
Laos None      None  None
Mongolia 04-Jan 10 3.1 6.98E+00 46.50 118.50 2922 2.13E+09 1978 04-Jan 3.1 6.98E+00 46.50 118.50 2922 2.13E+09 1978 None
N. Korea 07-Jan 17 5.2 1.30E+01 42.50 130.50 2375 2.28E+09 227852 07-Jan 5.2 1.30E+01 42.50 130.50 2375 2.28E+09 227852 04-Dec 0.3 2.17E-12 43.00 130.00 2372 2.26E+09 175327
Russia 21-Mar 320 98.2 1.79E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 98.2 1.79E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 89.3 1.79E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 1.57E+00 36.50 126.00 3112 2.49E+09 26386 05-Jan 1.5 1.57E+00 36.50 126.00 3112 2.49E+09 26386 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 24-Jan 269 82.5 6.39E+02 52.50 185.50 1807 1.89E+09 63 24-Jan 82.5 6.39E+02 52.50 185.50 1807 1.89E+09 63 10-Mar 28.5 1.42E+02 53.00 172.50 935 1.87E+09 0
Alaska (U.S.) 18-Feb 225 69.0 5.81E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 69.0 5.81E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 1.70E+01 56.00 198.00 2537 1.74E+09 26
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively.  
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 4.  PRS Total Deposition (tdep) Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 21-Mar 326 100.0 2.78E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.78E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.78E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 326 100.0 2.20E+04 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 2.20E+04 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 2.20E+04 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 05-Jan 58 17.8 1.95E+02 52.50 126.00 2169 1.89E+09 7721 05-Jan 17.8 1.95E+02 52.50 126.00 2169 1.89E+09 7721 04-Dec 1.5 9.99E-04 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 82 25.2 2.76E+02 43.50 142.50 1581 2.25E+09 155808 26-Apr 25.2 2.76E+02 43.50 142.50 1581 2.25E+09 155808 01-Jan 3.1 7.05E+01 45.50 142.00 1454 2.17E+09 34622
Laos None      None  None
Mongolia 04-Jan 13 4.0 1.09E+01 46.50 119.50 2855 2.13E+09 1835 04-Jan 4.0 1.09E+01 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 18 5.5 5.42E+01 43.00 130.00 2372 2.26E+09 175327 07-Jan 5.5 5.42E+01 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 3.17E-12 43.00 130.00 2372 2.26E+09 175327
Russia 21-Mar 326 100.0 2.78E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.78E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.78E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 4.09E+00 37.50 126.50 3001 2.45E+09 2006368 05-Jan 1.5 4.09E+00 37.50 126.50 3001 2.45E+09 2006368 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 24-Jan 273 83.7 8.56E+02 52.50 185.50 1807 1.89E+09 63 24-Jan 83.7 8.56E+02 52.50 185.50 1807 1.89E+09 63 20-May 32.5 3.66E+02 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 229 70.2 1.28E+03 58.50 198.00 2507 1.62E+09 22 18-Feb 70.2 1.28E+03 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 5.27E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 5.  PRS Integrated Concentration Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 09-Feb 326 100.0 3.53E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.53E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.53E+03 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 2.89E+03 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 2.89E+03 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 2.88E+03 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 07-Jan 58 17.8 1.25E+01 43.50 130.50 2306 2.25E+09 70383 07-Jan 17.8 1.25E+01 43.50 130.50 2306 2.25E+09 70383 04-Dec 1.5 1.01E-04 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 82 25.2 5.11E+01 43.50 142.50 1581 2.25E+09 155808 26-Apr 25.2 5.11E+01 43.50 142.50 1581 2.25E+09 155808 02-Jan 3.1 8.18E+00 44.50 145.50 1338 2.21E+09 2136
Laos None      None  None
Mongolia 04-Jan 13 4.0 7.64E-01 46.50 119.50 2855 2.13E+09 1835 04-Jan 4.0 7.64E-01 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 18 5.5 7.85E+00 43.00 130.00 2372 2.26E+09 175327 07-Jan 5.5 7.85E+00 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 1.84E-13 43.00 130.00 2372 2.26E+09 175327
Russia 09-Feb 326 100.0 3.53E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.53E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.53E+03 52.50 157.50 87 1.89E+09 1944
S. Korea 06-Jan 5 1.5 5.63E-01 37.50 129.50 2818 2.45E+09 1434 06-Jan 1.5 5.63E-01 37.50 129.50 2818 2.45E+09 1434 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 20-May 273 83.7 8.81E+01 52.50 174.00 1043 1.89E+09 0 20-May 83.7 8.81E+01 52.50 174.00 1043 1.89E+09 0 20-May 32.5 6.67E+01 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 229 70.2 1.30E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 70.2 1.30E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 9.75E+00 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 6.  Least-Squares Fitted Parameters Relating I-131 to Cs-137 from Five Days in CY2000 
I-131 PRS ddep Corr. Cs137Raw(td) R
2 Addep,td  I-131 VRS ddep Corr. Cs137Raw(td) R
2 Addep,td 
MaxRaw 0.9631 Cs137Raw042 0.9280 2.0877 MaxRaw 0.9555 Cs137Raw042 0.9136 2.4144
I131Raw144 0.9721 Cs137Raw042 0.9450 1.4396 I131Raw144 0.9634 Cs137Raw042 0.9283 1.7046
I131Raw120 0.9721 Cs137Raw042 0.9451 1.5692 I131Raw120 0.9635 Cs137Raw042 0.9286 1.8579
I131Raw096 0.9722 Cs137Raw042 0.9453 1.7102 I131Raw096 0.9636 Cs137Raw042 0.9290 2.0240
I131Raw072 0.9724 Cs137Raw042 0.9458 1.8633 I131Raw072 0.9676 Cs137Raw042 0.9368 2.1891
I131Raw048 0.9695 Cs137Raw042 0.9403 1.9856 I131Raw048 0.9651 Cs137Raw042 0.9322 2.2541
I131Raw024 0.9860 Cs137Raw024 0.9724 2.7837 I131Raw024 0.9912 Cs137Raw024 0.9825 2.9590
           
I-131 PRS ddep Corr. Cs137Raw(td) R
2 Addep,td  I-131 VRS ddep Corr. Cs137Raw(td) R
2 Addep,td 
MaxFrac 0.9625 Cs137Frac042 0.9268 2.0999 MaxFrac 0.9555 Cs137Frac042 0.9136 2.4144
I131Frac144 0.9715 Cs137Frac042 0.9438 1.4469 I131Frac144 0.9634 Cs137Frac042 0.9283 1.7046
I131Frac120 0.9715 Cs137Frac042 0.9440 1.5771 I131Frac120 0.9635 Cs137Frac042 0.9286 1.8579
I131Frac096 0.9716 Cs137Frac042 0.9442 1.7188 I131Frac096 0.9636 Cs137Frac042 0.9290 2.0240
I131Frac072 0.9719 Cs137Frac042 0.9448 1.8727 I131Frac072 0.9676 Cs137Frac042 0.9368 2.1891
I131Frac048 0.9690 Cs137Frac042 0.9395 1.9964 I131Frac048 0.9651 Cs137Frac042 0.9322 2.2541
I131Frac024 0.9860 Cs137Frac024 0.9724 2.7945 I131Frac024 0.9912 Cs137Frac024 0.9825 2.9590
           
I-131 PRS wdep Corr. Cs137Raw(td) R
2 Awdep,td  I-131 VRS wdep Corr. Cs137Raw(td) R
2 Awdep,td
MaxRaw 0.9844 Cs137Raw042 0.9691 0.5429 MaxRaw 0.9808 Cs137Raw078 0.9621 0.6129
I131Raw144 0.9856 Cs137Raw042 0.9715 0.3690 I131Raw144 0.9698 Cs137Raw078 0.9408 0.4281
I131Raw120 0.9856 Cs137Raw042 0.9715 0.4022 I131Raw120 0.9698 Cs137Raw078 0.9409 0.4666
I131Raw096 0.9859 Cs137Raw042 0.9721 0.4384 I131Raw096 0.9699 Cs137Raw078 0.9409 0.5086
I131Raw072 0.9858 Cs137Raw042 0.9719 0.4775 I131Raw072 0.9986 Cs137Raw054 0.9972 0.5349
I131Raw048 0.9874 Cs137Raw042 0.9750 0.5185 I131Raw048 0.9997 Cs137Raw048 0.9994 0.5831
I131Raw024 0.9912 Cs137Raw024 0.9825 0.6338 I131Raw024 0.9997 Cs137Raw024 0.9994 0.6617
           
I-131 PRS wdep Corr. Cs137Raw(td) R
2 Awdep,td  I-131 VRS wdep Corr. Cs137Raw(td) R
2 Awdep,td
MaxFrac 0.9851 Cs137Frac042 0.9705 0.5467 MaxFrac 0.9827 Cs137Frac078 0.9659 0.6105
I131Frac144 0.9865 Cs137Frac042 0.9732 0.3714 I131Frac144 0.9735 Cs137Frac078 0.9480 0.4227
I131Frac120 0.9865 Cs137Frac042 0.9732 0.4048 I131Frac120 0.9736 Cs137Frac078 0.9481 0.4608
I131Frac096 0.9867 Cs137Frac042 0.9736 0.4412 I131Frac096 0.9736 Cs137Frac078 0.9481 0.5022
I131Frac072 0.9865 Cs137Frac042 0.9733 0.4806 I131Frac072 0.9985 Cs137Frac054 0.9969 0.5351
I131Frac048 0.9878 Cs137Frac042 0.9759 0.5220 I131Frac048 0.9997 Cs137Frac048 0.9994 0.5832
I131Frac024 0.9910 Cs137Frac024 0.9821 0.6366 I131Frac024 0.9997 Cs137Frac024 0.9994 0.6618
           
I-131 PRS dose Corr. Cs137Raw(td) R
2 Adose,td  I-131 VRS dose Corr. Cs137Raw(td) R
2 Adose,td 
MaxRaw 0.9660 Cs137Raw042 0.9334 0.5483 MaxRaw 0.9627 Cs137Raw042 0.9286 0.6612
I131Raw144 0.9660 Cs137Raw042 0.9334 0.5483 I131Raw144 0.9627 Cs137Raw042 0.9286 0.6612
I131Raw120 0.9660 Cs137Raw042 0.9335 0.5482 I131Raw120 0.9627 Cs137Raw042 0.9288 0.6612
I131Raw096 0.9661 Cs137Raw042 0.9336 0.5482 I131Raw096 0.9628 Cs137Raw042 0.9291 0.6609
I131Raw072 0.9662 Cs137Raw042 0.9339 0.5480 I131Raw072 0.9651 Cs137Raw042 0.9330 0.6570
I131Raw048 0.9625 Cs137Raw042 0.9270 0.5369 I131Raw048 0.9775 Cs137Raw036 0.9534 0.7447
I131Raw024 0.9844 Cs137Raw024 0.9691 0.7131 I131Raw024 0.9900 Cs137Raw024 0.9806 0.7680
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Table 7.  Least-Squares Fitted Parameters Relating Sr-90 to Cs-137 from Five Days in CY2000 
Sr-90 PRS ddep Corr. Cs137Raw(td) R
2 Addep,td  Sr-90 VRS ddep Corr. Cs137Raw(td) R
2 Addep,td 
MaxRaw 0.9981 Cs137Raw138 0.9961 1.1752 MaxRaw 0.9970 Cs137Raw126 0.9942 1.1359
SR90Raw144 0.9981 Cs137Raw138 0.9961 1.1751 SR90Raw144 0.9970 Cs137Raw126 0.9942 1.1359
SR90Raw120 0.9982 Cs137Raw120 0.9964 1.1766 SR90Raw120 0.9971 Cs137Raw114 0.9944 1.1357
SR90Raw096 0.9984 Cs137Raw096 0.9968 1.1793 SR90Raw096 0.9976 Cs137Raw090 0.9952 1.1544
SR90Raw072 0.9985 Cs137Raw072 0.9970 1.1823 SR90Raw072 0.9988 Cs137Raw066 0.9976 1.2431
SR90Raw048 0.9988 Cs137Raw048 0.9976 1.2001 SR90Raw048 0.9988 Cs137Raw048 0.9976 1.2313
SR90Raw024 0.9998 Cs137Raw024 0.9996 1.2854 SR90Raw024 0.9999 Cs137Raw024 0.9997 1.2961
           
Sr-90 PRS ddep Corr. Cs137Raw(td) R
2 Addep,td  Sr-90 VRS ddep Corr. Cs137Raw(td) R
2 Addep,td 
MaxFrac 0.9981 Cs137Frac138 0.9962 1.1765 MaxFrac 0.9969 Cs137Frac126 0.9940 1.1399
I131Frac144 0.9981 Cs137Frac138 0.9962 1.1764 SR90Frac144 0.9969 Cs137Frac126 0.9940 1.1399
I131Frac120 0.9982 Cs137Frac120 0.9964 1.1778 SR90Frac120 0.9970 Cs137Frac114 0.9942 1.1395
I131Frac096 0.9984 Cs137Frac096 0.9968 1.1805 SR90Frac096 0.9975 Cs137Frac090 0.9950 1.1577
I131Frac072 0.9985 Cs137Frac072 0.9970 1.1834 SR90Frac072 0.9988 Cs137Frac066 0.9976 1.2449
I131Frac048 0.9988 Cs137Frac048 0.9976 1.2011 SR90Frac048 0.9988 Cs137Frac048 0.9977 1.2339
I131Frac024 0.9998 Cs137Frac024 0.9996 1.2859 SR90Frac024 0.9999 Cs137Frac024 0.9997 1.2965
           
Sr-90 PRS wdep Corr. Cs137Raw(td) R
2 Awdep,td  Sr-90 VRS wdep Corr. Cs137Raw(td) R
2 Awdep,td
MaxRaw 0.9994 Cs137Raw138 0.9989 0.9311 MaxRaw 0.9988 Cs137Raw138 0.9976 0.8920
SR90Raw144 0.9994 Cs137Raw138 0.9989 0.9309 SR90Raw144 0.9988 Cs137Raw138 0.9976 0.8919
SR90Raw120 0.9995 Cs137Raw120 0.9989 0.9311 SR90Raw120 0.9988 Cs137Raw120 0.9977 0.8919
SR90Raw096 0.9995 Cs137Raw090 0.9990 0.9323 SR90Raw096 0.9991 Cs137Raw090 0.9983 0.9033
SR90Raw072 0.9996 Cs137Raw072 0.9991 0.9329 SR90Raw072 0.9993 Cs137Raw072 0.9997 0.9529
SR90Raw048 0.9997 Cs137Raw048 0.9994 0.9377 SR90Raw048 1.0000 Cs137Raw048 1.0000 0.9555
SR90Raw024 0.9999 Cs137Raw024 0.9998 0.9540 SR90Raw024 1.0000 Cs137Raw024 1.0000 0.9600
           
Sr-90 PRS wdep Corr. Cs137Raw(td) R
2 Awdep,td  Sr-90 VRS wdep Corr. Cs137Raw(td) R
2 Awdep,td
MaxFrac 0.9995 Cs137Frac138 0.9990 0.9329 MaxFrac 0.9987 Cs137Frac138 0.9974 0.8972
I131Frac144 0.9995 Cs137Frac138 0.9990 0.9327 SR90Frac144 0.9987 Cs137Frac138 0.9974 0.8970
I131Frac120 0.9995 Cs137Frac114 0.9990 0.9330 SR90Frac120 0.9987 Cs137Frac120 0.9975 0.8971
I131Frac096 0.9995 Cs137Frac090 0.9991 0.9338 SR90Frac096 0.9991 Cs137Frac090 0.9982 0.9079
I131Frac072 0.9996 Cs137Frac072 0.9992 0.9344 SR90Frac072 0.9999 Cs137Frac072 0.9997 0.9527
I131Frac048 0.9997 Cs137Frac048 0.9995 0.9389 SR90Frac048 1.0000 Cs137Frac048 1.0000 0.9555
I131Frac024 0.9999 Cs137Frac024 0.9998 0.9545 SR90Frac024 1.0000 Cs137Frac024 1.0000 0.9600
           
Sr-90 PRS dose Corr. Cs137Raw(td) R
2 Adose,td  Sr-90 VRS dose Corr. Cs137Raw(td) R
2 Adose,td 
MaxRaw 0.9981 Cs137Raw138 0.9961 0.8814 MaxRaw 0.9970 Cs137Raw126 0.9942 0.8519
SR90Raw144 0.9981 Cs137Raw138 0.9961 0.8814 SR90Raw144 0.9970 Cs137Raw126 0.9942 0.8519
SR90Raw120 0.9982 Cs137Raw120 0.9850 0.8825 SR90Raw120 0.9971 Cs137Raw114 0.9943 0.8518
SR90Raw096 0.9984 Cs137Raw096 0.9968 0.8845 SR90Raw096 0.9976 Cs137Raw090 0.9952 0.8658
SR90Raw072 0.9985 Cs137Raw072 0.9970 0.8867 SR90Raw072 0.9988 Cs137Raw066 0.9976 0.9324
SR90Raw048 0.9988 Cs137Raw048 0.9976 0.9001 SR90Raw048 0.9988 Cs137Raw048 0.9976 0.9235
SR90Raw024 0.9998 Cs137Raw024 0.9996 0.9640 SR90Raw024 0.9999 Cs137Raw024 0.9997 0.9721
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Table 8.  PRS Dry Deposition (ddep) Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 09-Feb 326 100.0 2.29E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 2.24E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 2.29E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 1.87E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.83E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.87E+04 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 07-Jan 50 15.3 7.93E+01 43.50 130.50 2306 2.25E+09 70383 07-Jan 15.3 7.93E+01 43.50 130.50 2306 2.25E+09 70383 04-Dec 1.5 6.53E-04 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 76 23.3 3.19E+02 43.50 142.50 1581 2.25E+09 155808 26-Apr 23.3 3.19E+02 43.50 142.50 1581 2.25E+09 155808 02-Jan 3.1 5.30E+01 44.50 145.50 1338 2.21E+09 2136
Laos None      None  None
Mongolia 04-Jan 11 3.4 4.85E+00 46.50 119.50 2855 2.13E+09 1835 04-Jan 3.4 4.85E+00 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 14 4.3 4.96E+01 43.00 130.00 2372 2.26E+09 175327 07-Jan 4.3 4.96E+01 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 1.19E-12 43.00 130.00 2372 2.26E+09 175327
Russia 09-Feb 326 100.0 2.29E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 2.24E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 2.29E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 1.72E+00 38.00 126.50 2962 2.44E+09 612497 05-Jan 1.5 1.72E+00 38.00 126.50 2962 2.44E+09 612497 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 20-May 269 82.5 5.61E+02 52.50 174.00 1043 1.89E+09 0 20-May 82.5 5.59E+02 52.50 174.00 1043 1.89E+09 0 20-May 32.5 4.32E+02 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 215 66.0 8.23E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 66.0 8.23E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 6.32E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 9.  PRS Wet Deposition (wdep) Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 21-Mar 326 100.0 1.68E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 1.66E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 98.8 1.68E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 326 100.0 1.47E+04 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 1.44E+04 52.50 159.00 65 1.89E+09 0 05-Nov 98.8 1.45E+04 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 05-Jan 39 12.0 1.34E+02 52.50 126.00 2169 1.89E+09 7721 05-Jan 12.0 1.33E+02 52.50 126.00 2169 1.89E+09 7721 04-Dec 1.2 4.41E-04 52.50 121.50 2463 1.89E+09 17115
Hong Kong None       
Japan 01-Jan 42 12.9 3.80E+01 45.00 142.50 1462 2.19E+09 71857 01-Jan 12.9 3.77E+01 45.00 142.50 1462 2.19E+09 71857 01-Jan 1.8 3.80E+01 45.00 142.50 1462 2.19E+09 71857
Laos None      None  None
Mongolia 04-Jan 8 2.5 6.50E+00 46.50 118.50 2922 2.13E+09 1978 04-Jan 2.5 6.50E+00 46.50 118.50 2922 2.13E+09 1978 None
N. Korea 07-Jan 14 4.3 1.15E+01 42.50 130.50 2375 2.28E+09 227852 07-Jan 4.3 1.15E+01 42.50 130.50 2375 2.28E+09 227852 04-Dec 0.3 2.04E-12 43.00 130.00 2372 2.26E+09 175327
Russia 21-Mar 319 97.9 1.68E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 97.9 1.66E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 89.3 1.68E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 5.37E-01 37.50 126.50 3001 2.45E+09 2006368 05-Jan 1.5 5.37E-01 37.50 126.50 3001 2.45E+09 2006368 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 24-Jan 265 81.3 5.96E+02 52.50 185.50 1807 1.89E+09 63 24-Jan 81.3 5.95E+02 52.50 185.50 1807 1.89E+09 63 10-Mar 28.5 1.33E+02 53.00 172.50 935 1.87E+09 0
Alaska (U.S.) 18-Feb 211 64.7 5.41E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 64.7 5.41E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 1.60E+01 56.00 198.00 2537 1.74E+09 26
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 10.  PRS Total Deposition (tdep) Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 21-Mar 326 100.0 2.86E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.83E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.86E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 326 100.0 2.30E+04 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 2.20E+04 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 2.23E+04 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 05-Jan 50 15.3 1.93E+02 52.50 126.00 2169 1.89E+09 7721 05-Jan 15.3 1.93E+02 52.50 126.00 2169 1.89E+09 7721 04-Dec 1.5 1.08E-03 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 76 23.3 3.19E+02 43.50 142.50 1581 2.25E+09 155808 26-Apr 23.3 3.19E+02 43.50 142.50 1581 2.25E+09 155808 01-Jan 3.1 7.42E+01 45.50 142.00 1454 2.17E+09 34622
Laos None      None  None
Mongolia 04-Jan 11 3.4 1.11E+01 46.50 119.50 2855 2.13E+09 1835 04-Jan 3.4 1.11E+01 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 14 4.3 6.04E+01 43.00 130.00 2372 2.26E+09 175327 07-Jan 4.3 6.04E+01 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 3.23E-12 43.00 130.00 2372 2.26E+09 175327
Russia 21-Mar 326 100.0 2.86E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.83E+04 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 2.86E+04 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 2.14E+00 37.50 126.50 3001 2.45E+09 2006368 05-Jan 1.5 2.14E+00 37.50 126.50 3001 2.45E+09 2006368 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 24-Jan 269 82.5 8.51E+02 52.50 185.50 1807 1.89E+09 63 24-Jan 82.5 8.49E+02 52.50 185.50 1807 1.89E+09 63 20-May 32.5 4.38E+02 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 215 66.0 1.36E+03 58.50 198.00 2507 1.62E+09 22 18-Feb 66.0 1.36E+03 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 6.32E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 11.  PRS Integrated Concentration Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 09-Feb 326 100.0 3.18E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.11E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.18E+03 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 2.59E+03 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 2.55E+03 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 2.59E+03 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 07-Jan 50 15.3 1.10E+01 43.50 130.50 2306 2.25E+09 70383 07-Jan 15.3 1.10E+01 43.50 130.50 2306 2.25E+09 70383 04-Dec 1.5 9.07E-05 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 76 23.3 4.43E+01 43.50 142.50 1581 2.25E+09 155808 26-Apr 23.3 4.43E+01 43.50 142.50 1581 2.25E+09 155808 02-Jan 3.1 7.37E+00 44.50 145.50 1338 2.21E+09 2136
Laos None      None  None
Mongolia 04-Jan 11 3.4 6.74E-01 46.50 119.50 2855 2.13E+09 1835 04-Jan 3.4 6.73E-01 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 14 4.3 6.89E+00 43.00 130.00 2372 2.26E+09 175327 07-Jan 4.3 6.89E+00 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 1.66E-13 43.00 130.00 2372 2.26E+09 175327
Russia 09-Feb 326 100.0 3.18E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.11E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.18E+03 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 2.39E-01 38.00 126.50 2962 2.44E+09 612497 05-Jan 1.5 2.39E-01 38.00 126.50 2962 2.44E+09 612497 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 20-May 269 82.5 7.79E+01 52.50 174.00 1043 1.89E+09 0 20-May 82.5 7.77E+01 52.50 174.00 1043 1.89E+09 0 20-May 32.5 6.00E+01 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 215 66.0 1.14E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 66.0 1.14E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 8.78E+00 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 12.  PRS Dry Deposition (ddep) Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
Regional 12-Jun 326 100.0 4.65E+04 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 2.75E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.79E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 3.09E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 2.24E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 3.09E+04 52.50 159.00 65 1.89E+09 0
Burma None      None   None
China 04-Dec 4 1.2 5.22E-05 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 3.78E-05 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 5.22E-05 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None   None
Japan 03-Jan 10 3.1 3.83E+01 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 2.78E+01 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 3.83E+01 44.50 145.50 1338 2.21E+09 2136
Laos None      None   None
Mongolia None      None   None
N. Korea None      None   None
Russia 12-Jun 326 100.0 4.65E+04 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 2.75E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.79E+04 52.50 157.50 87 1.89E+09 1944
S. Korea None      None   None
Taiwan None      None   None
Thailand None      None   None
Aleutians (U.S.) 18-Jan 86 26.4 5.06E+02 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 3.67E+02 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 5.06E+02 52.50 174.00 1043 1.89E+09 0
Alaska (U.S.) 20-Jan 7 2.1 3.41E+01 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 2.47E+01 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 3.41E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None   None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 13.  PRS Wet Deposition (wdep) Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 05-Nov 316 96.9 9.77E+03 52.50 159.00 65 1.89E+09 0 21-Mar 96.9 6.59E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 96.9 9.27E+03 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 316 96.9 9.77E+03 52.50 159.00 65 1.89E+09 0 05-Nov 96.9 5.72E+03 52.50 159.00 65 1.89E+09 0 05-Nov 96.9 8.03E+03 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 04-Dec 3 0.9 9.72E-06 52.50 123.00 2365 1.89E+09 5976 04-Dec 0.9 6.92E-06 52.50 123.00 2365 1.89E+09 5976 04-Dec 0.9 9.72E-06 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 01-Jan 6 1.8 9.18E+00 45.50 142.00 1454 2.17E+09 34622 01-Jan 1.8 6.54E+00 45.50 142.00 1454 2.17E+09 34622 01-Jan 1.8 9.18E+00 45.50 142.00 1454 2.17E+09 34622
Laos None      None  None
Mongolia None      None  None
N. Korea None      None  None
Russia 21-Mar 285 87.4 9.27E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 87.4 6.59E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 87.4 9.27E+03 52.50 157.50 87 1.89E+09 1944
S. Korea None      None  None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 10-Mar 71 21.8 7.24E+01 53.00 172.50 935 1.87E+09 0 10-Mar 21.8 5.15E+01 53.00 172.50 935 1.87E+09 0 10-Mar 21.8 7.24E+01 53.00 172.50 935 1.87E+09 0
Alaska (U.S.) 23-Jan 7 2.1 2.11E-01 54.50 195.00 2379 1.80E+09 38 23-Jan 2.1 1.50E-01 54.50 195.00 2379 1.80E+09 38 23-Jan 2.1 2.11E-01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 14.  PRS Total Deposition (tdep) Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
Regional 12-Jun 326 100.0 4.65E+04 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 2.75E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.79E+04 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 3.09E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 2.24E+04 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 3.09E+04 52.50 159.00 65 1.89E+09 0
Burma None      None   None
China 04-Dec 4 1.2 6.19E-05 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 4.48E-05 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 6.19E-05 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None   None
Japan 03-Jan 10 3.1 3.83E+01 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 2.78E+01 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 3.83E+01 44.50 145.50 1338 2.21E+09 2136
Laos None      None   None
Mongolia None      None   None
N. Korea None      None   None
Russia 12-Jun 326 100.0 4.65E+04 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 2.75E+04 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 3.79E+04 52.50 157.50 87 1.89E+09 1944
S. Korea None      None   None
Taiwan None      None   None
Thailand None      None   None
Aleutians (U.S.) 18-Jan 86 26.4 5.06E+02 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 3.67E+02 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 5.06E+02 52.50 174.00 1043 1.89E+09 0
Alaska (U.S.) 20-Jan 7 2.1 3.41E+01 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 2.47E+01 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 3.41E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None   None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 15.  PRS Integrated Concentration Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
Regional 12-Jun 326 100.0 2.21E+03 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 1.94E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.90E+03 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 1.58E+03 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.58E+03 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.55E+03 52.50 159.00 65 1.89E+09 0
Burma None      None   None
China 04-Dec 4 1.2 2.67E-06 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 2.67E-06 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 2.61E-06 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None   None
Japan 03-Jan 10 3.1 1.96E+00 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 1.96E+00 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 1.92E+00 44.50 145.50 1338 2.21E+09 2136
Laos None      None   None
Mongolia None      None   None
N. Korea None      None   None
Russia 12-Jun 326 100.0 2.21E+03 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 1.94E+03 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.90E+03 52.50 157.50 87 1.89E+09 1944
S. Korea None      None   None
Taiwan None      None   None
Thailand None      None   None
Aleutians (U.S.) 18-Jan 86 26.4 2.59E+01 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 2.59E+01 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 2.53E+01 52.50 174.00 1043 1.89E+09 0
Alaska (U.S.) 20-Jan 7 2.1 1.74E+00 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 1.74E+00 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 1.71E+00 54.50 195.00 2379 1.80E+09 38
Vietnam None      None   None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 16.  VRS Dry Deposition (ddep) Maximum Values Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 2.62E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.62E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.43E+04 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 8.74E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 8.74E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 8.10E+03 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 262 79.6 6.90E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 79.6 6.90E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 6.10E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 12-Sep 9 2.7 5.57E+00 22.50 114.50 2794 2.85E+09 125994 12-Sep 2.7 5.57E+00 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 317 96.4 3.69E+03 40.50 141.00 796 2.35E+09 358298 16-Dec 96.4 3.68E+03 40.50 141.00 796 2.35E+09 358298 13-Jan 74.2 1.67E+03 34.50 132.00 945 2.55E+09 496677
Laos None      None  None
Mongolia 10-May 40 12.2 6.70E+01 47.00 120.00 1042 2.11E+09 33341 10-May 12.2 6.70E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 4.75E-02 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 202 61.4 3.80E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 61.4 3.80E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 3.80E+03 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 324 98.5 2.62E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 2.62E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 2.43E+04 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 156 47.4 9.75E+02 38.50 127.50 628 2.42E+09 292252 11-Jan 47.4 9.75E+02 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 7.89E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 32 9.7 1.91E+02 24.00 121.50 2322 2.82E+09 152461 29-Nov 9.7 1.91E+02 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 172 52.3 5.86E+01 52.00 177.00 3464 1.91E+09 0 23-Apr 52.3 5.86E+01 52.00 177.00 3464 1.91E+09 0 29-May 0.6 2.15E-04 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 25-Mar 140 42.6 4.62E+01 58.50 204.00 5071 1.62E+09 36 25-Mar 42.6 4.62E+01 58.50 204.00 5071 1.62E+09 36 None
Vietnam 29-Nov 1 0.3 2.73E-06 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 2.73E-06 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 17.  VRS Wet Deposition (wdep) Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 18-Nov 329 100.0 7.42E+03 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 7.42E+03 42.00 133.50 166 2.30E+09 0 18-Nov 97.9 7.42E+03 42.00 133.50 166 2.30E+09 0
Transboundary** 18-Nov 329 100.0 7.42E+03 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 7.42E+03 42.00 133.50 166 2.30E+09 0 18-Nov 97.6 7.42E+03 42.00 133.50 166 2.30E+09 0
Burma None      None  None
China 01-Jan 233 70.8 4.62E+03 43.50 130.50 134 2.25E+09 70383 01-Jan 70.8 4.62E+03 43.50 130.50 134 2.25E+09 70383 01-Jan 61.1 4.62E+03 43.50 130.50 134 2.25E+09 70383
Hong Kong None      None  None
Japan 30-Jan 296 90.0 1.81E+03 36.00 138.00 933 2.50E+09 405254 30-Jan 90.0 1.81E+03 36.00 138.00 933 2.50E+09 405254 30-Jan 53.2 1.81E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 02-Jan 27 8.2 1.01E-01 45.00 114.00 1454 2.19E+09 1583 02-Jan 8.2 1.01E-01 45.00 114.00 1454 2.19E+09 1583 05-Jan 0.6 4.92E-09 48.00 119.00 1154 2.07E+09 3738
N. Korea 01-Jan 171 52.0 2.11E+03 43.00 130.00 163 2.26E+09 175327 01-Jan 52.0 2.11E+03 43.00 130.00 163 2.26E+09 175327 01-Jan 26.1 2.11E+03 43.00 130.00 163 2.26E+09 175327
Russia 20-Mar 306 93.0 5.54E+03 43.50 133.50 134 2.25E+09 34008 20-Mar 93.0 5.54E+03 43.50 133.50 134 2.25E+09 34008 20-Mar 77.2 5.54E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 127 38.6 1.63E+02 37.50 129.00 662 2.45E+09 155901 11-Jan 38.6 1.63E+02 37.50 129.00 662 2.45E+09 155901 27-Mar 14.0 1.48E+01 36.50 126.00 886 2.49E+09 26386
Taiwan 15-Nov 3 0.9 9.78E-05 25.50 121.50 2168 2.78E+09 3122073 15-Nov 0.9 9.78E-05 25.50 121.50 2168 2.78E+09 3122073 None
Thailand None      None  None
Aleutians (U.S.) 06-Mar 161 48.9 1.46E+01 52.50 174.00 3260 1.89E+09 0 06-Mar 48.9 1.46E+01 52.50 174.00 3260 1.89E+09 0 07-Nov 0.3 2.74E-08 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 24-Mar 137 41.6 8.67E+01 60.00 210.00 5359 1.55E+09 1314 24-Mar 41.6 8.67E+01 60.00 210.00 5359 1.55E+09 1314 None
Vietnam 29-Nov 1 0.3 1.47E-07 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 1.47E-07 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 18.  VRS Total Deposition (tdep) Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 02-Aug 329 100.0 2.64E+04 43.50 133.50 134 2.25E+09 34008 02-Aug 100.0 2.64E+04 43.50 133.50 134 2.25E+09 34008 02-Aug 100.0 2.44E+04 43.50 133.50 134 2.25E+09 34008
Transboundary** 18-Nov 329 100.0 9.06E+03 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 9.06E+03 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 9.04E+03 42.00 133.50 166 2.30E+09 0
Burma None      None  None
China 07-Jun 262 79.6 6.93E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 79.6 6.93E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 6.10E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 12-Sep 9 2.7 5.57E+00 22.50 114.50 2794 2.85E+09 125994 12-Sep 2.7 5.57E+00 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 317 96.4 3.85E+03 40.50 141.00 796 2.35E+09 358298 16-Dec 96.4 3.85E+03 40.50 141.00 796 2.35E+09 358298 30-Jan 74.2 2.66E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 10-May 40 12.2 6.70E+01 47.00 120.00 1042 2.11E+09 33341 10-May 12.2 6.70E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 4.75E-02 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 202 61.4 4.26E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 61.4 4.26E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 4.26E+03 42.00 129.00 270 2.30E+09 200822
Russia 02-Aug 324 98.5 2.64E+04 43.50 133.50 134 2.25E+09 34008 02-Aug 98.5 2.64E+04 43.50 133.50 134 2.25E+09 34008 02-Aug 97.9 2.44E+04 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 156 47.4 1.03E+03 38.50 127.50 628 2.42E+09 292252 11-Jan 47.4 1.03E+03 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 7.90E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 32 9.7 1.91E+02 24.00 121.50 2322 2.82E+09 152461 29-Nov 9.7 1.91E+02 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 172 52.3 5.86E+01 52.00 177.00 3464 1.91E+09 0 23-Apr 52.3 5.86E+01 52.00 177.00 3464 1.91E+09 0 29-May 0.6 2.15E-04 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 24-Mar 140 42.6 1.12E+02 60.00 210.00 5359 1.55E+09 1314 24-Mar 42.6 1.12E+02 60.00 210.00 5359 1.55E+09 1314 None
Vietnam 29-Nov 1 0.3 2.88E-06 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 2.88E-06 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 19.  VRS Integrated Concentration Maximum Values for Cs-137 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 4.86E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 4.86E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 4.50E+03 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 1.62E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.62E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.50E+03 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 262 79.6 1.28E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 79.6 1.28E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 1.13E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 12-Sep 9 2.7 1.03E+00 22.50 114.50 2794 2.85E+09 125994 12-Sep 2.7 1.03E+00 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 317 96.4 6.82E+02 40.50 141.00 796 2.35E+09 358298 16-Dec 96.4 6.82E+02 40.50 141.00 796 2.35E+09 358298 13-Jan 74.2 3.09E+02 34.50 132.00 945 2.55E+09 496677
Laos None      None  None
Mongolia 10-May 40 12.2 1.24E+01 47.00 120.00 1042 2.11E+09 33341 10-May 12.2 1.24E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 8.80E-03 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 202 61.4 7.04E+02 42.00 129.00 270 2.30E+09 200822 20-Aug 61.4 7.04E+02 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 7.04E+02 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 324 98.5 4.86E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 4.86E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 4.50E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 156 47.4 1.81E+02 38.50 127.50 628 2.42E+09 292252 11-Jan 47.4 1.81E+02 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 1.46E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 32 9.7 3.54E+01 24.00 121.50 2322 2.82E+09 152461 29-Nov 9.7 3.54E+01 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 172 52.3 1.09E+01 52.00 177.00 3464 1.91E+09 0 23-Apr 52.3 1.09E+01 52.00 177.00 3464 1.91E+09 0 29-May 0.6 3.99E-05 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 25-Mar 140 42.6 8.55E+00 58.50 204.00 5071 1.62E+09 36 25-Mar 42.6 8.55E+00 58.50 204.00 5071 1.62E+09 36 None
Vietnam 29-Nov 1 0.3 5.06E-07 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 5.06E-07 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 20.  VRS Dry Deposition (ddep) Maximum Values Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 3.24E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.98E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.99E+04 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 1.08E+04 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 9.93E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 9.98E+03 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 257 78.1 7.84E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 78.1 7.81E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 7.51E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 29-Nov 4 1.2 2.26E-03 22.50 114.50 2794 2.85E+09 125994 29-Nov 1.2 2.26E-03 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 316 96.0 4.25E+03 40.50 141.00 796 2.35E+09 358298 16-Dec 96.0 4.19E+03 40.50 141.00 796 2.35E+09 358298 13-Jan 74.2 2.05E+03 34.50 132.00 945 2.55E+09 496677
Laos None      None  None
Mongolia 10-May 34 10.3 7.52E+01 47.00 120.00 1042 2.11E+09 33341 10-May 10.3 7.52E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 5.85E-02 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 194 59.0 4.72E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 59.0 4.32E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 4.68E+03 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 324 98.5 3.24E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 2.98E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 2.99E+04 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 147 44.7 1.15E+03 38.50 127.50 628 2.42E+09 292252 11-Jan 44.7 1.11E+03 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 9.72E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 21 6.4 2.17E+02 24.00 121.50 2322 2.82E+09 152461 29-Nov 6.4 2.17E+02 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 135 41.0 6.05E+01 52.00 177.00 3464 1.91E+09 0 23-Apr 41.0 6.05E+01 52.00 177.00 3464 1.91E+09 0 29-May 0.6 2.65E-04 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 25-Mar 87 26.4 4.17E+01 58.50 202.50 4986 1.62E+09 15 25-Mar 26.4 4.17E+01 58.50 202.50 4986 1.62E+09 15 None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 21.  VRS Wet Deposition (wdep) Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 18-Nov 329 100.0 7.11E+03 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 6.62E+03 42.00 133.50 166 2.30E+09 0 18-Nov 97.9 7.09E+03 42.00 133.50 166 2.30E+09 0
Transboundary** 18-Nov 329 100.0 7.11E+03 42.00 133.50 166 2.30E+09 0 18-Nov-00 100.0 6.62E+03 42.00 133.50 166 2.30E+09 0 18-Nov-00 97.6 7.09E+03 42.00 133.50 166 2.30E+09 0
Burma None      None  None
China 01-Jan 230 69.9 4.41E+03 43.50 130.50 134 2.25E+09 70383 01-Jan 69.9 4.12E+03 43.50 130.50 134 2.25E+09 70383 01-Jan 61.1 4.41E+03 43.50 130.50 134 2.25E+09 70383
Hong Kong None      None  None
Japan 30-Jan 295 89.7 1.73E+03 36.00 138.00 933 2.50E+09 405254 30-Jan 89.7 1.61E+03 36.00 138.00 933 2.50E+09 405254 30-Jan 53.2 1.73E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 02-Jan 24 7.3 4.00E-02 46.50 111.00 1698 2.13E+09 2016 02-Jan 7.3 4.00E-02 46.50 111.00 1698 2.13E+09 2016 05-Jan 0.6 4.70E-09 48.00 119.00 1154 2.07E+09 3738
N. Korea 01-Jan 170 51.7 2.01E+03 43.00 130.00 163 2.26E+09 175327 01-Jan 51.7 1.88E+03 43.00 130.00 163 2.26E+09 175327 01-Jan 26.1 2.01E+03 43.00 130.00 163 2.26E+09 175327
Russia 20-Mar 302 91.8 5.29E+03 43.50 133.50 134 2.25E+09 34008 20-Mar 91.8 4.94E+03 43.50 133.50 134 2.25E+09 34008 20-Mar 77.2 5.29E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 122 37.1 1.50E+02 37.50 129.00 662 2.45E+09 155901 11-Jan 37.1 1.45E+02 37.50 129.00 662 2.45E+09 155901 27-Mar 14.0 1.41E+01 36.50 126.00 886 2.49E+09 26386
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 06-Mar 149 45.3 1.30E+01 52.50 174.00 3260 1.89E+09 0 06-Mar 45.3 1.30E+01 52.50 174.00 3260 1.89E+09 0 07-Nov 0.3 2.62E-08 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 25-Mar 119 36.2 2.13E+01 60.00 210.00 5359 1.55E+09 1314 25-Mar 36.2 2.13E+01 60.00 210.00 5359 1.55E+09 1314 None
Vietnam 29-Nov 1 0.3 4.41E-10 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 4.41E-10 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 22.  VRS Total Deposition (tdep) Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 02-Aug 329 100.0 3.26E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.98E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 3.00E+04 43.50 133.50 134 2.25E+09 34008
Transboundary** 02-Aug 329 100.0 1.09E+04 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 9.95E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.00E+04 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 259 78.7 7.87E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 78.7 7.84E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 7.51E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 29-Nov 4 1.2 2.26E-03 22.50 114.50 2794 2.85E+09 125994 29-Nov 1.2 2.26E-03 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 316 96.0 4.40E+03 40.50 141.00 796 2.35E+09 358298 16-Dec 96.0 4.33E+03 40.50 141.00 796 2.35E+09 358298 30-Jan 74.2 2.78E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 10-May 36 10.9 7.52E+01 47.00 120.00 1042 2.11E+09 33341 10-May 10.9 7.52E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 5.85E-02 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 199 60.5 5.16E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 60.5 4.73E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 5.12E+03 42.00 129.00 270 2.30E+09 200822
Russia 02-Aug 324 98.5 3.26E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 2.98E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 3.00E+04 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 151 45.9 1.19E+03 38.50 127.50 628 2.42E+09 292252 11-Jan 45.9 1.16E+03 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 9.72E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 21 6.4 2.17E+02 24.00 121.50 2322 2.82E+09 152461 29-Nov 6.4 2.17E+02 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 154 46.8 6.05E+01 52.00 177.00 3464 1.91E+09 0 23-Apr 46.8 6.05E+01 52.00 177.00 3464 1.91E+09 0 29-May 0.6 2.65E-04 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 25-Mar 119 36.2 4.17E+01 58.50 202.50 4986 1.62E+09 15 25-Mar 36.2 4.17E+01 58.50 202.50 4986 1.62E+09 15 None
Vietnam 29-Nov 1 0.3 4.41E-10 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 4.41E-10 20.50 107.00 3416 2.89E+09 13869
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 23.  VRS Integrated Concentration Maximum Values for Sr-90 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 4.51E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 4.14E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 4.16E+03 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 1.50E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.38E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.39E+03 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 257 78.1 1.09E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 78.1 1.09E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 1.04E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 29-Nov 4 1.2 3.14E-04 22.50 114.50 2794 2.85E+09 125994 29-Nov 1.2 3.14E-04 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 316 96.0 5.91E+02 40.50 141.00 796 2.35E+09 358298 16-Dec 96.0 5.81E+02 40.50 141.00 796 2.35E+09 358298 13-Jan 74.2 2.85E+02 34.50 132.00 945 2.55E+09 496677
Laos None      None  None
Mongolia 10-May 34 10.3 1.04E+01 47.00 120.00 1042 2.11E+09 33341 10-May 10.3 1.04E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 8.12E-03 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 194 59.0 6.56E+02 42.00 129.00 270 2.30E+09 200822 20-Aug 59.0 6.00E+02 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 6.50E+02 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 324 98.5 4.51E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 4.14E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 4.16E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 147 44.7 1.59E+02 38.50 127.50 628 2.42E+09 292252 11-Jan 44.7 1.54E+02 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 1.35E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 21 6.4 3.02E+01 24.00 121.50 2322 2.82E+09 152461 29-Nov 6.4 3.02E+01 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 135 41.0 8.41E+00 52.00 177.00 3464 1.91E+09 0 23-Apr 41.0 8.41E+00 52.00 177.00 3464 1.91E+09 0 29-May 0.6 3.68E-05 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 25-Mar 87 26.4 5.79E+00 58.50 202.50 4986 1.62E+09 15 25-Mar 26.4 5.79E+00 58.50 202.50 4986 1.62E+09 15 None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 24.  VRS Dry Deposition (ddep) Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 5.28E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 3.99E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 5.28E+04 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 1.76E+04 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.33E+04 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.76E+04 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 238 72.3 1.64E+04 43.50 131.50 69 2.25E+09 42463 07-Jun 72.3 1.04E+04 43.50 131.50 69 2.25E+09 42463 07-Jun 72.3 1.37E+04 43.50 131.50 69 2.25E+09 42463
Hong Kong None      None  None
Japan 20-Nov 222 67.5 2.61E+03 36.00 138.00 933 2.50E+09 405254 20-Nov 67.5 1.98E+03 36.00 138.00 933 2.50E+09 405254 20-Nov 67.5 2.61E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 21-Apr 3 0.9 5.86E-04 47.00 120.00 1042 2.11E+09 33341 21-Apr 0.9 4.43E-04 47.00 120.00 1042 2.11E+09 33341 21-Apr 0.9 5.86E-04 47.00 120.00 1042 2.11E+09 33341
N. Korea 20-Aug 110 33.4 9.59E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 33.4 6.47E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 33.4 8.55E+03 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 322 97.9 5.28E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 3.99E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 5.28E+04 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 59 17.9 1.14E+03 37.50 129.00 662 2.45E+09 155901 11-Jan 17.9 8.64E+02 37.50 129.00 662 2.45E+09 155901 11-Jan 17.9 1.14E+03 37.50 129.00 662 2.45E+09 155901
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 07-Nov 1 0.3 1.34E-13 52.50 173.00 3192 1.89E+09 0 07-Nov 0.3 1.02E-13 52.50 173.00 3192 1.89E+09 0 07-Nov 0.3 1.34E-13 52.50 173.00 3192 1.89E+09 0
Alaska (U.S.) None      None  None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 25.  VRS Wet Deposition (wdep) Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 18-Nov 328 99.7 4.90E+03 42.00 133.50 166 2.30E+09 0 18-Nov 99.7 3.18E+03 42.00 133.50 166 2.30E+09 0 18-Nov 97.9 4.33E+03 42.00 133.50 166 2.30E+09 0
Transboundary** 18-Nov 328 99.7 4.90E+03 42.00 133.50 166 2.30E+09 0 18-Nov 99.7 3.18E+03 42.00 133.50 166 2.30E+09 0 18-Nov 97.6 4.33E+03 42.00 133.50 166 2.30E+09 0
Burma None      None  None
China 01-Jan 214 65.0 2.69E+03 43.50 130.50 134 2.25E+09 70383 01-Jan 65.0 1.98E+03 43.50 130.50 134 2.25E+09 70383 01-Jan 61.1 2.69E+03 43.50 130.50 134 2.25E+09 70383
Hong Kong None      None  None
Japan 30-Jan 248 75.4 1.05E+03 36.00 138.00 933 2.50E+09 405254 30-Jan 75.4 7.74E+02 36.00 138.00 933 2.50E+09 405254 30-Jan 53.2 1.05E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 05-Jan 4 1.2 9.01E-05 46.50 119.50 1060 2.13E+09 1835 05-Jan 1.2 7.59E-05 46.50 119.50 1060 2.13E+09 1835 05-Jan 0.6 2.87E-09 48.00 119.00 1154 2.07E+09 3738
N. Korea 01-Jan 126 38.3 1.23E+03 43.00 130.00 163 2.26E+09 175327 01-Jan 38.3 9.02E+02 43.00 130.00 163 2.26E+09 175327 01-Jan 26.1 1.23E+03 43.00 130.00 163 2.26E+09 175327
Russia 20-Mar 277 84.2 3.23E+03 43.50 133.50 134 2.25E+09 34008 20-Mar 84.2 2.37E+03 43.50 133.50 134 2.25E+09 34008 20-Mar 77.2 3.23E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 76 23.1 8.24E+01 37.50 129.00 662 2.45E+09 155901 11-Jan 23.1 6.94E+01 37.50 129.00 662 2.45E+09 155901 27-Mar 14.0 8.60E+00 36.50 126.00 886 2.49E+09 26386
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 07-Mar 25 7.6 6.59E+00 52.00 177.00 3464 1.91E+09 0 07-Mar 7.6 5.55E+00 52.00 177.00 3464 1.91E+09 0 07-Nov 0.3 1.60E-08 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 14-Nov 5 1.5 5.36E-12 55.00 198.00 4801 1.78E+09 46 14-Nov 1.5 4.51E-12 55.00 198.00 4801 1.78E+09 46 None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 26.  VRS Total Deposition (tdep) Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 5.28E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 3.99E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 5.28E+04 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 1.76E+04 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.33E+04 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 1.76E+04 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 245 74.5 1.64E+04 43.50 131.50 69 2.25E+09 42463 07-Jun 74.5 1.04E+04 43.50 131.50 69 2.25E+09 42463 07-Jun 72.6 1.37E+04 43.50 131.50 69 2.25E+09 42463
Hong Kong None      None  None
Japan 20-Nov 270 82.1 2.61E+03 36.00 138.00 933 2.50E+09 405254 20-Nov 82.1 1.98E+03 36.00 138.00 933 2.50E+09 405254 20-Nov 70.2 2.61E+03 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 21-Apr 5 1.5 5.86E-04 47.00 120.00 1042 2.11E+09 33341 21-Apr 1.5 4.43E-04 47.00 120.00 1042 2.11E+09 33341 21-Apr 0.9 5.86E-04 47.00 120.00 1042 2.11E+09 33341
N. Korea 20-Aug 150 45.6 9.86E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 45.6 6.67E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 35.6 8.82E+03 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 324 98.5 5.28E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 3.99E+04 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 5.28E+04 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 89 27.1 1.14E+03 37.50 129.00 662 2.45E+09 155901 11-Jan 27.1 9.33E+02 37.50 129.00 662 2.45E+09 155901 11-Jan 18.8 1.14E+03 37.50 129.00 662 2.45E+09 155901
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 07-Mar 25 7.6 6.59E+00 52.00 177.00 3464 1.91E+09 0 07-Mar 7.6 5.55E+00 52.00 177.00 3464 1.91E+09 0 07-Nov 0.3 1.60E-08 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 14-Nov 5 1.5 5.36E-12 55.00 198.00 4801 1.78E+09 46 14-Nov 1.5 4.51E-12 55.00 198.00 4801 1.78E+09 46 None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 27.  VRS Integrated Concentration Maximum Values for I-131 for CY2000 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 2.87E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.87E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.82E+03 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 9.55E+02 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 9.55E+02 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 9.39E+02 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 238 72.3 8.39E+02 43.50 131.50 69 2.25E+09 42463 07-Jun 72.3 7.47E+02 43.50 131.50 69 2.25E+09 42463 07-Jun 70.5 8.39E+02 43.50 131.50 69 2.25E+09 42463
Hong Kong None      None  None
Japan 20-Nov 222 67.5 1.42E+02 36.00 138.00 933 2.50E+09 405254 20-Nov 67.5 1.42E+02 36.00 138.00 933 2.50E+09 405254 27-Jan 62.9 1.01E+02 39.00 140.00 805 2.40E+09 239517
Laos None      None  None
Mongolia 21-Apr 3 0.9 3.18E-05 47.00 120.00 1042 2.11E+09 33341 21-Apr 0.9 3.18E-05 47.00 120.00 1042 2.11E+09 33341 21-Apr 0.6 2.97E-08 48.00 119.00 1154 2.07E+09 3738
N. Korea 20-Aug 110 33.4 5.20E+02 42.00 129.00 270 2.30E+09 200822 20-Aug 33.4 4.65E+02 42.00 129.00 270 2.30E+09 200822 20-Aug 28.9 5.20E+02 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 322 97.9 2.87E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 2.87E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 2.82E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 15-Sep 59 17.9 6.95E+01 37.50 127.50 721 2.45E+09 1269429 11-Jan 17.9 6.21E+01 37.50 129.00 662 2.45E+09 155901 15-Sep 14.0 6.95E+01 37.50 127.50 721 2.45E+09 1269429
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 07-Nov 1 0.3 7.29E-15 53.00 172.50 3162 1.87E+09 0 07-Nov 0.3 7.29E-15 53.00 172.50 3162 1.87E+09 0 None
Alaska (U.S.) None      None  None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 28.  UNSCEAR P23 Transfer Coefficient in mBq a kg
-1
 per Bq m
-2 
 Sr-90 Cs-137 
Specific Pathway Min Max Ave Min Max Ave 
Milk products 2.6 4.9 3.7 5.7 8.8 6.8 
Grain Products 4.1 17.2 9.1 8.9 26.6 15.7 
Vegetables 0.4 4 2.5 1.8 4.4 3.2 
Fruit 1 2.5 1.8 3.1 3.5 3.3 
Meat 0.4 3 1.4 7.9 26.2 20.1* 
Total Diet Min Max Ave Min Max Ave 
Sum of Weighted Components 2.7 5.6 3.6 5.8 11.4 8.4 
Fit on Total Diet 3.0 5.5 3.8 5.1 11.4 8.2 
 
* Average not provided in Reference 13. The value (i.e., 20.1) provided is the average 
of the values (i.e., 7.9, 26.2, and 26.2) given in Reference 13. The value (i.e., 26.2) 
was the same for two of the countries.  
 
Table 29.  1993 UNSCEAR P34 Type Transfer Coefficients in kg a
-1  
(500 kg a
-1
 Consumption Rate Basis) 
 Sr-90  Cs-137 
Pathway Argentina Denmark U.S. Ave  Argentina Denmark U.S. Ave 
Milk Products 130 175 155 153.3  130 175 165 156.7 
Grain products 100 80 75 85.0  100 80 70 83.3 
Vegetables 120 120 95 111.7  155 120 95 123.3 
Fruit 100 50 75 75.0  80 50 85 71.7 
Meat 40 75 95 70.0  40 75 85 66.7 
 
Table 30.  Percentage Contributions from the Ingestion Pathways 
Pathway Cs-137 Sr-90 I-131 
Milk Products 24.52 30.62 100.00 
Grain products 30.11 41.74 --- 
Vegetables 9.08 15.07 --- 
Fruit 5.44 7.29 --- 
Meat 30.84 5.29 --- 
 
Table 31.  Transfer Coefficients based upon UNSCEAR 1993 Report 
 Cs-137 Sr-90 I-131 
Pathway 
nSv per 
Bq m
-2
 
% of  
Total 
nSv per 
Bq m
-2
 
% of  
Total 
nSv per  
Bq m
-2
 
% of  
Total 
Ingestion, P2345 56.48 36.49 51.88 91.86 4.20 93.50 
   Milk Products 13.85 8.95 15.89 28.13 4.20 93.50 
   Grain products 17.01 10.99 21.66 38.35 --- --- 
   Vegetables 5.13 3.31 7.82 13.84 --- --- 
   Fruit 3.07 1.99 3.78 6.69 --- --- 
   Meat 17.42 11.26 2.74 4.86 --- --- 
Inhalation, P245 0.11 0.07 4.60 8.14 0.17 3.80 
External Exposure, P25 98.18 63.43 0.00 0.00 0.12 2.70 
Total 154.78 100.00 56.48 100.00 4.49 100.00 
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Table 32.  PRS UNSCEAR Cs-137 Maximum Total Dose Commitment (per Person) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 21-Mar-00 326 100.0 4.22E+00 52.50 157.50 87 1.89E+09 1944 1.53E+00 36.2 3.05E-03 0.1 2.69E+00 63.8
Transboundary** 18-Feb-00 316 96.9 1.95E-01 58.50 198.00 2507 1.62E+09 22 7.05E-02 36.2 1.41E-04 0.1 1.24E-01 63.8
Burma None     
China 05-Jan-00 58 17.8 2.96E-02 52.50 126.00 2169 1.89E+09 7721 1.07E-02 36.2 2.14E-05 0.1 1.89E-02 63.8
Hong Kong None     
Japan 26-Apr-00 82 25.2 4.20E-02 43.50 142.50 1581 2.25E+09 155808 1.52E-02 36.2 3.03E-05 0.1 2.68E-02 63.8
Laos None     
Mongolia 04-Jan-00 13 4.0 1.65E-03 46.50 119.50 2855 2.13E+09 1835 5.97E-04 36.2 1.19E-06 0.1 1.05E-03 63.8
N. Korea 07-Jan-00 18 5.5 8.25E-03 43.00 130.00 2372 2.26E+09 175327 2.98E-03 36.2 5.97E-06 0.1 5.26E-03 63.8
Russia 21-Mar-00 326 100.0 4.22E+00 52.50 157.50 87 1.89E+09 1944 1.53E+00 36.2 3.05E-03 0.1 2.69E+00 63.8
S. Korea 05-Jan-00 5 1.5 6.22E-04 37.50 126.50 3001 2.45E+09 2006368 2.25E-04 36.2 4.50E-07 0.1 3.97E-04 63.8
Taiwan None     
Thailand None     
Aleutians (U.S.) 24-Jan-00 273 83.7 1.30E-01 52.50 185.50 1807 1.89E+09 63 4.71E-02 36.2 9.41E-05 0.1 8.30E-02 63.8
Alaska (U.S.) 18-Feb-00 229 70.2 1.95E-01 58.50 198.00 2507 1.62E+09 22 7.05E-02 36.2 1.41E-04 0.1 1.24E-01 63.8
Vietnam None     
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 33.  PRS UNSCEAR Sr-90 Maximum Total Dose Commitment (per Person) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 21-Mar-00 326 100.0 1.60E+00 52.50 157.50 87 1.89E+09 1944 1.47E+00 91.9 1.30E-01 8.1 0.00E+00 0.0
Transboundary** 18-Feb-00 215 66.0 7.72E-02 58.50 198.00 2507 1.62E+09 22 7.09E-02 91.9 6.27E-03 8.1 0.00E+00 0.0
Burma None     
China 05-Jan-00 50 15.3 1.09E-02 52.50 126.00 2169 1.89E+09 7721 1.01E-02 91.9 8.90E-04 8.1 0.00E+00 0.0
Hong Kong None     
Japan 26-Apr-00 76 23.3 1.81E-02 43.50 142.50 1581 2.25E+09 155808 1.66E-02 91.9 1.47E-03 8.1 0.00E+00 0.0
Laos None     
Mongolia 04-Jan-00 11 3.4 6.29E-04 46.50 119.50 2855 2.13E+09 1835 5.78E-04 91.9 5.11E-05 8.1 0.00E+00 0.0
N. Korea 07-Jan-00 14 4.3 3.42E-03 43.00 130.00 2372 2.26E+09 175327 3.14E-03 91.9 2.78E-04 8.1 0.00E+00 0.0
Russia 21-Mar-00 326 100.0 1.60E+00 52.50 157.50 87 1.89E+09 1944 1.47E+00 91.9 1.30E-01 8.1 0.00E+00 0.0
S. Korea 05-Jan-00 5 1.5 1.21E-04 37.50 126.50 3001 2.45E+09 2006368 1.11E-04 91.9 9.83E-06 8.1 0.00E+00 0.0
Taiwan None     
Thailand None     
Aleutians (U.S.) 24-Jan-00 269 82.5 4.81E-02 52.50 185.50 1807 1.89E+09 63 4.42E-02 91.9 3.91E-03 8.1 0.00E+00 0.0
Alaska (U.S.) 18-Feb-00 215 66.0 7.72E-02 58.50 198.00 2507 1.62E+09 22 7.09E-02 91.9 6.27E-03 8.1 0.00E+00 0.0
Vietnam None     
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 34.  PRS UNSCEAR I-131 Maximum Total Dose Commitment (per Person) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
Ingest 
(mSv) 
Ingest
(%) 
Inhalat
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 09-Feb-00 326 100.0 1.79E-01 52.50 157.50 87 1.89E+09 1944 1.67E-01 93.5 6.77E-03 3.8 4.78E-03 2.7
Transboundary** 18-Jan-00 98 30.1 2.39E-03 52.50 174.00 1043 1.89E+09 0 2.23E-03 93.5 9.04E-05 3.8 6.38E-05 2.7
Burma None       
China 04-Dec-00 4 1.2 2.92E-10 52.50 123.00 2365 1.89E+09 5976 2.73E-10 93.5 1.11E-11 3.8 7.81E-12 2.7
Hong Kong None       
Japan 03-Jan-00 10 3.1 1.81E-04 44.50 145.50 1338 2.21E+09 2136 1.69E-04 93.5 6.85E-06 3.8 4.84E-06 2.7
Laos None       
Mongolia None       
N. Korea None       
Russia 09-Feb-00 326 100.0 1.79E-01 52.50 157.50 87 1.89E+09 1944 1.67E-01 93.5 6.77E-03 3.8 4.78E-03 2.7
S. Korea None       
Taiwan None       
Thailand None       
Aleutians (U.S.) 18-Jan-00 86 26.4 2.39E-03 52.50 174.00 1043 1.89E+09 0 2.23E-03 93.5 9.04E-05 3.8 6.38E-05 2.7
Alaska (U.S.) 20-Jan-00 7 2.1 1.61E-04 54.50 195.00 2379 1.80E+09 38 1.51E-04 93.5 6.10E-06 3.8 4.30E-06 2.7
Vietnam None       
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 35.  Selected Site-Specific Parameter Summary from RESRAD 6 Results 
 
Menu 
 
Parameter 
User 
Input 
 
Default 
Parameter 
Name 
R011 Area of contaminated zone (m**2) 1.89E+09 1.00E+04 AREA  
R011 Thickness of contaminated zone (m) 3.00E-02 2.00E+00 THICK0  
R011 Basic radiation dose limit (mSv/yr) 2.50E-01 2.50E-01 BRDL  
R012 Initial principal radionuclide (Bq/g): Cs-137 9.47E-02 0.00E+00 S1( 1)  
R013 Cover depth (m) 0.00E+00 0.00E+00 COVER0  
R013 Density of contaminated zone (g/cm**3) 1.50E+00 1.50E+00 DENSCZ  
R013 Contaminated zone erosion rate (m/yr) 0.00E+00 1.00E-03 VCZ  
R017 Inhalation rate (m**3/yr) 8.40E+03 8.40E+03 INHALR  
R017 Exposure duration 5.00E+01 3.00E+01 ED  
R017 Shielding factor, inhalation 0.00E+00 4.00E-01 SHF3  
R017 Shielding factor, external gamma 2.00E-01 7.00E-01 SHF1  
R017 Fraction of time spent indoors 8.00E-01 5.00E-01 FIND  
R017 Fraction of time spent outdoors (on site) 2.00E-01 2.50E-01 FOTD  
R018 Fruits, vegetables and grain consumption (kg/yr) 1.55E+02 1.60E+02 DIET(1)  
R018 Leafy vegetable consumption (kg/yr) 1.23E+02 1.40E+01 DIET(2)  
R018 Milk consumption (L/yr) 1.49E+02 9.20E+01 DIET(3)  
R018 Meat and poultry consumption (kg/yr) 6.67E+01 6.30E+01 DIET(4)  
R018 Fish consumption (kg/yr) 0.00E+00 5.40E+00 DIET(5)  
R018 Other seafood consumption (kg/yr) 0.00E+00 9.00E-01 DIET(6)  
R018 Soil ingestion rate (g/yr) 0.00E+00 3.65E+01 SOIL  
R018 Drinking water intake (L/yr) 0.00E+00 5.10E+02 DWI  
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Table 36.  VRS UNSCEAR Cs-137 Maximum Total Dose Commitment Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m2) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 02-Aug-00 329 100.0 4.01E+00 43.50 133.50 134 2.25E+09 34008 1.45E+00 36.2 2.90E-03 0.1 2.56E+00 63.8
Transboundary** 07-Jun-00 329 100.0 1.05E+00 43.50 131.50 69 2.25E+09 42463 3.81E-01 36.2 7.62E-04 0.1 6.72E-01 63.8
Burma None     
China 07-Jun-00 262 79.6 1.05E+00 43.50 131.50 69 2.25E+09 42463 3.81E-01 36.2 7.62E-04 0.1 6.72E-01 63.8
Hong Kong 12-Sep-00 9 2.7 8.48E-04 22.50 114.50 2794 2.85E+09 125994 3.07E-04 36.2 6.13E-07 0.1 5.41E-04 63.8
Japan 16-Dec-00 317 96.4 5.85E-01 40.50 141.00 796 2.35E+09 358298 2.12E-01 36.2 4.23E-04 0.1 3.73E-01 63.8
Laos None     
Mongolia 10-May-00 40 12.2 1.02E-02 47.00 120.00 1042 2.11E+09 33341 3.68E-03 36.2 7.37E-06 0.1 6.50E-03 63.8
N. Korea 20-Aug-00 202 61.4 6.48E-01 42.00 129.00 270 2.30E+09 200822 2.34E-01 36.2 4.69E-04 0.1 4.13E-01 63.8
Russia 02-Aug-00 324 98.5 4.01E+00 43.50 133.50 134 2.25E+09 34008 1.45E+00 36.2 2.90E-03 0.1 2.56E+00 63.8
S. Korea 11-Jan-00 156 47.4 1.57E-01 38.50 127.50 628 2.42E+09 292252 5.69E-02 36.2 1.14E-04 0.1 1.00E-01 63.8
Taiwan 29-Nov-00 32 9.7 2.91E-02 24.00 121.50 2322 2.82E+09 152461 1.05E-02 36.2 2.11E-05 0.1 1.86E-02 63.8
Thailand None     
Aleutians (U.S.) 23-Apr-00 172 52.3 8.91E-03 52.00 177.00 3464 1.91E+09 0 3.22E-03 36.2 6.44E-06 0.1 5.68E-03 63.8
Alaska (U.S.) 24-Mar-00 140 42.6 1.71E-02 60.00 210.00 5359 1.55E+09 1314 6.18E-03 36.2 1.24E-05 0.1 1.09E-02 63.8
Vietnam 29-Nov-00 1 0.3 4.38E-10 20.50 107.00 3416 2.89E+09 13869 1.58E-10 36.2 3.17E-13 0.1 2.79E-10 63.8
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 37.  VRS UNSCEAR Sr-90 Maximum Total Dose Commitment Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m2) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 12-Jun-00 329 100.0 1.69E+00 43.50 133.50 134 2.25E+09 34008 1.55E+00 91.9 1.37E-01 8.1 0.00E+00 0.0
Transboundary** 07-Jun-00 329 100.0 4.44E-01 43.50 131.50 69 2.25E+09 42463 4.08E-01 91.9 3.61E-02 8.1 0.00E+00 0.0
Burma None     
China 07-Jun-00 259 78.7 4.44E-01 43.50 131.50 69 2.25E+09 42463 4.08E-01 91.9 3.61E-02 8.1 0.00E+00 0.0
Hong Kong 29-Nov-00 4 1.2 1.28E-07 22.50 114.50 2794 2.85E+09 125994 1.18E-07 91.9 1.04E-08 8.1 0.00E+00 0.0
Japan 16-Dec-00 316 96.0 2.45E-01 40.50 141.00 796 2.35E+09 358298 2.25E-01 91.9 1.99E-02 8.1 0.00E+00 0.0
Laos None     
Mongolia 10-May-00 36 10.9 4.26E-03 47.00 120.00 1042 2.11E+09 33341 3.91E-03 91.9 3.46E-04 8.1 0.00E+00 0.0
N. Korea 20-Aug-00 199 60.5 2.68E-01 42.00 129.00 270 2.30E+09 200822 2.46E-01 91.9 2.18E-02 8.1 0.00E+00 0.0
Russia 12-Jun-00 324 98.5 1.69E+00 43.50 133.50 134 2.25E+09 34008 1.55E+00 91.9 1.37E-01 8.1 0.00E+00 0.0
S. Korea 11-Jan-00 151 45.9 6.57E-02 38.50 127.50 628 2.42E+09 292252 6.04E-02 91.9 5.34E-03 8.1 0.00E+00 0.0
Taiwan 29-Nov-00 21 6.4 1.23E-02 24.00 121.50 2322 2.82E+09 152461 1.13E-02 91.9 1.00E-03 8.1 0.00E+00 0.0
Thailand None     
Aleutians (U.S.) 23-Apr-00 154 46.8 3.43E-03 52.00 177.00 3464 1.91E+09 0 3.15E-03 91.9 2.79E-04 8.1 0.00E+00 0.0
Alaska (U.S.) 25-Mar-00 119 36.2 2.36E-03 58.50 202.50 4986 1.62E+09 15 2.17E-03 91.9 1.92E-04 8.1 0.00E+00 0.0
Vietnam 29-Nov-00 1 0.3 2.50E-14 20.50 107.00 3416 2.89E+09 13869 2.29E-14 91.9 2.03E-15 8.1 0.00E+00 0.0
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 38.  VRS UNSCEAR I-131 Maximum Total Dose Commitment Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m2) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat
(mSv) 
Inhalat 
(%) 
ExtExp
(mSv) 
ExtExp
(%) 
Regional 12-Jun-00 329 100.0 2.54E-01 43.50 133.50 134 2.25E+09 34008 2.38E-01 93.5 9.62E-03 3.8 6.79E-03 2.7
Transboundary** 07-Jun-00 329 100.0 6.61E-02 43.50 131.50 69 2.25E+09 42463 6.19E-02 93.5 2.50E-03 3.8 1.77E-03 2.7
Burma None      
China 07-Jun-00 245 74.5 6.61E-02 43.50 131.50 69 2.25E+09 42463 6.19E-02 93.5 2.50E-03 3.8 1.77E-03 2.7
Hong Kong None      
Japan 20-Nov-00 270 82.1 1.26E-02 36.00 138.00 933 2.50E+09 405254 1.18E-02 93.5 4.76E-04 3.8 3.36E-04 2.7
Laos None      
Mongolia 21-Apr-00 5 1.5 2.82E-09 47.00 120.00 1042 2.11E+09 33341 2.64E-09 93.5 1.07E-10 3.8 7.54E-11 2.7
N. Korea 20-Aug-00 150 45.6 4.24E-02 42.00 129.00 270 2.30E+09 200822 3.97E-02 93.5 1.61E-03 3.8 1.13E-03 2.7
Russia 12-Jun-00 324 98.5 2.54E-01 43.50 133.50 134 2.25E+09 34008 2.38E-01 93.5 9.62E-03 3.8 6.79E-03 2.7
S. Korea 11-Jan-00 89 27.1 5.94E-03 37.50 129.00 662 2.45E+09 155901 5.56E-03 93.5 2.25E-04 3.8 1.59E-04 2.7
Taiwan None      
Thailand None      
Aleutians (U.S.) 07-Mar-00 25 7.6 3.57E-05 52.00 177.00 3464 1.91E+09 0 3.34E-05 93.5 1.35E-06 3.8 9.53E-07 2.7
Alaska (U.S.) 14-Nov-00 5 1.5 2.90E-17 55.00 198.00 4801 1.78E+09 46 2.71E-17 93.5 1.10E-18 3.8 7.74E-19 2.7
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 39.  UNSCEAR Maximum Regional Dose Commitments Compared to Reference Limits [17] 
 PRS* VRS* 
 Cs-137 Sr-90 I-131 Cs-137 Sr-90 I-131 
Criterion Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
<0.15 mSv 135 41.4 219 67.2 323 99.1 125 38.0 220 66.9 324 98.48
<1.0 mSv 155 47.5 100 30.7 3 0.9 173 52.6 104 31.6 5 1.52
<10.0 mSv 36 11.0 7 2.1 0 0.0 31 9.4 5 1.5 0 0.00
<100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.00
>100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.00
Total 326 100.0 326 100.0 326 100.0 329 100.0 329 100.0 329 100.00
 
* As stated above, there were complete data (i.e., all 144 hours) for 326 and 329 out of 366 days of CY2000 for 
the PRS and VRS, respectively. 
 
Table 40.  UNSCEAR Maximum Transboundary Dose Commitments Compared to Reference Limits [17] 
 PRS* VRS* 
 Cs-137 Sr-90 I-131 Cs-137 Sr-90 I-131 
Criterion Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
<0.15 mSv 325 99.7 326 100.0 326 100.0 202 61.4 295 89.7 329 100.00
<1.0 mSv 1 0.3 0 0.0 0 0.0 126 38.3 34 10.3 0 0.00
<10.0 mSv 0 0.0 0 0.0 0 0.0 1 0.3 0 0.0 0 0.00
<100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.00
>100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.00
Total 326 100 326 100.0 326 100.0 329 100.0 329 100.0 329 100.00
 
* As stated above, there were complete data (i.e., all 144 hours) for 326 and 329 out of 366 days of CY2000 for 
the PRS and VRS, respectively. 
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Table 41.  PRS UNSCEAR Cs-137 Maximum Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 1-Jan 2.98E+02 1.08E+02 2.16E-01 1.90E+02 1.89E+12 1.38E+08 14-Jun 8.28E+01 2.99E+01 5.99E-02 5.28E+01 1.22E+11 1.17E+05 14-Jun 8.21E+01 2.97E+01 5.94E-02 5.24E+01 1.16E+11 1.11E+05
Transboundary* 1-Jan 2.76E+02 9.99E+01 2.00E-01 1.76E+02 1.02E+12 1.34E+08 24-Jan 1.47E-01 5.31E-02 1.06E-04 9.37E-02 7.60E+09 1.38E+03 18-Feb 1.66E-02 6.00E-03 1.20E-05 1.06E-02 4.85E+09 1.00E+02
Burma None    None  None
China 4-Jan 6.96E+01 2.52E+01 5.04E-02 4.44E+01 1.48E+12 1.13E+08 None  None
Hong Kong None    None  None
Japan 1-Jan 2.76E+02 9.99E+01 2.00E-01 1.76E+02 4.28E+11 9.75E+07 None  None
Laos None    None  None
Mongolia 4-Jan 1.59E-01 5.76E-02 1.15E-04 1.02E-01 3.11E+11 3.43E+05 None  None
N. Korea 7-Jan 8.47E+00 3.06E+00 6.13E-03 5.40E+00 1.72E+11 2.63E+07 None  None
Russia 14-Jun 8.63E+01 3.12E+01 6.24E-02 5.50E+01 1.76E+12 9.98E+05 14-Jun 8.28E+01 2.99E+01 5.99E-02 5.28E+01 1.22E+11 1.17E+05 14-Jun 8.21E+01 2.97E+01 5.94E-02 5.24E+01 1.16E+11 1.11E+05
S. Korea 5-Jan 9.75E+00 3.52E+00 7.05E-03 6.22E+00 1.52E+11 4.48E+07 None  None
Taiwan None    None  None
Thailand None    None  None
Aleutians (U.S.) 24-Jan 2.21E-01 8.00E-02 1.60E-04 1.41E-01 5.29E+10 5.47E+03 24-Jan 1.47E-01 5.31E-02 1.06E-04 9.37E-02 7.60E+09 1.38E+03 None
Alaska (U.S.) 13-Oct 1.48E+01 5.37E+00 1.07E-02 9.46E+00 9.93E+11 4.61E+05 18-Feb 7.45E-02 2.69E-02 5.39E-05 4.75E-02 1.12E+10 5.86E+02 18-Feb 1.66E-02 6.00E-03 1.20E-05 1.06E-02 4.85E+09 1.00E+02
Vietnam None    None  None
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 42.  PRS UNSCEAR Cs-137 Maximum Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Mar 6.00E+01 2.17E+01 4.34E-02 3.82E+01 3.41E+10 2.81E+04
Transboundary* None    
Burma None    
China None    
Hong Kong None    
Japan None    
Laos None    
Mongolia None    
N. Korea None    
Russia 21-Mar 6.00E+01 2.17E+01 4.34E-02 3.82E+01 3.41E+10 2.81E+04
S. Korea None    
Taiwan None    
Thailand None    
Aleutians (U.S.) None    
Alaska (U.S.) None    
Vietnam None    
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 43.  PRS UNSCEAR Sr-90 Maximum Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 1-Jan 1.27E+02 1.17E+02 1.03E+01 1.23E+12 1.19E+08 14-Jun 3.47E+01 3.19E+01 2.82E+00 1.01E+11 9.62E+04 14-Jun 3.22E+01 2.96E+01 2.62E+00 7.94E+10 7.52E+04
Transboundary* 1-Jan 1.19E+02 1.09E+02 9.64E+00 7.23E+11 1.16E+08 None  None
Burma None    None  None
China 7-Jan 2.78E+01 2.56E+01 2.26E+00 1.03E+12 7.61E+07 None  None
Hong Kong None    None  None
Japan 1-Jan 1.19E+02 1.09E+02 9.63E+00 4.28E+11 9.75E+07 None  None
Laos None    None  None
Mongolia 4-Jan 5.98E-02 5.50E-02 4.86E-03 3.11E+11 3.43E+05 None  None
N. Korea 7-Jan 3.38E+00 3.10E+00 2.74E-01 1.27E+11 1.42E+07 None  None
Russia 14-Jun 3.76E+01 3.46E+01 3.06E+00 1.73E+12 9.94E+05 14-Jun 3.47E+01 3.19E+01 2.82E+00 1.01E+11 9.62E+04 14-Jun 3.22E+01 2.96E+01 2.62E+00 7.94E+10 7.52E+04
S. Korea 5-Jan 1.78E+00 1.63E+00 1.45E-01 1.49E+11 4.48E+07 None  None
Taiwan None    None  None
Thailand None    None  None
Aleutians (U.S.) 24-Jan 8.15E-02 7.49E-02 6.63E-03 5.29E+10 5.47E+03 None  None
Alaska (U.S.) 13-Oct 5.20E+00 4.77E+00 4.22E-01 8.69E+11 4.54E+05 None  None
Vietnam None    None  None
 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 44.  PRS UNSCEAR Sr-90 Maximum Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Mar 6.00E+01 2.17E+01 4.34E-02 3.82E+01 3.41E+10 2.81E+04
Transboundary* None     
Burma None     
China None     
Hong Kong None     
Japan None     
Laos None     
Mongolia None     
N. Korea None     
Russia 21-Mar 6.00E+01 2.17E+01 4.34E-02 3.82E+01 3.41E+10 2.81E+04
S. Korea None     
Taiwan None     
Thailand None     
Aleutians (U.S.) None     
Alaska (U.S.) None     
Vietnam None     
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 45.  PRS UNSCEAR I-131 Maximum Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 14-Jun 3.78E+00 3.54E+00 1.43E-01 1.01E-01 2.99E+11 2.54E+05 9-Feb 1.28E+00 1.20E+00 4.84E-02 3.42E-02 9.45E+09 9.73E+03 9-Feb 3.48E-01 3.25E-01 1.32E-02 9.29E-03 1.89E+09 1.94E+03
Transboundary** 1-Jan 7.46E-02 6.98E-02 2.83E-03 1.99E-03 8.04E+10 3.63E+06 None  None
Burma None    None  None
China 4-Dec 4.08E-08 3.81E-08 1.54E-09 1.09E-09 5.62E+11 2.16E+07 None  None
Hong Kong None    None  None
Japan 1-Jan 7.46E-02 6.98E-02 2.83E-03 1.99E-03 8.04E+10 3.63E+06 None  None
Laos None    None  None
Mongolia None    None  None
N. Korea None    None  None
Russia 14-Jun 3.78E+00 3.54E+00 1.43E-01 1.01E-01 2.99E+11 2.54E+05 9-Feb 1.28E+00 1.20E+00 4.84E-02 3.42E-02 9.45E+09 9.73E+03 9-Feb 3.48E-01 3.25E-01 1.32E-02 9.29E-03 1.89E+09 1.94E+03
S. Korea None    None  None
Taiwan None    None  None
Thailand None    None  None
Aleutians (U.S.) 20-Jan 2.49E-03 2.33E-03 9.43E-05 6.66E-05 5.29E+10 5.47E+03 None  None
Alaska (U.S.) 12-Oct 7.10E-05 6.64E-05 2.69E-06 1.90E-06 5.47E+10 3.10E+03 None  None
Vietnam None    None  None
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 46.  PRS UNSCEAR I-131 Maximum Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp 
(per-Sv) 
Area
(m2)
 
Pop
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop
Regional 
Transboundary** 
Burma 
China 
Hong Kong 
Japan 
Laos 
Mongolia 
N. Korea 
Russia 
S. Korea 
Taiwan 
Thailand 
Aleutians (U.S.) 
Alaska (U.S.) 
Vietnam 
No dose commitments at this  
threshold value 
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 47.  VRS UNSCEAR Cs-137 Maximum Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Nov 8.23E+03 2.97E+03 5.95E+00 5.25E+03 2.10E+12 2.70E+08 30-Jan 5.40E+03 1.95E+03 3.91E+00 3.44E+03 6.52E+10 3.58E+07 30-Jan 3.04E+03 1.10E+03 2.20E+00 1.94E+03 3.51E+10 1.55E+07
Transboundary** 21-Nov 8.22E+03 2.97E+03 5.94E+00 5.24E+03 1.21E+12 2.69E+08 30-Jan 5.40E+03 1.95E+03 3.91E+00 3.44E+03 6.52E+10 3.58E+07 30-Jan 3.04E+03 1.10E+03 2.20E+00 1.94E+03 3.51E+10 1.55E+07
Burma None    None  None
China 9-May 7.21E+03 2.61E+03 5.21E+00 4.60E+03 1.71E+12 2.17E+08 9-May 3.95E+03 1.43E+03 2.85E+00 2.52E+03 1.63E+11 3.01E+07 30-Aug 2.02E+03 7.30E+02 1.46E+00 1.29E+03 9.88E+10 9.98E+06
Hong Kong 12-Sep 1.59E+00 5.75E-01 1.15E-03 1.01E+00 5.70E+09 5.42E+06 None  None
Japan 21-Nov 7.99E+03 2.89E+03 5.78E+00 5.09E+03 6.37E+11 1.25E+08 30-Jan 5.40E+03 1.95E+03 3.91E+00 3.44E+03 6.52E+10 3.58E+07 30-Jan 3.04E+03 1.10E+03 2.20E+00 1.94E+03 3.51E+10 1.55E+07
Laos None    None  None
Mongolia 10-May 1.35E+00 4.88E-01 9.75E-04 8.60E-01 4.06E+11 4.77E+05 None  None
N. Korea 12-Sep 2.09E+03 7.56E+02 1.51E+00 1.33E+03 1.84E+11 2.76E+07 7-Jun 1.49E+03 5.39E+02 1.08E+00 9.50E+02 6.02E+10 5.28E+06 7-Jun 1.36E+03 4.90E+02 9.80E-01 8.64E+02 5.08E+10 4.19E+06
Russia 2-Aug 1.36E+03 4.91E+02 9.81E-01 8.65E+02 6.64E+11 6.09E+06 2-Aug 1.26E+03 4.57E+02 9.15E-01 8.07E+02 1.53E+11 1.77E+06 2-Aug 1.21E+03 4.38E+02 8.76E-01 7.72E+02 1.04E+11 1.33E+06
S. Korea 27-Sep 2.05E+03 7.41E+02 1.48E+00 1.31E+03 1.52E+11 4.48E+07 11-Jan 2.46E+02 8.91E+01 1.78E-01 1.57E+02 2.68E+10 2.01E+06 11-Jan 6.95E+01 2.51E+01 5.03E-02 4.43E+01 4.87E+09 4.48E+05
Taiwan 29-Nov 2.67E+02 9.66E+01 1.93E-01 1.70E+02 6.49E+10 2.17E+07 None  None
Thailand None    None  None
Aleutians (U.S.) 6-Mar 1.39E-02 5.04E-03 1.01E-05 8.89E-03 5.29E+10 5.47E+03 None  None
Alaska (U.S.) 24-Mar 1.54E+00 5.58E-01 1.12E-03 9.84E-01 1.01E+12 4.66E+05 None  None
Vietnam 29-Nov 6.07E-09 2.20E-09 4.39E-12 3.87E-09 2.89E+09 1.39E+04 None  None
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 48.  VRS UNSCEAR Cs-137 Maximum Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 2-Aug 9.47E+02 3.42E+02 6.85E-01 6.04E+02 3.13E+10 4.61E+05
Transboundary** 7-Jun 4.48E+01 1.62E+01 3.24E-02 2.85E+01 2.25E+09 4.25E+04
Burma None    
China 7-Jun 4.48E+01 1.62E+01 3.24E-02 2.85E+01 2.25E+09 4.25E+04
Hong Kong None    
Japan None    
Laos None    
Mongolia None    
N. Korea None    
Russia 2-Aug 9.47E+02 3.42E+02 6.85E-01 6.04E+02 3.13E+10 4.61E+05
S. Korea None    
Taiwan None    
Thailand None    
Aleutians (U.S.) None    
Alaska (U.S.) None    
Vietnam None    
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 49.  VRS UNSCEAR Sr-90 Maximum Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Nov 3.33E+03 3.06E+03 2.70E+02 1.84E+12 2.40E+08 7-Jun 7.39E+02 6.79E+02 6.01E+01 9.27E+10 4.07E+06 7-Jun 5.92E+02 5.44E+02 4.81E+01 7.01E+10 2.93E+06
Transboundary** 21-Nov 3.32E+03 3.05E+03 2.70E+02 1.10E+12 2.39E+08 7-Nov 7.04E+02 6.46E+02 5.72E+01 2.50E+10 5.03E+06 7-Jun 4.87E+02 4.47E+02 3.96E+01 4.09E+10 2.54E+06
Burma None    None  None
China 9-May 2.93E+03 2.69E+03 2.38E+02 1.55E+12 1.91E+08 26-Aug 4.50E+02 4.13E+02 3.66E+01 3.51E+10 3.18E+06 7-Jun 3.02E+02 2.78E+02 2.46E+01 3.17E+10 1.50E+06
Hong Kong 29-Nov 3.72E-04 3.42E-04 3.02E-05 5.70E+09 5.42E+06 None  None
Japan 21-Nov 3.28E+03 3.01E+03 2.67E+02 6.28E+11 1.25E+08 7-Nov 7.04E+02 6.46E+02 5.72E+01 2.50E+10 5.03E+06 16-Dec 2.56E+02 2.35E+02 2.08E+01 1.18E+10 1.31E+06
Laos None    None  None
Mongolia 10-May 4.74E-01 4.36E-01 3.86E-02 3.86E+11 4.43E+05 None  None
N. Korea 12-Sep 8.68E+02 7.98E+02 7.06E+01 1.84E+11 2.76E+07 7-Jun 4.47E+02 4.11E+02 3.63E+01 3.22E+10 2.72E+06 7-Jun 3.44E+02 3.16E+02 2.80E+01 2.06E+10 1.93E+06
Russia 2-Aug 5.63E+02 5.17E+02 4.58E+01 6.64E+11 6.09E+06 2-Aug 4.64E+02 4.27E+02 3.77E+01 5.13E+10 7.39E+05 2-Aug 4.51E+02 4.14E+02 3.67E+01 4.48E+10 6.19E+05
S. Korea 27-Sep 8.53E+02 7.84E+02 6.93E+01 1.52E+11 4.48E+07 None  None
Taiwan 29-Nov 1.13E+02 1.04E+02 9.18E+00 6.49E+10 2.17E+07 None  None
Thailand None    None  None
Aleutians (U.S.) 6-Mar 3.29E-03 3.02E-03 2.67E-04 5.29E+10 5.47E+03 None  None
Alaska (U.S.) 25-Mar 8.66E-02 7.96E-02 7.04E-03 8.62E+11 3.78E+05 None  None
Vietnam 29-Nov 3.46E-13 3.18E-13 2.81E-14 2.89E+09 1.39E+04 None  None
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 50.  VRS UNSCEAR Sr-90 Maximum Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 2-Aug 2.11E+02 1.94E+02 1.72E+01 1.12E+10 1.69E+05
Transboundary** None    
Burma None    
China None    
Hong Kong None    
Japan None    
Laos None    
Mongolia None    
N. Korea None    
Russia 2-Aug 2.11E+02 1.94E+02 1.72E+01 1.12E+10 1.69E+05
S. Korea None    
Taiwan None    
Thailand None    
Aleutians (U.S.) None    
Alaska (U.S.) None    
Vietnam None    
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 51.  VRS UNSCEAR I-131 Maximum Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 30-Jan 2.06E+02 1.92E+02 7.79E+00 5.50E+00 2.37E+11 8.58E+07 12-Jun 4.57E+01 4.28E+01 1.73E+00 1.22E+00 2.02E+10 2.93E+05 12-Jun 3.16E+01 2.96E+01 1.20E+00 8.44E-01 1.12E+10 1.69E+05
Transboundary** 30-Jan 2.06E+02 1.92E+02 7.79E+00 5.50E+00 2.25E+11 8.57E+07 None  None
Burma None    None  None
China 10-May 1.76E+02 1.65E+02 6.68E+00 4.71E+00 8.68E+11 1.04E+08 None  None
Hong Kong None    None  None
Japan 30-Jan 2.06E+02 1.92E+02 7.79E+00 5.50E+00 2.25E+11 8.57E+07 None  None
Laos None    None  None
Mongolia 21-Apr 1.13E-07 1.06E-07 4.29E-09 3.03E-09 1.48E+10 4.92E+04 None  None
N. Korea 14-Sep 9.12E+01 8.53E+01 3.45E+00 2.44E+00 1.84E+11 2.76E+07 None  None
Russia 12-Jun 6.68E+01 6.25E+01 2.53E+00 1.78E+00 3.06E+11 4.29E+06 12-Jun 4.57E+01 4.28E+01 1.73E+00 1.22E+00 2.02E+10 2.93E+05 12-Jun 3.16E+01 2.96E+01 1.20E+00 8.44E-01 1.12E+10 1.69E+05
S. Korea 15-Sep 9.82E+01 9.18E+01 3.72E+00 2.62E+00 1.47E+11 4.48E+07 None  None
Taiwan None    None  None
Thailand None    None  None
Aleutians (U.S.) 14-Nov 4.74E-07 4.44E-07 1.80E-08 1.27E-08 4.73E+10 5.47E+03 None  None
Alaska (U.S.) 14-Nov 4.95E-18 4.63E-18 1.88E-19 1.32E-19 3.66E+10 2.16E+03 None  None
Vietnam None    None  None
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 52.  VRS UNSCEAR I-131 Maximum Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp 
(per-Sv) 
Area
(m2)
 
Pop
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop
Regional 
Transboundary** 
Burma 
China 
Hong Kong 
Japan 
Laos 
Mongolia 
N. Korea 
Russia 
S. Korea 
Taiwan 
Thailand 
Aleutians (U.S.) 
Alaska (U.S.) 
Vietnam 
No dose commitments at this  
threshold value 
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 53.  Isotopic Inventories for Nuclear Submarines and Major Facilities Pertinent  
to the PRS and VRS 
 Inventory (Bq)    
Name Cs-137 Sr-90 Site(s) Ref. Description 
Reference NS* 4.9x1015 4.15x1015 PRS, VRS 28 Typical NS reactor core 3 years after  
shutdown assuming 42 GWd burnup. 
NS K-541 
 
NS K-541x2 
5.73x1014 
1.23x1013 
5.85x1014 
5.39x1014 
1.20x1013 
5.51x1014 
PRS, VRS 29,30 Starboard reactor 
Port (Damaged) reactor 
Total Activity 
NS K-610 
 
NS K-610x2 
1.04x1015 
1.04x1015 
2.08x1015 
9.47x1014 
9.47x1014 
1.89x1015 
PRS, VRS 29,30 Starboard reactor 
Port (Damaged) reactor 
Total Activity 
PM-32 8.00x1014 
1.20x1015 
7.62x1014 
1.10x1015 
PRS 29 
30 
126 SFA’s* of different cores from 
1st generation NS [30] 
PM-74** 1.12x1016 
1.48x1016 
1.04x1016 
1.37x1016 
VRS 29 
30 
2 1st gen. cores (10 GWd) and 4 2nd 
gen. core (20 GWd). 1368 SFA’s [30] 
PM-80 1.14x1015 
 
2.19x1014 
1.09x1015 
 
2.01x1014 
VRS 29 
 
30 
113 SFA’s*** of different cores from 
1st generation NS [29] 
23 SFA’s* of different cores from 
1st generation NS [30] 
PM-125 4.83x1015 
1.90x1015 
4.50x1015 
1.90x1015 
VRS 29 
30 
2 1st gen. cores (10 GWd).  
360 SFA’s* [30] 
PM-133 4.83x1015 
4.45x1015 
4.50x1015 
4.13x1015 
VRS 29 
30 
2 2nd gen. cores (20 GWd).  
560 SFA’s* [30] 
Storage Site 11 3.74x1015[29] 
3.98x1015[30] 
3.48x1015[29]
3.70x1015[30]
VRS 31,32 Total activity is 8.14x1015 Bq. 
PM-74 isotopic concentrations**. 
Storage Site 30 6.07x1016[29] 
6.47x1016[30] 
5.64x1016[29]
6.02x1016[30]
VRS 31,32 Total activity is 1.32x1017 Bq. 
PM-74 isotopic concentrations**. 
Storage Site 7 1.70x1015[29] 
1.81x1015[30] 
1.58x1015[29]
1.68x1015[30]
VRS 29,31
32 
Total activity is 3.70x1015 Bq. 
PM-74 isotopic concentrations**. 
Storage Site 31 9.93x1014[29] 
1.06x1015[30] 
9.22x1014[29]
9.82x1014[30]
VRS 29,31
32 
Total activity is 2.16x1015 Bq. 
PM-74 isotopic concentrations**. 
Transport 
Cask† 
8.37x1014 7.17x1014 VRS 28,32 Ref. NS core with 287 SFA’s* [32] 
49 assemblies per TUK-18 [32] 
RadLeg NS* 0.4x1015 0.4x1015 PRS, VRS 33 2 years after shutdown. No GWd given. 
NATO NS5*,†† 3.40x1015 3.40x1015 PRS, VRS 34 NS reactor core after 31 GWd followed 
by a 5-y cooling period after shutdown. 
 
*  Nuclear Submarine (NS) and spent fuel assembly (SFA). Most first and second generation NS’s have 
two reactors and thus the inventory would be twice that shown. 
** Note that the total activity for the PM-74 is between 2.44x1016 [29] and 3.02x1016 [30].  Thus, of the 
total, 46.0 to 48.9% is Cs-137 and 42.7 to 45.5% is Sr-90 [29,30]. The PM-74 values are used for 
Buildings 11 and 30 and Constructions 7 and 31 per Reference 32. 
*** The number of fuel assemblies representing the PM-80 inventory provided in Reference 29 was not 
obvious from the information provided. From inspection of the total inventory and other information 
provided in Reference 30, the number of spent fuel assemblies appears to be 113; this is the value used 
in these computations. 
† For this study, the transport cask is assumed to be a fully loaded type TUK-18 cask holding 49 SFA’s 
[32]. The values in the table are based upon the Reference NS [28] with a core of 287 SFA’s [32]. 
†† Inventories are also provided in Reference 34 for 0 and 1 year cooling periods after shutdown (for a 
burnup of 31 GWd). These are 3.8x1015 and 3.7x1015 Bq for both Cs-137 and Sr-90 for 0 and 1 year, 
respectively. A value of 6.2x1016 Bq is given for I-131 for the same conditions without cooling. 
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Table 54.  Cs-137 and Sr-90 Inventories (in Bq) by Spent Fuel Assembly (SFA) 
 Inventory (Bq)   SFA* Inventory / SFA (Bq)
Name Cs-137 Sr-90 Site(s) Ref. Type No. Cs-137 Sr-90 
Reference NS* 4.90x1015 4.15x1015 PRS, VRS 28 Unknown 287 1.71x1013 1.45x1013
NS K-541 (starboard) 5.73x1014 5.39x1014 PRS, VRS 29,30 Unknown 287 2.00x1012 1.88x1012
NS K-541 (port) 1.23x1013 1.20x1013 PRS, VRS 29,30 Unknown 287 4.29x1010 4.18x1010
NS K-610 (starboard) 1.04x1015 9.47x1014 PRS, VRS 29,30 Unknown 287 3.62x1012 3.30x1012
NS K-610 (port) 1.04x1015 9.47x1014 PRS, VRS 29,30 Unknown 287 3.62x1012 3.30x1012
PM-32 8.00x1014 7.62x1014 PRS 29 1st gen. only 126 6.35x1012 6.05x1012
 1.20x1015 1.10x1015 PRS 30 1st gen. only 126 9.52x1012 8.73x1012
PM-74 1.12x1016 1.04x1016 VRS 29 1st and 2nd gen. 1368 8.19x1012 7.60x1012
 1.48x1016 1.37x1016 VRS 30 1st and 2nd gen. 1368 1.08x1013 1.00x1013
PM-80 1.14x1015 1.09x1015 VRS 29 1st gen. only 113** 1.01x1013 9.65x1012
 2.19x1014 2.01x1014 VRS 30 1st gen. only 23 9.52x1012 8.74x1012
PM-125 4.83x1015 4.50x1015 VRS 29 1st gen. only 360 1.34x1013 1.25x1013
 1.90x1015 1.90x1015 VRS 30 1st gen. only 360 5.28x1012 5.28x1012
PM-133 4.83x1015 4.50x1015 VRS 29 2nd gen. only 560 8.63x1012 8.04x1012
 4.45x1015 4.13x1015 VRS 30 2nd gen. only 560 7.95x1012 7.38x1012
RadLeg NS 4.00x1014 4.00x1014 PRS, VRS 33 Unknown 287 1.39x1012 1.39x1012
NATO NS5 3.40x1015 3.40x1015 PRS, VRS 34 Unknown 287 1.18x1013 1.18x1013
NATO NS1 3.70x1015 3.70x1015 PRS, VRS 34 Unknown 287 1.29x1013 1.29x1013
NATO NS0 3.80x1015 3.80x1015 PRS, VRS 34 Unknown 287 1.32x1013 1.32x1013
         
Overall Minimum 1.23x1013 1.20x1013 --- Minimum --- 4.29x1010 4.18x1010
Overall Mean 1.90x1015 1.80x1015 --- Mean --- 7.42x1012 7.01x1012
Overall Median 1.04x1015 9.47x1014 --- Median --- 6.35x1012 6.05x1012
Overall Maximum 4.90x1015 4.15x1015
P
R
S
 
--- Maximum --- 1.71x1013 1.45x1013
Overall Minimum 1.23x1013 1.20x1013 --- Minimum --- 4.29x1010 4.18x1010
Overall Mean 3.66x1015 3.43x1015 --- Mean --- 8.21x1012 7.74x1012
Overall Median 3.40x1015 3.40x1015 --- Median --- 8.63x1012 8.04x1012
Overall Maximum 1.48x1016 1.37x1016
V
R
S
 
--- Maximum --- 4.96x1013 4.74x1013
 
*  Spent fuel assemblies (SFA) and nuclear submarine (NS). The number of fuel assemblies per core for the 
nuclear submarines was not available; thus a value of 287 fuel assemblies per NS core [32] was used. 
** The number of fuel assemblies representing the PM-80 inventory provided in Reference 29 was not 
obvious from the information given. From inspection of the total inventory and other information provided 
in Reference 30, the number of spent fuel assemblies appears to be 113; this is the value used in these 
computations. 
 
Table 55.  Range of Inventories (Bq) Pertinent to PRS and VRS* 
Site Name SFA Cs-137 Ratio** Sr-90 Ratio** I-131*** Ratio** 
NS Minimum 180 7.71x1012 8.9x10-3 7.53x1012 8.7x10-3 1.30x1010 1.50x10-5 
NS Median 230 8.33x1014 0.96 7.59x1014 0.88 1.45x1011 1.68x10-4 
NS Maximum 287 4.90x1015 5.67 4.15x1015 4.80 4.30x1012 4.98x10-3 P
R
S
 
PM-32 126 1.20x1015 1.39 1.10x1015 1.27 --- --- 
NS Minimum 180 7.71x1012 8.9x10-3 7.53x1012 8.7x10-3 1.30x1010 1.50x10-5 
NS Median 230 8.33x1014 0.96 7.59x1014 0.88 1.45x1011 1.68x10-4 
NS Maximum 287 4.90x1015 5.67 4.15x1015 4.80 4.30x1012 4.98x10-3 V
R
S
 
Cask Maximum 49 8.37x1014 0.97 7.09x1014 0.82 --- --- 
 
*  Spent fuel assemblies (SFA) and nuclear submarine (NS). 
** Ratio of Inventory to the “unit hypothetical release” of 8.64x1014 Bq. 
*** The values for I-131 are based upon the total number of fissions from a criticality accident. 
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Table 56.  Atmospheric Release Fractions for Different Accident Scenarios* 
 Release Fraction   
Name Cs-137 Sr-90 I-131 Ref. Description 
High-Temperature Fire 0.9 2x10-3 0.8 32,37 Severe criticality accident resulting in 
melting of fuel cladding with a consequent 
steam explosion. Self-sustaining cladding 
oxidation. 
Low-Temperature Fire 10-6–10-8 10-8 3x10-3 32,37 Less severe accident in which fuel exposed 
to air but no cladding ignition. 
Heated Spent Fuel 0.2 0.03 0.05 32,38
36 
Alternative release terms based upon 
Department of Energy source. 
Mechanical Destruction 0.05 0 0.05 32,36 Complete cladding failure leading to the 
release of the volatile material in gaps 
between the fuel matrix and cladding. 
WASH-1400 Study 0.4–0.5 0.05–0.06 0.7 39 NUREG study of commercial U.S. 
nuclear reactor safety 
Chernobyl 0.2–0.4  0.04–0.06 0.5–0.6 40 Evaluation of Chernobyl accident 
Khlopkin/Kurchatov 0.01 0.002 0.01 41 Release fractions proposed by Kurchatov 
Institute 
NATO 0.1 0.02 0.2 34 Values used in the NATO Study [34] 
Lysenko Case A 10-3–10-2 10-3–10-2 --- 28 Helicopter crash on NS during SNF 
removal 
Lysenko Case B 10-4–10-3 10-4–10-3 --- 28 Airplane crash on shore storage of SNF 
      
Minimum 1x10-8 1x10-8 3x10-3 --- Minimum including endpoints of ranges 
Median 0.075 0.0125 0.125 --- Median using midpoints of ranges 
Maximum 0.9 0.06 0.8 --- Maximum including endpoints of ranges 
 
*  Spent nuclear fuel (SNF) and nuclear submarine (NS). 
 
Table 57.  Possible Environmental Source Terms, A0, (in Bq) for PRS and VRS* 
Site Name Cs-137 Ratio** Sr-90 Ratio** I-131 Ratio** 
NS Minimum 7.71x104 8.9x10-11 7.53x104 8.7x10-11 3.90x107 5x10-8 
NS Median 1.26x1014 0.15 9.49x1012 0.01 1.81x1010 2x10-5 
NS Maximum 4.41x1015 5.10 2.49x1014 0.29 3.44x1012 4x10-3 P
R
S
 
PM-32 1.08x1015 1.25 6.60x1013 0.08 --- --- 
NS Minimum 7.71x104 8.9x10-11 7.53x1014 8.7x10-11 3.90x107 5x10-8 
NS Median 1.26x1014 0.15 9.49x1012 0.01 1.81x1010 2x10-5 
NS Maximum 4.41x1015 5.10 2.49x1014 0.29 3.44x1012 4x10-3 V
R
S
 
Cask Maximum 7.53x1014 0.87 4.25x1013 0.05 --- --- 
 
*  Spent fuel assemblies (SFA) and nuclear submarine (NS). 
** Ratio of Inventory to the “unit hypothetical release” of 8.64x1014 Bq. 
 
Table 58.  Design Basis for the P23 Transfer Coefficient in mBq a kg
-1
 per Bq m
-2 
 Cs-137 P23 Sr-90 P23 
 UNSCEAR Adjusted (10%) UNSCEAR Adjusted (10%) 
Pathway Min Max Min Max Min Max Min Max 
Milk products 5.7 8.8 5.13 9.68 2.6 4.9 2.34 5.39 
Grain Products 8.9 26.6 8.01 29.26 4.1 17.2 3.69 18.92 
Vegetables 1.8 4.4 1.62 4.84 0.4 4 0.36 4.4 
Fruit 3.1 3.5 2.79 3.85 1 2.5 0.9 2.75 
Meat 7.9 26.2 7.11 28.82 0.4 3 0.36 3.3 
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Table 59.  1993 UNSCEAR P34 Type Transfer Coefficients in kg a
-1
 (500 kg a
-1
 Consumption Rate Basis) 
 Cs-137 Sr-90 
Pathway Argentina Denmark U.S. Min Max Argentina Denmark U.S. Min Max 
Milk Products 130 175 165 130 175 130 175 155 130 175 
Grain products 100 80 70 70 100 100 80 75 75 100 
Vegetables 155 120 95 95 155 120 120 95 95 120 
Fruit 80 50 85 50 85 100 50 75 50 100 
Meat 40 75 85 40 85 40 75 95 40 95 
 
Table 60. UNSCEAR 1982 Reference [42] Annual Intake of Food (P34) and Air (P14) 
 Food Consumption (kg a
-1
) 
Intake, P34 Adults* Children Infants
Milk products 105 110 120
Meat products 50 35 15
Grain products 140 90 45
Leafy vegetables 60 40 20
Roots and fruits 170 110 60
Fish products 25 10 5
Water and beverages 500 350 150
 Breathing Rate (m
3
 a
-1
) 
Intake, P14 Adults* Children Infants
Air 8,000 5,500 1,400
 
* Considered to apply to both adults and 9-19 year olds. 
 
Table 61.  Trends in food available for consumption from 1962-96 for Asian 
countries grouped by income levels (annual quantity of food in kg/capita) [43] 
  Year  1996 
Food group Level 1962 1967 1972 1977 1982 1987 1992 1996  Min* Max* 
Milk products High income 5.1 4.6 7 10.2 14.8 19.9 25.6 27.9    
(Dairy Only) Middle income 12.4 14.5 14.7 17.6 16.8 18.8 34.5 40.8    
 Small islands 9.5 12.6 15 14 14.2 14.5 16.3 16.7  10.1 55 
 Upper Low income 2.9 2.5 6.5 3.3 4.2 5.5 8.9 10.1    
 Lower low income 38.5 35.5 35.7 37.8 41.7 46.8 50.2 55    
Grain Products High income 217.8 244.2 262.1 242.4 207.4 201 180.1 181.7    
(Cereals and  Middle income 155.2 154.9 157 173.3 165.9 158.1 173.9 165.3    
starchy roots) Small islands 343.8 341.2 333.2 323.3 316.9 311.8 300.3 296  165.3 296 
 Upper Low income 231 254.2 260.1 266.8 276.3 264.4 256.7 254.7    
 Lower low income 159.3 159.3 168.9 169.1 175.5 179.3 185.1 193    
Vegetables High income 70.4 84.4 97.1 168.7 171.2 160.5 167.6 169.5    
(Vegetables  Middle income 47.6 47 48.7 47.6 47.6 45.6 45.3 48.5    
Only) Small islands 65.7 69.6 70.5 70 71.5 73 71.7 67.9  46.3 169.5 
 Upper Low income 59.1 42.2 36.7 38.2 47.8 71.8 88.6 123.2    
 Lower low income 32.5 35.3 37.5 38.8 41.1 43.8 44.4 46.3    
Fruit High income 11.5 19.9 26.1 33.5 44.6 55.1 82.8 94.9    
(Fruit Only) Middle income 81.8 81 73.3 100 109.6 105.3 88 93.5    
 Small islands 176.3 179.5 181.7 181.1 176.6 168.6 173.6 165.9  33.4 165.9 
 Upper Low income 16.3 14.4 13.9 14.3 17.5 28 33.1 51.5    
 Lower low income 26.6 28.1 26 25.4 27 29.1 29.8 33.4    
Meat High income 8.6 10.8 13.5 16.8 23.7 28.8 40.2 48.1    
(Meat/Poultry) Middle income 12.7 15.2 15 15.8 18.1 18.7 27.7 30.6    
 Small islands 15.9 17.8 20.9 22.8 22.9 25.5 27.9 27.3  6.9 48.1 
 Upper Low income 4.6 8.6 9.2 9.4 13.7 19.2 26.9 35.2    
 Lower low income 4.9 5 4.9 4.9 5.3 5.8 6.5 6.9    
 
* The minimum and maximum pertain to those for the 1996 values for a given food group. 
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Table 62.  CY2000 Per Capita Food Supply in kg a
-1
 (adapted from UNFAO, 2000 [44]) 
 China Japan Mongolia N. Korea Russia S. Korea Thailand U.S. Vietnam  Min Max 
Milk Products 9.73 68.53 151.48 3.84 154.48 28.49 21.27 261.38 4.71  3.84 261.38
Grains 283.45 192.26 135.39 230.58 311.27 231.59 271.57 265.68 262.11  135.39 311.27
Vegetables 211.2 125.12 23.01 156.57 98.76 243.86 43.54 152.06 77.46  23.01 243.86
Fruits 43.05 51 54.75 54.75 37.25 68.46 124.79 124.79 47.67  37.25 124.79
Meat 55.43 48.72 112.58 10.31 50.71 52.27 26.15 129.48 27.17  10.31 129.48
Eggs 16.13 19.26 0.15 4.62 12.72 9.52 9.89 14.58 2.31  0.15 19.26
Fish, Seafood 25.03 64.76 0.05 8.22 19.87 51.4 28.66 21.39 19.21  0.05 64.76
 
Table 63.  Food Consumption Rates by Individuals in kg a-1 [45] 
 
Country 
 
Milk 
 
Grain 
Leafy 
Vegetables 
Fruit/ 
Vegetables 
 
Meat 
 
Total 
USSR 332* 133 37 118 63 683 
China 5* 229 29 173 30 466 
Japan 50 193 30 180 120 573 
United States 174 91 25 260 146 696 
       
Minimum 50 91 25 118 30 466 
Maximum 174 229 37 260 146 696 
 
* Unusually high or low values indicated per Reference 45. Although the milk value is relatively 
close to that used in the UNSCEAR 1993 Report [13] for the calculation of the I-131 transfer factor. 
 
Table 64.  Recommended Consumption Values for Average 
Individual from NRC 1.109 [46] 
Pathway Infant Child Teen Adult 
Milk (L a-1) --- 170 200 110 
Grain (kg a-1) --- 48 57.6 45.6 
Vegetables (kg a-1) --- 108 129.6 102.6 
Fruit (kg a-1) --- 44 52.8 41.8 
Meat (kg a-1) --- 37 59 95 
Total (kg a-1)* --- 407 499 395 
Inhalation (m3 a-1) --- 3700 8000 8000 
 
*  Using a milk specific gravity of 1.03. 
 
Table 65. Recommended Consumption Values for Maximum  
Exposed Individual from NRC 1.109 [46] 
Pathway Infant Child Teen Adult 
Milk (L a-1) 330 330 400 310 
Grain (kg a-1) --- 124.8 151.2 124.8 
Vegetables (kg a-1) --- 306.8 382.2 344.8 
Fruit (kg a-1) --- 114.4 138.6 114.4 
Meat (kg a-1) --- 41 65 110 
Total (kg a-1)* 339.9 926.9 1149 1013.3 
Inhalation (m3 a-1) 1400 3700 8000 8000 
 
*  Using a milk specific gravity of 1.03. 
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Table 66.  Ranges of Consumption Rates in kg a
-1
 
Pathway Min Source Max Source 
Milk products 3.84 Table 62 412 Table 65*
Grain Products 45 Table 60 311.3 Table 62
Vegetables 20 Table 60 382.2 Table 65
Fruit 33.4 Table 61 170 Table 60
Meat 6.9 Table 61 146 Table 63
Sum 109.14 N/A 1421.5 N/A
 
* NRC 1.109 value of 400 L a-1 for teens [46] converted to kg a-1 
using a milk specific gravity of 1.03. 
 
Table 67.  Age-specific Consumption Values as They Relate to 
Adult Consumption Rates (%) 
Pathway Type Infant* Child Teen 
Milk (L a-1 or kg a-1) Min 106.45 104.76 100.00**
Max 366.67 200.00 181.82
Grain (kg a-1) Min 28.93 57.14 100.00**
Max 35.36 105.26 126.32
Vegetables (kg a-1) Min 30.00 66.67 100.00**
Max 36.67 105.26 126.32
Fruit (kg a-1) Min 31.76 64.71 100.00**
Max 38.82 105.26 126.32
Meat (kg a-1) Min 27.00 37.27 59.09
Max 33.00 70.00 100.00**
 
* Other than milk, only a single value was available. Therefore, an 
arbitrary 10% adjustment was made to provide a suitable range. 
** The maximum or minimum was adjusted to be the same as that for 
adult consumption to provide a suitable range for study. 
 
Table 68.  Ingestion P34 Design Space (in kg a
-1) 
Pathway Type Ref. Adult Infant Child Teen
Min Table 62 4.0 4.2 4.1 4.0
Milk 
Max Table 65 319.3 1170.8 638.6 580.5
Min Table 64 45.6 13.2 26.1 45.6
Grain 
Max Table 62 311.3 110.1 327.7 393.2
Min Table 62 23.0 6.9 15.3 23.0
Vegetables 
Max Table 65 344.8 126.4 362.9 435.5
Min Table 61 33.4 10.6 21.6 33.4
Fruit 
Max Table 60 170.0 66.0 178.9 214.7
Min Table 61 6.9 1.9 2.6 4.1
Meat 
Max Table 63 146.0 48.2 102.2 146.0
Min N/a 112.9 36.8 69.7 110.0
Total 
Max N/a 1291.4 1521.4 1610.3 1770.0
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Table 69.  Exposure-to-Dose Conversion Factor, P45, for Ingestion 
(Effective Committed Dose Equivalent per Unit Intake in nSv Bq-1) 
Radio- 
nuclide 
 
Source 
Uptake 
Factor, f1
 
T(y) 
 
3-mo
 
1-y
Infant
Ave* 
Child
5-y 
Teen 
15-y 
 
Adult 
Cs-137 UNSCEAR [13,20] 1E+0 I 50/70** 21 10 15.5 10 13 13 
Cs-137 FGR-11 [27] 1.0 50 --- --- --- --- --- 13.5 
Cs-137 ICRP 72 [47] 1.000 70 21 12 16.5 9.6 13 13 
Cs-137 NRC 1.109 [46]*** max 50 --- --- 11.7 12.5 14.0 19.3 
Sr-90 UNSCEAR [13,20] 3E-1 I 50/70** 260 120 190 74 30 28 
Sr-90 FGR-11 [27] 3 10-1 50 --- --- --- --- --- 38.5 
Sr-90 ICRP 72 [47] 0.300 70 230 73 151.5 47 80 28 
Sr-90 NRC 1.109 [46]*** max 50 --- --- 1273 1165 554 503 
I-131 UNSCEAR [13,20] 1E+0 I 50/70** 240 180 210 110 29 22 
I-131 FGR-11 [27] 1.0 50 --- --- --- --- --- 14.4 
I-131 ICRP 72 [47] 1.000 70 180 180 180 100 34 22 
I-131 NRC 1.109 [46]*** max 50 --- --- 5.0 2.7 1.2 0.92 
 
* Average of the 3-mo and 1-y values. 
** Dose integration period is to age 70 for infants and children and age 50 for adults. The P45 value given in 
Reference 13 for I-131 is 61 nSv Bq-1, which was computed at a P34 value of 109.5 L a
-1 of milk as shown 
in Equation 7.   
*** Population considered to be comprised of infants (0-1 year), children (1-11 years), teenagers (11-17 years), 
and adults. Thus the infant category will be used for the 3-mo, 1-y and average values, the children 
category for 5-y, and the teenager for 15-y. The dose conversion factors are based on continuous intake for 
the “maximum individual” over a one-year exposure period and a dose commitment extending over a 50-
year period from the initiation of intake [46]. 
 
Table 70.  Selected Population Statistics (in %) 
Ages UNSCEAR[13] Alaska[50] Japan[51] S. Korea[52] Minimum Maximum 
0-1 2 3.0 1.8 2.4 1.8 3.0 
1-9 16 13.2 7.5 11.3 7.5 16.0 
9-19 20 17.0 10.8 14.0 10.8 20.0 
Adult 62 66.8 79.9 72.3 62.0 79.9 
 
Table 71.  Extreme Vertex Design for the Population Data in Table 70 
 Ages 
Vertex 0-1 1-9 9-19 Adult
e01 2.00 16.00 20.00 62.00
e02 3.00 15.00 20.00 62.00
e03 3.00 16.00 19.00 62.00
e04 1.80 7.50 10.80 79.90
e05 3.00 7.50 10.80 78.70
e06 1.80 16.00 10.80 71.40
e07 3.00 16.00 10.80 70.20
e08 1.80 7.50 20.00 70.70
e09 3.00 7.50 20.00 69.50
e10 1.80 16.00 20.00 62.20
centroid 2.42 12.50 16.22 68.86
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Table 72.  Ingestion P2345 Ranges for Cs-137 in nSv per Bq m
-2
 
P2345 Infant Child Teen Adult Weighted 
Pathway Min Max Min Max Max Max Min Max Min Max 
Milk products 0.28 187.00 0.20 83.45 0.27 75.86 0.27 41.73 0.26 58.23 
Grain Products 1.37 53.16 2.01 129.44 4.75 155.32 4.75 122.97 4.22 129.04 
Vegetables 0.15 10.09 0.24 23.71 0.48 28.46 0.48 22.53 0.44 23.65 
Fruit 0.38 4.19 0.58 9.30 1.21 11.16 1.21 8.84 1.09 9.28 
Meat 0.18 22.92 0.18 39.76 0.38 56.80 0.64 56.80 0.50 54.84 
Total 2.36 277.36 3.20 285.67 7.09 327.60 7.35 252.86 6.50 275.03 
UNSCEAR[13] 55 
 
Table 73.  Ingestion P2345 Ranges for Sr-90 nSv per Bq m
-2
 
P2345 Infant Child Teen Adult Weighted 
Pathway Min Max Min Max Max Max Min Max Min Max 
Milk products 0.28 1199.02 3.69 893.04 0.26 250.31 0.26 66.26 0.26 132.89 
Grain Products 1.36 395.79 0.27 254.71 4.71 595.15 4.71 226.76 4.29 274.45 
Vegetables 0.07 105.67 2.70 458.81 0.23 153.30 0.23 58.41 0.21 70.78 
Fruit 0.27 34.48 0.15 118.16 0.84 47.23 0.84 18.00 0.78 21.86 
Meat 0.02 30.22 0.54 36.41 0.04 38.54 0.07 18.55 0.06 19.17 
Total 1.99 1765.18 0.03 24.96 6.09 1084.53 6.12 387.97 5.60 519.15 
UNSCEAR[13] 52 
 
Table 74.  Ingestion P2345 Ranges for I-131  
Parameter Min Max 
P23 (mBq a L
-1 per Bq m-2) 0.57 0.69
P34 (L a
-1) at ρ = 1.03 (Milk) Table 68 
P45 (nSv Bq
-1) Table 69 
P2345 (nSv per Bq m
-2) Min Max 
 Infant 0.033 165.42
 Child 0.033 47.26
 Teen 0.032 23.82
 Adult 0.032 13.10
 Weighted 0.032 18.29
UNSCEAR P25 [13] 4.2 
 
Table 75.  Breathing Rate Information from the 2000 UNSCEAR Report [16,53] 
Age Breathing rate UNSCEAR Rate (m
3
 y
-1
)
group m
3
 d
-1
m
3
 y
-1
group Min Max
0-1 2.86 1044 Infant 1044 1044
1-2 5.16 1883 Child* 1883 3183
2-7 8.72 3183 Teen** 5585 7337
7-12 15.3 5585 Adult 8103 8103
12-17 20.1 7337
>17 22.2 8103
 
* Child data are from the 1-2 and 2-7 age groups. 
** Teen data are from the 7-12 and 12-17 age groups. 
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Table 76.  Summary of Breathing Rate (P14) Information (in m
3
 a
-1
) 
Age Group Minimum Ref. Maximum Ref. 
Infant 1044 16,53 1400 42,46 
Child 1883 16,53 5500 42 
Teen 5585 16,53 8000 42,46 
Adult 7300 13 8103 16,53 
 
Table 77. Exposure-to-Dose Conversion Factor, P45, for Inhalation 
(Effective Committed Dose Equivalent per Unit Intake in nSv Bq
-1
) 
Radio- 
nuclide 
 
Source 
 
Class*
 
T(y) 
 
3-mo
 
1-y 
Infant
Ave**
Child
5-y 
Teen 
15-y 
 
Adult 
Cs-137 UNSCEAR [13,20] D 50/70*** 14 7.0 10.5 6.7 8.3 8.5 
Cs-137 FGR-11 [27] D 50 --- --- --- --- --- 8.63 
Cs-137 ICRP 72 [47] F 70 8.8 5.4 7.1 3.6 4.4 4.6 
Cs-137 NRC 1.109 [46] D 50 --- --- 8.8 9.4 10.5 14.5 
Sr-90 UNSCEAR [13,20] Y 50/70*** 1900 1600 1750 990 370 350 
Sr-90 FGR-11 [27] Y 50 --- --- --- --- --- 351 
Sr-90 ICRP 72 [47] S 70 420 400 410 270 160 160 
Sr-90 NRC 1.109 [46] Y 50 --- --- 500 470 226 206 
I-131 UNSCEAR [13,20] D 50/70*** 150 110 130 67 18 13 
I-131 FGR-11 [27] D 50 --- --- --- --- --- 8.89 
I-131 ICRP 72 [47] F 70 72 72 72 37 11 7.4 
I-131 NRC 1.109 [46] D 50 --- --- 3.8 2.0 0.89 0.69 
 
* ICRP 72 [47] classes Fast (F), Moderate (M), and Slow (S) correspond to classes Days (D), 
Months (M), and Years (Y) used previously. 
** Average of the 3-mo and 1-y values per the 1993 UNSCEAR Report [13]. 
*** Dose integration period is to age 70 for infants and children and age 50 for adults. The P45 
value given in Reference 13 for inhalation of I-131 is 13 nSv Bq-1.   
 
Table 78. Inhalation P245 Design Space 
(in nSv per Bq m-2) 
P245 Cs-137 Sr-90 I-131 
Age Group Min Max Min Max Min Max 
Infant 0.013 0.311 0.658 38.82 0.017 0.961 
Child 0.012 1.003 0.916 86.27 0.030 1.946 
Teen 0.044 1.459 1.609 46.90 0.089 0.761 
Adult 0.060 1.477 2.103 45.06 0.097 0.556 
Weighted 0.048 1.418 1.779 51.83 0.095 0.830 
UNSCEAR 0.11 4.6 0.17 
 
Table 79. External Exposure Parameters 
Parameter UNSCEAR[13] Min Source Max Source 
Outdoor occupancy 0.2 0.2 UNSCEAR [13] 1 Max. possible 
Indoor occupancy 0.8 0 Min. possible 0.8 UNSCEAR [13] 
Building shielding factor 0.2 0.2 UNSCEAR [13] 0.7 RESRAD [25] 
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Table 80.  Possible Ranges of Cs-137 Deposition-to-Dose Coefficients in nSv per Bq m
-2
 
nSv  per Bq m
-2
 Infant Child Teen Adult Weighted 
Ingestion, P2345 Min Max Min Max Max Max Min Max Min Max 
   Milk products 0.28 187.0 0.20 83.5 0.27 75.9 0.27 41.7 0.26 58.2 
   Grain Products 1.37 53.2 2.01 129.4 4.75 155.3 4.75 123.0 4.22 129.0 
   Vegetables 0.15 10.1 0.24 23.7 0.48 28.5 0.48 22.5 0.44 23.6 
   Fruit 0.38 4.2 0.58 9.3 1.21 11.2 1.21 8.8 1.09 9.3 
   Meat 0.18 22.9 0.18 39.8 0.38 56.8 0.64 56.8 0.50 54.8 
   Total 2.36 277.4 3.20 285.7 7.09 327.6 7.35 252.9 6.50 275.0 
UNSCEAR P2345 55 
Inhalation, P245 0.01 0.31 0.01 1.0 0.04 1.5 0.06 1.5 0.05 1.4 
UNSCEAR P245 0.11 
Ext. Exposure, P25 97.00 432.4 97.00 432.4 97.00 432.4 97.00 432.4 97.00 432.4 
UNSCEAR P25 97 
P2345+P245+P25 99.37 710.1 100.22 719.1 104.13 761.5 104.41 686.7 103.5 708.8 
UNSCEAR Total 152.11 
Ratio to UNSCEAR 0.65 4.67 0.66 4.73 0.68 5.01 0.69 4.51 0.68 4.66 
 
Table 81.  Possible Ranges of Sr-90 Deposition-to-Dose Coefficients in nSv per Bq m-2 
nSv  per Bq m-2 Infant Child Teen Adult Weighted 
Ingestion, P2345 Min Max Min Max Max Max Min Max Min Max 
   Milk products 0.28 1199 3.69 893 0.26 250 0.26 66 0.26 133 
   Grain Products 1.36 396 0.27 255 4.71 595 4.71 227 4.29 274 
   Vegetables 0.07 106 2.70 459 0.23 153 0.23 58 0.21 71 
   Fruit 0.27 34 0.15 118 0.84 47 0.84 18 0.78 22 
   Meat 0.02 30 0.54 36 0.04 39 0.07 19 0.06 19 
   Total 1.99 1765 0.03 25 6.09 1085 6.12 388 5.60 519 
UNSCEAR P2345 52 
Inhalation, P245 0.66 39 0.92 86 1.61 47 2.10 45 1.78 52 
UNSCEAR P245 4.6 
Ext. Exposure, P25 0 0.38 0 0.38 0 0.38 0 0.38 0 0.38 
UNSCEAR P25 0 
P2345+P245+P25 2.65 1804 0.95 112 7.70 1132 8.22 433 7.38 571 
UNSCEAR Total 56.6 
Ratio to UNSCEAR 0.05 31.87 0.02 1.98 0.14 20.00 0.15 7.65 0.13 10.09 
 
Table 82.  Possible Ranges of I-131 Deposition-to-Dose Coefficients in nSv per Bq m
-2
 
nSv  per Bq m
-2
 Infant Child Teen Adult Weighted 
Ingestion, P2345 Min Max Min Max Max Max Min Max Min Max 
   Milk products 0.033 165.4 0.033 47.3 0.032 23.82 0.032 13.1 0.032 18.29 
UNSCEAR P2345 4.2 
Inhalation, P245 0.017 0.96 0.03 1.95 0.089 0.76 0.097 0.56 0.095 0.83 
UNSCEAR P245 0.17 
Ext. Exposure, P25 0.12 0.38 0.12 0.38 0.12 0.38 0.12 0.38 0.12 0.38 
UNSCEAR P25 0.12 
P2345+P245+P25 0.17 166.8 0.183 49.6 0.241 24.96 0.249 14.04 0.25 19.5 
UNSCEAR Total 4.49 
Ratio to UNSCEAR 0.04 37.15 0.04 11.05 0.05 5.56 0.06 3.13 0.06 4.34 
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Table 83.  PRS Adjusted CY2000 Total Deposition (tdep) Values for Cs-137 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 21-Mar 326 100.0 1.42E+05 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 1.42E+05 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 1.42E+05 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 326 100.0 1.12E+05 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 1.12E+05 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 1.12E+05 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 05-Jan 58 17.8 9.93E+02 52.50 126.00 2169 1.89E+09 7721 05-Jan 17.8 9.93E+02 52.50 126.00 2169 1.89E+09 7721 04-Dec 1.5 5.10E-03 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 82 25.2 1.41E+03 43.50 142.50 1581 2.25E+09 155808 26-Apr 25.2 1.41E+03 43.50 142.50 1581 2.25E+09 155808 01-Jan 3.1 3.60E+02 45.50 142.00 1454 2.17E+09 34622
Laos None      None  None
Mongolia 04-Jan 13 4.0 5.54E+01 46.50 119.50 2855 2.13E+09 1835 04-Jan 4.0 5.54E+01 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 18 5.5 2.77E+02 43.00 130.00 2372 2.26E+09 175327 07-Jan 5.5 2.77E+02 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 1.62E-11 43.00 130.00 2372 2.26E+09 175327
Russia 21-Mar 326 100.0 1.42E+05 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 1.42E+05 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 1.42E+05 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 2.09E+01 37.50 126.50 3001 2.45E+09 2006368 05-Jan 1.5 2.09E+01 37.50 126.50 3001 2.45E+09 2006368 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 24-Jan 273 83.7 4.37E+03 52.50 185.50 1807 1.89E+09 63 24-Jan 83.7 4.37E+03 52.50 185.50 1807 1.89E+09 63 20-May 32.5 1.87E+03 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 229 70.2 6.54E+03 58.50 198.00 2507 1.62E+09 22 18-Feb 70.2 6.54E+03 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 2.69E+02 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 84.  PRS Adjusted CY2000 Total Deposition (tdep) Values for Sr-90 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 21-Mar 326 100.0 8.25E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 8.14E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 8.25E+03 52.50 157.50 87 1.89E+09 1944
Transboundary** 05-Nov 326 100.0 6.63E+03 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 6.35E+03 52.50 159.00 65 1.89E+09 0 05-Nov 100.0 6.42E+03 52.50 159.00 65 1.89E+09 0
Burma None      None  None
China 05-Jan 50 15.3 5.58E+01 52.50 126.00 2169 1.89E+09 7721 05-Jan 15.3 5.57E+01 52.50 126.00 2169 1.89E+09 7721 04-Dec 1.5 3.11E-04 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None  None
Japan 26-Apr 76 23.3 9.19E+01 43.50 142.50 1581 2.25E+09 155808 26-Apr 23.3 9.19E+01 43.50 142.50 1581 2.25E+09 155808 01-Jan 3.1 2.14E+01 45.50 142.00 1454 2.17E+09 34622
Laos None      None  None
Mongolia 04-Jan 11 3.4 3.20E+00 46.50 119.50 2855 2.13E+09 1835 04-Jan 3.4 3.20E+00 46.50 119.50 2855 2.13E+09 1835 None
N. Korea 07-Jan 14 4.3 1.74E+01 43.00 130.00 2372 2.26E+09 175327 07-Jan 4.3 1.74E+01 43.00 130.00 2372 2.26E+09 175327 04-Dec 0.3 9.30E-13 43.00 130.00 2372 2.26E+09 175327
Russia 21-Mar 326 100.0 8.25E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 8.14E+03 52.50 157.50 87 1.89E+09 1944 21-Mar 100.0 8.25E+03 52.50 157.50 87 1.89E+09 1944
S. Korea 05-Jan 5 1.5 6.16E-01 37.50 126.50 3001 2.45E+09 2006368 05-Jan 1.5 6.16E-01 37.50 126.50 3001 2.45E+09 2006368 None
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 24-Jan 269 82.5 2.45E+02 52.50 185.50 1807 1.89E+09 63 24-Jan 82.5 2.45E+02 52.50 185.50 1807 1.89E+09 63 20-May 32.5 1.26E+02 52.50 173.00 976 1.89E+09 0
Alaska (U.S.) 18-Feb 215 66.0 3.93E+02 58.50 198.00 2507 1.62E+09 22 18-Feb 66.0 3.93E+02 58.50 198.00 2507 1.62E+09 22 20-Jan 3.4 1.82E+01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 85.  PRS Adjusted CY2000 Total Deposition (tdep) Values for I-131 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop
Regional 12-Jun 326 100.0 1.85E+02 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 1.09E+02 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.51E+02 52.50 157.50 87 1.89E+09 1944
Transboundary** 07-Feb 326 100.0 1.23E+02 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 8.92E+01 52.50 159.00 65 1.89E+09 0 07-Feb 100.0 1.23E+02 52.50 159.00 65 1.89E+09 0
Burma None      None   None
China 04-Dec 4 1.2 2.47E-07 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 1.78E-07 52.50 123.00 2365 1.89E+09 5976 04-Dec 1.2 2.47E-07 52.50 123.00 2365 1.89E+09 5976
Hong Kong None      None   None
Japan 03-Jan 10 3.1 1.53E-01 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 1.11E-01 44.50 145.50 1338 2.21E+09 2136 03-Jan 3.1 1.53E-01 44.50 145.50 1338 2.21E+09 2136
Laos None      None   None
Mongolia None      None   None
N. Korea None      None   None
Russia 12-Jun 326 100.0 1.85E+02 54.00 159.00 116 1.82E+09 1872 09-Feb 100.0 1.09E+02 52.50 157.50 87 1.89E+09 1944 09-Feb 100.0 1.51E+02 52.50 157.50 87 1.89E+09 1944
S. Korea None      None   None
Taiwan None      None   None
Thailand None      None   None
Aleutians (U.S.) 18-Jan 86 26.4 2.01E+00 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 1.46E+00 52.50 174.00 1043 1.89E+09 0 18-Jan 26.4 2.01E+00 52.50 174.00 1043 1.89E+09 0
Alaska (U.S.) 20-Jan 7 2.1 1.36E-01 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 9.85E-02 54.50 195.00 2379 1.80E+09 38 20-Jan 2.1 1.36E-01 54.50 195.00 2379 1.80E+09 38
Vietnam None      None   None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 86.  VRS Adjusted CY2000 Total Deposition (tdep) Values for Cs-137 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 02-Aug 329 100.0 1.35E+05 43.50 133.50 134 2.25E+09 34008 02-Aug 100.0 1.35E+05 43.50 133.50 134 2.25E+09 34008 02-Aug 100.0 1.25E+05 43.50 133.50 134 2.25E+09 34008
Transboundary** 18-Nov 329 100.0 4.62E+04 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 4.62E+04 42.00 133.50 166 2.30E+09 0 18-Nov 100.0 4.62E+04 42.00 133.50 166 2.30E+09 0
Burma None      None  None
China 07-Jun 262 79.6 3.54E+04 43.50 131.50 69 2.25E+09 42463 07-Jun 79.6 3.54E+04 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 3.11E+04 43.50 131.50 69 2.25E+09 42463
Hong Kong 12-Sep 9 2.7 2.84E+01 22.50 114.50 2794 2.85E+09 125994 12-Sep 2.7 2.84E+01 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 317 96.4 1.96E+04 40.50 141.00 796 2.35E+09 358298 16-Dec 96.4 1.96E+04 40.50 141.00 796 2.35E+09 358298 30-Jan 74.2 1.36E+04 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 10-May 40 12.2 3.42E+02 47.00 120.00 1042 2.11E+09 33341 10-May 12.2 3.42E+02 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 2.42E-01 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 202 61.4 2.18E+04 42.00 129.00 270 2.30E+09 200822 20-Aug 61.4 2.18E+04 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 2.18E+04 42.00 129.00 270 2.30E+09 200822
Russia 02-Aug 324 98.5 1.35E+05 43.50 133.50 134 2.25E+09 34008 02-Aug 98.5 1.35E+05 43.50 133.50 134 2.25E+09 34008 02-Aug 97.9 1.25E+05 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 156 47.4 5.28E+03 38.50 127.50 628 2.42E+09 292252 11-Jan 47.4 5.28E+03 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 4.03E+03 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 32 9.7 9.77E+02 24.00 121.50 2322 2.82E+09 152461 29-Nov 9.7 9.77E+02 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 172 52.3 2.99E+02 52.00 177.00 3464 1.91E+09 0 23-Apr 52.3 2.99E+02 52.00 177.00 3464 1.91E+09 0 29-May 0.6 1.10E-03 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 24-Mar 140 42.6 5.74E+02 60.00 210.00 5359 1.55E+09 1314 24-Mar 42.6 5.74E+02 60.00 210.00 5359 1.55E+09 1314 None
Vietnam 29-Nov 1 0.3 1.47E-05 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 1.47E-05 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 87.  VRS Adjusted CY2000 Total Deposition (tdep) Values for Sr-90 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 02-Aug 329 100.0 9.38E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 8.60E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 8.64E+03 43.50 133.50 134 2.25E+09 34008
Transboundary** 02-Aug 329 100.0 3.13E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 2.87E+03 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 2.88E+03 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 259 78.7 2.27E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 78.7 2.26E+03 43.50 131.50 69 2.25E+09 42463 07-Jun 73.6 2.16E+03 43.50 131.50 69 2.25E+09 42463
Hong Kong 29-Nov 4 1.2 6.52E-04 22.50 114.50 2794 2.85E+09 125994 29-Nov 1.2 6.52E-04 22.50 114.50 2794 2.85E+09 125994 None
Japan 16-Dec 316 96.0 1.27E+03 40.50 141.00 796 2.35E+09 358298 16-Dec 96.0 1.25E+03 40.50 141.00 796 2.35E+09 358298 30-Jan 74.2 8.00E+02 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 10-May 36 10.9 2.17E+01 47.00 120.00 1042 2.11E+09 33341 10-May 10.9 2.17E+01 47.00 120.00 1042 2.11E+09 33341 27-Jul 1.5 1.69E-02 50.00 116.50 1415 1.99E+09 4443
N. Korea 20-Aug 199 60.5 1.49E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 60.5 1.36E+03 42.00 129.00 270 2.30E+09 200822 20-Aug 37.7 1.48E+03 42.00 129.00 270 2.30E+09 200822
Russia 02-Aug 324 98.5 9.38E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 8.60E+03 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 8.64E+03 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 151 45.9 3.44E+02 38.50 127.50 628 2.42E+09 292252 11-Jan 45.9 3.34E+02 38.50 127.50 628 2.42E+09 292252 15-Nov 21.0 2.80E+02 38.50 127.50 628 2.42E+09 292252
Taiwan 29-Nov 21 6.4 6.27E+01 24.00 121.50 2322 2.82E+09 152461 29-Nov 6.4 6.27E+01 24.00 121.50 2322 2.82E+09 152461 None
Thailand None      None  None
Aleutians (U.S.) 23-Apr 154 46.8 1.74E+01 52.00 177.00 3464 1.91E+09 0 23-Apr 46.8 1.74E+01 52.00 177.00 3464 1.91E+09 0 29-May 0.6 7.64E-05 53.00 172.50 3162 1.87E+09 0
Alaska (U.S.) 25-Mar 119 36.2 1.20E+01 58.50 202.50 4986 1.62E+09 15 25-Mar 36.2 1.20E+01 58.50 202.50 4986 1.62E+09 15 None
Vietnam 29-Nov 1 0.3 1.27E-10 20.50 107.00 3416 2.89E+09 13869 29-Nov 0.3 1.27E-10 20.50 107.00 3416 2.89E+09 13869 None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
 
Table 88.  VRS Adjusted CY2000 Total Deposition (tdep) Values for I-131 
 
Region 
 
Date 
 
N 
 
N(%) 
Max 
(Bq m-2) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
144-h 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
 
Date 
 
N(%)
048-hr 
(Bq m-2)
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m2) 
 
Pop 
Regional 12-Jun 329 100.0 2.10E+02 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 1.59E+02 43.50 133.50 134 2.25E+09 34008 12-Jun 100.0 2.10E+02 43.50 133.50 134 2.25E+09 34008
Transboundary** 12-Jun 329 100.0 7.01E+01 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 5.30E+01 42.50 133.50 135 2.28E+09 717 12-Jun 100.0 7.01E+01 42.50 133.50 135 2.28E+09 717
Burma None      None  None
China 07-Jun 245 74.5 6.53E+01 43.50 131.50 69 2.25E+09 42463 07-Jun 74.5 4.14E+01 43.50 131.50 69 2.25E+09 42463 07-Jun 72.6 5.47E+01 43.50 131.50 69 2.25E+09 42463
Hong Kong None      None  None
Japan 20-Nov 270 82.1 1.04E+01 36.00 138.00 933 2.50E+09 405254 20-Nov 82.1 7.87E+00 36.00 138.00 933 2.50E+09 405254 20-Nov 70.2 1.04E+01 36.00 138.00 933 2.50E+09 405254
Laos None      None  None
Mongolia 21-Apr 5 1.5 2.33E-06 47.00 120.00 1042 2.11E+09 33341 21-Apr 1.5 1.77E-06 47.00 120.00 1042 2.11E+09 33341 21-Apr 0.9 2.33E-06 47.00 120.00 1042 2.11E+09 33341
N. Korea 20-Aug 150 45.6 3.93E+01 42.00 129.00 270 2.30E+09 200822 20-Aug 45.6 2.65E+01 42.00 129.00 270 2.30E+09 200822 20-Aug 35.6 3.51E+01 42.00 129.00 270 2.30E+09 200822
Russia 12-Jun 324 98.5 2.10E+02 43.50 133.50 134 2.25E+09 34008 12-Jun 98.5 1.59E+02 43.50 133.50 134 2.25E+09 34008 12-Jun 97.9 2.10E+02 43.50 133.50 134 2.25E+09 34008
S. Korea 11-Jan 89 27.1 4.55E+00 37.50 129.00 662 2.45E+09 155901 11-Jan 27.1 3.72E+00 37.50 129.00 662 2.45E+09 155901 11-Jan 18.8 4.55E+00 37.50 129.00 662 2.45E+09 155901
Taiwan None      None  None
Thailand None      None  None
Aleutians (U.S.) 07-Mar 25 7.6 2.62E-02 52.00 177.00 3464 1.91E+09 0 07-Mar 7.6 2.21E-02 52.00 177.00 3464 1.91E+09 0 07-Nov 0.3 6.36E-11 52.00 177.00 3464 1.91E+09 0
Alaska (U.S.) 14-Nov 5 1.5 2.13E-14 55.00 198.00 4801 1.78E+09 46 14-Nov 1.5 1.79E-14 55.00 198.00 4801 1.78E+09 46 None
Vietnam None      None  None
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all areas, including ocean, outside of Russia.  
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Table 89.  PRS Worst-Case Cs-137 Maximum Total Dose Commitment per Maximum Individual (i.e., Teen) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 21-Mar-00 326 100.0 1.08E+02 52.50 157.50 87 1.89E+09 1944 4.64E+01 43.0 2.07E-01 0.2 6.13E+01 56.8
Transboundary** 18-Feb-00 316 96.9 4.98E+00 58.50 198.00 2507 1.62E+09 22 2.14E+00 43.0 9.55E-03 0.2 2.83E+00 56.8
Burma None      
China 05-Jan-00 58 17.8 7.56E-01 52.50 126.00 2169 1.89E+09 7721 3.25E-01 43.0 1.45E-03 0.2 4.29E-01 56.8
Hong Kong None      
Japan 26-Apr-00 82 25.2 1.07E+00 43.50 142.50 1581 2.25E+09 155808 4.61E-01 43.0 2.06E-03 0.2 6.09E-01 56.8
Laos None      
Mongolia 04-Jan-00 13 4.0 4.22E-02 46.50 119.50 2855 2.13E+09 1835 1.81E-02 43.0 8.09E-05 0.2 2.40E-02 56.8
N. Korea 07-Jan-00 18 5.5 2.11E-01 43.00 130.00 2372 2.26E+09 175327 9.07E-02 43.0 4.04E-04 0.2 1.20E-01 56.8
Russia 21-Mar-00 326 100.0 1.08E+02 52.50 157.50 87 1.89E+09 1944 4.64E+01 43.0 2.07E-01 0.2 6.13E+01 56.8
S. Korea 05-Jan-00 5 1.5 1.59E-02 37.50 126.50 3001 2.45E+09 2006368 6.84E-03 43.0 3.05E-05 0.2 9.03E-03 56.8
Taiwan None      
Thailand None      
Aleutians (U.S.) 24-Jan-00 273 83.7 3.33E+00 52.50 185.50 1807 1.89E+09 63 1.43E+00 43.0 6.38E-03 0.2 1.89E+00 56.8
Alaska (U.S.) 18-Feb-00 229 70.2 4.98E+00 58.50 198.00 2507 1.62E+09 22 2.14E+00 43.0 9.55E-03 0.2 2.83E+00 56.8
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 90.  PRS Worst-Case Cs-137 Maximum Total Dose Commitment per Adult Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 21-Mar-00 326 100.0 9.73E+01 52.50 157.50 87 1.89E+09 1944 3.58E+01 36.8 2.10E-01 0.2 6.13E+01 63.0
Transboundary** 18-Feb-00 316 96.9 4.49E+00 58.50 198.00 2507 1.62E+09 22 1.65E+00 36.8 9.68E-03 0.2 2.83E+00 63.0
Burma None      
China 05-Jan-00 58 17.8 6.82E-01 52.50 126.00 2169 1.89E+09 7721 2.51E-01 36.8 1.47E-03 0.2 4.29E-01 63.0
Hong Kong None      
Japan 26-Apr-00 82 25.2 9.67E-01 43.50 142.50 1581 2.25E+09 155808 3.56E-01 36.8 2.08E-03 0.2 6.09E-01 63.0
Laos None      
Mongolia 04-Jan-00 13 4.0 3.80E-02 46.50 119.50 2855 2.13E+09 1835 1.40E-02 36.8 8.20E-05 0.2 2.40E-02 63.0
N. Korea 07-Jan-00 18 5.5 1.90E-01 43.00 130.00 2372 2.26E+09 175327 7.00E-02 36.8 4.10E-04 0.2 1.20E-01 63.0
Russia 21-Mar-00 326 100.0 9.73E+01 52.50 157.50 87 1.89E+09 1944 3.58E+01 36.8 2.10E-01 0.2 6.13E+01 63.0
S. Korea 05-Jan-00 5 1.5 1.43E-02 37.50 126.50 3001 2.45E+09 2006368 5.28E-03 36.8 3.09E-05 0.2 9.03E-03 63.0
Taiwan None      
Thailand None      
Aleutians (U.S.) 24-Jan-00 273 83.7 3.00E+00 52.50 185.50 1807 1.89E+09 63 1.10E+00 36.8 6.46E-03 0.2 1.89E+00 63.0
Alaska (U.S.) 18-Feb-00 229 70.2 4.49E+00 58.50 198.00 2507 1.62E+09 22 1.65E+00 36.8 9.68E-03 0.2 2.83E+00 63.0
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 91.  PRS Worst-Case Sr-90 Maximum Total Dose Commitment per Maximum Individual (i.e., Infant) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 21-Mar-00 326 100.0 1.47E+01 52.50 157.50 87 1.89E+09 1944 1.44E+01 97.8 3.16E-01 2.2 3.09E-03 0.02
Transboundary** 18-Feb-00 215 66.0 7.09E-01 58.50 198.00 2507 1.62E+09 22 6.94E-01 97.8 1.53E-02 2.2 1.49E-04 0.02
Burma None      
China 05-Jan-00 50 15.3 1.01E-01 52.50 126.00 2169 1.89E+09 7721 9.84E-02 97.8 2.16E-03 2.2 2.12E-05 0.02
Hong Kong None   0.00E+00   
Japan 26-Apr-00 76 23.3 1.66E-01 43.50 142.50 1581 2.25E+09 155808 1.62E-01 97.8 3.57E-03 2.2 3.49E-05 0.02
Laos None      
Mongolia 04-Jan-00 11 3.4 5.78E-03 46.50 119.50 2855 2.13E+09 1835 5.65E-03 97.8 1.24E-04 2.2 1.22E-06 0.02
N. Korea 07-Jan-00 14 4.3 3.14E-02 43.00 130.00 2372 2.26E+09 175327 3.07E-02 97.8 6.76E-04 2.2 6.62E-06 0.02
Russia 21-Mar-00 326 100.0 1.47E+01 52.50 157.50 87 1.89E+09 1944 1.44E+01 97.8 3.16E-01 2.2 3.09E-03 0.02
S. Korea 05-Jan-00 5 1.5 1.11E-03 37.50 126.50 3001 2.45E+09 2006368 1.09E-03 97.8 2.39E-05 2.2 2.34E-07 0.02
Taiwan None      
Thailand None      
Aleutians (U.S.) 24-Jan-00 269 82.5 4.42E-01 52.50 185.50 1807 1.89E+09 63 4.32E-01 97.8 9.50E-03 2.2 9.30E-05 0.02
Alaska (U.S.) 18-Feb-00 215 66.0 7.09E-01 58.50 198.00 2507 1.62E+09 22 6.94E-01 97.8 1.53E-02 2.2 1.49E-04 0.02
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 92.  PRS Worst-Case Sr-90 Maximum Total Dose Commitment per Adult Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 21-Mar-00 326 100.0 3.53E+00 52.50 157.50 87 1.89E+09 1944 3.16E+00 89.5 3.67E-01 10.4 3.09E-03 0.09
Transboundary** 18-Feb-00 215 66.0 1.70E-01 58.50 198.00 2507 1.62E+09 22 1.52E-01 89.5 1.77E-02 10.4 1.49E-04 0.09
Burma None      
China 05-Jan-00 50 15.3 2.42E-02 52.50 126.00 2169 1.89E+09 7721 2.16E-02 89.5 2.51E-03 10.4 2.12E-05 0.09
Hong Kong None      
Japan 26-Apr-00 76 23.3 3.99E-02 43.50 142.50 1581 2.25E+09 155808 3.57E-02 89.5 4.14E-03 10.4 3.49E-05 0.09
Laos None      
Mongolia 04-Jan-00 11 3.4 1.39E-03 46.50 119.50 2855 2.13E+09 1835 1.24E-03 89.5 1.44E-04 10.4 1.22E-06 0.09
N. Korea 07-Jan-00 14 4.3 7.55E-03 43.00 130.00 2372 2.26E+09 175327 6.76E-03 89.5 7.85E-04 10.4 6.62E-06 0.09
Russia 21-Mar-00 326 100.0 3.53E+00 52.50 157.50 87 1.89E+09 1944 3.16E+00 89.5 3.67E-01 10.4 3.09E-03 0.09
S. Korea 05-Jan-00 5 1.5 2.67E-04 37.50 126.50 3001 2.45E+09 2006368 2.39E-04 89.5 2.78E-05 10.4 2.34E-07 0.09
Taiwan None      
Thailand None      
Aleutians (U.S.) 24-Jan-00 269 82.5 1.06E-01 52.50 185.50 1807 1.89E+09 63 9.50E-02 89.5 1.10E-02 10.4 9.30E-05 0.09
Alaska (U.S.) 18-Feb-00 215 66.0 1.70E-01 58.50 198.00 2507 1.62E+09 22 1.52E-01 89.5 1.77E-02 10.4 1.49E-04 0.09
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 93.  PRS Worst-Case I-131 Maximum Total Dose Commitment per Maximum Individual (i.e., Infant) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m
2
) 
 
Pop
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 09-Feb-00 326 100.0 2.64E-02 52.50 157.50 87 1.89E+09 1944 2.62E-02 99.2 1.52E-04 0.6 6.02E-05 0.2
Transboundary** 18-Jan-00 98 30.1 3.53E-04 52.50 174.00 1043 1.89E+09 0 3.50E-04 99.2 2.04E-06 0.6 8.05E-07 0.2
Burma None      
China 04-Dec-00 4 1.2 4.32E-11 52.50 123.00 2365 1.89E+09 5976 4.28E-11 99.2 2.49E-13 0.6 9.84E-14 0.2
Hong Kong None      
Japan 03-Jan-00 10 3.1 2.68E-05 44.50 145.50 1338 2.21E+09 2136 2.66E-05 99.2 1.54E-07 0.6 6.10E-08 0.2
Laos None      
Mongolia None      
N. Korea None      
Russia 09-Feb-00 326 100.0 2.64E-02 52.50 157.50 87 1.89E+09 1944 2.62E-02 99.2 1.52E-04 0.6 6.02E-05 0.2
S. Korea None      
Taiwan None      
Thailand None      
Aleutians (U.S.) 18-Jan-00 86 26.4 3.53E-04 52.50 174.00 1043 1.89E+09 0 3.50E-04 99.2 2.04E-06 0.6 8.05E-07 0.2
Alaska (U.S.) 20-Jan-00 7 2.1 2.38E-05 54.50 195.00 2379 1.80E+09 38 2.36E-05 99.2 1.37E-07 0.6 5.43E-08 0.2
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 94.  PRS Worst-Case I-131 Maximum Total Dose Commitment per Age-Weighted Individual Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist*
(km)
Area* 
(m
2
) 
 
Pop
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 09-Feb-00 326 100.0 3.09E-03 52.50 157.50 87 1.89E+09 1944 2.90E-03 93.8 1.32E-04 4.3 6.02E-05 1.9
Transboundary** 18-Jan-00 98 30.1 4.13E-05 52.50 174.00 1043 1.89E+09 0 3.87E-05 93.8 1.76E-06 4.3 8.05E-07 1.9
Burma None      
China 04-Dec-00 4 1.2 5.05E-12 52.50 123.00 2365 1.89E+09 5976 4.74E-12 93.8 2.15E-13 4.3 9.84E-14 1.9
Hong Kong None      
Japan 03-Jan-00 10 3.1 3.13E-06 44.50 145.50 1338 2.21E+09 2136 2.94E-06 93.8 1.33E-07 4.3 6.10E-08 1.9
Laos None      
Mongolia None      
N. Korea None      
Russia 09-Feb-00 326 100.0 3.09E-03 52.50 157.50 87 1.89E+09 1944 2.90E-03 93.8 1.32E-04 4.3 6.02E-05 1.9
S. Korea None      
Taiwan None      
Thailand None      
Aleutians (U.S.) 18-Jan-00 86 26.4 4.13E-05 52.50 174.00 1043 1.89E+09 0 3.87E-05 93.8 1.76E-06 4.3 8.05E-07 1.9
Alaska (U.S.) 20-Jan-00 7 2.1 2.78E-06 54.50 195.00 2379 1.80E+09 38 2.61E-06 93.8 1.19E-07 4.3 5.43E-08 1.9
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 95.  VRS Worst-Case Cs-137 Maximum Total Dose Commitment per Maximum Individual (i.e., Teen) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 02-Aug-00 329 100.0 1.02E+02 43.50 133.50 134 2.25E+09 34008 4.41E+01 43.0 1.96E-01 0.2 5.82E+01 56.8
Transboundary** 07-Jun-00 329 100.0 2.69E+01 43.50 131.50 69 2.25E+09 42463 1.16E+01 43.0 5.16E-02 0.2 1.53E+01 56.8
Burma None      
China 07-Jun-00 262 79.6 2.69E+01 43.50 131.50 69 2.25E+09 42463 1.16E+01 43.0 5.16E-02 0.2 1.53E+01 56.8
Hong Kong 12-Sep-00 9 2.7 2.17E-02 22.50 114.50 2794 2.85E+09 125994 9.32E-03 43.0 4.15E-05 0.2 1.23E-02 56.8
Japan 16-Dec-00 317 96.4 1.49E+01 40.50 141.00 796 2.35E+09 358298 6.43E+00 43.0 2.87E-02 0.2 8.49E+00 56.8
Laos None      
Mongolia 10-May-00 40 12.2 2.60E-01 47.00 120.00 1042 2.11E+09 33341 1.12E-01 43.0 4.99E-04 0.2 1.48E-01 56.8
N. Korea 20-Aug-00 202 61.4 1.66E+01 42.00 129.00 270 2.30E+09 200822 7.13E+00 43.0 3.18E-02 0.2 9.41E+00 56.8
Russia 02-Aug-00 324 98.5 1.02E+02 43.50 133.50 134 2.25E+09 34008 4.41E+01 43.0 1.96E-01 0.2 5.82E+01 56.8
S. Korea 11-Jan-00 156 47.4 4.02E+00 38.50 127.50 628 2.42E+09 292252 1.73E+00 43.0 7.71E-03 0.2 2.28E+00 56.8
Taiwan 29-Nov-00 32 9.7 7.44E-01 24.00 121.50 2322 2.82E+09 152461 3.20E-01 43.0 1.43E-03 0.2 4.22E-01 56.8
Thailand None      
Aleutians (U.S.) 23-Apr-00 172 52.3 2.28E-01 52.00 177.00 3464 1.91E+09 0 9.80E-02 43.0 4.37E-04 0.2 1.29E-01 56.8
Alaska (U.S.) 24-Mar-00 140 42.6 4.37E-01 60.00 210.00 5359 1.55E+09 1314 1.88E-01 43.0 8.38E-04 0.2 2.48E-01 56.8
Vietnam 29-Nov-00 1 0.3 1.12E-08 20.50 107.00 3416 2.89E+09 13869 4.81E-09 43.0 2.15E-11 0.2 6.35E-09 56.8
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 96.  VRS Worst-Case Cs-137 Maximum Total Dose Commitment per Adult Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 02-Aug-00 329 100.0 9.24E+01 43.50 133.50 134 2.25E+09 34008 3.40E+01 36.8 1.99E-01 0.2 5.82E+01 63.0
Transboundary** 07-Jun-00 329 100.0 2.43E+01 43.50 131.50 69 2.25E+09 42463 8.94E+00 36.8 5.23E-02 0.2 1.53E+01 63.0
Burma None      
China 07-Jun-00 262 79.6 2.43E+01 43.50 131.50 69 2.25E+09 42463 8.94E+00 36.8 5.23E-02 0.2 1.53E+01 63.0
Hong Kong 12-Sep-00 9 2.7 1.95E-02 22.50 114.50 2794 2.85E+09 125994 7.19E-03 36.8 4.21E-05 0.2 1.23E-02 63.0
Japan 16-Dec-00 317 96.4 1.35E+01 40.50 141.00 796 2.35E+09 358298 4.96E+00 36.8 2.91E-02 0.2 8.49E+00 63.0
Laos None      
Mongolia 10-May-00 40 12.2 2.35E-01 47.00 120.00 1042 2.11E+09 33341 8.64E-02 36.8 5.06E-04 0.2 1.48E-01 63.0
N. Korea 20-Aug-00 202 61.4 1.49E+01 42.00 129.00 270 2.30E+09 200822 5.50E+00 36.8 3.22E-02 0.2 9.41E+00 63.0
Russia 02-Aug-00 324 98.5 9.24E+01 43.50 133.50 134 2.25E+09 34008 3.40E+01 36.8 1.99E-01 0.2 5.82E+01 63.0
S. Korea 11-Jan-00 156 47.4 3.63E+00 38.50 127.50 628 2.42E+09 292252 1.34E+00 36.8 7.81E-03 0.2 2.28E+00 63.0
Taiwan 29-Nov-00 32 9.7 6.71E-01 24.00 121.50 2322 2.82E+09 152461 2.47E-01 36.8 1.45E-03 0.2 4.22E-01 63.0
Thailand None      
Aleutians (U.S.) 23-Apr-00 172 52.3 2.05E-01 52.00 177.00 3464 1.91E+09 0 7.56E-02 36.8 4.43E-04 0.2 1.29E-01 63.0
Alaska (U.S.) 24-Mar-00 140 42.6 3.94E-01 60.00 210.00 5359 1.55E+09 1314 1.45E-01 36.8 8.49E-04 0.2 2.48E-01 63.0
Vietnam 29-Nov-00 1 0.3 1.01E-08 20.50 107.00 3416 2.89E+09 13869 3.72E-09 36.8 2.17E-11 0.2 6.35E-09 63.0
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 97.  VRS Worst-Case Sr-90 Maximum Total Dose Commitment per Maximum Individual (i.e., Infant) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 12-Jun-00 329 100.0 1.55E+01 43.50 133.50 134 2.25E+09 34008 1.52E+01 97.8 3.34E-01 2.2 3.27E-03 0.02
Transboundary** 07-Jun-00 329 100.0 4.08E+00 43.50 131.50 69 2.25E+09 42463 3.99E+00 97.8 8.77E-02 2.2 8.59E-04 0.02
Burma None      
China 07-Jun-00 259 78.7 4.08E+00 43.50 131.50 69 2.25E+09 42463 3.99E+00 97.8 8.77E-02 2.2 8.59E-04 0.02
Hong Kong 29-Nov-00 4 1.2 1.18E-06 22.50 114.50 2794 2.85E+09 125994 1.15E-06 97.8 2.53E-08 2.2 2.48E-10 0.02
Japan 16-Dec-00 316 96.0 2.25E+00 40.50 141.00 796 2.35E+09 358298 2.20E+00 97.8 4.84E-02 2.2 4.74E-04 0.02
Laos None      
Mongolia 10-May-00 36 10.9 3.91E-02 47.00 120.00 1042 2.11E+09 33341 3.83E-02 97.8 8.42E-04 2.2 8.24E-06 0.02
N. Korea 20-Aug-00 199 60.5 2.46E+00 42.00 129.00 270 2.30E+09 200822 2.41E+00 97.8 5.29E-02 2.2 5.18E-04 0.02
Russia 12-Jun-00 324 98.5 1.55E+01 43.50 133.50 134 2.25E+09 34008 1.52E+01 97.8 3.34E-01 2.2 3.27E-03 0.02
S. Korea 11-Jan-00 151 45.9 6.04E-01 38.50 127.50 628 2.42E+09 292252 5.90E-01 97.8 1.30E-02 2.2 1.27E-04 0.02
Taiwan 29-Nov-00 21 6.4 1.13E-01 24.00 121.50 2322 2.82E+09 152461 1.11E-01 97.8 2.43E-03 2.2 2.38E-05 0.02
Thailand None      
Aleutians (U.S.) 23-Apr-00 154 46.8 3.15E-02 52.00 177.00 3464 1.91E+09 0 3.08E-02 97.8 6.77E-04 2.2 6.63E-06 0.02
Alaska (U.S.) 25-Mar-00 119 36.2 2.17E-02 58.50 202.50 4986 1.62E+09 15 2.12E-02 97.8 4.66E-04 2.2 4.56E-06 0.02
Vietnam 29-Nov-00 1 0.3 2.29E-13 20.50 107.00 3416 2.89E+09 13869 2.24E-13 97.8 4.93E-15 2.2 4.83E-17 0.02
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 98.  VRS Worst-Case Sr-90 Maximum Total Dose Commitment per Adult Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 12-Jun-00 329 100.0 3.73E+00 43.50 133.50 134 2.25E+09 34008 3.34E+00 89.5 3.87E-01 10.4 3.27E-03 0.09
Transboundary** 07-Jun-00 329 100.0 9.80E-01 43.50 131.50 69 2.25E+09 42463 8.77E-01 89.5 1.02E-01 10.4 8.59E-04 0.09
Burma None      
China 07-Jun-00 259 78.7 9.80E-01 43.50 131.50 69 2.25E+09 42463 8.77E-01 89.5 1.02E-01 10.4 8.59E-04 0.09
Hong Kong 29-Nov-00 4 1.2 2.83E-07 22.50 114.50 2794 2.85E+09 125994 2.53E-07 89.5 2.94E-08 10.4 2.48E-10 0.09
Japan 16-Dec-00 316 96.0 5.41E-01 40.50 141.00 796 2.35E+09 358298 4.84E-01 89.5 5.62E-02 10.4 4.74E-04 0.09
Laos None      
Mongolia 10-May-00 36 10.9 9.40E-03 47.00 120.00 1042 2.11E+09 33341 8.41E-03 89.5 9.77E-04 10.4 8.24E-06 0.09
N. Korea 20-Aug-00 199 60.5 5.91E-01 42.00 129.00 270 2.30E+09 200822 5.29E-01 89.5 6.14E-02 10.4 5.18E-04 0.09
Russia 12-Jun-00 324 98.5 3.73E+00 43.50 133.50 134 2.25E+09 34008 3.34E+00 89.5 3.87E-01 10.4 3.27E-03 0.09
S. Korea 11-Jan-00 151 45.9 1.45E-01 38.50 127.50 628 2.42E+09 292252 1.30E-01 89.5 1.51E-02 10.4 1.27E-04 0.09
Taiwan 29-Nov-00 21 6.4 2.72E-02 24.00 121.50 2322 2.82E+09 152461 2.43E-02 89.5 2.82E-03 10.4 2.38E-05 0.09
Thailand None      
Aleutians (U.S.) 23-Apr-00 154 46.8 7.56E-03 52.00 177.00 3464 1.91E+09 0 6.77E-03 89.5 7.86E-04 10.4 6.63E-06 0.09
Alaska (U.S.) 25-Mar-00 119 36.2 5.21E-03 58.50 202.50 4986 1.62E+09 15 4.66E-03 89.5 5.41E-04 10.4 4.56E-06 0.09
Vietnam 29-Nov-00 1 0.3 5.51E-14 20.50 107.00 3416 2.89E+09 13869 4.93E-14 89.5 5.72E-15 10.4 4.83E-17 0.09
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 99.  VRS Worst-Case I-131 Maximum Total Dose Commitment per Maximum Individual (i.e., Infant) Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 12-Jun-00 329 100.0 3.76E-02 43.50 133.50 134 2.25E+09 34008 3.73E-02 99.2 2.17E-04 0.6 8.56E-05 0.2
Transboundary** 07-Jun-00 329 100.0 9.78E-03 43.50 131.50 69 2.25E+09 42463 9.70E-03 99.2 5.64E-05 0.6 2.23E-05 0.2
Burma None      
China 07-Jun-00 245 74.5 9.78E-03 43.50 131.50 69 2.25E+09 42463 9.70E-03 99.2 5.64E-05 0.6 2.23E-05 0.2
Hong Kong None      
Japan 20-Nov-00 270 82.1 1.86E-03 36.00 138.00 933 2.50E+09 405254 1.84E-03 99.2 1.07E-05 0.6 4.24E-06 0.2
Laos None      
Mongolia 21-Apr-00 5 1.5 4.17E-10 47.00 120.00 1042 2.11E+09 33341 4.14E-10 99.2 2.40E-12 0.6 9.50E-13 0.2
N. Korea 20-Aug-00 150 45.6 6.27E-03 42.00 129.00 270 2.30E+09 200822 6.22E-03 99.2 3.61E-05 0.6 1.43E-05 0.2
Russia 12-Jun-00 324 98.5 3.76E-02 43.50 133.50 134 2.25E+09 34008 3.73E-02 99.2 2.17E-04 0.6 8.56E-05 0.2
S. Korea 11-Jan-00 89 27.1 8.78E-04 37.50 129.00 662 2.45E+09 155901 8.71E-04 99.2 5.06E-06 0.6 2.00E-06 0.2
Taiwan None      
Thailand None      
Aleutians (U.S.) 07-Mar-00 25 7.6 5.27E-06 52.00 177.00 3464 1.91E+09 0 5.23E-06 99.2 3.04E-08 0.6 1.20E-08 0.2
Alaska (U.S.) 14-Nov-00 5 1.5 4.29E-18 55.00 198.00 4801 1.78E+09 46 4.25E-18 99.2 2.47E-20 0.6 9.76E-21 0.2
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 100.   VRS Worst-Case I-131 Maximum Total Dose Commitment per Age-Weighted Individual Estimates and Breakdown by Type 
 
Region 
 
Date 
 
N 
N 
(%) 
MaxTot 
(mSv) 
 
Lat 
 
Lon 
Dist
(km)
Area 
(m
2
) 
 
Pop 
Ingest 
(mSv) 
Ingest
(%) 
Inhalat 
(mSv) 
Inhalat 
(%) 
ExtExp 
(mSv) 
ExtExp
(%) 
Regional 12-Jun-00 329 100.0 4.39E-03 43.50 133.50 134 2.25E+09 34008 4.12E-03 93.8 1.87E-04 4.3 8.56E-05 1.9
Transboundary** 07-Jun-00 329 100.0 1.14E-03 43.50 131.50 69 2.25E+09 42463 1.07E-03 93.8 4.87E-05 4.3 2.23E-05 1.9
Burma None      
China 07-Jun-00 245 74.5 1.14E-03 43.50 131.50 69 2.25E+09 42463 1.07E-03 93.8 4.87E-05 4.3 2.23E-05 1.9
Hong Kong None      
Japan 20-Nov-00 270 82.1 2.17E-04 36.00 138.00 933 2.50E+09 405254 2.04E-04 93.8 9.26E-06 4.3 4.24E-06 1.9
Laos None      
Mongolia 21-Apr-00 5 1.5 4.88E-11 47.00 120.00 1042 2.11E+09 33341 4.57E-11 93.8 2.08E-12 4.3 9.50E-13 1.9
N. Korea 20-Aug-00 150 45.6 7.33E-04 42.00 129.00 270 2.30E+09 200822 6.88E-04 93.8 3.12E-05 4.3 1.43E-05 1.9
Russia 12-Jun-00 324 98.5 4.39E-03 43.50 133.50 134 2.25E+09 34008 4.12E-03 93.8 1.87E-04 4.3 8.56E-05 1.9
S. Korea 11-Jan-00 89 27.1 1.03E-04 37.50 129.00 662 2.45E+09 155901 9.63E-05 93.8 4.37E-06 4.3 2.00E-06 1.9
Taiwan None      
Thailand None      
Aleutians (U.S.) 07-Mar-00 25 7.6 6.17E-07 52.00 177.00 3464 1.91E+09 0 5.78E-07 93.8 2.62E-08 4.3 1.20E-08 1.9
Alaska (U.S.) 14-Nov-00 5 1.5 5.01E-19 55.00 198.00 4801 1.78E+09 46 4.70E-19 93.8 2.13E-20 4.3 9.76E-21 1.9
Vietnam None      
 
* Dist and Area represent the distance from the risk site to the maximum deposition and area impacted by the maximum deposition, respectively. 
** The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 101.  Maximum, Worst-Case Regional Dose Commitments for the Maximum Individual 
Compared to Reference Limits [17] 
 PRS* VRS* 
 Cs-137 (Teen) Sr-90 (Infant) I-131 (Infant) Cs-137 (Teen) Sr-90 (Infant) I-131 (Infant) 
Criterion Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
<0.15 mSv 2 0.6 47 14.4 323 100.0 1 0.3 20 6.1 329 100.0
<1.0 mSv 46 14.1 139 42.6 3 0.0 19 5.8 172 52.3 0 0.0
<10.0 mSv 180 55.2 135 41.4 0 0.0 209 63.5 133 40.4 0 0.0
<100.0 mSv 97 29.8 5 1.5 0 0.0 98 29.8 4 1.2 0 0.0
>100.0 mSv 1 0.3 0 0.0 0 0.0 2 0.6 0 0.0 0 0.0
Total 326 100.0 326 100.0 326 100.0 329 100.0 329 100.0 329 100.0
 
* As stated above, there were complete data (i.e., all 144 hours) for 326 and 329 out of 366 days of CY2000 for the 
PRS and VRS, respectively. 
 
Table 102.  Maximum, Worst-Case Regional Dose Commitments for Adults 
Compared to Reference Limits [17] 
 PRS* VRS* 
 Cs-137 (Adult) Sr-90 (Adult) I-131 (Weighted) Cs-137 (Adult) Sr-90 (Adult) I-131 (Weighted)
Criterion Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent 
<0.15 mSv 3 0.9 142 43.6 326 100.0 1 0.3 135 41.0 329 100.0
<1.0 mSv 47 14.4 152 46.6 0 0.0 20 6.1 169 51.4 0 0.0
<10.0 mSv 190 58.3 32 9.8 0 0.0 215 65.3 25 7.6 0 0.0
<100.0 mSv 86 26.4 0 0.0 0 0.0 93 28.3 0 0.0 0 0.0
>100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Total 326 100.0 326 100.0 326 100.0 329 100.0 329 100.0 329 100.0
 
* As stated above, there were complete data (i.e., all 144 hours) for 326 and 329 out of 366 days of CY2000 for the 
PRS and VRS, respectively. 
 
Table 103.  Maximum, Worst-Case Transboundary Dose Commitments for the Maximum Individual 
Compared to Reference Limits [17] 
 PRS* VRS* 
 Cs-137 (Teen) Sr-90 (Infant) I-131 (Infant) Cs-137 (Teen) Sr-90 (Infant) I-131 (Infant) 
Criterion Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
<0.15 mSv 168 51.5 303 92.9 326 100.0 1 0.3 67 20.4 329 100.0
<1.0 mSv 135 41.4 23 7.1 0 0.0 65 19.8 199 60.5 0 0.0
<10.0 mSv 23 7.1 0 0.0 0 0.0 234 71.1 63 19.1 0 0.0
<100.0 mSv 0 0.0 0 0.0 0 0.0 29 8.8 0 0.0 0 0.0
>100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Total 326 100.0 326 100.0 326 100.0 329 100.0 329 100.0 329 100.0
 
* As stated above, there were complete data (i.e., all 144 hours) for 326 and 329 out of 366 days of CY2000 for the 
PRS and VRS, respectively. 
 
Table 104.  Maximum, Worst-Case Transboundary Dose Commitments for Adults 
Compared to Reference Limits [17] 
 PRS* VRS* 
 Cs-137 (Adult) Sr-90 (Adult) I-131 (Weighted) Cs-137 (Adult) Sr-90 (Adult) I-131 (Weighted)
Criterion Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent 
<0.15 mSv 172 52.8 325 99.7 326 100.0 1 0.3 216 65.7 329 100.0
<1.0 mSv 138 42.3 1 0.3 0 0.0 75 22.8 113 34.3 0 0.0
<10.0 mSv 16 4.9 0 0.0 0 0.0 229 69.6 0 0.0 0 0.0
<100.0 mSv 0 0.0 0 0.0 0 0.0 24 7.3 0 0.0 0 0.0
>100.0 mSv 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Total 326 100.0 326 100.0 326 100.0 329 100.0 329 100.0 329 100.0
 
* As stated above, there were complete data (i.e., all 144 hours) for 326 and 329 out of 366 days of CY2000 for the 
PRS and VRS, respectively. 
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Table 105.    PRS Maximum Weighted Cs-137 Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 1-Jan 7.09E+03 2.75E+03 1.42E+01 4.33E+03 1.89E+12 1.38E+08 1-Jan 4.44E+03 1.72E+03 8.89E+00 2.71E+03 3.76E+11 2.70E+07 26-Apr 2.47E+03 9.56E+02 4.93E+00 1.50E+03 2.61E+11 4.89E+06
Transboundary* 1-Jan 6.57E+03 2.55E+03 1.31E+01 4.01E+03 1.02E+12 1.34E+08 1-Jan 3.98E+03 1.55E+03 7.97E+00 2.43E+03 2.20E+11 2.63E+07 26-Apr 2.37E+03 9.18E+02 4.73E+00 1.44E+03 1.50E+11 4.61E+06
Burma None      None   None   
China 4-Jan 1.66E+03 6.43E+02 3.31E+00 1.01E+03 1.48E+12 1.13E+08 7-Jan 8.05E+02 3.12E+02 1.61E+00 4.91E+02 7.78E+10 4.90E+06 7-Jan 5.49E+02 2.13E+02 1.10E+00 3.35E+02 4.46E+10 2.83E+06
Hong Kong None      None   None   
Japan 1-Jan 6.57E+03 2.55E+03 1.31E+01 4.01E+03 4.28E+11 9.75E+07 1-Jan 3.98E+03 1.55E+03 7.97E+00 2.43E+03 2.20E+11 2.63E+07 26-Apr 2.37E+03 9.18E+02 4.73E+00 1.44E+03 1.01E+11 4.61E+06
Laos None      None   None   
Mongolia 4-Jan 3.79E+00 1.47E+00 7.58E-03 2.31E+00 3.11E+11 3.43E+05 None   None   
N. Korea 7-Jan 2.02E+02 7.82E+01 4.03E-01 1.23E+02 1.72E+11 2.63E+07 7-Jan 1.54E+02 5.98E+01 3.09E-01 9.41E+01 9.09E+09 1.03E+06 7-Jan 8.67E+01 3.36E+01 1.73E-01 5.29E+01 4.53E+09 5.10E+05
Russia 14-Jun 2.05E+03 7.96E+02 4.11E+00 1.25E+03 1.76E+12 9.98E+05 14-Jun 2.04E+03 7.93E+02 4.09E+00 1.25E+03 2.84E+11 2.48E+05 14-Jun 2.04E+03 7.92E+02 4.08E+00 1.25E+03 2.63E+11 2.32E+05
S. Korea 5-Jan 2.32E+02 9.00E+01 4.64E-01 1.41E+02 1.52E+11 4.48E+07 None   None   
Taiwan None      None   None   
Thailand None      None   None   
Aleutians (U.S.) 24-Jan 5.26E+00 2.04E+00 1.05E-02 3.21E+00 5.29E+10 5.47E+03 24-Jan 5.17E+00 2.01E+00 1.04E-02 3.16E+00 4.19E+10 2.37E+03 24-Jan 5.17E+00 2.01E+00 1.04E-02 3.16E+00 4.19E+10 2.37E+03
Alaska (U.S.) 13-Oct 3.53E+02 1.37E+02 7.06E-01 2.15E+02 9.93E+11 4.61E+05 13-Oct 3.50E+02 1.36E+02 6.99E-01 2.13E+02 2.58E+11 3.08E+05 13-Oct 3.48E+02 1.35E+02 6.97E-01 2.12E+02 2.26E+11 2.98E+05
Vietnam None      None   None   
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 106.  PRS Maximum Weighted Cs-137 Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 14-Jun 1.99E+03 7.74E+02 3.99E+00 1.22E+03 1.37E+11 1.32E+05 14-Jun 1.67E+03 6.49E+02 3.35E+00 1.02E+03 7.05E+10 6.60E+04
Transboundary* 13-Oct 2.94E+02 1.14E+02 5.87E-01 1.79E+02 5.33E+10 1.99E+05 None    
Burma None      None    
China None      None    
Hong Kong None      None    
Japan None      None    
Laos None      None    
Mongolia None      None    
N. Korea None      None    
Russia 14-Jun 1.99E+03 7.74E+02 3.99E+00 1.22E+03 1.37E+11 1.32E+05 14-Jun 1.67E+03 6.49E+02 3.35E+00 1.02E+03 7.05E+10 6.60E+04
S. Korea None      None    
Taiwan None      None    
Thailand None      None    
Aleutians (U.S.) 24-Jan 5.05E+00 1.96E+00 1.01E-02 3.08E+00 1.53E+10 2.21E+03 None    
Alaska (U.S.) 13-Oct 2.94E+02 1.14E+02 5.87E-01 1.79E+02 5.33E+10 1.99E+05 None    
Vietnam None      None    
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 107.  PRS Maximum Weighted Sr-90 Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 1-Jan 3.69E+02 3.36E+02 3.35E+01 2.46E-01 1.23E+12 1.19E+08 14-Jun 1.06E+02 9.61E+01 9.59E+00 7.03E-02 1.29E+11 1.23E+05 14-Jun 1.05E+02 9.52E+01 9.51E+00 6.97E-02 1.20E+11 1.15E+05
Transboundary* 1-Jan 3.45E+02 3.13E+02 3.13E+01 2.29E-01 7.23E+11 1.16E+08 13-Oct 7.33E-01 6.66E-01 6.65E-02 4.88E-04 7.42E+09 7.19E+03 18-Feb 5.72E-02 5.20E-02 5.19E-03 3.81E-05 8.03E+09 3.45E+02
Burma None      None   None   
China 7-Jan 8.10E+01 7.36E+01 7.35E+00 5.39E-02 1.03E+12 7.61E+07 None   None   
Hong Kong None      None   None   
Japan 1-Jan 3.45E+02 3.13E+02 3.13E+01 2.29E-01 4.28E+11 9.75E+07 None   None   
Laos None      None   None   
Mongolia 4-Jan 1.74E-01 1.58E-01 1.58E-02 1.16E-04 3.11E+11 3.43E+05 None   None   
N. Korea 7-Jan 9.82E+00 8.92E+00 8.91E-01 6.53E-03 1.27E+11 1.42E+07 None   None   
Russia 14-Jun 1.09E+02 9.94E+01 9.92E+00 7.28E-02 1.73E+12 9.94E+05 14-Jun 1.06E+02 9.61E+01 9.59E+00 7.03E-02 1.29E+11 1.23E+05 14-Jun 1.05E+02 9.52E+01 9.51E+00 6.97E-02 1.20E+11 1.15E+05
S. Korea 5-Jan 5.18E+00 4.70E+00 4.70E-01 3.44E-03 1.49E+11 4.48E+07 None   None   
Taiwan None      None   None   
Thailand None      None   None   
Aleutians (U.S.) 24-Jan 2.37E-01 2.16E-01 2.15E-02 1.58E-04 5.29E+10 5.47E+03 24-Jan 2.00E-01 1.82E-01 1.82E-02 1.33E-04 1.14E+10 1.79E+03 None   
Alaska (U.S.) 13-Oct 1.51E+01 1.37E+01 1.37E+00 1.01E-02 8.69E+11 4.54E+05 13-Oct 7.33E-01 6.66E-01 6.65E-02 4.88E-04 7.42E+09 7.19E+03 18-Feb 5.72E-02 5.20E-02 5.19E-03 3.81E-05 8.03E+09 3.45E+02
Vietnam None      None   None   
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 108.  PRS Maximum Weighted Sr-90 Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Mar 7.16E+01 6.51E+01 6.50E+00 4.76E-02 3.97E+10 3.33E+04
Transboundary* None      
Burma None      
China None      
Hong Kong None      
Japan None      
Laos None      
Mongolia None      
N. Korea None      
Russia 21-Mar 7.16E+01 6.51E+01 6.50E+00 4.76E-02 3.97E+10 3.33E+04
S. Korea None      
Taiwan None      
Thailand None      
Aleutians (U.S.) None      
Alaska (U.S.) None      
Vietnam None      
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 109.  PRS Maximum Weighted I-131 Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person  Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp 
(per-Sv) 
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop 
  
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop
Regional 14-Jun 6.54E-02 6.14E-02 2.78E-03 1.27E-03 2.99E+11 2.54E+05  
Transboundary* 1-Jan 1.29E-03 1.21E-03 5.49E-05 2.51E-05 8.04E+10 3.63E+06  
Burma None       
China 4-Dec 7.05E-10 6.61E-10 3.00E-11 1.37E-11 5.62E+11 2.16E+07  
Hong Kong None       
Japan 1-Jan 1.29E-03 1.21E-03 5.49E-05 2.51E-05 8.04E+10 3.63E+06  
Laos None       
Mongolia None       
N. Korea None       
Russia 14-Jun 6.54E-02 6.14E-02 2.78E-03 1.27E-03 2.99E+11 2.54E+05  
S. Korea None       
Taiwan None       
Thailand None       
Aleutians (U.S.) 20-Jan 4.31E-05 4.04E-05 1.83E-06 8.39E-07 5.29E+10 5.47E+03  
Alaska (U.S.) 12-Oct 1.23E-06 1.15E-06 5.23E-08 2.39E-08 5.47E+10 3.10E+03  
Vietnam None      
No dose commitments at this  
threshold value 
 
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 110.  PRS Maximum Weighted I-131 Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp 
(per-Sv) 
Area
(m2) 
 
Pop
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop
Regional 
Transboundary* 
Burma 
China 
Hong Kong 
Japan 
Laos 
Mongolia 
N. Korea 
Russia 
S. Korea 
Taiwan 
Thailand 
Aleutians (U.S.) 
Alaska (U.S.) 
Vietnam 
No dose commitments at this  
threshold value 
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 111.  VRS Maximum Weighted Cs-137 Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Nov 1.96E+05 7.59E+04 3.91E+02 1.19E+05 2.10E+12 2.70E+08 21-Nov 1.95E+05 7.57E+04 3.90E+02 1.19E+05 6.49E+11 1.39E+08 21-Nov 1.95E+05 7.56E+04 3.90E+02 1.19E+05 6.08E+11 1.36E+08
Transboundary* 21-Nov 1.95E+05 7.58E+04 3.91E+02 1.19E+05 1.21E+12 2.69E+08 21-Nov 1.95E+05 7.56E+04 3.90E+02 1.19E+05 6.26E+11 1.38E+08 21-Nov 1.95E+05 7.55E+04 3.89E+02 1.19E+05 5.94E+11 1.36E+08
Burma None      None   None   
China 9-May 1.72E+05 6.65E+04 3.43E+02 1.05E+05 1.71E+12 2.17E+08 9-May 1.71E+05 6.63E+04 3.42E+02 1.04E+05 7.09E+11 9.67E+07 9-May 1.71E+05 6.62E+04 3.41E+02 1.04E+05 6.35E+11 9.43E+07
Hong Kong 12-Sep 3.78E+01 1.47E+01 7.57E-02 2.31E+01 5.70E+09 5.42E+06 None   None   
Japan 21-Nov 1.90E+05 7.37E+04 3.80E+02 1.16E+05 6.37E+11 1.25E+08 21-Nov 1.90E+05 7.36E+04 3.80E+02 1.16E+05 5.70E+11 1.17E+08 21-Nov 1.89E+05 7.35E+04 3.79E+02 1.16E+05 5.41E+11 1.15E+08
Laos None      None   None   
Mongolia 10-May 3.21E+01 1.24E+01 6.42E-02 1.96E+01 4.06E+11 4.77E+05 10-May 2.88E+01 1.12E+01 5.75E-02 1.75E+01 1.24E+11 1.61E+05 10-May 2.22E+01 8.63E+00 4.45E-02 1.36E+01 8.05E+10 1.07E+05
N. Korea 12-Sep 4.97E+04 1.93E+04 9.94E+01 3.03E+04 1.84E+11 2.76E+07 12-Sep 4.95E+04 1.92E+04 9.91E+01 3.02E+04 1.80E+11 2.56E+07 12-Sep 4.95E+04 1.92E+04 9.91E+01 3.02E+04 1.77E+11 2.56E+07
Russia 2-Aug 3.23E+04 1.25E+04 6.46E+01 1.97E+04 6.64E+11 6.09E+06 2-Aug 3.23E+04 1.25E+04 6.45E+01 1.97E+04 3.70E+11 4.58E+06 2-Aug 3.22E+04 1.25E+04 6.44E+01 1.96E+04 3.56E+11 3.99E+06
S. Korea 27-Sep 4.87E+04 1.89E+04 9.75E+01 2.97E+04 1.52E+11 4.48E+07 27-Sep 4.87E+04 1.89E+04 9.75E+01 2.97E+04 1.49E+11 4.48E+07 27-Sep 4.87E+04 1.89E+04 9.75E+01 2.97E+04 1.49E+11 4.48E+07
Taiwan 29-Nov 6.35E+03 2.46E+03 1.27E+01 3.88E+03 6.49E+10 2.17E+07 29-Nov 6.35E+03 2.46E+03 1.27E+01 3.88E+03 6.49E+10 2.17E+07 29-Nov 6.35E+03 2.46E+03 1.27E+01 3.88E+03 6.49E+10 2.17E+07
Thailand None      None   None   
Aleutians (U.S.) 6-Mar 3.31E-01 1.29E-01 6.63E-04 2.02E-01 5.29E+10 5.47E+03 7-Mar 5.84E-02 2.27E-02 1.17E-04 3.56E-02 1.14E+10 5.29E+02 None   
Alaska (U.S.) 24-Mar 3.67E+01 1.42E+01 7.34E-02 2.24E+01 1.01E+12 4.66E+05 24-Mar 2.82E+01 1.09E+01 5.64E-02 1.72E+01 5.80E+10 2.01E+05 24-Mar 5.17E+00 2.01E+00 1.03E-02 3.15E+00 2.67E+10 2.54E+04
Vietnam 29-Nov 1.44E-07 5.60E-08 2.89E-10 8.81E-08 2.89E+09 1.39E+04 None   None   
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 112.  VRS Maximum Weighted Cs-137 Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp 
(per-Sv) 
Area 
(m2) 
 
Pop 
Regional 21-Nov 1.69E+05 6.54E+04 3.37E+02 1.03E+05 2.32E+11 7.80E+07 2-Aug 2.55E+04 9.90E+03 5.10E+01 1.56E+04 4.48E+10 6.19E+05
Transboundary* 21-Nov 1.68E+05 6.54E+04 3.37E+02 1.03E+05 2.23E+11 7.79E+07 7-Jun 1.25E+04 4.86E+03 2.51E+01 7.65E+03 2.03E+10 9.30E+05
Burma None      None    
China 9-May 1.58E+05 6.12E+04 3.16E+02 9.62E+04 3.78E+11 6.91E+07 1-Jan 9.72E+03 3.77E+03 1.94E+01 5.93E+03 1.80E+10 7.21E+05
Hong Kong None      None    
Japan 21-Nov 1.68E+05 6.54E+04 3.37E+02 1.03E+05 2.23E+11 7.79E+07 16-Dec 1.10E+04 4.27E+03 2.20E+01 6.71E+03 7.08E+09 9.41E+05
Laos None      None    
Mongolia None      None    
N. Korea 7-Jun 4.16E+04 1.61E+04 8.31E+01 2.53E+04 9.55E+10 8.97E+06 20-Aug 9.85E+03 3.82E+03 1.97E+01 6.01E+03 9.22E+09 8.47E+05
Russia 2-Aug 3.14E+04 1.22E+04 6.29E+01 1.92E+04 2.31E+11 2.57E+06 2-Aug 2.55E+04 9.90E+03 5.10E+01 1.56E+04 4.48E+10 6.19E+05
S. Korea 15-Nov 3.37E+04 1.31E+04 6.75E+01 2.06E+04 5.64E+10 2.29E+07 None    
Taiwan None      None    
Thailand None      None    
Aleutians (U.S.) None      None    
Alaska (U.S.) None      None    
Vietnam None      None    
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 113.  VRS Maximum Weighted Sr-90 Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date 
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat 
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 21-Nov 9.68E+03 8.80E+03 8.78E+02 6.44E+00 1.84E+12 2.40E+08 30-Jan 6.22E+03 5.65E+03 5.64E+02 4.14E+00 7.26E+10 3.70E+07 30-Jan 3.92E+03 3.56E+03 3.56E+02 2.61E+00 4.77E+10 1.91E+07
Transboundary* 21-Nov 9.67E+03 8.78E+03 8.77E+02 6.43E+00 1.10E+12 2.39E+08 30-Jan 6.22E+03 5.65E+03 5.64E+02 4.14E+00 7.26E+10 3.70E+07 30-Jan 3.92E+03 3.56E+03 3.56E+02 2.61E+00 4.77E+10 1.91E+07
Burma None      None   None   
China 9-May 8.53E+03 7.75E+03 7.73E+02 5.67E+00 1.55E+12 1.91E+08 9-May 5.23E+03 4.76E+03 4.75E+02 3.48E+00 1.97E+11 3.57E+07 30-Aug 2.74E+03 2.49E+03 2.48E+02 1.82E+00 1.21E+11 1.30E+07
Hong Kong 29-Nov 1.08E-03 9.84E-04 9.82E-05 7.20E-07 5.70E+09 5.42E+06 None   None   
Japan 21-Nov 9.55E+03 8.67E+03 8.66E+02 6.35E+00 6.28E+11 1.25E+08 30-Jan 6.22E+03 5.65E+03 5.64E+02 4.14E+00 7.26E+10 3.70E+07 30-Jan 3.92E+03 3.56E+03 3.56E+02 2.61E+00 4.77E+10 1.91E+07
Laos None      None   None   
Mongolia 10-May 1.38E+00 1.25E+00 1.25E-01 9.18E-04 3.86E+11 4.43E+05 None   None   
N. Korea 12-Sep 2.53E+03 2.29E+03 2.29E+02 1.68E+00 1.84E+11 2.76E+07 12-Sep 1.92E+03 1.74E+03 1.74E+02 1.28E+00 9.08E+10 8.71E+06 7-Jun 1.72E+03 1.56E+03 1.56E+02 1.14E+00 5.55E+10 4.66E+06
Russia 2-Aug 1.64E+03 1.49E+03 1.49E+02 1.09E+00 6.64E+11 6.09E+06 2-Aug 1.55E+03 1.41E+03 1.41E+02 1.03E+00 1.62E+11 1.93E+06 2-Aug 1.49E+03 1.36E+03 1.36E+02 9.94E-01 1.13E+11 1.45E+06
S. Korea 27-Sep 2.48E+03 2.25E+03 2.25E+02 1.65E+00 1.52E+11 4.48E+07 11-Jan 3.67E+02 3.34E+02 3.33E+01 2.44E-01 2.93E+10 2.64E+06 11-Jan 1.32E+02 1.20E+02 1.20E+01 8.78E-02 7.30E+09 7.37E+05
Taiwan 29-Nov 3.28E+02 2.98E+02 2.98E+01 2.18E-01 6.49E+10 2.17E+07 None   None   
Thailand None      None   None   
Aleutians (U.S.) 6-Mar 9.57E-03 8.69E-03 8.68E-04 6.36E-06 5.29E+10 5.47E+03 None   None   
Alaska (U.S.) 25-Mar 2.52E-01 2.29E-01 2.29E-02 1.68E-04 8.62E+11 3.78E+05 None   None   
Vietnam 29-Nov 1.01E-12 9.15E-13 9.13E-14 6.70E-16 2.89E+09 1.39E+04 None   None   
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 114.  VRS Maximum Weighted Sr-90 Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
 Threshold of 1.0 mSv per person Threshold of 10.0 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
Regional 2-Aug 1.27E+03 1.15E+03 1.15E+02 8.42E-01 4.03E+10 5.52E+05
Transboundary* 14-Jun 1.30E+02 1.18E+02 1.18E+01 8.64E-02 4.36E+09 1.25E+05
Burma None      
China 14-Jun 1.30E+02 1.18E+02 1.18E+01 8.64E-02 4.36E+09 1.25E+05
Hong Kong None      
Japan None      
Laos None      
Mongolia None      
N. Korea None      
Russia 2-Aug 1.27E+03 1.15E+03 1.15E+02 8.42E-01 4.03E+10 5.52E+05
S. Korea None      
Taiwan None      
Thailand None      
Aleutians (U.S.) None      
Alaska (U.S.) None      
Vietnam None      
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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Table 115.  VRS Maximum Weighted I-131 Collective Dose Estimates for Threshold Values of 0.0, 0.1 and 0.15 mSv 
 No Threshold Threshold of 0.1 mSv per person  Threshold of 0.15 mSv per person 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area 
(m2) 
 
Pop 
  
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop
Regional 30-Jan 3.56E+00 3.34E+00 1.51E-01 6.93E-02 2.37E+11 8.58E+07  
Transboundary* 30-Jan 3.56E+00 3.34E+00 1.51E-01 6.93E-02 2.25E+11 8.57E+07  
Burma None       
China 10-May 3.05E+00 2.86E+00 1.30E-01 5.94E-02 8.68E+11 1.04E+08  
Hong Kong None       
Japan 30-Jan 3.56E+00 3.34E+00 1.51E-01 6.93E-02 2.25E+11 8.57E+07  
Laos None       
Mongolia 21-Apr 1.96E-09 1.84E-09 8.35E-11 3.82E-11 1.48E+10 4.92E+04  
N. Korea 14-Sep 1.58E+00 1.48E+00 6.72E-02 3.07E-02 1.84E+11 2.76E+07  
Russia 12-Jun 1.15E+00 1.08E+00 4.91E-02 2.25E-02 3.06E+11 4.29E+06  
S. Korea 15-Sep 1.70E+00 1.59E+00 7.22E-02 3.31E-02 1.47E+11 4.48E+07  
Taiwan None       
Thailand None       
Aleutians (U.S.) 14-Nov 8.20E-09 7.69E-09 3.49E-10 1.60E-10 4.73E+10 5.47E+03  
Alaska (U.S.) 14-Nov 8.57E-20 8.03E-20 3.65E-21 1.67E-21 3.66E+10 2.16E+03  
Vietnam None      
No dose commitments at this  
threshold value 
 
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
 
Table 116.  VRS Maximum Weighted I-131 Collective Dose Estimates for Threshold Values of 1.0 and 10.0 mSv 
  
Date 
Total 
(per-Sv) 
Ingest 
(per-Sv) 
Inhalat 
(per-Sv) 
ExtExp 
(per-Sv) 
Area
(m2) 
 
Pop
 
Date
Total 
(per-Sv)
Ingest 
(per-Sv)
Inhalat
(per-Sv)
ExtExp
(per-Sv)
Area
(m2)
 
Pop
Regional 
Transboundary* 
Burma 
China 
Hong Kong 
Japan 
Laos 
Mongolia 
N. Korea 
Russia 
S. Korea 
Taiwan 
Thailand 
Aleutians (U.S.) 
Alaska (U.S.) 
Vietnam 
No dose commitments at this  
threshold value 
No dose commitments at this  
threshold value 
 
* The transboundary region includes all land areas (i.e., excluding ocean) outside of Russia.  
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10 List of Symbols 
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Symbol Definition 
A0 Environmental input 
Aj,td  Least-squares parameter from linear regression 
AREA  Area of contaminated zone (m**2) 
BRDL  Basic radiation dose limit (mSv/yr) 
COVER0  Cover depth (m) 
Cs137j(tp) Value of the corresponding Cs-137 parameter at either the same or previous time (or tp ≤ 
td) that provides the best least-squares fit 
Dc UNSCEAR dose commitment for a specific radionuclide 
DENSCZ  Density of contaminated zone (g/cm**3) 
DIET(1)  Fruits, vegetables and grain consumption (kg/yr) 
DIET(2)  Leafy vegetable consumption (kg/yr) 
DIET(3)  Milk consumption (L/yr) 
DIET(4)  Meat and poultry consumption (kg/yr) 
DIET(5)  Fish consumption (kg/yr) 
DIET(6)  Other seafood consumption (kg/yr) 
DWI  Drinking water intake (L/yr) 
ED  Exposure duration 
FIND  Fraction of time spent indoors 
FOTD  Fraction of time spent outdoors (on site) 
INHALR  Inhalation rate (m**3/yr) 
P01 The integrated concentration of a radionuclide in the air at a given location or averaged 
for a broader region divided by the amount released, A0 
P12 Ground deposition velocity 
P14 Average breathing rate 
P23 Transfer from deposition to diet 
P234 P23P34 for ingestion of I-131 
P2345 P23P34P45 for ingestion 
P245 (P14P45)/P12 for inhalation 
P25 Transfer coefficients for external irradiation due to ground contamination to effective 
committed dose 
P34 Coefficient linking the concentrations of radionuclides in diet to those in the body 
P45 Effective committed dose per unit intake for the ingestion of a given radinuclide 
pi Fractional population 
Ri Indoor occupancy rate 
S1( 1)  Initial principal radionuclide (Bq/g): Cs-137 
Sf (1-Ri) + (Ri)(Sh) 
  184 
Symbol Definition 
Sh Shielding factor 
SHF1  Shielding factor, external gamma 
SHF3  Shielding factor, inhalation 
SOIL  Soil ingestion rate (g/yr) 
t1/2 Half-life 
THICK0  Thickness of contaminated zone (m) 
VCZ  Contaminated zone erosion rate (m/yr) 
Xj(td) Value of the parameter represented by j (i.e., j = wdep, ddep, or integrated concentration) 
at the desired time, td 
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11 List of Acronyms 
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CERCLA Comprehensive Environmental Response, Compensation, and Liability Act  
CY2000 Calendar Year 2000 
ddep Dry deposition 
DERMA Danish Emergency Response Model of the Atmosphere 
DMI Danish Meterological Institute 
DOE U.S. Department of Energy 
ECMWF European Center for Medium-Range Weather Forecasts 
EPA Environmental Protection Agency 
FARECS Assessment of Impact of Russian Nuclear Fleet Operations on Russian Far East Coastal 
Regions 
FGR Federal Guidance Report  
GPW Gridded Population of the World 
ICRP International Commission on Radiological Protection 
IIASA International Institute forApplied Systems Analysis 
NARP Nordic Arctic Research Programme 
NATO  North Atlantic Treaty Organisation 
NRC U.S. Nuclear Regulatory Commission 
NRS Nuclear Risk Site 
NS Nuclear Submarine  
PRS Petropavlovsk Risk Site 
RAD Radiation Safety of the Biosphere 
RESRAD RESidual RADioactivity 
SFA Spent Fuel Assembly  
SFA Spent Fuel Assembly 
tdep Total deposition 
UNFAO Food and Agricultural Organization of the United Nations 
UNSCEAR United Nations Scientific Committee on the Effects of Atomic Radiation 
VRS Vladivostok Risk Site 
wdep Wet deposition 
 
